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Breast cancer will affect one in every nine Canadian women during their lifetime. As diagnostic and 
treatment methods improve, survival rates are approaching 90%. However, an alarming 30-82% of 
survivors suffer from persistent upper limb morbidity as a result of their cancer treatments (Kwan, 
Jackson, Weir, Dingee, McGregor, & Olivotto, 2002; Lauridsen, Overgaard, Overgaard, Hessov, & 
Cristiansen, 2008; Rietman, Dijkstra, Debreczeni, Geertzen, Robinson, & De Vries, 2004). These 
persistent disabilities compromise function and quality of life, hindering survivors from returning to 
work and leading functional and independent lives. In order to prevent and rehabilitate upper limb 
morbidities, quantification of the physical capabilities of this population must occur.  
This thesis quantified the upper limb physical capabilities and limitations of breast cancer 
survivors by producing the most comprehensive collection of 3-D kinematics, muscle activation 
patterns, muscle-specific strength, and quality of life and disability measures during a wide range of 
functional tasks. Compared to the contralateral limb, the affected side demonstrated reduced humeral 
elevation (-6.5°) and external rotation angles (-8.9°), increased humeral internal rotation (+13.1°), 
reduced scapular protraction (-3.9°) (although both sides demonstrated protraction), increased 
upward rotation (+2.8°) and increased posterior tilting (+4.1°) of the scapula. These relationships 
varied with the task being performed. Muscle activation patterns revealed increased total muscle 
effort on the affected side during work tasks (p = 0.0258), and reductions in pectoralis major sternal 
activation (p<0.0001 – p = 0.0230). Increased muscle effort, weakness and discomfort levels were 
evident in both primary and secondary muscles (muscles outside the field of surgery and radiation).  
Humeral internal (IR) and external rotation (ER) co-activation was defined in both healthy 
(H) and breast cancer survivor populations (BCP) (H: r
2
 = 0.70 (IR) and 0.35 (ER); BCP: r
2
 = 0.77 
(IR) and 0.77 (ER)). Humeral abduction angle and task intensity were important factors in the 
prediction of co-activation in both populations. Inclusion of physiological cross-sectional area 
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(PCSA) weightings did not sufficiently improve the representation of co-activation in the healthy 
population. Healthy co-activation relationships were successfully extrapolated to a novel set of IR 
exertions (r
2 
= 0.76 IR exertions; r
2 
= 0.40 ER exertions). Comparisons made between populations 
identified differing muscle strategies used by survivors to maintain glenohumeral joint stability. 
Compared to healthy population co-activation, the survivors demonstrated greater activation of IR 
and ER muscles during their respective rotation type. Survivors demonstrated increased (≤8.7%) 
activation of pectoralis major muscle activation compared to the healthy population. 
An optimization-based muscle force prediction model was used to reflect specific muscle 
dysfunction of the pectoralis major muscles, and population-specific co-activation was enforced as a 
constraint. Empirically measured EMG was more closely associated to muscle force predictions of 
external rotator muscles (r = 0.567) than internal rotator muscles (r = 0.347). Model predictions were 
influenced by exertion type, co-activation constraint, hand force and pectoralis major capability 
constraints. The model predicted muscle forces more closely to empirical measurements of activation 
when the co-activation constraint was enforced, emphasizing the importance of consideration of 
antagonistic muscle activation in biomechanical modeling. 
This comprehensive description of physical capabilities of the breast cancer population has 
never been performed in such detail. This body of work has furthered the knowledge available 
regarding the capacity and functional limitations of survivors and preliminary recommendations 
regarding therapeutic treatment and directions for future works have been suggested. The continued 
development of this research and future application of interventions designed to address these 
disabilities will promote the eventual return to function and work of survivors through targeted 
rehabilitation and treatment strategies. Development of effective rehabilitation and prevention 
strategies could potentially lower the social and economic burdens of survivor aftercare and 
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Chapter 1 Introduction 
Breast cancer is a disease that often strikes women in their prime, compromising their ability to lead 
rich, productive lives as a result of persistent disability related to complications of the disease and its 
treatment. These persistent disabilities compromise quality of life, and arguably question successful 
survivorship status when resulting in such blatant and disruptive dysfunction. The first necessary step 
towards improving function and return to work of this valuable working population is comprehensive 
documentation of the physical capabilities of breast cancer survivors. This thesis seeks to do this 
with unprecedented quality and thoroughness, providing a strong basis for future rehabilitative and 
preventative ergonomics strategies to help improve the lives of those persons who have survived 
breast cancer. It is desired to make the post-cancer years count more for these affected women. 
Doing so will have the potential to generate profound social and economic benefits for Ontario and 
world-wide. 
Section 1.1 Breast cancer statistics and impact on life 
Breast cancer is the most common cancer among Canadian women (excluding non-melanoma skin 
cancer), and each year 24,400 women will be diagnosed with it and 5,000 will die from it (Canadian 
Cancer Society, 2014). Almost 9,000 of these new cases will be diagnosed in Ontario alone 
(Canadian Cancer Society's Steering Committee, 2010). The 5-year survival rate is 88% (Canadian 
Cancer Society, 2014) and amongst survivors there is a 30 - 82% prevalence of long term upper limb 
morbidity, most commonly including reduced range of motion (ROM), weakness, pain, swelling and 
numbness (Kwan, Jackson, Weir, Dingee, McGregor, & Olivotto, 2002; Lauridsen, Overgaard, 
Overgaard, Hessov, & Cristiansen, 2008; Maycock, Dillon, & Dixon, 1998; Rietman, Dijkstra, 
Debreczeni, Geertzen, Robinson, & De Vries, 2004). The prevalence of decreased ROM ranges from 
2 to 51% with severe restrictions (greater than 50% reduction) in 2% of patients (Rietman, et al., 
2003). Survivors also experience decreased functional capacity, meaning they exert more effort 
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relative to their maximal ability to perform usual activities, therefore leading to higher levels of 
fatigue (Mock, et al., 2005). Cancer treatment side effects can last days, months, and even years 
(Hsieh, Sprod, Hydock, Carter, Hayward, & Schneider, 2008). These impairments interfere with 
survivors’ ability to perform activities of daily life (ADL) and return to work, and negatively affect 
quality of life (QoL) (Markes, Brockow, & Resch, 2006; Rietman, et al., 2003). Only 28% of new 
breast cancer cases are in women older than 69 years, indicating that the majority (72%) of diagnoses 
occur in the workforce-age population (Canadian Cancer Society's Steering Committee, 2010), 
effectively influencing the workforce across sectors and skill levels. As diagnostic and treatment 
techniques improve and survival rates increase, long-term adverse effects of adjuvant treatments are 
becoming more important as they may influence ADL and QoL (Nikander, Sievanen, Ojala, 
Oivanen, Kellokumpu-Lehtinen, & Saarto, 2007; Rietman, Dijkstra, Debreczeni, Geertzen, 
Robinson, & De Vries, 2004). 
  Chronic arm morbidity is relatively understudied and is one of the most troublesome long-
term complications of breast cancer treatments (Kwan, Jackson, Weir, Dingee, McGregor, & 
Olivotto, 2002). As the survival rates increase, more research needs to focus on life after diagnosis 
and treatment (Sandel, Judge, Landry, Faria, Ouellette, & Majczak, 2005). Upper limb morbidity has 
rarely been accurately documented (Thompson, Air, Jack, Kerr, Rodger, & Chetty, 1995), and few 
have investigated the mechanisms of change associated with these morbidities (Courneya K. S., 
Mackey, Bell, Jones, Field, & Fairey, 2003). Late morbidity (symptoms appear some time after 
treatment is complete) interferes with ADL and QoL, but the relationships between impairments, 
disability, performance of tasks and QoL of breast cancer patients have only scarce documentation 
(Rietman, et al., 2003; Rietman, Dijkstra, Debreczeni, Geertzen, Robinson, & De Vries, 2004). 
Current quantitative measures of physical capacity of breast cancer populations (BCPs) consist of 
basic evaluations that thwart meaningful interpretations. Variability is high in assessments of 
impairments, and no uniform criteria exist for ROM, muscle strength, pain and arm volume measures 
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(Rietman, et al., 2003). Further, muscle coordination, muscle specific strength measures and 3-D 
kinematic assessments of this population during ADL and work tasks have not been assessed. This 
stark lack of description of upper limb disability requires immediate attention. 
Section 1.2 Dissertation overview and context 
Upper limb dysfunction within the BCP has not been systematically evaluated, which has limited 
development of specific and effective preventative and treatment strategies to promote healthy return 
to function and work. A prerequisite for creating these strategies is population physical capability 
description. This thesis will describe upper limb capacities and dysfunctions in a female BCP in 
terms of kinematics, muscle coordination and strength during ROM, ADL and work activities. These 
findings will be compared between unaffected (non-cancer) and affected (cancer-affected) sides. 
Further, a previously developed theoretical shoulder model will be adjusted to reflect proposed 
survivor changes in specific muscular capacity in attempt to improve predicted muscle forces. An 
accurate muscle force prediction model could assist in assessing return-to-work readiness. 
This research will also act as a foundation for future research projects, which will ultimately 
improve the eventual return to work of the BCP through improved rehabilitation and treatment 
strategies. Future studies will also evolve follow-up assessments of capability to assess effective and 
sustainability of integration into the workspace, as well as general longitudinal recovery. Progression 
of these future studies is outlined in Figure 1. Development of effective rehabilitation and reduction 
of symptoms could potentially lower the social and economic burdens of survivor aftercare and 
dramatically enhance quality of life. Improving the health of this population will allow these 










Section 1.3 Global thesis objectives & hypotheses 
This thesis is made up of four studies that seek to investigate eight major objectives with associated 
hypotheses, as described below and illustrated in Figure 2. 
 
Study 1 - Quantification of upper limb capabilities and dysfunction of breast cancer survivors, and 
relationship to quality of life (QoL) and performance of activities of daily living (ADL) and work 
tasks 
Objectives: 
1. Describe the upper limb capabilities and dysfunction of the BCP in terms of 3-D upper limb 
kinematics (specifically, motions of the humerus and scapula with respect to the thorax), 
muscle activation patterns (electromyography), and muscle-specific strength (force). 
2. Determine relationships between total muscle effort (a physical muscle activation quantity of 
(dys)function) with subjective measures of function (QoL and disability scores) during 
ROM, ADL and work task performance. 
 
The hypotheses of this study are as follows: 
1. Three-dimensional kinematic description of the BCP will indicate reduced elevation angles 
and reduced external rotation range of motion, but increased scapular protraction range of 
motion on the affected side compared to the contralateral limb. 
Past literature have reported reduced humeral abduction and flexion ROM (Hack, Cohen, Katz, 
Robson, & Goss, 1999; Isaksson & Feuk, 2000; Kuehn, et al., 2000; Rietman, Dijkstra, Debreczeni, 
Geertzen, Robinson, & De Vries, 2004; Swedborg & Wallgren, 1981), reduced external rotation 
ROM (Rietman, Dijkstra, Debreczeni, Geertzen, Robinson, & De Vries, 2004; Swedborg & 
Wallgren, 1981), and increased scapular winging (protraction) (Lauridsen, Torsleff, Husted, & 
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Erichsen, 2000) amongst the BCP. These measures have been recorded manually with goniometry 
and inclinometer tools or have been reported via clinicians’ visual assessment. Two studies have 
recorded 3-D scapulothoracic kinematics with electromagnetic tracking, and have reported increase 
in scapular protraction on the affected side of survivors (Borstad & Szucs, 2012; Shamley, 
Srinaganathan, Oskrochi, Lascurain-Aguirrebena, & Sugden, 2009). 
 
2. The BCP will demonstrate reduced strength and increased muscle activity (enhanced EMG 
amplitude) on the affected side when performing muscle specific strength tests, ROM, ADL 
and work tasks compared to their unaffected side.  
Reductions in strength are commonly reported amongst the BCP (Isaksson & Feuk, 2000; Kuehn, et 
al., 2000; Rietman, et al., 2003), but often measures include subjective reports or quantitative 
measures of grip strength. Quantification of muscle-specific weakness is scarce amongst the BCP. 
Discrepancies exist even between the two groups that reported muscle activation in survivors. 
Shamley et al. (2007) reported decreased activation of the pectoralis minor, upper trapezius and 
rhomboid on the affected side during scaption; whereas increased activation of the upper trapezius 
was found in survivors performing a functional writing task by Galiano-Castillo et al. (2011). Later, 
Shamley et al. (2012) re-examined normalized muscle activity of pectoralis major, serratus anterior, 
rhomboids and upper trapezius during scaption of a BCP with mastectomy or wide local excision. 
With the exception of upper trapezius in the mastectomy group, the authors reported an increase in 
activity of all muscles on the left affected side of patients with either mastectomy or wide local 
excision compared to the left side of a healthy control group; and reported greater activation of the 
upper trapezius, rhomboids and serratus on the right affected side of patients with mastectomy 
compared to the right side of a healthy control, suggesting the BCP was working at a higher level of 
percent capability. Shamley et al. (2012) also reported a decrease in pectoralis major activity and an 




3. As physical data indicates increased dysfunction (increased total muscle effort), there will be 
decreased QoL scores (FACT-B) and increased disability scores (QuickDASH). 
The number of chronic symptoms of late morbidity of the BCP has been significantly correlated with 
anxiety and depression levels (Rietman, Dijkstra, Debreczeni, Geertzen, Robinson, & De Vries, 
2004). Decreased muscular activity of the upper trapezius and rhomboid muscles have been 
associated with increased Shoulder Pain and Disability Index scores in the BCP (Shamley, et al., 
2007). Box et al. (2002) reported a trend of decreased shoulder ROM associated with breast cancer 
patients’ increased rating of performance difficulty while performing functional tasks. 
 
Study 2 – Empirical quantification of internal and external rotation co-activation in healthy 
shoulders 
Objective: 
1. Quantification of the co-activation relationships of humeral internal and external rotators in 
young healthy adults using traditional (non-weighted) and PCSA-weighted co-activation index 
ratios. 
2. Determine if the co-activation relationships defined from a subset of exertions can be 
extrapolated to other additional postures and intensities.  
Hypotheses: 
1. It was hypothesized that the PCSA-weighted co-activation prediction models would better 
represent empirically measured co-activation (with predictions yielding higher r
2 
values) 
compared to the traditional non-weighted co-activation prediction models. 
2. It was hypothesized that the co-activation relationship determined for a subset of postures 
(original data set) would be successfully extrapolated to a unique subset of exertions 
(extrapolated data set). Recent work has demonstrated that co-activation relationships 
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defined at the elbow for a subset of exertions can be extrapolated successfully to unique 
postural data sets (Brookham, Middlebrook, Grewal, & Dickerson, 2011; Middlebrook, 
Brookham, & Dickerson, 2013). 
 
Study 3 – Comparison of humeral rotation co-activation of breast cancer survivors and healthy 
shoulders 
Objectives: 
1. Quantification of the co-activation relationships of humeral internal and external rotators in a 
BCP 
2. Comparison of survivor co-activation relationships with those of a healthy population (defined 
in Study 2 of this thesis) 
Hypothesis: It was hypothesized that muscle-activation patterns of the BCP will reveal survivors 
have a reduced internal/external humeral rotation co-activation ratio compared to healthy individuals 
during IR exertions (reflecting a decrease in pectoralis major activation). 
The co-activation ratio provides a relative measure of internal rotation (IR) contribution to 
total activation (IR and external rotation (ER) activation) about the shoulder. Due to the location of 
the breast cancer treatment (surgery and radiation is typically directed to the anterior aspect of the 
chest), the pectoralis muscles are primarily in the field of disturbance. It is hypothesized that these 
anterior chest muscles (humeral internal rotators) will be unable to produce force, causing a 
reduction in total activation of the internal rotator muscles in relation to the posteriorly located 
humeral external rotators. It was hypothesized that this dysfunction would present as a reduction in 






Study 4 – Modelling changes in humeral internal and external rotation strength of breast cancer 
survivors to investigate employed muscle strategies 
Objectives: 
The purposes of this study were to modify an existing 3-D, inverse dynamic link-segment 
model of the right upper limb (specifically, the Shoulder Loading Analysis Modules (SLAM) 
(Dickerson, 2005; Dickerson, Chaffin, & Hughes, 2007)) in terms of survivor pectoralis major 
capability, co-activation (defined from Study 3 of this thesis) and population anthropometrics to 
determine the following: 
1. Determine how muscle strategy is affected by specific muscle dysfunction (using an inverse 
dynamics approach). Specifically, compare how closely SLAM muscle force predictions 
represent empirically measured survivor EMG during IR and ER exertions with different 
pectoralis major force producing capabilities. 
2. Determine if inclusion of BCP IR and ER exertion type co-activation constraints improve the 
physiological realism of the muscle force predictions (more closely represent the empirically 
recorded EMG). 
 
It was hypothesized that: 
1. SLAM muscle force predictions will be more closely associated with empirically measured 
EMG activation levels during states of reduced pectoralis major capability. Specifically, 
correlations between EMG and muscle force predictions will be highest when the pectoralis 
major capability is set to 0.25, 0.50 and 0.75; and correlations will be lowest when capability 
is set to 0.0 or 1.0.  
Due to the nature of surgeries and adjuvant treatments received in the BCP, and the resultant 
evidence of dysfunctional changes prevalent in this population (as demonstrated by muscle activation 
and kinematic changes in Study 1 of this thesis), it is assumed that survivors will neither have total 
disability (pectoralis major capability of 0) nor total capability (100% capable of producing maximal 
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force) of the pectoralis major muscles. It is hypothesized that survivors maintain 0.25-0.75 ability of 
the pectoralis major capability, which will be reflected by higher correlations between EMG and 
model predictions during these conditions. 
 
2.  Inclusion of the co-activation constraint would result in the muscle force predictions more 
closely representing the empirically recorded muscle activation.  
Previously, elbow flexor and extensor co-activation constraints were included in an optimization 
muscle force prediction model of the elbow, and results demonstrated that inclusion of these 
constraints improved the model predictions, bringing them closer to the empirically measured 
activation levels (Brookham, Middlebrook, Grewal, & Dickerson, 2011).  
 
Figure 2 An outline of the specific goals and outcomes of the four studies which comprise this thesis. Shaded boxes 
indicate general study purposes. Studies 1 and 3 comprised of a shared data collection. 
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Chapter 2 General review of breast cancer research literature 
This chapter introduces and describes the disease of breast cancer, its affected population, associated 
diagnostic and treatment regimens and the subsequent sequelae to these treatments. A review of 
literature investigating the effects of exercise treatment on these morbidities is presented, and is 
followed by identification of gaps in the current literature that relate to the proposed work. 
Section 2.1 Breast cancer: disease stages, treatment and prognosis 
Cancer is a class of diseases in which cells display abnormal and uncontrolled growth creating a 
mass of cells and in some cases metastasize to other areas of the body. Breast cancer is cancer 
originating in the breast tissue, which spans the region laterally from the sternum to the axilla and 
superiorly to the clavicle. Breast cancer can metastasize through the blood stream or the lymphatic 
system, spreading to other areas of the body. Breast cancer is the most frequently diagnosed cancer 
in females (Figure 3), and one in nine women will develop breast cancer in their lifetime. 
Approximately 23,200 cases of breast cancer were diagnosed in women in Canada in 2010, and 
5,300 are expected to die from it (Canadian Cancer Society's Steering Committee, 2010) (Table 1). 
Almost 9,000 of these new cases were diagnosed in Ontario alone (Canadian Cancer Society's 
Steering Committee, 2010). Breast cancer occurs in males as well, and it was estimated that 150 
males were diagnosed in Canada in 2010, with only 100 of these surviving (Canadian Cancer 




Figure 3 Percentage distribution of estimated new cases [left] and deaths [right] for selected cancers for females in 
Canada in 2010 (Canadian Cancer Society's Steering Committee, 2010). New cases exclude an estimated 34,300 non-
melanoma skin cancer. Figure was taken from the Canadian Cancer Statistics 2010 (Canadian Cancer Society's 
Steering Committee, 2010). 
 
Table 1 Estimated new cases and deaths for the most common cancers by age and sex in Canada in 2010. Dash lines 
(-) indicate fewer than three cases or deaths. Table was taken from the Canadian Cancer Statistics 2010 (Canadian 




Breast cancer occurs primarily in females between 50 and 69 years of age, with 28% of cases 
diagnosed in women older than 69 years, and 19% of cases being diagnosed in women younger than 
50 years (Canadian Cancer Society's Steering Committee, 2010). Likely attributable to an increase in 
mammography screening, breast cancer incidence rates rose from 1980 through the early 1990s; and 
similarly perhaps due to increased mammography screening as well as the use of more effective 
adjuvant therapies following surgery, mortality rates have decreased since the mid-1980s (Figure 4). 
The 5 year survival rate is currently 88% for women with breast cancer (Canadian Cancer Society, 
2014). 
 
Figure 4 Age-standardized incidence rates (ASIR) and age-standardized mortality rates (ASMR) for selected 
cancers for females in Canada from the years 1981-2010. Rates were age-standardized to the 1991 Canadian 
population. Figure was taken from the Canadian Cancer Statistics 2010 (Canadian Cancer Society's Steering 
Committee, 2010). 
 
The precise causes of breast cancer are unknown but it is believed to be a result of interactions 
between genetic and environmental risk factors. These include female gender, age, family history, 
breast density, early menstruation and late menopause, radiation exposure, hormone replacement 
therapy, oral contraceptives, increased body weight, and alcohol and tobacco use (Canadian Breast 
Cancer Foundation, 2010). The incidence of breast cancer is 2 - 4 times greater in women who have 
a family history of the disease (Fisher, Fisher, Sass, & Wickerham, 1984). The incidence of 
contralateral metastases from breast cancer is extremely rare (Fisher, Fisher, Sass, & Wickerham, 
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1984) and post-lumpectomy treatment, 85% of all local breast recurrences are noted within the first 4 
years, and 95% are noted within 5 years (Fisher, Sass, Fisher, Gregorio, Brown, & Wickerham, 
1986). 
Section 2.1.1 Disease stages and prognosis 
There are many types of breast cancer, with each type having dissimilar prognoses and treatment 
recommendations. The types are defined on the basis of what parts of the breast are infected (Figure 
5), and how the cancer progresses. The Canadian Breast Cancer Foundation (2010) describes four 
main types of breast cancer as depicted in Table 2. 
. 
 





Table 2 Four main types of breast cancer and associated description. 
Breast Cancer Type Description 
Non-invasive (in situ) Breast Cancer 
i.e.) ductal carcinoma in situ or lobular 
carcinoma in situ 
Cancer in which cells remain within the place of 
origin (within milk ducts or breast lobules) and 
have not spread to surrounding breast tissue.  
  
Invasive Breast Cancer 
i.e.) invasive ductal, lobular, mucinous, tubular, 
medullary, micropapillary carcinomas 
Cancer may grow and invade neighbouring 
tissue and spread to other body parts. 
  
Inflammatory Breast Cancer Indicated by redness and swelling of the breasts 
and is often misdiagnosed as a breast infection. 
Uncommon, occurring in only 1-4% of breast 
cancer cases. 
  
Paget’s disease Affects the nipple (itchiness, scaling, weeping). 
Uncommon, occurring in only 1% of all breast 
cancer cases. 
 
Breast cancer is staged according to the size of the tumor, the number of lymph nodes affected (if 
any), and the presence or absence of distant metastases (Segal, et al., 2001). The stages are indicated 
by levels 0 to IV, with a higher number indicating more advanced stages of cancer with poorer 
prognosis. The TNM Staging System was developed by the American Joint Committee on Cancer 
and the International Union Against Cancer, and is based on the extent of the tumor (T), the extent of 
spread to the lymph nodes (N), and the presence of metastasis (M) (AJCC, 2009).  
Individuals with breast cancer are usually termed as ‘patients’ or ‘survivors’ depending on 
their current state of treatment or completion thereof, however there is discrepancy in the literature 
concerning the definition of a cancer survivor. Some consider anyone who has been diagnosed with 
cancer, from the time of diagnosis throughout the rest of their life to be a survivor (Doyle, et al., 
2006). Whereas, others consider survivorship to begin once cancer treatments are completed, and the 
individual continues to live with the memories of their treatment and the possibility of cancer 
recurrence (Pelusi, 1997; Thomas-MacLean, 2004). For the purposes of this dissertation, a cancer 
patient will be defined as an individual currently undergoing cancer treatment, whereas a cancer 
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survivor will be defined as an individual that has completed cancer treatment including surgery, 
chemotherapy and/or radiation treatment.  
Although 5 year cancer survivor rates are approaching 90%, the associated physical and 
psychosocial prognoses are negative. Seventy nine percent of patients that had modified 
mastectomies and 83% of patients treated surgically with lumpectomies suffered from one or more 
late symptoms 1 – 4 years post-surgery (Husted, Lauridsen, Torsleff, & Erichsen, 1995). Late 
symptoms persist following treatments, and include pain around the scar and operative area, neck 
and shoulder pain, decreased ROM, weakness, swelling and sensation disturbances (Lauridsen, 
Torsleff, Husted, & Erichsen, 2000). The most common impairments of post breast cancer treatment 
are reported to be decreased shoulder ROM, numbness around the axilla and lateral chest wall, 
decreased grip strength, pain, and increased arm volume (Rietman, Dijkstra, Debreczeni, Geertzen, 
Robinson, & De Vries, 2004). Anemia is common in patients acquiring solid tumors, and it is 
associated with increased fatigue, decreased QoL and impaired exercise tolerance (Courneya, et al., 
2008). More than 48% of Canadian breast cancer survivors are overweight or obese and 50% are 
inactive  (Courneya, et al., 2008).  
Section 2.1.2 Surgical treatment 
The purpose of surgical treatment is to remove the cancerous tumor(s), and can involve various 
procedures depending on the cancer severity. Surgery is generally one of the first lines of treatment 
and is widely associated with causing fatigue (Cimprich, 1993). 
Section 2.1.2.1 Mastectomy 
In 1894 the radical mastectomy was introduced by William Steward Halsted, which involved breast 
ablation and removal of the overlying skin and pectoralis major muscle (Dalberg, Krawiec, & 
Sandelin, 2010). This procedure followed by radiation caused lymphedema and ROM restrictions in 
about 50% of patients (Sugden, Rezvani, Harrison, & Hughes, 1998). As imaging modalities and 
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adjuvant treatments improved, this procedure was considerably abandoned in the 1950s-1960s and 
replaced with a more limited surgery, the modified radical mastectomy (MRM) (Dalberg, Krawiec, 
& Sandelin, 2010).The MRM involves breast ablation and removal of the fascia overlying the 
pectoralis major muscle, but the muscle itself is preserved (Dalberg, Krawiec, & Sandelin, 2010). 
The change from radical to modified mastectomies reduced the incidence of lymphedema and 
restrictions in ROM (Sugden, Rezvani, Harrison, & Hughes, 1998). However, ROM restrictions, 
especially during shoulder abduction, flexion and external rotation, are still prevalent with this 
procedure because the subcutaneous tissues of skin flaps tend to adhere to the raw muscle, inhibiting 
the usual smooth gliding between the muscle and the subcutaneous tissue (Lauridsen, Overgaard, 
Overgaard, Hessov, & Cristiansen, 2008). Dalberg et al. (2010) evaluated the long term (11 year 
follow-up) benefits of fascia preservation in breast cancer patients undergoing modified radical 
mastectomies and found in cases of which the tumor did not involve the pectoralis fascia, 
preservation of the fascia did not have a significant impact on chest wall recurrence rate or survival, 
but there was a trend towards lower recurrence with those patients that had the fascia removed. 
Additional studies with larger sample sizes are required to examine these trends. Figure 6 depicts an 








Figure 6 Depiction of radical and modified mastectomy. [Top row depicts surface anatomy prior to mastectomy; 
bottom row, left, depicts post radical mastectomy with pectoralis major removed; bottom row, centre and right, 
depict post modified mastectomy with and without fascia preservation, respectively.] Figures taken from (Primal 
Pictures, 2006). 
 
Section 2.1.2.2 Breast conserving therapy 
Breast conserving therapy (BCT) (or lumpectomy) was introduced in the 1960s and further 
developed in the 1970s and 1980s and is a less invasive surgery requiring tumor excision which is 
generally followed by radiation (Rietman, et al., 2003). It often involves excision of a tumor with 
cancer free margins (distance between the tumor and edge of surrounding tissue that is removed 
along with it) greater than 3 mm (Nesvold, Dahl, Lokkevik, Mengshoel, & Fossa, 2008). In most 
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Western countries this type of surgery is predominately performed (except in the case of large and/or 
multi-centric tumors), but in the world, mastectomies are still the dominating surgical option 
(Dalberg, Krawiec, & Sandelin, 2010). Figure 7 depicts a local region excised during BCT. Gerber et 
al., (1992) compared morbidities from patients who had received modified radical mastectomies 
versus breast conserving therapies and found that mastectomy patients were slower to achieve pre-
surgical ROM measures, but that patients receiving breast conserving therapies (followed by axillary 
dissection and radiation) had more chest wall tenderness at 1-2 years post-surgery.  
 
 
Figure 7 Breast conserving therapy (lumpectomy). The tumor and a small portion of surrounding breast tissue [area 
surrounding by dashed triangular shape] are removed. Figure taken from (Canadian Cancer Society, 2011). 
 
Section 2.1.2.3 Axillary node dissection 
The lymphatic system is an extensive drainage system which functions to return interstitial fluid to 
the blood, absorb fats and fat-soluble vitamins from the digestive system and transport them to 
venous circulation and aid the immune system in defending against invading microorganisms and 
disease. The lymphatic system is made up of a series of lymphatic channels and lymph nodes 
throughout the body (Figure 8). The axillary lymph nodes (Figure 9) are an essential prognosis factor 
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for breast cancer recurrence and survival, along with the size of the tumor (Carter, Allen, & Henseon, 
1989; Hack, Cohen, Katz, Robson, & Goss, 1999; Maycock, Dillon, & Dixon, 1998). Axillary lymph 
nodes are the most common site of tumor metastases from breast cancer (Maycock, Dillon, & Dixon, 
1998) and the presence of cancer cells in the axilla indicates that cancer has spread from the breast, 
suggesting a poorer patient prognosis (Hack, Cohen, Katz, Robson, & Goss, 1999). It is 
recommended that about 10 lymph nodes be removed during axillary dissections to minimize the risk 
of erroneous classification (Mathiesen, Carl, Bonderup, & Panduro, 1990). However, axillary 
dissections lead to several morbidities including decreased shoulder and arm ROM, decreased 
strength, pain, seroma, lymphedema and numbness (Bendz & Olsen, 2002; Haid, et al., 2002; Ivens, 
Hoe, Podd, Hamilton, Taylor, & Royle, 1992; Kuehn, et al., 2000; Polinsky, 1994; Sugden, Rezvani, 
Harrison, & Hughes, 1998).  
 





Figure 9 Axillary lymph nodes. Anterior view of the scapula: thin axillary lymph channels and small nodes [an 
example directed by the arrow] within the area of the axilla. Figure modified from (Primal Pictures, 2006). 
 
Several nerves are exposed and susceptible to damage during axillary dissections (Figure 10). 
Numbness and altered sensation have been attributed to disruptions or division of the 
intercostobrachial nerve (Sugden, Rezvani, Harrison, & Hughes, 1998). Damage to other nerves can 
affect muscles and movements including: serratus anterior resulting in winged scapula (long thoracic 
nerve), latissimus dorsi affecting shoulder internal rotation and abduction (thoracodorsal nerve), and 
the pectoralis major affecting shoulder flexion, adduction and internal rotation (pectoral nerve) 
(Lauridsen, Torsleff, Husted, & Erichsen, 2000). The intercostobrachial nerve is commonly 
sacrificed or damaged during axillary dissections (Chiverton & Perry, 1987), and the preservation of 
such is considered difficult and time-consuming, leading to only modest improvements in sensory 




Figure 10 Nerves within the axilla. [Anterior view of the scapula] Intercostalbrachial nerve is commonly sacrificed 
during axillary dissections. Other nerves within this area may also be affected. Figure modified from (Primal 
Pictures, 2006). 
 
Sentinel lymph node biopsies are a newer procedure which involve sampling (dissecting) only one or 
a few sentinel lymph nodes. The sentinel lymph node is the first node in a cluster of nodes that 
receives lymph fluid from the area around the tumor, and is the first node the cancer cells will likely 
spread to (Canadian Cancer Society, 2011). If cancerous cells are not found in these sentinel nodes, it 
is unlikely (less than 5% chance) that the cancer has spread to other nodes (Canadian Cancer Society, 
2011). Sentinel node biopsies have become the standard procedure in managing the axilla 
(Lauridsen, Overgaard, Overgaard, Hessov, & Cristiansen, 2008) and were developed to reduce the 
number of unnecessary axillary lymph node dissections and reduce morbidity rates associated with 
these dissections (Rietman, et al., 2003). Maycock et al. (1998) examined long term problems 
associated with axillary sampling compared to clearance and concluded that patients who received 
axillary sampling reported less post-operative numbness than patients who received axillary 
clearance. However, despite improvements in tumor detection techniques and resultant decreases in 
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the total number of mastectomies and sentinel node dissections, there are still a significant number of 
women that require mastectomies and axillary dissections (Kilgour, Jones, & Keyserlingk, 2008). 
Imaging techniques such as ultrasound or positron emission tomography are insufficiently sensitive 
and specific for the detection of positive axillary lymph nodes (Avril, et al., 1996; De Freitas, Costa, 
Schneider, Nicolau, & Mrussi, 1991; Tate, Lewis, Archer, Guyer, Royle, & Taylor, 1998), so 
histological evaluation of axillary status through surgery seem indispensable at present. 
Section 2.1.3 Chemotherapy treatment 
Adjuvant therapies are defined as a type of treatment that is used once the primary tumor has been 
removed surgically and may include chemotherapy, radiation, hormonal therapy or any combination 
thereof (Segal, et al., 2001). Adjuvant therapies are administered if the risk of metastatic disease may 
be favourably influenced by the adjuvant therapy and the form of therapy depends on the tumor 
prognostic factors, cancer stage, surgical approach, patient menopausal status and any pre-existing 
co-morbidities (Segal, et al., 2001). 
 Chemotherapy is a form of cancer treatment that uses medication to control suspected micro 
metastases. It is a systemic treatment, meaning that it affects the whole body by going through the 
blood stream. It is administered intravenously or orally and works to destroy cancer cells that may 
have spread from the breast, but this treatment affects healthy cells as well. Chemotherapy is 
generally administered in cycles, given for about 4-8 cycles over approximately 9-21 weeks 
(Courneya, Mackey, & McKenzie, 2002). It is well established that chemotherapy causes fatigue 
(Courneya, Mackey, & McKenzie, 2002; de Jong, Kester, Schouten, Abu-Saad, & Courtens, 2006; 
Markes, Brockow, & Resch, 2006). Chemotherapy also causes impaired exercise tolerance (Pihkala, 
et al., 1995), nausea, vomiting, mood disturbances and weight gain (Markes, Brockow, & Resch, 
2006) and has been found to increase the fat to lean body mass ratio (Demark-Wahnfried, et al., 
2001). Chemotherapy has been reported to interfere with performance of ADL and return to work 
(Markes, Brockow, & Resch, 2006). 
24 
 
Section 2.1.4 Radiation treatment 
Radiation is a local method of cancer treatment during which high energy x-rays are used to destroy 
cancer cells. Radiation has been reported the most effective adjuvant treatment for prevention of 
loco-regional recurrences after mastectomies or breast conserving surgeries (Early Breast Cancer 
Trialists' Collaborative Group, 1995; Overgaard, et al., 1997; Overgaard, et al., 1999). Radiation 
usually occurs in short sessions only lasting a few minutes for 5 days a week, for approximately 3-6 
weeks (Canadian Breast Cancer Foundation, 2010). Since the early 1970s the standard treatment of 
radiation includes moderate doses (50 Gr) to the breast and local regions of lymphatic drainage 
including the axilla and supraclavicular areas (Rietman, et al., 2003). Radiation can also affect 
healthy cells, resulting in irreversible lung fibrosis (Courneya, Mackey, & McKenzie, 2002), 
coronary and carotid artery arteriosclerosis (Rubin, Finkelstein, & Shapiro, 1992), interstitial 
myocardial fibrosis (Renzi, Straus, & Glatstein, 1992), cardiac and pulmonary toxicities, brachial 
plexopathy and skin erythema (redness) (Truong, Olivotto, Whelan, & Levine, 2004). Fatigue has 
been reported as the most common side effect of radiation (Greenberg, Sawicka, Eisenthal, & Ross, 
1992; Longman, Braden, & Mishel, 1996; Winningham, et al., 1994), but other side effects include 
lymphedema (Swedborg & Wallgren, 1981; Truong, Olivotto, Whelan, & Levine, 2004), chronic 
pain (Tasmuth, von Smitten, Hietanen, Kataja, & Kalso, 1995), brachial plexus neuropathies (Olsen, 
Pfeiffer, Johannsen, Schroder, & Rose, 1993) and rib fractures (Overgaard, 1988). Sugden et al., 
(1998) reported that radiation can cause (even months after radiation) cell death within subcutaneous 
tissues, which results in formation of microscopic areas of scar tissue that could purportedly “set” a 
shoulder that is not regularly taken through full ROM. Other authors have reported that radiation can 
add to the fibrous firm attachments made between muscle and tissue following surgery, further 
restricting ROM (Lauridsen M. C., Overgaard, Overgaard, Hessov, & Cristiansen, 2008). Near full 
ROM is critical for patients undergoing radiation treatments, as the arm must be put into almost full 
abduction and external rotation for precise radiation positioning (Sugden, Rezvani, Harrison, & 
Hughes, 1998). Hojris et al., (2000) compared patients treated with chemotherapy and with or 
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without radiation, and found that 52% of patients in the radiation group had impairment of shoulder 
movement (compared to 15% in the non-radiated group). Furthermore, 16% of radiated patients 
(compared to 2% of non-radiated patients) reported shoulder impairments that interfered with their 
work and ADL (Hojris, Andersen, Overgaard, & Overgaard, 2000). Sugden et al. (1998) compared 
morbidities caused by axillary dissection and radiation and reported that radiation at the axilla caused 
decreased shoulder ROM, and that radiation following axillary dissection increased the risk of 
developing lymphedema. Radiation has been reported to interfere with performance of ADL and 
return to work (Markes, Brockow, & Resch, 2006). 
Section 2.1.5 Hormonal treatment 
In some breast cancer patients, the presence of estrogen can promote cancer cell growth. Hormonal 
(endocrine) therapy is a form of cancer treatment that uses medication to block the way estrogen 
promotes the growth of estrogen receptor-positive breast cancers (Canadian Breast Cancer 
Foundation, 2010). In some cases hormonal therapy is therapeutically approached surgically, such as 
the removal of the ovaries (oophorectomy) (Schmitz, et al., 2010). Hormonal drug therapy is usually 
administered after surgery, chemotherapy and radiation are complete, and is often administered daily 
for many years. Hormonal treatments are known to cause fatigue, weight gain, and ovarian oblation 
leading to early menopause (Courneya, Mackey, & McKenzie, 2002), as well as lead to hot flashes, 
bone demineralization and psychosexual effects (Rutqvist, 2004). Early menopause may accelerate 
bone loss and result in osteopenia or osteoporosis (Swenson, Nissen, Anderson, Shapiro, Schousboe, 
& Leach, 2009), making this population of women more susceptible to bone fracture. 
Section 2.2 Treatment-related sequelae 
There are numerous treatment-related sequelae of breast cancer treatments. The side effects of cancer 
treatment can last days, months, and even years (Hsieh, Sprod, Hydock, Carter, Hayward, & 
Schneider, 2008).  
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Section 2.2.1 Physical factors 
The physical sequelae from breast cancer treatments are numerous and diverse. Common toxicities 
include diarrhea, stomatitis, nausea, vomiting, and hand-foot syndrome (redness, burning and paining 
of the hands and feet) (Prado, et al., 2009). Other symptoms include weakness, edema, pain and 
decreased mobility (Kuehn, et al., 2000). Survivors also display decreased functional capacity, 
meaning they expend more effort (relative to their maximal ability) than normally required to 
perform usual activities, therefore leading to higher levels of fatigue (Mock, et al., 2005).  
Breast cancer survivors are at a high risk for decreased bone mineral density due to 
chemotherapy (which contains bone wasting agents), use of glucocorticoids, resulting ovarian failure 
and lack of physical activity (Reichman & Green, 1994; Reyno, Levine, Skingley, Arnold, & Abu 
Zahra, 1992; Rodriguez-Rodriguez, et al., 2005; Shapiro, Manola, & Leboff, 2001; Shapiro & Recht, 
1994; van Poznak & Sauter, 2005). Chemotherapy causes early menopause in 75% to 90% of female 
patients older than 40 years of age (Bines, Oleske, & Cobleigh, 1996), and endocrine therapies can 
also promote early menopause (Courneya, Mackey, & McKenzie, 2002). Early menopause means 
that these survivors have more years of estrogen depletion than postmenopausal women and 
therefore have more years of potential bone loss (Twiss, Waltman, Berg, Ott, Gross, & Lindsey, 
2009). Breast cancer survivors are almost 5 times more likely to experience a vertebral fracture one 
year post-treatment compared to healthy women (Swenson, Henly, Shapiro, & Schroeder, 2005). 
Section 2.2.2 Psychosocial factors 
Treatment-related sequelae often involve psychosocial challenges, which can negatively influence 
QoL. Improvements in detection and treatment of breast cancer, and resultant increases in survival 
rates has caused an emphasis to be placed on addressing QoL issues within this population 
(Blanchard, Courneya, & Laing, 2001). Women suffer substantial psychological distress during 
cancer treatment, including symptoms of depression and anxiety, both of which are highly correlated 
with women suffering from breast cancer (Badger, Segrin, Dorros, Meek, & Lopez, 2007; Schreier & 
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Williams, 2004). Patients receiving chemotherapy or radiation report anxiety and depression before, 
during and after treatment as a result of treatment side-effects (Spiegel, 1997). Depression in cancer 
populations is estimated between 1.5% to 50% (Trask, 2004), and anxiety estimates range from 20% 
to 50% (Stark, Kiely, Smith, Velikova, House, & Selby, 2002). Kuehn et al., (2000) determined that 
surgery-related arm symptoms and fear of cancer recurrence were the most important long-term 
sources of distress for a sample of 396 breast cancer patients. This particular population also reports 
disturbances in body image (Kemeny, Wellisch, & Schain, 1988), and often describe negative 
consequences of the illness on themselves and their families (Manne, et al., 2003). Significant 
improvements in body image have been related to performing 12 weeks of supervised aerobic 
exercise (Pinto B. M., Clark, Maruyama, & Feder, 2003). Long term exercise can reduce anxiety in 
breast cancer patients (Mock, et al., 1997) and acute bouts of exercise may also be effective in 
reducing anxiety, especially if pre-exercise anxiety levels are high (Blanchard, Courneya, & Laing, 
2001). Specifically, dragon boat racing has been reported to contribute to social, emotional, physical, 
spiritual and mental dimensions of health (Parry, 2007). 
Section 2.3 Upper limb dysfunction related to breast cancer 
Chronic arm morbidity is relatively understudied and is claimed to be one of the most troublesome 
long-term complications of breast cancer treatments (Kwan, Jackson, Weir, Dingee, McGregor, & 
Olivotto, 2002). Long term effects include side effects and complications that begin during or very 
shortly after treatment and persist afterward for which survivors must compensate; whereas late 
effects include those that appear months or years after treatment completion (Schmitz, et al., 2010). 
“Persistent effects” is a term used to describe both long term and late effects (Aziz & Rowland, 
2003). Shoulder disability has been reported in 35% of patients as a late complication to early breast 
cancer treatments (Lauridsen, Overgaard, Overgaard, Hessov, & Cristiansen, 2008), and 30 - 70% of 
patients have been reported to suffer from at least mild arm and shoulder symptoms (Kwan, Jackson, 
Weir, Dingee, McGregor, & Olivotto, 2002). Common impairments post breast cancer treatment 
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include decreased shoulder ROM, numbness at the axilla and/or lateral chest wall, decreased grip 
strength, pain and increased arm volume (Rietman, Dijkstra, Debreczeni, Geertzen, Robinson, & De 
Vries, 2004). Adverse effects of cancer treatment may persist and last years after treatment is 
completed (Schmitz, et al., 2010). Late morbidities of the upper limb restrict ADL and negatively 
affect QoL (Rietman, et al., 2003). Factors thought to influence the development of shoulder 
morbidity include age of the patient, extent of axillary and breast surgery performed and the nature of 
the adjuvant treatments received (Lauridsen, Cristiansen, & Hessove, 2005).  
Section 2.3.1 Range of motion 
Range of motion is essential for effective performance of ADL and work. Decreased ROM is a well-
known sequelae to breast cancer (Lauridsen, Cristiansen, & Hessove, 2005). It has been suggested 
that less than 100° to 120° of shoulder abduction or flexion is associated with reduced functional use 
(Badley, Wagstaff, & Wood, 1984). Humeral abduction, flexion and external rotation ROM is often 
limited in survivors (Rietman, Dijkstra, Debreczeni, Geertzen, Robinson, & De Vries, 2004). Near 
full ROM is essential for breast cancer patients undergoing chest radiation. The arm needs to be in an 
abducted and externally rotated posture (hand held above the head) for precise radiation positioning, 
and if motion is severely limited, this crucial treatment can be delayed or prevented (Sugden, 
Rezvani, Harrison, & Hughes, 1998). 
 The exact causes of restricted ROM associated with breast cancer are not completely 
understood, but is usually ascribed to surgical trauma and scarring caused by axillary dissection, plus 
the additional fibrosing effects caused by adjuvant radiation (Aitken, Gaze, Rodger, Chetty, & 
Forrest, 1989; Bentzen, Overgaard, & Thames, 1989; Box, Reul-Hirche, Bullock-Saxton, & 
Furnnival, 2002; Hack, Cohen, Katz, Robson, & Goss, 1999; Ivens, Hoe, Podd, Hamilton, Taylor, & 
Royle, 1992; Kolden, et al., 2002; Kuehn, et al., 2000; Lane, Jespersen, & McKenzie, 2005; 
Rietman, Dijkstra, Debreczeni, Geertzen, Robinson, & De Vries, 2004; Ryttov, Holm, Qvist, & 
Blichert-Toft, 1988). Decreases in shoulder mobility are not believed to be caused by changes in the 
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glenohumeral joint itself, but rather because of mechanical inhibition of movement caused by 
adhesions between the muscles, subcutaneous tissues and skin around the axilla and pectoralis major 
muscles, which can be further aggravated with adjuvant chemotherapy and radiation therapies which 
cause further firm fibrous attachments among these structures (Lauridsen, Cristiansen, & Hessove, 
2005). A delay, reduction or lack of immediate post-surgical activity could also lead to muscle 
spasms around the glenohumeral joint, muscle atrophy and a tightened glenohumeral capsule, which 
could lead to short and long term mobility reductions and pain (Kilgour, Jones, & Keyserlingk, 
2008). 
Reductions in shoulder range of motion are commonly associated with individuals with 
breast cancer. Table 3 displays some long term restrictions in shoulder ROM as described by four 
studies. Although not outlined in Table 3, the variability of ROM restrictions was high. Kuehn et al. 
(2000), Rietman et al. (2004) and  Hack et al. (1999) assessed long term shoulder ROM restrictions 
on 396, 55 and 222 patients, respectively, who had undergone axillary dissections followed by either 
MRM or BCT at approximately 32 months, 2.7 years and 33.2 months post-surgery. The mean 
differences in shoulder ROM compared to the contralateral (non-surgery side) for these three studies 
are outlined in Table 3. Hack et al. (1999) found that 73% of patients showed a difference between 
their affected and non-affected shoulder with respect to the sensation point of pain or discomfort, or 
the point of maximum arm and shoulder movement. Swedborg & Wallgren (1981) examined the 
shoulder ROM of three groups of patients at approximately 49 months post-surgery: Group A (N = 
163) had received radiation before MRM; Group B (N = 168) had received radiation after MRM; and 
Group C (N= 144) consisted of MRM patients that had not received any radiation. The authors 
(Swedborg & Wallgren, 1981) presented ROM as a percentage of the non-affected arm ROM as 





Table 3 Restrictions in ROM associated with breast cancer 








Hack et al., (1999)
*




abduction -21° -7.5° -6.4° (P.O.P: -13.8°) Grp A 85.2% 
Grp B 84.9% 
Grp C 91.7% 
flexion -12° -5.7° -4.3° (P.O.P: -10.2°) Grp A 94.6% 
Grp B 94.9% 





-6.2° \ Grp A 94.0% 
Grp B 93.5% 





\ \ Grp A 95.1%  
Grp B 95.9% 
  Grp C 101.7% 
Extension \ \ -1.3° (P.O.P: -2.2°) \ 
horizontal 
abduction 
\ \ -7.3° (P.O.P: -10.7°) \ 
horizontal 
adduction 
\ \ -1.0° (P.O.P: -1.4°) \ 
external 
rotation at 90° 
abduction 
\ \ \ Grp A 86.3% 
Grp B 87.4% 
Grp C 96.8% 
*
Mean difference in shoulder ROM compared to contralateral arm 
§
ROM expressed as a percentage of control arm 
\ = not measured 
P.O.P = sensation point of pain/discomfort 
 
Differing assessment techniques and definitions of functional ROM complicate comparisons 
between studies, but several studies concur that surgery (axillary dissection, MRM and BCT) causes 
reductions in ROM. In a review of 6 studies that assessed early breast cancer patients who had 
received axillary clearance followed by either MRM or BCT, Rietman et al. (2003) concluded that 
the prevalence of decreased ROM ranged from 2 to 51% with severe restrictions (greater than 50% 
reduction) in 2% of patients. Shoulder ROM was less when the axilla was irradiated, and was worse 
with patients that received MRM compared to BCT (Rietman, et al., 2003). Bendz & Olsen (2002) 
assessed shoulder flexion, abduction, internal and external rotation of 205 patients who had 
undergone axillary dissections and either MRM or BCT at 2 weeks, 1 month and 2 years post-
surgery. All movements decreased at the earlier time points and shoulder flexion and abduction were 
still significantly reduced at 2 years in both MRM and BCT patient groups (Bendz & Olsen, 2002). 
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 Other studies have demonstrated that shoulder ROM restrictions are more frequent or severe 
in patients who have undergone MRM compared to BCT. Nesvold et al. (2008) compared the ROM 
of patients who had undergone axillary dissection and radiation as well as either MRM or BCT and 
determined that 24% and 38% of MRM patients had significantly restricted ROM in shoulder flexion 
and abduction compared to only 7% and 18%  in the BCT group, respectively. In addition, subjective 
reports revealed that chest wall tightness and moderate to severe problems with arm function were 
reported in 16% and 58% of MRM patients, compared to 1% and 33% of BCT patients, respectively 
(Nesvold, Dahl, Lokkevik, Mengshoel, & Fossa, 2008). Lauridsen et al. (2008) assessed the ROM of 
89 patients who had received axillary dissection followed by either BCT or MRM, and found that 
BCT patients were found to suffer less frequently from shoulder disability compared to patients that 
had received MRM (odds ratio = 8.5, p = 0.002). Sugden et al. (1998) assessed 93 BCT and MRM 
patients at baseline and approximately 18 months post radiation, defining relative shoulder 
movement as the ratio of ipsilateral movement to contralateral movement, multiplied by 100. Sugden 
et al. (1998) did not report specific measures of ROM, but did report objective reductions in at least 
one shoulder movement in 48% of patients (with 79% of these as MRM patients and 35% as BCT 
patients). The authors examined shoulder flexion, extension, abduction, internal and external rotation 
and warned that limiting examination to flexion and abduction motions would have caused them to 
miss more than half of all patients having mobility restrictions (Sugden, Rezvani, Harrison, & 
Hughes, 1998). The type of surgery (MRM or BCT) was the most important factor in the 
development of shoulder problems: with MRM displaying more problems than patients with BCT 
(79% versus 35%), but that radiation also restricted ROM and when combined with MRM, resulted 
in more complaints of swelling, pain and telangectasis (spider veins), and posed more difficulties 
with performance of ADLs (Sugden, Rezvani, Harrison, & Hughes, 1998). 
 Adjuvant radiation treatments are suspected to contribute to reduced shoulder ROM. 
Particularly, axillary dissection in combination with radiation therapy is thought to be the main 
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reason why patients surgically treated for breast cancer develop shoulder mobility restrictions on the 
operated side (Lauridsen, Overgaard, Overgaard, Hessov, & Cristiansen, 2008). Chemotherapy does 
not seem to cause restrictions in ROM. The effects of chemotherapy and radiation on ROM were 
investigated by Ryttov et al. (1988) by comparing three groups: patients with MRM (Group A), 
patients with MRM who underwent adjuvant chemotherapy and radiation (Group B), and patients 
with MRM who underwent only chemotherapy (Group C). The authors found that the frequency of 
impaired shoulder mobility significantly increased with radiation (38% in Group B versus 4% in 
Group A and 12% in Group C), and concluded that therefore, the administration of the systemic 
treatment of chemotherapy had no influence on the development of ROM restrictions (Ryttov, Holm, 
Qvist, & Blichert-Toft, 1988). Objective measures of shoulder movement impairment during long 
term follow-up (approximately 9 years) of 84 patients post mastectomy and chemotherapy indicated 
that 52% of irradiation patients developed some degree of ROM impairment, compared to only 15% 
of non-irradiated patients (Hojris, Andersen, Overgaard, & Overgaard, 2000). The timing of radiation 
administration apparently does not influence the effect radiation has on ROM. A comparison of 
patients (N = 928) who received radiation before or after surgery with those who did not receive 
radiation revealed that ROM was always less for patients that were irradiated compared to patients 
that did not receive radiation (Swedborg & Wallgren, 1981). Furthermore, the extent of axillary 
surgery combined with radiation has not been found to affect the impairment of shoulder mobility. 
Radiation was found to impair shoulder mobility regardless of the type of axillary surgery performed 
(node sampling or clearance) (Thompson, Air, Jack, Kerr, Rodger, & Chetty, 1995). Since the 
humeral head and glenohumeral joint are protected by barriers during radiation, Thompson et al. 
(1995) suggested that the reduction in mobility may reflect damage to the rotator cuff muscles. The 
supraspinatus (humeral abductor), infraspinatus and teres minor (humeral external rotators) insert on 
the greater tubercle of the humerus, and the subscapularis (humeral internal rotator) insert on the 
lesser tubercle of the humerus. It is possible that these tendon attachments could be damaged during 
radiation. Thompson et al. (1995) suggested that although axillary surgery alone can cause upper 
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limb morbidity (specifically more extensive surgeries can result in greater amounts of swelling), 
radiation can compound the problem by reducing shoulder girdle mobility. 
 Despite the considerable potential for rotator cuff involvement with restricted shoulder 
ROM, there has been limited information gathered regarding muscle activation or scapulothoracic 
kinematics in this population. Although several studies assess shoulder muscle strength, typically 
during basic chest press exercises (Ahmed, Thomas, Yee, & Schmitz, 2006; Battaglini, et al., 2007; 
Courneya K. S., et al., 2007; Lane, Jespersen, & McKenzie, 2005), there are no known studies that 
have investigated rotator cuff muscular activity in this population. Furthermore, likely due to the 
popular use of basic assessment tools such as goniometers, scapular movement is rarely assessed. 
Lauridsen et al. (2000) had physiotherapists visually assess 100 patients that received either BCT or 
MRM for scapular ‘winging’ (definite protrusion of the medial border of the scapula often attributed 
to a tight pectoralis major muscle or dysfunctional serratus anterior muscle) prior to and post exercise 
treatment. Eight patients displayed scapular winging prior to exercise therapy, and this number was 
reduced to 4 patients post exercise therapy, demonstrating that exercise can decrease the incidence of 
scapular winging (Lauridsen, Torsleff, Husted, & Erichsen, 2000). However, if the cause of scapular 
winging is due to severance of the long thoracic nerve which supplies the serratus anterior, winging 
is permanent (Tasmuth, von Smitten, Hietanen, Kataja, & Kalso, 1995). Reduced shoulder ROM 
may result in a change of upper body posture as individuals attempt to compensate for a reduction in 
mobility (Lauridsen, Torsleff, Husted, & Erichsen, 2000). There is a need for tracking of 
scapulothoracic and humerothoracic kinematics with 3-D motion capture in order to generate 
accurate and precise characterizations of shoulder movement and ability. 
Section 2.3.2 Lymphedema 
One complication of breast cancer treatment is lymphedema of the ipsilateral forearm and upper arm 
as depicted in Figure 11. Lymphedema is a chronic and progressive swelling of the arm, shoulder, 
neck and/or torso caused by compression or physical disruption of the axillary lymphatic channels 
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caused by surgery or radiation (Ahmed, Thomas, Yee, & Schmitz, 2006), which results in functional 
overload of the lymphatic system during which the lymph volume exceeds the transport capabilities, 
thereby causing a build-up of interstitial macromolecules (Petrek & Heelan, 1998). Clinical 
lymphedema is often described as a greater than 200 mL difference in volume between the ipsilateral 
arm and the non-affected arm (Kwan, Jackson, Weir, Dingee, McGregor, & Olivotto, 2002) or 
greater than a 10% increase in volume on the ipsilateral side (Bendz & Olsen, 2002; Kuehn, et al., 
2000; Schmitz K. H., et al., 2009). Persistent swelling and stagnant protein can lead to fibrosis (or 
scarring: formation of excessive fibrous connective tissue), cellulitis (inflammation of skin) and 
lymphangitis (infection within lymphatic channels) (Petrek & Heelan, 1998). Symptoms commonly 
include a sensation of heaviness, achiness and tenderness (Moffatt, et al., 2003), and can lead to 
distress, depression and anxiety (Carter B. J., 1997). Lymphedema can affect performance of gross 
and fine motor skills (Rymal, 2001) and can impact activities at work and at home (Passik & 
McDonald, 1998). Treatments of lymphedema involve managing symptoms usually by use of 
complex decongestive therapy, which involves wearing compression garments, skin and wound care 
to reduce infection risk, physiotherapy and manual lymphatic drainage massage (Koul, et al., 2007). 
 
Figure 11 Lymphedema of the upper limb: left limb (ipsilateral breast cancer side) is swollen. Figure taken from 
(Phimaimedicine). 
 Lymphedema prevalence rates (number of survivors with lymphedema) range from 6% to 
43% (Rietman J. S., et al., 2003), and incidence rates (frequency of developing lymphedema within a 
certain period of time) to range from 6% to 70%, depending on the criteria for defining lymphedema 
and the follow-up interval (Armer & Stewart, 2005; Ronka, Pamilo, von Smitten, & Leidenius, 2004; 
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Vignes, Arrault, & Dupuy, 2007). Ranges differ considerably between studies due to the diverse 
populations under study, and the differing methodology and timing of measurements (Petrek & 
Heelan, 1998). Lymphedema can develop at various times from initial cancer treatment (Petrek & 
Heelan, 1998) to 20 years post treatment (Petrek, Senie, Peters, & Rosen, 2001). There is a 50% 
probability that survivors will develop lymphedema at some point by 20 years post treatment 
(McKenzie & Kalda, 2003). However, incidence rates seem to be declining likely due to earlier 
detection and diagnosis, less advanced disease states and less extensive axillary surgeries (Petrek & 
Heelan, 1998). Factors believed to contribute to lymphedema include axillary dissection, radiation to 
the breast or axilla, pathological nodal status, obesity and the tumor stage (McKenzie & Kalda, 
2003). 
 The type and extent of surgery and adjuvant treatment affect the development of 
lymphedema. Axillary dissection and radiation of the axilla are associated with much higher risks of 
lymphedema (Kwan, Jackson, Weir, Dingee, McGregor, & Olivotto, 2002; Rietman, et al., 2003): an 
odds ratio of 4.8 was determined for patients developing lymphedema following axillary dissection 
and radiation (Kwan, Jackson, Weir, Dingee, McGregor, & Olivotto, 2002). There is consensus that 
lymphedema occurs more frequently in patients that undergo MRM compared to those that undergo 
BCT (Nesvold, Dahl, Lokkevik, Mengshoel, & Fossa, 2008; Rietman, et al., 2003). Nesvold et al. 
(2008) examined 263 women and found that 8% of patients with BCT developed lymphedema, 
compared to 20% of MRM patients at approximately 47 months post-surgery. Ryttov et al. (1988) 
compared patients that had received axillary dissection and MRM (control group) with patients that 
had also had radiation and chemotherapy (Group 2) or solely chemotherapy (Group 3). The authors 
found that the frequency of lymphedema was significantly greater in the radiated Group 2 (seven 
times higher than the control group, which was equal to Group 3); therefore concluding that systemic 
treatment (chemotherapy) had no influence on the development of lymphedema (Ryttov, Holm, 
Qvist, & Blichert-Toft, 1988). Ryttov et al. (1988) suggested that radiation leads to subcutaneous 
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fibrosis and damage to the endothelial cells of small blood and lymph vessels, causing it to play a 
greater role in the development of lymphedema compared to the extensiveness of surgery.  
 Individuals with lymphedema have often been excluded from participating in exercise for 
fear of exacerbating the condition (Hayes, Reul-Hirche, & Turner, 2008). However, exercise should 
be encouraged amongst individuals with lymphedema. Limiting the use of the arm for fear of 
lymphedema may limit physical recovery and affect activity and work (Schmitz, et al., 2009). 
Further, there is evidence to suggest that exercise enhances lymphatic flow (Mortimer, 1990; 
Mortimer, 1995) and that increased pulmonary work (blood flow) associated with exercise also aids 
lymphatic flow (Brennan & Miller, 1998). Schmitz et al., (2009) performed a randomized controlled 
trial of progressive weightlifting for 1 year in 141 breast cancer survivors that demonstrated stable 
lymphedema of the arm, and found that slowly progressive weight training had no significant effect 
on limb swelling, and resulted in a decrease in exacerbations of lymphedema, reduced symptoms and 
increased strength compared to the control group. Ahmed et al. (2006) demonstrated that weight 
training twice a week for 6 months did not increase the incidence of lymphedema nor did it increase 
the signs and symptoms of lymphedema in breast cancer survivors compared to a control group. 
Similarly, Hayes et al. (2008) investigated the effects of exercise on breast cancer survivors that had 
developed unilateral upper limb lymphedema compared to a control group, and concluded that 
exercise was safe and did not exacerbate secondary lymphedema. Physical activity amongst 
lymphedema sufferers is encouraged to optimize physical and psychosocial recovery of cancer 
(Hayes, Reul-Hirche, & Turner, 2008), in conjunction with appropriate compression garments and 
close monitoring (Schmitz, et al., 2009).  
Section 2.3.3 Strength 
Strength is often reduced in breast cancer survivors, and is generally assessed with grip strength, one-
repetition maximum tests or manual muscle tests. The side effects of cancer treatment can reduce 
functional capabilities such as aerobic capacity, muscular strength, flexibility and body composition, 
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which can decrease health-related QoL (Mustian, Katula, & Zhao, 2006). Reductions of strength in 
breast cancer survivors are logical due to potential neurological structural damage during surgery, 
muscle dysfunction caused by radiation or muscle atrophy caused by disuse. A review by Rietman et 
al. (2003) revealed that strength is often evaluated via a grip strength measure or through subjective 
reports of weakness, with a prevalence of strength decreases reported to range from 17% to 33% of 
survivors. Decreases in grip strength are significantly greater if the dominate side is operated on 
(Rietman, et al., 2003). Kuehn et al. (2000) systematically evaluated the long-term sequelae of 346 
breast cancer survivors who had undergone axillary dissections and either BCT or MRM. Isotonic 
strength was assessed by measuring the angle to which a 3 kg dumbbell could be elevated with an 
outstretched arm, and at approximately 32 months post-surgery 43.4% of patients demonstrated a 
reduction in strength (Kuehn, et al., 2000). One-repetition maximum strength tests, often bench press 
and leg press exercises, are also used as an indication of overall strength (Kolden, et al., 2002; 
Schmitz, et al., 2009). One repetition maximum tests are considered safe for most populations if 
properly supervised (Barnard, Adams, Swank, Mann, & Denny, 1999; Shaw, McCully, & Posner, 
1995) and are also specifically safe for breast cancer survivors with and at risk for lymphedema 
(Schmitz, et al., 2010). Other techniques to define one-repetition maximum include determining the 
maximal weight based on ratings of perceived difficulty during 4 to 6 repetitions of a 40 lbs leg press 
and a 5 lbs bench press, while continuing to add resistance until the participant rates maximal 
difficulty and refuses to attempt to lift anymore, is clearly unable to perform the lift properly, or 
reports a symptom that required stopping (Schmitz, et al., 2009). Exercise has proven to effectively 
increase upper and lower body muscle strength of breast cancer survivors (Ahmed, Thomas, Yee, & 
Schmitz, 2006; Herrero, et al., 2006; Mustian, Katula, & Zhao, 2006; Schmitz, et al., 2009; Twiss, 
Waltman, Berg, Ott, Gross, & Lindsey, 2009). Strength has also been assessed subjectively on a 
grading scale of 0 to 5 with the use of manual muscle tests which consisted of resisted movements in 
shoulder external rotation, flexion and abduction and increases in ER strength (higher scores) were 
seen in a BCP following exercise therapy (Kilgour, Jones, & Keyserlingk, 2008), but the literature is 
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limited regarding quantitative assessment of muscle-specific strength. It is difficult to compare and 
make population-based conclusions regarding strength using subjective assessments. By identifying 
specific exertions in which weakness is evident, it can be assumed to be attributed to muscle-specific 
strength deficits. Quantifying force levels will allow for comparisons between and within individuals 
and acquisition of this knowledge will help focus and direct therapeutic treatments and preventative 
techniques to reduce or eliminate these deficits. 
Section 2.3.4 Cording 
Axillary web syndrome, or cording, is a significant morbidity that occurs early in the post-operative 
stages (usually within the first post-operative month (Lauridsen, Cristiansen, & Hessove, 2005)) and 
is characterized by tight, painful, fibrous cords of tissue that extend from the axilla into the medial 
arm and sometimes extend distally to the antecubital fossa at the elbow and to the wrist or base of the 
thumb of the ipsilateral arm (Box, Reul-Hirche, Bullock-Saxton, & Furnnival, 2002; Lauridsen, 
Cristiansen, & Hessove, 2005; Moskovitz, Anderson, Yeung, Byrd, Lawton, & Moe, 2001; Tilley, 
Thomas-MacLean, & Kwan, 2009). These cords of tissue (usually 2 – 3 cords) are made taut and 
visible or palpable during shoulder abduction as depicted in Figure 12 (Moskovitz, Anderson, 




Figure 12 Cording: fibrous cords of tissue extend from the axilla into the medial arm and sometimes extend distally 
to the antecubital fossa at the elbow and to the wrist or base of the thumb. Figure taken from Moskovitz et al. 
(2001). 
 
The interruption of axillary lymphatics appears to play an important role in the development 
of cording. Initially, it was hypothesized that the intercostobrachial nerve may be the origin of the 
palpable taut cords, but Moskovitz et al. (2001) demonstrated that of 44 patients that had developed 
cording, the intercostobrachial nerve had been preserved in 43% of these patients, suggesting that 
ligation of this nerve does not contribute to the development of cording. Rather, cording is 
hypothesized to result from a disruption to and/or damage of superficial lymphatics and vessels 
during axillary surgery, causing a disruption or ceasing of flow and resulting in hypercoagulation 
(Lacomba, del Moral, Zazo, Gerwin, & Goni, 2010; Moskovitz, Anderson, Yeung, Byrd, Lawton, & 
Moe, 2001). Surgical biopsies and histological analyses have been performed on these taut tissues, 
identifying these cords as lymphatic vessels without red blood cell components or hemosiderin 
pigments (which if these components had been identified in similar thin-walled vessels would be 
considered veins rather than lymphatics) (Moskovitz, Anderson, Yeung, Byrd, Lawton, & Moe, 
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2001). Although cording is a significant morbidity following breast cancer treatment, it has received 
little attention in the literature (Box, Reul-Hirche, Bullock-Saxton, & Furnnival, 2002). 
Cording is painful and causes a significant reduction in ROM, but the effects of treatment are 
understudied. Moskovitz et al. (2001) investigated the ROM of 750 breast cancer patients over 16 
years, and noted that 44 (6%) of these patients had developed cording and shoulder abduction was 
limited to 90° or less in 74% of patients with cording. Lacomba et al. (2010) assessed 116 women 
with breast cancer following axillary dissection and found that 56 (48%) of them had developed 
cording, and after 12 months of follow-up, the most frequent cause of pain was cording (n = 56), 
followed closely by myofascial pain syndrome (n = 52). The authors suggested that concurrence of 
cording and myofascial pain syndrome experienced in the pronator teres may reflect a protective 
splinting response of the muscle to avoid painful stretching of the tightened lymphatic vessels at the 
elbow (Lacomba, del Moral, Zazo, Gerwin, & Goni, 2010). The influence of cording on the recovery 
of shoulder movement of 65 breast cancer survivors assigned to either physiotherapy (n = 32) or 
control groups (n = 33) post-surgery, of which initially, 21.2% and 37.5% of survivors in the control 
and treatment groups, respectively, had developed cording was assessed by Box et al. (2002). ROM 
recovery for abduction and flexion at 3 months and 6 months were positively influenced by the 
presence of cording during early post-surgery stages, which may reflect the survivors increased 
attention to maintain shoulder movement after an initial difficult recovery post-surgery (Box, Reul-
Hirche, Bullock-Saxton, & Furnnival, 2002). One case study described a patient that had regained 
full ROM immediately post-surgery, but developed cording 1 week later and had reduced ROM 
(135° and 123° of flexion and abduction, respectively) at 2 weeks post-surgery (Tilley, Thomas-
MacLean, & Kwan, 2009). While this patient was being treated (stretched) by a physiotherapist, an 
audible ‘snap’ was heard, and immediately there was a relief of tension and an increase of ROM by 
10° (Tilley, Thomas-MacLean, & Kwan, 2009). Further research is needed to determine the effects 
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of cording on ROM and performance of ADL and work tasks, and safe and effective treatment 
modalities need to be identified. 
Section 2.3.5 Pain 
Pain is commonly experienced by breast cancer patients and survivors. The prevalence of pain in 
patients with early stages of breast cancer that have received BCT or MRM range from 12% to 51% 
(Rietman, et al., 2003). The etiology of pain post cancer treatment varies and can include surgical 
damage, post-surgical complications or complications of radiation and chemotherapy (Lacomba, del 
Moral, Zazo, Gerwin, & Goni, 2010). Pain has been reported to be a side effect of axillary dissection 
(Hack, Cohen, Katz, Robson, & Goss, 1999; Kuehn, et al., 2000; Polinsky, 1994; Rietman, Dijkstra, 
Debreczeni, Geertzen, Robinson, & De Vries, 2004; Sugden, Rezvani, Harrison, & Hughes, 1998)), 
and can be caused by surgical scarring, radiation fibrosis, or intercostobrachial nerve damage 
(Sugden, Rezvani, Harrison, & Hughes, 1998). Pain can last months and even years after surgery 
(Kuehn, et al., 2000), and can affect mood and QoL (Keays, Harris, Lucyshyn, & MacIntyre, 2008). 
 Performance of activity may be restricted due to pain. Pain is worsened during certain 
activities, commonly reported as reaching out, carrying, working with the arm during household or 
handicraft tasks, or sleeping on the operated side (Rietman, et al., 2003). Pain is often reported in 
areas of the neck, arm and shoulder, as well as areas around the operative area and scar (Lauridsen, 
Overgaard, Overgaard, Hessov, & Cristiansen, 2008). Myofascial pain syndrome is a common source 
of pain during the first year post surgery in women undergoing breast cancer surgery that includes 
axillary dissection (Lacomba, del Moral, Zazo, Gerwin, & Goni, 2010). Myofacial pain syndrome is 
caused by active myofascial trigger points which cause hyperirritability and tenderness in palpable 
bands of taut skeletal muscle, which refer pain at a distance (Lacomba, del Moral, Zazo, Gerwin, & 
Goni, 2010). Lacomba et al. (2010) assessed the incidence of myofascial pain syndrome in 116 
breast cancer survivors 12 months post-surgery (axillary dissection and BCT or MRM), and found 68 
survivors reported pain, and the cause of pain was cording in 56 survivors, and myofascial pain 
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syndrome in 52 survivors (Lacomba, del Moral, Zazo, Gerwin, & Goni, 2010). The muscles (and 
incidence) involved with myofascial pain syndrome included: latissimus dorsi (25%), serratus 
anterior (24%), pectoralis major (20.7%), infraspinatus (19%), trapezius (13%), teres major (8.6%), 
teres minor (8.6%), pronator teres (5.2%), levator scapulae (0.9%) and supraspinatus (0.9%) 
(Lacomba, del Moral, Zazo, Gerwin, & Goni, 2010). Pain can restrict or discourage activity and use 
of full ROM, and continued disuse or fearful avoidance of full ROM can lead to further 
developments of ROM restrictions and muscle atrophy, further affecting performance of ADL and 
work. 
Section 2.3.6 Fatigue 
Cancer related fatigue is defined as a persistent and subjective sense of tiredness related to cancer or 
cancer treatment that interferes with usual functioning (National Comprehensive Cancer Network, 
2004). Cancer-related fatigue leads to a reduced capacity for work, causing sufferers to be less 
efficient while completing tasks due to feelings of weariness or tiredness (Stasi, Abriani, Beccaglia, 
Terzoli, & Amadori, 2003). The prevalence of fatigue post radiation ranges from 30% to 80% of 
patients (Jereczek-Fossa, Marsiglia, & Oreccchia, 2001), and ranges from 60% to 90% of patients 
post chemotherapy (Feyer & Steingraeber, 2001). Other reports have suggested that fatigue is the 
most prevalent and debilitating symptoms of breast cancer patients treated with chemotherapy or 
radiation (Mock, et al., 2005), affecting 70% to 100% of patients (Irvine, Vincent, Graydon, Bubela, 
& Thompson, 1994; Jacobsen, Hann, Azzarello, Horton, Balducci, & Lyman, 1999; Longman, 
Braden, & Mishel, 1996), and persisting for months or years (Andrykowski, Curran, & Lightner, 
1998; Broeckel, Jacobsen, Horton, Balducci, & Lyman, 1998). Fatigue can cause a self-perpetuating 
condition such that patients may avoid activity in order to reduce symptoms of fatigue, but the 
resulting physical inactivity may induce muscle wasting and a loss of endurance, leading to easy 
fatigability, which can then discourage further activity as depicted in Figure 13 (Dimeo, Stieglitz, 
Novelli-Fischer, Fetscher, & Keul, 1999; Winningham, et al., 1994). In the fight to combat fatigue, 
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there has been a paradigm shift from encouraging rest, to encouraging exercise (Mock, et al., 2005). 
Aerobic exercise and relaxation training have been effective in improving fatigue of cancer patients 
post-surgery (Dimeo, Thomas, Raabe-Menssen, Propper, & Mathias, 2004), and physical activity and 
stress management education have been shown to improve fatigue, energy and emotional distress 
levels specifically of breast cancer survivors (Fillion, et al., 2008). 
 
Figure 13 Fatigue: a self-perpetuating cycle 
 
Section 2.3.7 Dysfunction progression 
The self-perpetuating cycle of dysfunction is not only related to fatigue, but encompasses many other 
morbidities associated with the breast cancer population. Similar to symptoms of fatigue, pain, 
weakness, lymphedema and restricted ROM can also lead to reduced activity and resultant de-
conditioning, which can result in further fatigue and inactivity. Often breast cancer patients 
undergoing adjuvant therapies become fearful of overexertion and are uncertain as to what they can 
safely perform, therefore they stop doing physical activity – and this inactivity further contributes to 
their debilitation (Segal, et al., 2001). Patients or survivors suffering from reduced mobility may alter 
their upper body posture as they attempt to compensate for their decreased ROM, and these 
compensations may lead to strained muscles and pain, discouraging the performance of activities, 
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and further contributing to disability (Lauridsen M. C., Overgaard, Overgaard, Hessov, & 
Cristiansen, 2008). Figure 14 demonstrates the progressive nature of dysfunction and the many 
variables that may promote the cyclic nature of disability. 
 
Figure 14 Cyclic progression of disability 
 
Section 2.4 Quality of life 
Quality of life is defined as an “individuals’ perception of their position in life in the context of the 
culture and value systems in which they live and in relation to their goals, expectations, standards 
and concerns” (World Health Organization, 1997). The concept of QoL is said to be affected by 6 
broad domains as demonstrated in Table 4. For the purposes and relevance of this thesis only the 





Table 4 Domains and associated facets of QoL. [Table taken from (World Health Organization, 1997).] 
Domain Facets incorporated within domains 
Physical health Energy & fatigue 
Pain & discomfort 
Sleep & rest 




Thinking, learning, memory & concentration 
Level of independence Mobility 
Activities of daily living 
Dependence on medicinal substances & medical aids 
Work Capacity 
Social relationships Personal relationships 
Social support 
Sexual activity 
Environment Financial resources 
Freedom, physical safety & security 
Health & social care: accessibility & quality 
Home environment 
Opportunities for acquiring new information & skills 
Participation in & opportunities for recreation/leisure 
Physical environment (pollution/noise/traffic/climate) 
Transport 
Spirituality/Religion/Personal beliefs Religion /Spirituality/Personal beliefs 
 
Section 2.4.1 Associations between performance of ADL and QoL 
Physical health and an individuals’ level of independence are directly related to each other and to 
QoL. The physical health of breast cancer survivors directly influences their performance of ADL 
and ability to perform work, and therefore, ultimately affects their level of independence. 
Researchers agree that managing symptoms and maintaining or resuming ADL are important 
components of QoL (Ferrell, Grant, Dean, Funk, & Ly, 1996; Graydon, 1994; Kiebert, de Haes, & 
van de Velde, 1991). 
Investigations are scarce regarding the performance of ADL or work in the breast cancer 
population, and the relationship between performance of these activities and QoL are not well 
understood, but documented findings indicate that survivors have difficulty performing ADL and 
work post treatment. Box et al. (2002) investigated the changes in shoulder movement during 
46 
 
functional tasks (e.g. wash contralateral scapula, brush hair, reach overhead, push a grocery cart) of 
65 patients after surgery to determine the effect of elective physiotherapy intervention. Abduction 
ROM returned to preoperative levels more quickly in the treatment group and the treatment group 
had more abduction at 3 months (+14°) and 24 months (+7°) compared to the control group. Mean 
shoulder ROM during functional tasks (assessed with a goniometer) and patient-rated scores of 
performance difficulty (scale of 1 (no difficulty) to 5 (unable to perform the task) indicated a trend of 
increased ratings of performance difficulty with decreased shoulder ROM (Box, Reul-Hirche, 
Bullock-Saxton, & Furnnival, 2002). The mean shoulder ROM of women who rated more than slight 
difficulty with task performance was less than 120° of abduction and ranged from 120° to 140° of 
flexion (Box, Reul-Hirche, Bullock-Saxton, & Furnnival, 2002). Hojris et al. (2000) compared 
subjective and objective measures of shoulder movement impairment and found that objective 
measures revealed 52% of irradiated patients and 15% of non-irradiated patients had some degree of 
impaired shoulder movement, while subjective reports revealed that only 16% of irradiated patients 
and 2% of non-irradiated patients felt their impairments of shoulder function interfered with work or 
daily activities. Wingate (1985) assigned 92 patients to either physiotherapy or control groups post-
surgery, and assessed objective ROM and subjective ratings of performance difficulty (scale of 1 (no 
difficulty) to 5 (unable to perform the task). The physiotherapy group had far less difficulty 
performing functional tasks at 5 days and at 3 months postoperatively, compared to the control 
group, but a substantial percentage of patients in both groups experienced difficulty performing 
functional tasks, as indicated in Table 5. As the 5 and 10 year breast cancer survival rates continue to 
increase, impairments induced by treatment are increasingly important as they may influence 





Table 5 Percentage of patients with difficulty performing functional tasks 5 days and 3 months postoperatively 
[Data taken from (Wingate, 1985).] 
Functional Task 
% at 5 days % at 3 months 
Physiotherapy Control Physiotherapy Control 
Brush hair 34.7 43.9 0.0 2.4 
Sweater over head 65.3 65.9 10.2 17.1 
Pull on pants 26.5 34.1 0.0 4.9 
Fasten bra 32.7 51.2 8.2 19.5 
Back zipper 77.6 97.6 28.6 51.2 
Ipsilateral scapula 40.8 68.3 16.3 26.8 
Contralateral 
scapula 
36.7 65.9 8.0 22.0 
Reach over head 42.9 56.1 8.2 14.5 
Make bed 44.9 61.0 4.1 17.1 
Carry groceries 67.3 85.4 10.2 19.5 
 
Section 2.4.2 Associations between physical health and QoL 
The relationships between physical health (impairments, disabilities) and QoL in the breast cancer 
population are scarcely investigated (Rietman, Dijkstra, Debreczeni, Geertzen, Robinson, & De 
Vries, 2004). The number of chronic symptoms of late morbidity has been significantly correlated 
with anxiety and depression levels (Rietman, Dijkstra, Debreczeni, Geertzen, Robinson, & De Vries, 
2004). Kuehn et al. (2000) emphasized the necessity of reducing functional impairments of the 
shoulder-arm complex since arm problems have a reported greater influence on QoL than the 
alteration of body shape, even in cases of mastectomy.  
QoL has been reported to be associated with patient demographics, work status and physical 
symptoms. Liljegren & Holmberg (1997) proposed that patient age and employment state were 
strongly associated with arm symptoms found in breast cancer patients, and reported that 86% of 
patients  under 65y were employed, suggesting that the patients’ jobs may accentuate their 
symptoms. Voogd et al. (2003) investigated the associations between measures of arm circumference 
and shoulder abduction ROM and QoL in 332 breast cancer survivors approximately 4 years after 
axillary dissection, and found that in 26% of survivors, differences of circumference (>2 cm) and 
reduced ROM (>20°) were strong indicators of complaints (including difficulty performing 
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household chores, more likely to give up hobbies, felt more disabled, and were more likely to be 
treated by a physiotherapist). However, complaints also occurred in women without swelling or 
reduced shoulder abduction, indicating that these physical measures only identify some women 
whose ADL and well-being are affected (Voogd, Ververs, Vingerhoets, Roumen, Coebergh, & 
Crommelin, 2003). Rietman et al. (2003) reviewed the literature to evaluate the relationship of late 
morbidity to ADL in a breast cancer population, and found that there was a significant relationship 
between edema and restricted ROM and subjective assessments of functional impairments. Patients 
who underwent MRM had more difficulty performing ADL than patients who received BCT, but 
certain tasks were difficult for both groups, including: pulling a sweater overhead (20%), bra 
fastening (18%), doing up a back zipper (72%), reaching overhead (16%), and carrying heavy bags 
(29%) (Rietman, et al., 2003). The authors concluded that there is a significant relationship between 
late morbidity, restrictions of ADL and poorer QoL (Rietman, et al., 2003).  
Long-term morbidity negatively affects QoL of the BCP. Long-term (≥ 8 years post-
diagnosis) QoL of breast cancer survivors was compared with similarly aged women who had never 
experienced cancer, and results indicated disease-free survivors reported similar QoL to healthy 
women, except that the survivors reported more arm problems (specifically swelling and decreased 
sensation), worried more about their health and were less satisfied with their sexual life (Dorval, 
Maunsell, Deschenes, Brisson, & Masse, 1998). The authors emphasized that a non-negligible 
proportion of survivors still reported arm problems long-term, at more than 8 years post-diagnosis 
(Dorval, Maunsell, Deschenes, Brisson, & Masse, 1998). Kuehn et al. (2000) assessed the long-term 
morbidity associated with 346 survivors who had received BCT or mastectomies followed by 
axillary node dissections at approximately 32 months post-surgery. Surgery-related arm morbidities 
and fear of cancer recurrence were the most important long-term sources of distress for these 
survivors (29% and 22%, respectively) (Kuehn, et al., 2000). It is well-agreed that managing 
symptoms and maintaining and resuming ADL (physical and functional well-being) are important 
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components of QoL (Cella & Tulsky, 1990; Courneya & Friedenreich, 1997; Ferrell, Grant, Dean, 
Funk, & Ly, 1996; Graydon, 1994; Kiebert, de Haes, & van de Velde, 1991). 
Section 2.5 Exercise effects 
In the last two decades it has become clear that exercise plays a crucial role in cancer prevention and 
control (Courneya & Friedenreich, 2001; World Cancer Research Fund/American Institute for 
Cancer Research, 2007, p. 198-209). Exercise may extend breast cancer survival (Holmes, Chen, 
Kroenke, & Colditz, 2005; Irwin, et al., 2008) and exercise can increase physical functioning of 
patients during cancer treatments (Markes, Brockow, & Resch, 2006). Exercise is effective in 
increasing QoL, improving cardio-respiratory fitness, physical functioning and symptoms of fatigue 
in breast cancer patients and survivors (McNeely, Campbell, Rowe, Klassen, & Mackey, 2006), but 
it is unclear what type, amount, and frequency of exercise is most beneficial for specific outcomes 
(Pinto B. M., Clark, Maruyama, & Feder, 2003). 
Section 2.5.1 Exercise benefits 
Exercise has been proven to be a safe, feasible and beneficial QoL intervention for most BC patients 
and survivors (Courneya, Mackey, & Jones, 2000). There is strong evidence to suggest that aerobic 
exercise can reduce cancer-related fatigue and improve measures of cardiopulmonary function, 
global health, strength, sleep, self-esteem, weight gain, depression, anxiety and QoL (Kirshbaum, 
2006). 
 Exercise positively influences both physical (weight gain, muscle strength, bone density, 
functional capacity) and psychosocial (social, emotional, mental) factors. Obesity is associated with 
an increased prevalence or recurrence of breast cancer and 50% to 96% of women experience weight 
gain during cancer treatment (Vance, Mourtzakis, McCargar, & Hanning, 2010). Weight gain is 
more common in pre-menopausal women that receive chemotherapy (Vance, Mourtzakis, McCargar, 
& Hanning, 2010). A review by Schmitz et al. (2010) examined randomized controlled trials that 
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investigated the effect of exercise to improve body size or body composition during  (6 studies) or 
after (16 studies) cancer treatment, and found that during treatment the majority of studies indicate 
exercise results in significant reductions in percent body fat, body weight or improved lean muscle 
mass. After cancer treatments, the review indicated that about half of the studies demonstrated 
exercise had a positive effect on one or more variables related to body size or composition (Schmitz, 
et al., 2010). Aerobic weight bearing exercise has been shown to attenuate the decline in bone 
mineral density associated with the breast cancer population (Schwartz, Winters-Stone, & Gallucci, 
2007). Bone loss in breast cancer patients may increase the risk of osteoporosis and bone fracture 
(Nikander, Sievanen, Ojala, Oivanen, Kellokumpu-Lehtinen, & Saarto, 2007). Long-term (1 – 2 
year) strength and weight training can increase bone mineral density by increasing the tension on the 
bone and influencing bone formation during remodelling cycles (Twiss, Waltman, Berg, Ott, Gross, 
& Lindsey, 2009). Exercise increases functional capacity of cancer populations (Courneya K. S., 
Friedenreich, Sela, Quinney, Rhodes, & Handman, 2003; MacVicar, Winningham, & Nickel, 1989) 
and breast cancer patients that have received physiotherapy post-mastectomy obtain better functional 
outcomes than those who do not (Wingate, 1985). Conversational interviews with breast cancer 
survivors have revealed that exercise in the form of dragon boat racing contributes to social, 
emotional, physical, spiritual and mental dimensions of health (Parry D. C., 2007; Parry D. C., 
2008). There is little doubt that exercise benefits breast cancer patients and survivors, but due to the 
heterogeneous population represented, differing methodologies, and limited research done in this 
area, it is difficult to attribute causal-effect relationships presently. 
Section 2.5.2 Contraindications to exercise 
 Health contraindications or concerns, motivational and adherence factors may play a role in 
discouraging the BCP from exercising. Frequently a ‘sentinel life event’, such as a cancer diagnosis, 
may initiate self-evaluation of current lifestyle and provide an education opportunity for exercise 
promotion, which may motivate lifestyle change after initial diagnosis or treatment (Demark-
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Wahnefried, Peterson, McBride, Lipkus, & Clipp, 2000; Jones & Courneya, 2002). However, 
exercise adherence (how well individuals adhere to their exercise prescription (Courneya, Mackey, & 
McKenzie, 2002)) is a challenge amongst this population: women who have regularly exercised 
before diagnosis are most prone to maintaining exercise programs (Pickett, Mock, Ropka, Cameron, 
Coleman, & Podewils, 2002). Exercise adherence is challenged by cancer treatment effects and 
resulting sequelae (Ingram, Wessel, & Courneya, 2010), and is influenced by pre-treatment exercise 
levels and readiness to change (Pickett, Mock, Ropka, Cameron, Coleman, & Podewils, 2002), 
motivational interviewing (Bennett J. A., Lyons, Winters-Stone, Nail, & Scherer, 2007), social 
support, goal setting, commitment and self-efficacy (Owens, Jackson, & Berndt, 2009), higher peak 
oxygen consumption, location of exercise centre (convenience), more advanced disease stage and 
less depression (Courneya K. S., et al., 2008). It seems logical that individuals who previously 
exercised regularly (likely representing those with higher peak oxygen consumption levels) would 
continue to do so after diagnosis, and that individuals who have more advanced disease would realize 
the seriousness of their health status and be more motivated to exercise to attempt to battle their 
prognosis. 
 Participation in and adherence to exercise is affected by cancer treatments, health concerns 
or fears and health contraindications. Fears that exercise will exacerbate arm swelling discourages 
some from exercising (Hayes, Reul-Hirche, & Turner, 2008), but several studies have demonstrated 
that exercise is safe and does not exacerbate lymphedema (Ahmed, Thomas, Yee, & Schmitz, 2006; 
Hayes, Reul-Hirche, & Turner, 2008; Schmitz, et al., 2009) and may actually improve lymphatic 
flow (Brennan & Miller, 1998; Mortimer, 1990; Mortimer, 1995; McKenzie & Kalda, 2003). Cancer 
treatments affect performance and adherence to exercise: adherence to a walking program was 
compromised during chemotherapy but improved after this treatment was complete (Swenson, 
Nissen, & Henly, 2010). Jansen et al. (1990) investigated the role of delayed (8 days post-surgery) 
shoulder exercises compared to immediate (1 day post-surgery) on wound drainage after axillary 
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dissection, and found that there was an increased trend toward more wound drainage (14% more; 701 
± 398 mL versus 600 ± 436 mL) with early start exercises, suggesting that exercises regimes start no 
sooner than 8 days post-surgery. Pre-exercise medical assessments should evaluate for peripheral 
neuropathies, musculoskeletal morbidities and cardiac toxicities secondary to cancer treatment, and 
individuals prescribed hormonal therapy should be evaluated for bone metastasis and fracture risk 
(Schmitz, et al., 2010). Exercise testing is not required before walking, flexibility or resistance 
training, and the American College of Sports Medicine guidelines for exercise testing should be 
followed before moderate to vigorous aerobic exercise (Schmitz, et al., 2010). Other factors that 
could warrant exercise prescription modification or cessation are listed in Table 6. 





hemoglobin < 8.0g/dL 
fever > 38° C 





compromised immune function (exercising in 
public areas)* 
chlorine exposure (if skin is irradiated)* 
indwelling catheters (avoid water or other 
microbial exposures)* 
Referenced from (Courneya, Mackey, & McKenzie, 2002) or * from 
(Doyle, et al., 2006)* 
 
Section 2.5.3 Exercise during and after adjuvant treatment 
A multitude of studies have been performed investigating the effects of exercise on various 
physiological measures during and after adjuvant cancer treatments. Several research and review 
papers have demonstrated exercise is safe, feasible and has a positive effect on various measures of 
physical function both during and after adjuvant therapies. Markes et al. (2006) reviewed the 
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literature regarding the effects of exercise on women with breast cancer receiving adjuvant therapy 
and reported that exercise has been found to statistically improve cardio-respiratory fitness, anxiety, 
and sleep disturbances and relieve nausea; however no significant improvements were found for 
fatigue, weight gain, QoL, depression, strength, immune function or mood. However, these results 
are based on a small number of studies, with limited sample sizes and considerable heterogeneity 
between studies (Markes, Brockow, & Resch, 2006). Another review by McNeely et al. (2006) 
similarly concluded that the literature suggests exercise improves cardio-respiratory fitness and has 
no significant effect on weight gain, but also contrarily concluded that exercise improves QoL, 
physical functioning and symptoms of fatigue in breast cancer patients and survivors. McNeely et al. 
(2006) also conceded these findings are based on a small number of studies with significant 
methodological weaknesses. A recent review by the American College of Sports Medicine (Schmitz, 
et al., 2010) reported high quality literature (randomized controlled trials with high internal validity) 
that demonstrated exercise is safe to perform during adjuvant breast cancer treatment (Battaglini, et 
al., 2007; Campbell, Mutrie, White, McGuire, & Kearney, 2005; Courneya & Friedenreich, 2001; 
Courneya, et al., 2008) and significantly improves: 
 aerobic capacity (Adamsen, et al., 2009; Dimeo, Fetscher, Lange, Mertelsmann, & Keul, 1997) 
 muscular strength (Courneya K. S., et al., 2007; Schwartz, Winters-Stone, & Gallucci, 2007) 
 body size and composition (Segal, et al., 2001) 
 QoL (Mutrie, et al., 2007) 
 fatigue (Adamsen, et al., 2009) 
 anxiety (Badger, Segrin, Dorros, Meek, & Lopez, 2007) 
The review by Schmitz et al. (2010) also reported findings from randomized controlled trials of high 
internal validity that demonstrated exercise among survivors (post-treatment) is safe (Ahmed, 
Thomas, Yee, & Schmitz, 2006) and significantly improves: 
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 aerobic capacity (Basen-Engquist, et al., 2006; Bennett J. A., Lyons, Winters-Stone, Nail, & 
Scherer, 2007) 
 strength (Berglund, Bolund, Gustafsson, & Sjoden, 1994) 
 flexibility (Burnham & Wilcox, 2002) 
 body size (Demark-Wahnefried W. , et al., 2007) 
 QoL (Daley, Crank, Saxton, Mutrie, Coleman, & Roalfe, 2007) 
 fatigue (Fillion, et al., 2008) 
 depression (Daley, Crank, Saxton, Mutrie, Coleman, & Roalfe, 2007) 
 anxiety (Burnham & Wilcox, 2002) 
This review also reported other randomized controlled trials with high internal validity that found 
non-significant positive effects or no effect of exercise (Schmitz, et al., 2010).  Table 7 provides an 
overview of evidence regarding the efficacy of exercise interventions for specific outcomes in breast 
cancer patients and survivors (Schmitz, et al., 2010). The conflicting findings and conclusions 
regarding the effect of exercise on breast cancer patients and survivors may be attributed to limited 
research and study limitations including small sample sizes and heterogeneity of samples and 
methodologies. McNeely et al. (2006) recommends methodologically rigorous studies examine 
different exercise regimens to understand the role of physical exercise among breast cancer 
populations, and that these studies include detail regarding the frequency, intensity, time and type of 
exercise, and that consensus be made regarding standardized methods of assessing physical fitness 





Table 7 Overview of evidence regarding efficacy of exercise interventions for breast cancer survivors a [Table taken 







Number of studies reviewed 
b
 21 32 
Safety (no exercise-related adverse 
events reported) 
13 15 
Physical function 2 4 
Physical fitness 
   Aerobic fitness 
   Muscular strength 








Physical activity level 5 8 
Body size (weight, BMI, body 
composition, muscle mass) 
4 8 
Bone health 2 1 
Safety about lymphedema-related 
outcomes 
2 7 
QoL 4 12 
Energy level or vigour/vitality - 3 
Fatigue 4 4 
Sleep 1  
Depression - 3 
Anxiety 3 3 




 numbers in the table reflect the number of studies with a significant positive effect on the 
outcomes listed 
b
 only randomized controlled trials with high internal validity were reviewed 
 
Section 2.5.4 General exercise recommendations 
Appropriate and safe exercise must be prescribed in order for breast cancer patients and survivors to 
benefit from it and adhere to it. Exercise location and format (supervised or self-directed) are equally 
important factors to consider as are frequency, type, intensity and duration of exercise. Finding the 
appropriate combination is highly dependent on individual preference, health, capability, and 
responsibilities at home and work. 
 The majority of cancer survivors prefer unsupervised exercises performed at home (Jones & 
Courneya, 2002). Exercises performed at home are generally cheaper, require less formal equipment 
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and are more convenient and less time consuming. In general, women are more likely to adhere to 
exercises at home and when it is convenient for them (Huberty, et al., 2008). Several studies have 
shown that unsupervised home-based exercises are effective. Mock et al. (1997) found that self-
paced walking programs performed at home helped to manage symptoms and improve physical 
function of breast cancer populations treated with radiation. Home-based walking exercise programs 
have also been shown to be safe and effective in increasing short-term physical activity levels, even 
of individuals who were not previously active on a regular basis (Matthews, et al., 2007). Segal et al. 
(2001) compared the effects of self-directed and supervised exercise to usual care breast cancer 
patients and found that the self-directed exercises group had moderate-large significant increases 
(increased 5.7 points) in physical function (compared to usual care (decreased 4.1 points)) compared 
to smaller improvements (increased 2.2 points) seen in the supervised exercise group (compared to 
usual care), despite adherence being the same between both exercise groups.  
 Various types of exercise including aerobic, resistance and flexibility all provide potential 
benefits to different aspects of health such as cardiopulmonary fitness, muscle and bone strength and 
stretching of tight muscles, tendons or scar tissue, respectively. Women with or at risk of 
lymphedema should wear a well-fitted compression garment during exercise (Schmitz, et al., 2010). 
It has been recommended that survivors start with a supervised exercise program at very low 
resistance, progressing at small increments with no upper limit on the amount of weight to which 
they can progress (Schmitz, et al., 2010). If a break is taken, the level of resistance should be 
decreased by 2 weeks’ worth for every week of rest (e.g. 1 week vacation = back off to resistance 
used 2 weeks ago) (Schmitz, et al., 2010). Specific exercise recommendations are outlined in Table 8 
(Courneya, Mackey, & McKenzie, 2002). To promote psychological health, exercises should be 
included that are enjoyable, help to develop new skills, promote social interaction and that occur in a 
stimulating environment (Courneya, Mackey, & McKenzie, 2002).  
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Table 8 General aerobic exercise recommendations for cancer survivors and early-stage cancer patients. [Table 
taken from (Courneya, Mackey, & McKenzie, Exercise for breast cancer survivors, 2002).] 
Parameter Recommendation & Comment 
Mode Most exercises involving large muscle groups are appropriate, but 
walking and cycling are especially recommended. The key is to 
modify exercise mode based on acute or chronic treatment effects 
from surgery, chemotherapy, and/or radiation therapy. 
Frequency At least 3-5 times/week, but daily exercise may be preferable for 
deconditioned cancer patients performing lighter-intensity and 
shorter-duration exercises 
Intensity Moderate intensity, depending on patient’s current fitness level 
and severity of side effects from treatments. Guidelines include 
50%-75% VO2max or HRreserve, 60%-80% HRmax, or an RPE of 
11-14. HRreserve is the best guideline if HRmax is estimated rather 
than measured. * 
Duration At least 20-30 min of continuous activity, but this goal may 
require multiple intermittent shorter bouts (e.g. 5-10 min) with rest 
intervals in deconditioned patients or those experiencing severe 
side effects of treatment. 
Progression Initial progression should be in frequency and duration. Only 
when these goals are met should intensity be increased. 
Progression should be slower and more gradual for deconditioned 
patients or those with severe side effects of treatment. 
*HRreserve = maximal heart rate (HRmax) minus standing resting heart rate (HRrest). Multiply 
HRreserve by 0.60 and 0.80. Add each of these values to HRrest to obtain the target heart rate 
range. HRmax can be estimated as 220 minus age in years. 
HR = heart rate; RPE = rating of perceived exertion 
 
Section 2.6 Unknown aspects of breast cancer survivorship addressed by this 
thesis 
In summary, the breast cancer research literature demonstrates that upper arm dysfunction is 
a common and serious consequence of cancer treatment among the breast cancer population. It 
demonstrably adversely affects independence and function. However, the specific upper limb 
capabilities and dysfunction in terms of 3-dimensional kinematics, muscle activation and muscle-
specific strength of this population during ROM, ADL and work are inadequately described. 
Quantitative detail and description of survivor joint motion, muscle strategies and strength will help 
identify differences (indicative of dysfunction) between healthy and affected sides, which will be 
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useful in recommending more focused and accurate treatment and preventative therapies. The main 
unascertained themes in literature relating to the purposes of this thesis are as follows: 
1. Lack of standardized assessments and quantification of upper limb morbidities, including: 
a. 3-D upper limb ROM 
b. muscle activation (EMG) 
c. muscle-specific strength (defined as maximal force production during functional 
exertions) 
2. The relationship between physical dysfunction (in terms of muscle activation) and QoL and 
disability scores are unknown. 
3. Specific exercises which are appropriate and beneficial to breast cancer survivors are 
unidentified. 
This thesis aims to directly address the first two gaps in literature, and the findings from this research 
will be used in the future to address the third gap of determining appropriate exercises for this 
population. 
 Breast cancer survivors are a challenging population to research. Investigating cancer 
survivors is difficult as the group is extremely heterogeneous in terms of their demographics, 
behavioural profiles, disease pathology, treatment protocols and symptoms (McNeely, Campbell, 
Rowe, Klassen, & Mackey, 2006). This population generally feels unwell and has limited time or 
energy for activities outside of their medical treatment, and therefore, recruitment is difficult and 
most studies have a limited sample size and significant attrition of participants. Comparisons 
between studies are difficult to make due to differing methodologies, heterogeneous groups and 
methodological weaknesses (e.g. failure to blind participants and researchers during randomized 
controlled trials). Late morbidity may interfere with ADL and QoL, but it is not clear how strong the 
relationships are between late morbidity (pain, edema, decreased ROM, weakness) and ADL and 
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QoL (Rietman, et al., 2003). It is not known what type, duration, intensity or frequency of exercise is 
most beneficial for specific health and physical functioning outcomes in the breast cancer population 
(Courneya, Mackey, & McKenzie, 2002; Pinto B. M., Clark, Maruyama, & Feder, 2003). Current 
programs in cancer rehabilitation are mainly focused on psychotherapy or social support and do not 
address the physical limitations faced by this population (Mutrie, et al., 2007). Determining the role 
of different exercise regimens (McNeely, Campbell, Rowe, Klassen, & Mackey, 2006) and exercise 
prescription for breast cancer survivors are important for future research (Courneya, Mackey, & 
McKenzie, 2002).  
 Upper limb morbidity has rarely been accurately documented (Thompson, Air, Jack, Kerr, 
Rodger, & Chetty, 1995) but few studies have investigated the mechanisms of change or the 
mediating mechanisms between exercise and QoL of breast cancer survivors (Courneya K. S., 
Friedenreich, Sela, Quinney, Rhodes, & Handman, 2003). There is substantial variability in the 
instruments used for assessing impairments, and no standardized criteria exist for identifying pain, 
ROM, arm volume, or muscle strength impairments (Rietman, et al., 2003). Current quantitative 
measures of physical capacity of breast cancer populations consist of basic evaluations, such as 
manual goniometric measures of joint ROM. Only three groups have investigated 3-D scapular 
kinematic during basic motions of flexion, abduction and scaption (Borstad & Szucs, 2012; Crosbie, 
et al., 2010; Shamley, Srinaganathan, Oskrochi, Lascurain-Aguirrebena, & Sugden, 2009; Shamley, 
Lascurain-Aguirrebena, Oskrochi, & Srinaganathan, 2012) and only two groups have reported 
electromyographic measures (during a writing task and during scaption) on this population (Galiano-
Castillo, Fernandez-Lao, Cantarero-Villanueva, Fernandez-de-las-Penas, Menjon-Beltran, & Arroyo-
Morales, 2011; Shamley, et al., 2007; Shamley, Lascurain-Aguirrebena, Oskrochi, & Srinaganathan, 
2012). Limited information regarding kinematics, electromyography, muscle-specific strength or 
muscle coordination has been documented or related to ADL or work on this population. No known 
theoretical modelling attempt has assessed internal/external rotation muscle strategies demonstrated 
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by breast cancer survivors. This thesis aims to address these gaps in literature by thoroughly and 
accurately quantifying the capabilities and dysfunction of breast cancer survivors both empirically 
and theoretically. The specifics regarding methodology of biomechanical procedures used to 




Chapter 3 General review of biomechanical methods and research 
considerations 
This chapter provides a summary of the biomechanical methodological procedures, justifying their 
use through a review of literature of previously used, currently recommended, or identified 
inadequate techniques. 
Section 3.1 Data acquisition from a breast cancer population 
Data acquisition from the BCP introduces challenges absent in collections from healthy persons. 
Ability and endurance of this population is compromised due to the primary disease and associated 
treatment morbidities. Collections intentionally focused on safe and feasible measurements that 
accommodated for individual needs (e.g. rest periods), while specific and novel data was acquired 
(e.g. intramuscular EMG, 3-D kinematics, strength) during a wide range of tasks and intensities (total 
of 142 exertions).  
Section 3.1.1 Population precautions 
Precautions must be taken against spreading infections when performing research on a breast cancer 
population. This population has a compromised immune system due to their cancer treatments and 
are therefore susceptible to infection. Such acquired infection (e.g. common cold) could 
traumatically and dramatically deteriorate their health. Precautions were taken to ensure that 
participants were not exposed to any known acquired illnesses. A sign outside the laboratory was 
posted to alert people that were knowingly ill (cold or flu-like symptoms) to stay out of the room. 
Hand sanitation stations were placed in the laboratory, so that the participant and researchers could 
regularly sanitize their hands to avoid the spread of germs. Intramuscular electrode insertions were 
performed under sterilized conditions, as is discussed in more depth in the corresponding study 
methodology. Ethics was received from the University of Waterloo Office of Research Ethics, and 
permission was granted from the Grand River Hospital. In principle, these participants were not 
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exposed to any additional immune risk than would be associated with having blood taken at the 
doctors’ office. 
 Cancer survivors are a heterogeneous population in terms of their demographics, behavioural 
profiles, disease pathology, treatment protocols and symptoms (McNeely, Campbell, Rowe, Klassen, 
& Mackey, 2006). As such, each individual had different health concerns and physical limitations 
and levels of endurance. The experimental protocol was modified according to the specific needs of 
each participant, including provision of appropriate rest periods or negating performance of certain 
study elements (e.g. adjusting positioning of testing for comfort, declining insertion of intramuscular 
electrodes) if the participant was unable or unwilling to perform them. One-repetition maximum 
strength tests have been shown to be safe amongst the breast cancer population, even those with or at 
risk of lymphedema (Schmitz, et al., 2010). However, if these or other measures were painful or 
uncomfortable for the participant, or if additional risks prohibited a specific activity (e.g. increased 
risk of fracture), commensurate accommodations (modifications or neglect) were made. 
Deliberate timing of recruitment was important to ensure survivors were at low risk of 
infection during participation in the study. Breast cancer survivors were recruited at least 3 months 
following adjuvant treatments. This time should have allowed survivors to start regaining their health 
such as increased immune response and decreased skin sensitivities caused by radiation. In previous 
work, ‘recent’ breast cancer survivors were considered those that are 4-36 months post adjuvant 
therapy (Schmitz K. H., Ahmed, Hannan, & Lee, 2005). In this thesis distinctions were not made 
between survivors and end-range of post adjuvant therapy, due to recruitment complications and lack 
of participant availability. Adjustments have been made in previous work to accommodate for 
recruitment issues. Sandel et al. (2005) initially recruited breast cancer patients who had surgery 18 
months prior, but had trouble recruiting enough participants so later extended their criteria to 5 years 
post-surgery to attain an appropriate sample size. Further, these authors did not exclude participants 
with differing treatment regimens (surgery type, chemotherapy, radiation etc.), as obtaining 
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homogenous groups within this population is extremely difficult and would take a tremendous 
amount of resources and time. This thesis similarly involved a wide inclusion criteria and narrow 
exclusion criteria so as to promote recruitment. 
Section 3.1.2 Range of motion measurement 
 Range of motion among a breast cancer population has most commonly been reported via 
subjective measures (Lauridsen, Overgaard, Overgaard, Hessov, & Cristiansen, 2008) or by physical 
examination using goniometry (Box, Reul-Hirche, Bullock-Saxton, & Furnnival, 2002; Hack, Cohen, 
Katz, Robson, & Goss, 1999; Nesvold, Dahl, Lokkevik, Mengshoel, & Fossa, 2008; Rietman, 
Dijkstra, Debreczeni, Geertzen, Robinson, & De Vries, 2004; Ryttov, Holm, Qvist, & Blichert-Toft, 
1988; Sugden, Rezvani, Harrison, & Hughes, 1998; Swedborg & Wallgren, 1981; Tasmuth, von 
Smitten, Hietanen, Kataja, & Kalso, 1995). Often only a single motion is assessed (e.g. shoulder 
abduction) and is assumed to be indicative of restricted shoulder motion, even though there is 
evidence that some patients can have full abduction, but decreased flexion ROM (Lauridsen, 
Overgaard, Overgaard, Hessov, & Cristiansen, 2008). This emphasizes the importance of assessing 
several planes of shoulder motion. It appears that only three groups have recorded 3-D kinematics of 
this population, which included scapulothoracic motion during scaption (humeral elevation in the 
scapular plane), flexion and abduction (Borstad & Szucs, 2012; Crosbie, et al., 2010; Shamley, 
Srinaganathan, Oskrochi, Lascurain-Aguirrebena, & Sugden, 2009). Three-dimensional motion 
tracking to record kinematics is essential to obtain accurate assessments of ROM. It is difficult to 
visually assess and quantify the highly dynamic 3-D motions of the shoulder, including 
scapulothoracic angles (scapular winging is a potential complication amongst the breast cancer 
population (Lauridsen, Torsleff, Husted, & Erichsen, 2000)). 
Accurate assessment tools and standardized definitions of functional ROM are needed in 
order to achieve consistent inter-subject measures of ROM and allow for comparisons between 
studies. There is some consensus that ‘functional’ shoulder ROM (ROM required to perform most 
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ADL) is defined as 145° abduction, 160° flexion and 80° degrees external rotation (Ryttov, Blichert-
Toft, Madsen, & Weber, 1983; Ryttov, Holm, Qvist, & Blichert-Toft, 1988; Gerber, et al., 1992). 
However, there is considerable disagreement in the literature as to what defines impaired ROM. 
Nesvold et al., (2008) claimed clinical experience revealed that a decreased ROM of 10° - 20° did 
not limit ADL, and therefore chose ≥25° difference of affected arm to non-affected side as the 
definition of impaired shoulder function. Box et al. (2002) defined shoulder impairment as a post-
operative loss of 20° of shoulder abduction or flexion. Rietman et al. (2004) defined impaired ROM 
as ≥20° difference between sides, whereas Ryttov et al. (1988) defined impaired ROM as <170° of 
shoulder flexion or abduction. Sugden et al. (1998) defined functional impairment to be >90% when 
ipsilateral movement is divided by contralateral movement. Much smaller changes in scapular 
kinematics have been reported to be clinically meaningful by Shamely et al. (2009) (10° increase in 
scapular protraction) and Borstad & Szuks (2012) (11.5° increase in scapular protraction). Lack of 
consensus regarding the definition of functional impairment makes it difficult to make comparisons 
between studies regarding the physical capability of the breast cancer population. For this thesis, a 
definition of impairment will be defined as a significant difference in degrees between health and 
affected sides. 
 This thesis used 3-D motion capture to record scapulothoracic and humerothoracic kinematic 
measures of the BCP. Assessments included motions in several planes, including measures of 
flexion, extension, abduction, external and internal rotation, as well as a variety of functional ADL 
and work tasks. Measures of this detail and accuracy, in this number of planes and for such a 
diversity of active tasks is unprecedented within the BCP. 
Section 3.1.3 Muscle activation measures 
Very little is known about shoulder muscle activation amongst the breast cancer population. Only 
two groups have investigated surface EMG of the BCP. Galiano et al. (2011) recorded surface EMG 
from the sternocleidomastoid, upper trapezius and deltoid during a functional writing task and 
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reported increased activation of the upper trapezius bilaterally (up to 20% and 4% increases on 
affected and unaffected side, respectively) and sternocleidomastoid muscles (up to 31% increase on 
affected side) of survivors compared to a healthy control group. Shamley et al., (2007) investigated 
surface EMG of the pectoralis major, pectoralis minor, rhomboid and serratus anterior of the BCP 
performing scaption. The authors indicated that there was a general loss of muscle activity of the 
affected arm during humeral elevation (significant loss on downward movement of arm; greatest loss 
at the highest point of elevation) compared to the unaffected arm, which would concur with 
diminished ability to perform ADLs. However, the interpretation of these results is difficult because 
EMG was not normalized; rather comparisons were made based on frequency of data points above or 
below those from the muscles of the unaffected contralateral arms. Past work has demonstrated 
because of the inherent signal variability, surface EMG requires normalization for physiologic 
interpretation and comparison between bilateral muscles and between the same muscle at different 
time points or across participants (Lehman & McGill, 1999). Later, Shamley et al. (2012) re-
examined normalized muscle activity of pectoralis major, serratus anterior, rhomboids and upper 
trapezius during scaption of a BCP with mastectomy or wide local excision. With the exception of 
upper trapezius in the mastectomy group, the authors reported an increase in activity of all muscles 
on the left affected side of patients with either mastectomy or wide local excision compared to the 
left side of a healthy control group; and reported greater activation of the upper trapezius, rhomboids 
and serratus on the right affected side of patients with mastectomy compared to the right side of a 
healthy control, suggesting the BCP was working at a higher level of percent capability. Shamley et 
al. (2012) also reported a decrease in pectoralis major activity and an increase in serratus anterior 
activity on the affected side compared to the unaffected side. 
Section 3.1.3.1 Intramuscular electrodes 
EMG has not been recorded directly from the rotator cuff within the breast cancer population, but has 
been recorded from some surrounding shoulder musculature via surface electrodes (Galiano-Castillo, 
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Fernandez-Lao, Cantarero-Villanueva, Fernandez-de-las-Penas, Menjon-Beltran, & Arroyo-Morales, 
2011; Shamley, et al., 2007; Shamley, Lascurain-Aguirrebena, Oskrochi, & Srinaganathan, 2012). 
Thompson et al., (1995)  suggested that the reduction in mobility may reflect damage to the rotator 
cuff muscles. Due to the depth and small size of these muscles, intramuscular electrodes are the gold 
standard for obtaining muscle activity information. The author of this thesis received intramuscular 
electrode training and a note of delegation from a medical doctor to perform this task without 
medical supervision. The author of this thesis also received ethics consent from the University of 
Waterloo Office of Research Ethics to perform this task. This thesis work incorporated intramuscular 
EMG measures of rotator cuff muscles, and surface EMG measures of other shoulder, neck and trunk 
muscles of healthy participants and breast cancer survivors. 
Section 3.1.3.2 Co-activation quantification 
This thesis described the empirical co-activation relationship between humeral internal and external 
rotators in healthy and breast cancer survivor populations. Co-activation has been measured between 
antagonist and agonist muscles at the ankle (Granata, Wilson, Massimini, & Gabriel, 2004), knee 
(Kellis, Arabatzi, & Papadopoulos, 2003; Kingma, Aalbersherg, & van Dieen, 2004), trunk (Lee, 
Rogers, & Granata, 2006) and elbow (Brookham, Middlebrook, Grewal, & Dickerson, 2011; 
Doheny, Lowery, Fitzpatrick, & O'Malley, 2008; Gottlieb, 1998; Praagman, Chadwick, van der 
Helm, & Veeger, 2010; Solomonow, Guzzi, Baratta, Shoji, & D'Ambrosia, 1986). Co-activation 
occurs for the purposes of limb or end effector motion control, joint or whole body stabilization and 
limb stiffness (Granata, Wilson, Massimini, & Gabriel, 2004; Latash, 1992; Milner & Cloutier, 1993; 
Zhang & Eymer, 1997). In biomechanical modeling, optimization procedures often involve 
simplifying assumptions, including that the body selectively activates specific muscles for a given 
activity according to some criterion (for example, minimum muscle stress or minimum physiological 
cost) (Crowninshield & Brand, 1981). In the mathematical formulation of these objective functions, 
antagonistic contraction is counterproductive - producing moments that do not contribute to 
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production of the required net joint moments, but increasing physiological cost. Therefore, 
optimization models that apply efficiency-based objective functions often negate or underestimate 
antagonist co-activation (Collins, 1995; Dickerson, 2008; Hughes & Chaffin, 1988; Zajac & Gordon, 
1989). Defining and applying co-activation relationships to biomechanical models could potentially 
improve model predictions, and could have additional utility for identifying muscular activation 
changes in a patient population compared to a healthy group. Identification of specific co-activation 
changes within breast cancer survivors could direct preventative and therapeutic interventions and 
define differential strategies of this population. 
 Co-activation index ratios were calculated to determine the relative activation of humeral 
internal rotation activation to internal and external rotation about the shoulder. A similar ratio was 
described by Kellis et al., (2003), and was used previously to describe co-activation at the elbow 
(Brookham, Middlebrook, Grewal, & Dickerson, 2011). A secondary ratio was calculated which was 
weighted according to physiological cross-sectional area (PCSA) for each respective muscle. PCSA 
data has been measured directly (Fick, 1911; Poppen & Walker, 1978; Shiino, 1913) and calculated 
(Bassett, 1983; Fick, 1911; Howell, Imobersteg, Segar, & Marone, 1986; Wood, Meek, & Jacobsen, 
1989) in past literature. Veeger et al., (1991) compares PCSA data for shoulder muscles across 
studies as demonstrated in Table 9. PCSA data inserted into the weighted co-activation ratios was 
from Veeger et al., (1991) and van der Helm (1994). 
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Table 9 Comparison of shoulder muscle PCSA data for past literature. [Table duplicated from Veeger et al., (1991)] 
 
This thesis focused on simplified co-activation of the shoulder: including internal and 
external rotators. The internal rotators (specifically the pectoralis major), located on the anterior 
aspect of the chest, are most likely to be affected in a breast cancer population due to the directed 
radiation field and location of surgery. Radiation can cause secondary damage to adjacent healthy 
tissues which may affect muscle contraction efficiency. Damage to the internal rotators may result in 
significant changes in the co-activation relationships between internal and external rotation activity. 
Determination and investigation of theses co-activation relationships has not yet been examined 
among breast cancer survivors. 
Section 3.1.4 Lymphedema measures 
Arm volume measurements can be used to monitor edema and the incidence of lymphedema. The 
gold standard for arm volume measurement is the water displacement method (Lette, 2006). Often 
edema is quantified using circumference measurements of the arm at different levels, but this 
measurement type is unreliable because of inter-subject variability of arm shape and differences in 
arm shape before and after swelling (Swedborg & Wallgren, 1981), and inaccurate measures due to 
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tape constriction (Petrek & Heelan, 1998). Water displacement is more accurate but rarely used 
(Petrek & Heelan, 1998). Water displacement arm volumeters are commonly large, cumbersome, 
fragile and expensive, and often inaccessible to patients (Lette, 2006). Lette (2006) designed a simple 
and inexpensive water displacement arm volumeter to measure arm volume, and found it to be a 
highly accurate measure of volume. This thesis work has duplicated Lette’s (2006) design and 
constructed two arm volumeters and tested their accuracy with known volumes. These volumeters 
were used to measure arm volume of breast cancer survivors as demonstrated in Figure 15. 
 There is some variation in volumetric measuring procedures used in literature. In particular, 
the depth to which the arm is inserted within a volumeter varies between studies. Lette (2006) 
recommended participants insert their straight arm until the middle finger reached the bottom of the 
volumeter. Lane et al., (2005) and McKenzie & Kalda (2003) had participants insert the arm until a 
depth of 45 cm proximal to the styloid process of the ulna. Lane et al., (2005) recommended 
participants slowly immerse the arm and measure the displaced water (read on a graduated cylinder 
as the volume to the nearest 10 mL) once the water drips less than once per second. On the contrary, 
Lette (2006) recommends weighing the displaced water, assuming the amount of water displaced is 
equivalent to its volume (1 L of water weighs 1 kg), since it is difficult to purchase large enough jugs 
with precise graduations and smaller variations in volume are more easily and accurately gauged by 
weighing. In this thesis, the participant’s arm was immersed until 20 cm above the lateral epicondyle, 
and the displaced water was weighed on a balance that was accurate to 0.01 g.  
 The definition of lymphedema varies between studies. Nesvold et al. (2008) defined 
lymphedema as ≥10% volume difference between arms or >2 cm increase of any circumference 
measure compared to the opposite arm, and defined severe lymphedema as >20% volume difference 
between arms. Similarly, Rietman et al. (2004) and Sugden et al. (1998) defined lymphedema as a 
volume difference between arms of ≥10%. Ryttov et al. (1988) defined lymphedema as ≥2.5 cm 
circumference difference between arms. Upper limb volume increases of 200 mL are considered 
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clinically significant and potentially disabling (Kissin, Querci della Rovere, Easton, & Westbury, 
1986; Hoe, Iven, Royle, & Taylor, 1992; Tracy, Reeve, Fritzsimmons, & Rundle, 1961). In this 
thesis, volume was recorded for all participants, and lymphedema was defined as ≥200 mL 
difference between arms. 
 
Figure 15 Arm volumeter used to measure arm volume via water displacement. Instrument designed by Lette 
(2006). 
 
Section 3.1.5 Strength measures 
Measures of muscle-specific strength, especially around the shoulder, within a breast cancer 
population have not been adequately quantified and lack of standardization in the measures makes 
comparisons between studies challenging. A review by Rietman et al. (2003) revealed that strength is 
commonly assessed using grip strength data or through subjective reports of weakness. Impaired grip 
strength has been defined as ≥10% difference between sides (Rietman, Dijkstra, Debreczeni, 
Geertzen, Robinson, & De Vries, 2004). Muscle strength has been assessed using submaximal 
muscle endurance protocols that predict one-repetition maximum during leg extension, seated leg 
curl, lateral pull down and seated chest press exercises (Battaglini, et al., 2007). Muscle strength has 
been defined as the peak torque achieved divided by participant body weight during hip, knee and 
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wrist flexion/extension, and mean baseline values for 249 postmenopausal breast cancer survivors 
have been determined (Twiss, Waltman, Berg, Ott, Gross, & Lindsey, 2009). This thesis determined 
muscle-specific strength measures (maximal force achieved during manual muscle tests found to 
maximally functionally isolate specific muscles) of breast cancer survivors. These forces were 
recorded with a hand-held digital dynanometer. Previous work by Brookham et al., (2010) has 
defined manual muscle testing positions which maximally functionally isolate the rotator cuff 
muscles, and also identified a variety of position-modified tests. These tests may be appropriate to 
use with breast cancer survivors with reduced ROM, who are not able to move into standard 
recommended muscle testing positions. 
Section 3.1.6 Quality of life measures 
There is no standardized method for assessing QoL of the breast cancer population, and often tools 
that are used are not validated. A review by Rietman et al. (2003) reviewed ADL and QoL among a 
breast cancer population and found that these measures were often assessed with questionnaires and 
rating scales, but that the tools were often not validated or reliable instruments. Another limitation to 
findings regarding QoL is often attributed to a lack of statistical power. One work that investigated 
the relationship between QoL and physical impairments cautioned against interpretation of the 
associations made (pain, grip strength and arm volume predicted QoL) due to a low sample size and 
lack of statistical power (Rietman, Dijkstra, Debreczeni, Geertzen, Robinson, & De Vries, 2004). 
Many studies are based on physical measures, but fail to ask patients how physical complaints affect 
their performance of ADL, including tasks at work, home, sports and hobbies (Voogd, Ververs, 
Vingerhoets, Roumen, Coebergh, & Crommelin, 2003). The Functional Assessment of Cancer 
Therapy – Breast (FACT-B) questionnaire is a multidimensional health-related QoL instrument 
designed specifically for breast cancer populations which has been proven to be a valid and reliable 
tool that is easy to administer, doesn’t take long to complete and is sensitive to change (Brady, et al., 
1997). The FACT-B has been used extensively in studies (Campbell, Mutrie, White, McGuire, & 
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Kearney, 2005; Courneya K. S., Mackey, Bell, Jones, Field, & Fairey, 2003; Daley, Crank, Saxton, 
Mutrie, Coleman, & Roalfe, 2007; Mutrie, et al., 2007; Sandel, Judge, Landry, Faria, Ouellette, & 
Majczak, 2005; Segal, et al., 2001; Vallance, Courneya, Plotnikoff, Yasui, & Mackey, 2007) and 
baseline FACT-B scores for 377 breast cancer survivors are reported by Vallance et al., (2007). 
These baseline scores were used to compare the baseline FACT-B scores obtained in the present 
thesis work. This current thesis work incorporated a detailed medical history questionnaire, a 
disability questionnaire (QuickDASH) and a FACT-B quality of life questionnaire. 
Section 3.2 Biomechanical modeling 
Biomechanical models are useful for predicting moments, joint and muscle forces that cannot 
feasibly be empirically measured. Link-segment models can be implemented to calculate these 
parameters using inverse methods. Numerical optimization approaches are commonly used to 
determine moment load sharing amongst muscles. 
Section 3.2.1 Link-segment models 
Link-segment modelling is the process by which net joint forces and moments are calculated 
(Winter, 2009). Five assumptions are commonly associated with link segment models, as outlined by 
Winter (2009): 
1. Each segment has a fixed mass located as a point mass at its centre of mass (COM). 
2. The location of each segment’s COM remains fixed (relative to the segment) during 
movement. 
3. The joints are considered hinge or ball-and-socket joints. 
4. The mass moment of inertia of each segment is about its mass centre or either proximal or 
distal joints, and is constant during movement. 
5. The length of each segment remains constant during movement. 
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Gravity, external forces and muscle and ligament forces act on the link-segment model. However, 
often the contribution of passive structures is ignored as these are incompletely described across 
postures, especially at the shoulder (Veeger & van der Helm, 2007). The situation is simplified by 
replacing every force that acts across the joint with an equivalent force and moment about a common 
axis (Robertson, Caldwell, Hamill, Kamen, & Whittlesey, 2004). Muscle forces are the main 
contributors to net moments as ligament and bone-on-bone forces contribute mainly during end 
ROM (Robertson, Caldwell, Hamill, Kamen, & Whittlesey, 2004). In this thesis a previously-built 
optimization-based muscle force prediction model of the shoulder, termed the Shoulder Loading 
Analysis Modules (SLAM) (Dickerson, 2005; Dickerson, Chaffin, & Hughes, 2007; Dickerson, 
2008) was modified to include co-activation constraints and strength inputs determined from the 
BCP, during static postures of humeral IR and ER exertions. The force equilibrium calculation, 
derived from the linear form of Newton’s second law of motion was applied for each segment using 
the equilibrium for each segment as described in Equation 1. 
Equation 1 Force equilibrium calculation. Where F are the forces; m is the mass of segment and a is the acceleration 
of segment COM. External forces are the hand forces and weights of the segments. Solving the resulting equation 
achieves the external joint load at each proximal joint segment. 
∑ 𝐹 = 𝑚𝑠𝑒𝑔𝑚𝑒𝑛𝑡 × 𝑎𝐶𝑂𝑀,𝑠𝑒𝑔𝑚𝑒𝑛𝑡 
To calculate moment values, the angular analog of Newton’s second law is applied to each segment 
as shown in Equation 2: 
Equation 2 Moment equilibrium calculation. Where M is external moment and Ḣ is the rate of change of segmental 
angular momentum. Ḣ is calculated based on segmental moments of inertia and the segmental velocities and 
accelerations. External moments are calculated based on the cross products of the produced forces and their 
moment arms. Moments are calculated at the proximal ends of each segment. 
∑ 𝑀 = ?̇? 
Static equilibrium equations (Equation 3, Equation 4)  were applied in the link-segment model to 
solve for net segmental forces and moments, which represented the summed effect of all structures 
producing moments and force across the joint. These equilibrium equations were solved using 
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inverse simulations, and allowed for the determination of muscle force, which could be compared 
with experimental EMG recordings. 
Equation 3 Translational equilibrium equation. Where Fm,i are the muscles active on segment i, Ji-1 is the joint 
contact force on the distal joint, Ji is the joint contact force on the proximal joint and FE are any external forces 
unaccounted for in the previous segmental calculations. 
∑ 𝐹𝑚,𝑖 +  𝐽𝑖−1 + 𝐽𝑖 = ∑ 𝐹𝐸 
Equation 4 Rotational equilibrium equation. Where mai is the moment arm of the i
th muscle, Fm,i are the muscles 
active on segment i, Mi-1 is the moment acting about the distal joint, Mi is the moment acting about the proximal 
joint and ME are any external moments unaccounted for in the previous segmental calculations. 
∑(𝑚𝑎𝑖 × 𝐹𝑚,𝑖) + 𝑀𝑖−1 + 𝑀𝑖 = ∑ 𝑀𝐸 
 
Section 3.2.2 Inverse solutions 
The majority of kinetic analysis of human movement has been performed using inverse dynamics 
(Winter, 2009). Inverse simulations are performed when kinematics, anthropometric measures and 
external forces are known or measured, resulting in the calculation of joint reaction forces and 
moments. In this thesis, the force produced at the hands was measured with a force transducer, 
individual anthropometrics (segment lengths and body mass) were measured for each participant, and 
segment parameters (segment mass, COM locations, muscle moment arms, and PCSA values) were 
determined from a previously described upper limb model termed Shoulder Loading Analysis 
Modules (SLAM) (Dickerson, 2005; Dickerson, Chaffin, & Hughes, 2007; Dickerson, 2008). In a 
dynamic model linear and angular accelerations would normally be calculated by double 
differentiating positional data, which can be recorded with motion capture, or assumed with 
goniometric confirmation. In this thesis, linear and angular accelerations were zero, as static 
positions were assumed, and goniometry was used to determine these static joint positions. A 
graphical depiction of traditional inverse simulation methods adapted from Buchanan et al., (2004), 




Figure 16 Traditional inverse simulation procedures (top) and inverse-type simulation (bottom) performed in this 
thesis [gray area represents steps excluded]. 
 
Muscle force is most simply determined by assuming a single-muscle equivalent model, 
during which only one muscle or group of muscles with one line of action and moment arm is 
assumed to actuate the movement at the joint (e.g. only the biceps is assumed to contribute to elbow 
flexion). This assumption does not allow for consideration of other contributing muscles, including 
antagonistic muscles that do not contribute to the net joint moment. This assumption is not always 
appropriate, particularly, at the glenohumeral joint where there are 6 degrees of freedom and many 
muscles crossing the joint. To improve physiological realism, a model should include other muscle 
contributions, including co-activation of antagonistic muscles, in the determination of net joint force. 
In Study 4 of this thesis, 38 muscle portions were modeled, of which seven muscles (11 muscle 
portions) were used to create the co-activation constraint and from which predicted muscle forces 
were compared directly with experimentally recorded EMG. In order to determine load sharing 
between muscles, an optimization approach was used. 
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Section 3.2.3 Optimization 
Estimating muscle force at the glenohumeral joint is difficult because the solution is indeterminate, 
meaning that there are more unknowns (many muscles contributing to the net moment) then there are 
independent equations. Many models use optimization at various joints to determine muscle force 
(Crowninshield & Brand, 1981; Dickerson, Chaffin, & Hughes, 2007; Hughes, Bean, & Chaffin, 
1995). Optimization assumes that the musculoskeletal system allocates certain muscles to generate 
the required net muscle moment in a mathematically describable manner, which usually involves 
minimizing some objective function, such as physiological cost (Dickerson, 2008b). The objective 
function used in this thesis was the minimization of the sum of the cubed muscle stresses, as has been 
used previously in the lower extremity, elbow and shoulder (Crowninshield & Brand, 1981; 
Brookham, Middlebrook, Grewal, & Dickerson, 2011; Dickerson, Chaffin, & Hughes, 2007). This 
simplifying assumption assumes that antagonistic contraction is counterproductive, producing 
moments that do not contribute to the net joint moment while increasing physiological cost. 
Therefore, optimization models that apply efficiency-based objective functions often underestimate 
or negate antagonistic co-activation (Collins, 1995; Dickerson, 2008b). Co-activation occurs for the 
purposes of limb or end effector motion control, stabilization and stiffness (Granata, Wilson, 
Massimini, & Gabriel, 2004; Latash, 1992; Milner & Cloutier, 1993; Zhang & Eymer, 1997). Co-
activation occurs at the shoulder as previous literature has reported that the rotator cuff muscles are 
simultaneously active and cannot be independently isolated (Brookham, McLean, & Dickerson, 
2010). Therefore, to improve physiological realism, optimization procedures were used to determine 
load sharing amongst muscles and survivor humeral rotator co-activation relationships (determined 
from Study 3) were added as constraints to this model. A similar study has enforced 
flexion/extension co-activation constraints in a 2-D model of the elbow (Brookham, Middlebrook, 
Grewal, & Dickerson, 2011). The constraints will enforce an a priori level of humeral rotator co-
activation during optimization. Prediction accuracy will be evaluated by correlating muscle force 
predictions to empirical measurements of muscle activity and determining magnitude differences 
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between predicted muscle levels and measured EMG. This analysis was similar to that performed by 
Dickerson et al. (2008) during which model muscle force predictions were compared with 
experimentally collected EMG from a healthy population. Comparisons of muscle force predictions 
to empirically measured EMG is a form of face validation, during which the model outcomes are 
compared to the expected behavior with respect to past historical data (Lewandowski, 1982). These 
methods describe a careful attempt to simulate muscle strategy related to muscle dysfunction in a 




Chapter 4 Study 1 – Quantification of upper limb capabilities and 
dysfunction of breast cancer survivors, and relationship to quality of life 
(QoL) and performance of activities of daily living (ADL) and work tasks 
Section 4.1 Introduction 
One in nine Canadian women will develop breast cancer in her lifetime (Canadian Breast Cancer 
Foundation, 2010). The five year survival rate is 88% (Canadian Cancer Society, 2014) and as the 
survival rates increase, more research needs to focus on life after diagnosis and treatment (Sandel, 
Judge, Landry, Faria, Ouellette, & Majczak, 2005). Treatment-related sequelae of breast cancer 
affect 30% - 82% of patients, commonly including reduced ROM, weakness, pain, numbness and 
swelling (Kwan, Jackson, Weir, Dingee, McGregor, & Olivotto, 2002; Lauridsen, Overgaard, 
Overgaard, Hessov, & Cristiansen, 2008; Maycock, Dillon, & Dixon, 1998; Rietman, Dijkstra, 
Debreczeni, Geertzen, Robinson, & De Vries, 2004). Cancer treatment side effects can last days, 
months, and even years (Schmitz, et al., 2010). 
Current detailed knowledge of upper limb physical capabilities of breast cancer survivors is 
limited. Some have reported that late upper limb morbidities restrict and interfere with completing 
ADL and return to work, negatively affecting QoL (Markes, Brockow, & Resch, 2006; Rietman, et 
al., 2003). However, upper limb morbidity has rarely been accurately documented (Thompson, Air, 
Jack, Kerr, Rodger, & Chetty, 1995). The relationships between impairments, disability, performance 
of tasks and QoL of breast cancer patients have only scarce documentation (Rietman, et al., 2003; 
Rietman, Dijkstra, Debreczeni, Geertzen, Robinson, & De Vries, 2004). Current quantitative 
measures of physical capacity of breast cancer populations consist of basic evaluations that thwart 
meaningful interpretations. Variability of the assessment methods of impairments is high, and no 
uniform criteria exist for ROM, muscle strength, pain and arm volume measures (Rietman, et al., 
2003). Further, muscle coordination, muscle-specific strength measures and 3-D kinematic 
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assessments of this population during ADL and work tasks have not been assessed. Only a few 
groups have investigated 3-D scapulothoracic kinematics of this population during scaption, flexion 
and abduction (Borstad & Szucs, 2012; Crosbie, et al., 2010; Shamley, Srinaganathan, Oskrochi, 
Lascurain-Aguirrebena, & Sugden, 2009; Shamley, Lascurain-Aguirrebena, Oskrochi, & 
Srinaganathan, 2012). This stark lack of description of upper limb disability requires immediate 
attention. 
Upper limb dysfunction within this population has not been systematically evaluated and 
therefore, specific and effective preventative and treatment strategies do not exist to promote return 
to function and work. Effective rehabilitation and reduction of symptoms could potentially lower the 
social and economic burdens of survivor aftercare and dramatically enhance quality of life. 
Improving the health of this population will allow these survivors not just the ability to live – but to 
live highly functional and independent lives. A prerequisite for creating these preventative and 
treatment strategies is rigorous quantification of the physical capabilities typical within this 
population. This study described these upper limb capacities and dysfunctions in female breast 
cancer survivors in terms of scapulothoracic and humerothoracic kinematics, muscle coordination 
and strength during ROM, ADL and simulated work activities. These findings will enable future 
projects, intended to improve the eventual return to work of breast cancer survivors through 
improved rehabilitation and treatment strategies.  
The two purposes of this study were to: 
1. Describe the upper limb capabilities and dysfunction of breast cancer survivors in terms of 3-D 
upper limb kinematics (specifically, motions of the humerus and scapula with respect to the 
thorax), muscle activation patterns (electromyography), and muscle-specific strength (force). 
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2. Determine relationships between total muscle effort (a physical muscle activation quantity of 
(dys)function) with subjective measures of function (QoL and disability scores) during ROM, 
ADL and work task performance. 
The hypotheses of this study were as follows: 
1. Three-dimensional kinematic description of breast cancer survivors will reveal survivors have 
reduced humeral angle of elevation and external rotation range of motion, but increased 
scapular protraction range of motion on their affected side compared to the contralateral limb. 
Past literature have reported reduced angles of elevation during humeral abduction and flexion ROM 
(Hack, Cohen, Katz, Robson, & Goss, 1999; Isaksson & Feuk, 2000; Kuehn, et al., 2000; Rietman, 
Dijkstra, Debreczeni, Geertzen, Robinson, & De Vries, 2004; Swedborg & Wallgren, 1981), reduced 
external rotation ROM (Rietman, Dijkstra, Debreczeni, Geertzen, Robinson, & De Vries, 2004; 
Swedborg & Wallgren, 1981), and increased scapular winging (protraction) (Lauridsen, Torsleff, 
Husted, & Erichsen, 2000) amongst the breast cancer population. These measures have been 
recorded manually with goniometry and inclinometer tools or have been reported via clinicians’ 
visual assessment. Two studies have recorded 3-D scapulothoracic kinematics with electromagnetic 
tracking, and have reported increase in scapular protraction on the affected side of survivors (Borstad 
& Szucs, 2012; Shamley, Srinaganathan, Oskrochi, Lascurain-Aguirrebena, & Sugden, 2009). 
2. Breast cancer survivors will demonstrate reduced strength and increased muscle activity 
(enhanced EMG amplitude) on the affected side when performing muscle specific strength 
tests, ROM, ADL and work tasks compared to their unaffected side.  
Reductions in strength are commonly reported amongst the breast cancer population (Isaksson & 
Feuk, 2000; Kuehn, et al., 2000; Rietman, et al., 2003), but often measures include subjective reports 
or quantitative measures of grip strength. Quantification of muscle-specific weakness is scarce 
amongst this population. There is discrepancy of findings of the two groups that reported muscle 
activation in survivors. Shamley et al. (2007) reported decreased activation of shoulder muscles on 
the affected side during scaption; whereas increased activation of the upper trapezius was found in 
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survivors performing a functional writing task by Galiano-Castillo et al. (2011). Later, Shamley et al. 
(2012) re-examined normalized muscle activity of pectoralis major, serratus anterior, rhomboids and 
upper trapezius during scaption of a BCP with mastectomy or wide local excision. With the 
exception of upper trapezius in the mastectomy group, the authors reported an increase in activity of 
all muscles on the left affected side of patients with either mastectomy or wide local excision 
compared to the left side of a healthy control group; and reported greater activation of the upper 
trapezius, rhomboids and serratus on the right affected side of patients with mastectomy compared to 
the right side of a healthy control, suggesting the BCP was working at a higher level of percent 
capability. Shamley et al. (2012) also reported a decrease in pectoralis major activity and an increase 
in serratus anterior activity on the affected side compared to the unaffected side. 
3. As physical data indicates increased dysfunction (increased total muscle effort), there will be 
decreased QoL scores (FACT-B) and increased disability (QuickDASH) scores. 
The number of chronic symptoms of late morbidity of breast cancer survivors has been reported to be 
significantly correlated with anxiety and depression levels (Rietman, Dijkstra, Debreczeni, Geertzen, 
Robinson, & De Vries, 2004). Decreased muscular activity of the upper trapezius and rhomboid 
muscles have been associated with increased Shoulder Pain and Disability Index scores in breast 
cancer survivors (Shamley, et al., 2007). Box et al. (2002) reported a trend of decreased shoulder 
ROM associated with breast cancer patients’ increased rating of performance difficulty while 
performing functional tasks. 
Section 4.2 Methods 
Anthropometrics (including arm volume), a brief medical history, disability and QoL scores were 
assessed from 50 breast cancer survivors. Survivors performed a total of 88 tasks including ROM, 
ADL and work tasks. Forty four unique tasks were performed twice each. Eighty tasks were 
performed unilaterally and 8 were performed bilaterally. Electromyography and kinematic data was 
recorded and muscle-specific force exertions were used to assess strength. The association between 
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physical capability (in terms of total muscle effort) and subjective QoL and disability scores were 
evaluated statistically. An outline of methods is described in Figure 17. 
 
Figure 17 Flow chart depicting methods of Study 1. Brief medical and demographic information was obtained from 
the BCP and skin was prepared for EMG and motion capture. Maximal voluntary force exertions were performed 
to obtain strength measures and allow for normalization. Participants performed a total of 88 tasks. Outputs 
included kinematics, strength and muscle activation information, as well as scores of QoL and disability. 
 
Section 4.2.1 Participants 
Participants included 50 female breast cancer survivors who were previously diagnosed with stages I, 
II or III unilateral breast cancer and who had completed cancer therapies including surgery, radiation 
and/or chemotherapy at least 3 months prior to participation. Participants had a mean age of 59.4 yr 
[+/- 9.7 yr; range 31-83 yr], mean height of 1.7 m [+/- 0.1 m; range 1.5-1.8 m], mean weight of 71.7 
kg [+/- 11.8 kg, range 51.4-97.7 kg] and were predominately right-hand dominant (n = 47). Cancer 
was on the left breast for 27 participants. Twenty seven participants had mastectomies (16 
prophylactic bilateral); 34 had lumpectomies and 48 had axial node dissection surgeries. Thirty four 
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participants had received hormone replacement therapy, 34 had received chemotherapy and 37 had 
received radiation treatments. Average time since diagnosis was 74.9 months (+/-59.6 months; range 
12-228 months]. Participants were able to communicate freely in English and had sufficient 
cognitive ability to participate and give informed consent. Participants were excluded if they had any 
of the following health disorders: blood clotting disorders, HIV, Hepatitis B or C, allergies to 
isopropyl alcohol, latex or nickel. Participants were recruited from the Kitchener-Waterloo area. This 
study received ethics clearance through the Office of Research Ethics at the University of Waterloo. 
Participants received a gift basket valued at $30 in appreciation for their time and efforts, as well as a 
summary of their ROM and strength results compared to normative data. 
 Due to limited study and discrepancy in the literature regarding the definition of impaired 
ROM, it was difficult to perform a power analysis a priori since an appropriate effect size 
(discrepancy between the null hypothesis (there is no difference in ROM = unaffected, ‘normal’ 
ROM) and alternative hypothesis (restricted ROM) was unclear. Two groups have defined impaired 
shoulder ROM as a loss of 20° compared to the unaffected limb (Box et al., 2002, Rietman et al, 
2004), therefore it was assumed that the expected response of the unaffected arm (π1) is 1.0 (no loss 
in ROM) and the expected response of the affected arm (π2) is 0.8 (20% loss of ROM). The α level 
(probability of a Type I error – claiming there was a difference in ROM when in fact there was not) 
was set conservatively to 0.05. The β level (probability of a Type II error – claiming there was no 
difference when in fact there was) was set to 0.2, meaning the power (1-β) was 0.8. With the f(α,β) = 
7.9, the sample size was estimated using Equation 5. 
Equation 5 Sample size equation 
𝑁 =  
𝜋1(1 − 𝜋1) + 𝜋2(1 − 𝜋2)
(𝜋1 − 𝜋2)2
∙ 𝑓(𝛼,𝛽) = 31.6 𝑝𝑎𝑟𝑡𝑖𝑐𝑖𝑝𝑎𝑛𝑡𝑠 
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Due to the anticipated heterogeneity likely to be recruited amongst the breast cancer survivor 
participants (differing cancer treatments, time since diagnostic etc.), the recommended sample of 
31.6 participants was increased to 50 participants. 
Section 4.2.2 Surface electromyography 
In preparation for the surface electrodes, the skin overlying the muscle of interest was shaved of hair 
and cleansed with isopropyl alcohol. Disposable bipolar Ag/AgCl surface electrodes (Product #272, 
Noraxon, USA, Inc., Arizona, USA) were placed on both sides of the body over the pectoralis major 
(clavicular and sternal insertions), posterior deltoid, latissimus dorsi, supraspinatus, infraspinatus, 
serratus anterior and upper trapezius. The electrode placements are described in Appendix E. A 
reference electrode was placed over the sternum, just inferior to the suprasternal notch. A wireless 
Noraxon TeleMyo 4200T G2 (Noraxon 2 USA Inc., Arizona, USA) sampled EMG channels at 3000 
Hz. This system had a 16-bit resolution on all analog inputs with a band-pass filter from 10-1500 Hz, 
an input impedance > 100 MΩ, a common mode rejection ratio > 100 dB and a base gain of 500. 
Section 4.2.3 Motion capture 
Three-dimensional kinematics were recorded using an 8-camera (2 MP) optoelectronic Vicon 
MX20+ motion tracking system (sampling rate 50 Hz) (Vicon, Oxford, UK). Light emitting diode 
cameras surrounded the collection area in which the participants moved. Prior to participant arrival, 
the space was calibrated using Vicon Nexus 1.2 software (Vicon, Oxford, UK) and the origin of the 
collection space was set on the floor, to the rear and right side of the participants chair (the 
participants were seated facing the positive global X-axis, with the positive global Z-axis pointing to 
the participants right and positive global Y pointing up). Twenty eight individual reflective markers 
(diameter = 9.0 mm) including 2 sets of marker clusters (3 markers each) affixed to rigid-plates were 
placed over anatomical landmarks and segments on both sides of the body as described in Table 10. 
Using an acromial marker cluster is a valid method of measuring scapular movement during arm 
elevation less than 90° and has been used to quantify scapular orientation in healthy individuals 
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(Picco, Fischer, & Dickerson, 2010; van Andel, van Hutten, Eversdijk, Veeger, & Harlaar, 2009). 
The acromial marker cluster was placed over the flat part of the posterior-lateral acromion, just 
medial to the origin of the deltoid when the shoulder was abducted 90° as per previous literature 
(Karduna, McClure, Michener, & Sennett, 2001; Ludewig & Cook, 2000; van Andel, van Hutten, 
Eversdijk, Veeger, & Harlaar, 2009). The cameras recorded the 3-D global positions of the markers.  
With the participant standing in the anatomical position, a static calibration frame was taken before 
experimental testing and was used to establish the relationship between rigid clusters and calibration 
markers over anatomical landmarks on a template formed using Vicon Nexus 1.2 software (Vicon, 
Oxford, UK). Six additional static calibration frames were taken with the stylus tip (diameter = 2.0 
mm) palpating each of the three scapula anatomical landmarks (acromial angle, trigonum spinae and 
inferior angle) on both left and right sides. This data was used to calculate joint centers and segment 










Location Associated Segment 
1, 2 (L/R)ME Medial epicondyle Upper Arm 
 3, 4 (L/R)LE Lateral epicondyle 






(L/R)AA Acromial angle (most latero-




(L/R)TS Trigonum Spinae Scapulae 
(Root of scapular spine; 






(L/R)IA Inferior angle of scapula 









15, 16 (L/R)SC2 Scapula 
Cluster II 
17, 18 (L/R)SC3 Scapula 
Cluster III 





20 SS Suprasternal notch* 
21 XP Xyphoid process* 












25, 26 (L/R)UAC2 Upper Arm 
cluster II 
27, 28 (L/R)UAC3 Upper Arm 
cluster III 
Markers placed bilaterally except in the instances as indicated by *. 
The glenohumeral joint centre (GH) was estimated to be 4 cm inferior to the midpoint of the 
acromion and acromial angle, along the long axis of the torso (Nussbaum & Zhang, 2000). 
 
Section 4.2.4 Pre-experimental protocol 
Prior to testing, anthropometric measurements (stature, body weight, upper arm length (tip of 
acromion to lateral epicondyle) and lower arm length (lateral epicondyle to ulnar styloid)) were 
recorded and the participants completed a brief demographic and medical questionnaire (Appendix 
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B), a Disability of Arm, Shoulder and Hand (QuickDASH) questionnaire (Appendix D) and an 
assessment of QoL using the FACT-B scale (Appendix C). Arm volume of each arm was measured 
using the water displacement method. The volumeter used was built following the protocol designed 
by Lette (2006), and is highly accurate (R
2
 = 0.9999 when compared with known volumes). 
Participants slowly inserted their bare arm into the volumeter until the upper arm was immersed 20 
cm above the lateral epicondyle. The displaced water was weighed on a digital balance, assuming 
1kg is equivalent to 1 L (at 4°C pure water has a density of approximately 1Kg/L). Lymphedema was 
defined as a volume difference of ≥ 200 mL difference between arms. Bilateral hand grip strength 
was assessed using a hand dynamometer (JAMAR, USA). 
 Two sets of each maximal voluntary force exertion (MVF) described in Table 11 
 were performed on both sides against a digital hand-held dynamometer (ergoFET300
TM
, Utah, 
USA).  MVFs were 3 s in duration, with at least two minutes of rest given between tests. The MVFs 
were used to obtain a measure of maximal force obtained during functionally-specific muscle tests 
and were also used for normalization of EMG. Ratings of perceived discomfort (RPD) were reported 
for each MVF, where a rating of zero indicated no discomfort and a rating of 100% indicated the 
“worst discomfort imaginable”. Data was transferred from the receiver to a personal computer, and 
analysed using Matlab
TM




Table 11 Study 1 Maximal voluntary force exertion protocol 
Muscle (tested on both arms) Test Contraction 
Supraspinatus Subject is seated. Shoulder is abducted to 5° with elbow extended 
(thumb pointing up). Abduction is resisted.  
Infraspinatus 
 
Subject is seated. Arm is at side with elbow bent to 90°. External 
rotation of the arm is resisted.  
Subscapularis 
 
Subject is seated. Arm is at side with elbow bent to 90°. Internal 
rotation of the arm is resisted. 
Latissimus Dorsi Subject is seated with shoulder horizontally abducted and externally 
rotated to 90° and elbow flexed to 90° (fingers point to ceiling). 
Shoulder adduction is resisted.  
Pectoralis Major (sternal and 
clavicular insertions) 
Subject is seated with shoulder horizontally abducted and externally 
rotated to 90° and elbow flexed to 90° (fingers point to ceiling). 
Shoulder horizontal adduction is resisted.  
Posterior Deltoid Subject is seated. Resistance is provided to shoulder extension when 
shoulder is abducted to 90° and externally rotated, with elbow flexed 
to 90° (fingers point to ceiling). 
Serratus Anterior Subject is seated. Subject protracts scapula with arm at 90° flexion. 
Resistance is provided at the hand. 
Upper Trapezius Subject is prone with head turned to right side. Participant resists 
shoulder abduction at 90º with elbow extended, thumb down to floor. 
 
Section 4.2.5 Experimental protocol 
EMG and 3-D kinematics were recorded as participants performed 88 tasks (2 sets of 20 unilateral 
tasks and 2 sets of 4 bilateral tasks) These tasks included 10 tasks of shoulder ROM (as a measure of 
full ROM capacity), 7 ADL tasks (involving personal body care activities) and 7 work tasks 
(reaching tasks with and without loads). These tasks were similar to those described previously 
within healthy and elderly populations (Hall, Middlebrook, & Dickerson, 2011; Magermans, 
Chadwick, Veeger, & van der Helm, 2005; Murray & Johnson, 2004)). These tasks are described in 
Table 12, Table 13 and Table 14. Participants were given 6 seconds to complete the tasks and were 
asked to perform each task as naturally as possible.   
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Table 12 Range of Motion tasks performed by survivors during experimental protocol 
Test # ROM tasks 
(performed separately 
with each arm) 
Description 
1 Humeral flexion Participants are instructed to elevate their arm anteriorly in the 
sagittal plane (elbow extended) to full range. Start/End position 
was arm at side. 
2 Humeral extension Participants are instructed to elevate their arm posteriorly in the 
sagittal plane (elbow extended) to full range. Start/End position 
was arm at side. 
3 Humeral abduction Participants are instructed to elevate their arm in the frontal 
plane (elbow extended) to full range. Start/End position was arm 
at side. 
4 Humeral ER at 45° 
elevation 
With the elbow flexed to 90° and arm abducted to 45°, 
participants are instructed to externally rotate their humerus to 
full range. 
5 Humeral IR at 45° 
elevation 
With the elbow flexed to 90° and arm abducted to 45°, 
participants are instructed to internally rotate their humerus to 
full range. 
6 Scaption Participants are instructed to elevate their arm (elbow extended) 
in the scapular plane (30° anterior to the frontal plane) to full 
range. Start/End position was arm at side. 
7 Neutral Scapular 
Orientation* 
Participants are instructed to identify the most comfortable 
neutral scapular posture while actively protracting and retracting 
the scapula. (Smith, Kotajarvi, Padgett, & Eischen, 2002) 
Start/End position was with hands resting on table in front of 
them. 
8 Scapular Protraction* Participants are instructed to protract the scapula (move the 
scapula in an anterior-lateral direction, moving the scapular 
border away from the vertebral column). (Solem-Bertoft & 
Wresterberg, 1993) Start/End position was with hands resting on 
table in front of them. 
9 Scapular Retraction* Participants are instructed to retract the scapula (move the 
scapula in a posterior-medial direction, moving the scapular 
border towards the vertebral column). (Solem-Bertoft & 
Wresterberg, 1993) Start/End position was with hands resting on 
table in front of them. 
10 Winging Scapula Test Flex humerus to 30° against inferiorly-directed resistance. 
*bilateral task. For later analysis, ROM tasks were further subdivided into 2 groups: “ROM – Reach 
Tasks” included [unshaded] Tests 1, 2, 3 and 6; and “ROM – Rotation Tasks” included [shaded] 






Table 13 Activities of daily living tasks performed by survivors during experimental protocol 
Test # ADL tasks (performed 
separately with each arm) 
Description (all tasks are performed seated and begin 
and end with hand on the table) 
11 Comb hair Participant combs the right, center and left side of the 
head once.  
12 Anterior reach to 
contralateral scapula 
Participant reaches across chest and over opposite 
shoulder to wash contralateral scapula. 
13 Posterior reach to 
contralateral scapula 
Participant reaches behind back and up to contralateral 
scapula. 
14 Wash opposite axilla Participant reaches across chest to wash contralateral 
axilla. 
15 Eat with spoon Participant brings a spoon to the mouth. 
16 Perineal care Participant reaches behind back and places hand on 
sacrum. 
17 Posterior bra unfasten Participant is instructed to simulate unfastening a bra at 
the spine height of the inferior angle of the scapula. 
All tasks were performed with participant seated in 43 cm high backless chair behind a 66 cm high 
table. Participants started and ended task with hand placed on table. 
 
Table 14 Work tasks performed by survivors during experimental protocol 
Test # Work tasks (performed 
separately with each arm) 
Description 
18 Seated reach above 
shoulder (no load) 
Participant reaches towards a target which is 1.5 m vertical 
from the ground and centered in front of the participant’s 
body. [Task simulates reaching up to a shelf.] 
19 Seated reach above 
shoulder (1 kg load) 
Same as Test#18 with 1 kg load. 
20 Seated reach above 
shoulder – scaled to torso-
reach height with (no 
load) 
Prior to collection, the researcher measures the ‘torso-reach’ 
distance, defined as the distance from participant’s greater 
trochanter of the hip to the tip of the fingers when the arm is 
raised vertically.  A target is placed in front (centre) of the 
participant at a height of 80% of torso-reach distance plus the 
height of the chair. The participant reaches towards the target. 
[Task simulates reaching up to a shelf.] 
21 Seated reach above 
shoulder – scaled to torso-
reach height (1 kg load) 
Same as Test#20 with 1 kg load. 
22 Seated side reach at 
shoulder height (no load) 
Participant reaches out to side (in frontal plane) at shoulder 
height with extended arm.  
23 Seated side reach at 
shoulder height (1 kg 
load) 
Same as Test#22 with 1 kg load. 
24 Standing 2-handed lift (4 
kg load )* 
Participant (standing) reaches for 4 kg load placed on floor in 
front of them. Participant lifts load and places it on table in 
front of them. [Simulates lifting a load equivalent to a 4 L milk 
bag.] 
All tasks (except Test 24 Standing 2-handed lift) were performed with participant seated in 43 cm high backless chair behind a 66 cm high 




Section 4.3 Analysis 
EMG and upper limb kinematic data were processed using custom-built scripts written in 
MATLAB™ R2010a (Mathworks, USA). Statistical analysis was performed in JMP 11
® 
(SAS 
Institute Inc., Cary, NC). 
Section 4.3.1 EMG data processing 
Raw EMG was high pass filtered (Fc 30Hz as recommended by Drake & Callaghan (2006)) to 
remove potential heart rate or motion artifact, and then linear enveloped with a single-pass 
Butterworth LPF (Fc = 2.5 Hz as determined by residual analysis on a random sample of more than 
20 exertions and participants for all channels). A 500 ms moving window average of linear 
enveloped MVC trials was calculated and the highest moving window average from the two sets (for 
each specific muscle and individual) was defined as maximal percent activation from which 
respective channels were normalized to. Integrated EMG (area under each 6 s test curve) was 
calculated for all channels and tests. Total muscle effort was defined as the summation of integrated 
EMG on affected and unaffected sides [Equation 6 and Equation 7]. The sum of all mean muscle 
activities has been used previously as an estimate of total shoulder effort in healthy individuals 
(Chopp, Fischer, & Dickerson, 2010). 
Equation 6 Total muscle effort on affected side. Where i = 1-8 are eight muscles on the affected side recorded with 
surface EMG. Integrated normalized EMG of these muscles was summed. 




Equation 7 Total muscle effort on unaffected side. Where i = 9-16 are the eight muscles on the unaffected side 
recorded with surface EMG. Integrated normalized EMG of these muscles was summed. 






Section 4.3.2 Kinematic data processing 
Raw kinematic data was initially processed using the Vicon Nexus 1.2 software (Vicon, Oxford, 
UK), which was used to confirm proper marker labelling and pattern-fill any gaps (missing marker 
data) by reconstructing the marker trajectory using locations of other markers on defined segments. 
Further data reduction of kinematic data was performed in a custom-built software program 
developed using MATLAB R2010a (Mathworks, USA). Kinematic data was dual-pass filtered with a 
Butterworth low pass filter (LPF) with a cut-off frequency (Fc) of 4 Hz. 
Using the global positions of the reflective markers, local coordinate systems were defined 
for each segment according to the International Society of Biomechanics recommendations (Johnson, 
Bogduk, Nowitzke, & House, 1994) during static calibration as described for the right side in Table 
15 (Wu, et al., 2005). For development of local coordinate systems on the left side, the same 
anatomical landmarks were used as expressed in Table 15; however directions were reversed when 
required to maintain the Z axis pointing to the right, the Y axis pointing superiorly and the X axis 
pointing anteriorly. Three non-collinear anatomical landmarks were required on each segment to 
construct a local coordinate system. The global coordinates of the left and right scapula landmarks  
(AA, IA, TS) were identified using the position of the digitizing stylus tip in each of the six 
calibration tests (one calibration per digitized landmark) as demonstrated in Equation 8: 
Equation 8 Determining scapular landmarks. Where TX,GLOBAL, TY,GLOBAL, and TZ,GLOBAL is the position vector of 
the stylus tip (and therefore scapular landmark) in the global system; OSX,GLOBAL, OSY,GLOBAL, and OSZ,GLOBAL is the 
position vector of the origin of the LCS of the digitizing stylus during the landmark calibration in the global system; 
[R] is the stylus LCS to global rotational matrix; TX,stylus, TY,stylus, and TZ,stylus are the position coordinates of the 

















Static calibration tests were used to determine the position of the scapular landmarks relative to the 
acromial cluster, and the humeral landmarks relative to the humeral cluster, as demonstrated in 
Equation 9.  
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Equation 9 Relationship between cluster and anatomical landmark. Where VX,cluster, VY,cluster, and VZ,cluster are the 
coordinates of the vector between the (acromial or humeral) cluster and a respective (scapular or humeral) 
landmark (AA, IA, and TS for the scapula, or ME and LE for the humerus); [R] is the global to cluster rotational 
matrix; VX,GLOBAL, VY,GLOBAL, and VZ,GLOBAL are the global coordinates of the position vector of the (scapula or 
humeral) landmark; OX,GLOBAL, OY,GLOBAL, and OZ.GLOBAL are the global coordinates of the position vector of the 
















These relationships were used to generate virtual scapular and humeral landmarks during dynamic 
tests, as described in Equation 10. 
 
Equation 10 Calculating virtual markers. Where VVX,GLOBAL, VVY,GLOBAL, and VVZ,GLOBAL is the position vector of 
the virtual landmarks in the global system; OX,GLOBAL, OY,GLOBAL, and OZ,GLOBAL are the global coordinates of the 
position vector of the origin of the cluster; [R] is the cluster to global rotational matrix; VX,cluster, VY,cluster, and 
VZ,cluster are the coordinates of the vector between the (acromial or humeral) cluster and a respective (scapular or 
















Using virtual markers, local coordinate systems for the humerus, thorax and scapula were defined 
during dynamic tests (with the same procedures as done during static calibration). The relative 
rotation matrices were found by multiplying the distal segment (scapula or humerus) by the transpose 




Table 15 Right side segment local coordinate systems as recommended by ISB and described by Wu et al., (2005). 
X,Y and Z axis descriptions are provided for each segment. Figures A, B and C represent the thorax, scapula and 
humerus local coordinate systems, respectively. Refer to Table 10 for definitions of short-form terminology. 
Description of Local Coordinate System 
Thorax - xtytzt 
Origin: The origin coincident with SS. 
yt: The line connecting the mid-point between XP and T8 and the mid-point between SS 
and C7, pointing upward. 
zt: The line perpendicular to the plane formed by SS, C7, and midpoint between SS, C7 
and the midpoint between XP and T8 pointing upward. 
xt: The common line perpendicular to z t- and yt-axis, pointing forwards 
Scapula - xsyszs 
Origin: The origin coincident with AA. 
zs: The line connecting TS and AA, pointing to AA. 
xs: The line perpendicular to the plane formed by IA, AA, and TS, pointing forward. 
ys: The common line perpendicular to the xs- and zs-axis pointing upward. 
Humerus – xhyhzh 
Origin: The origin coincident with GH. 
yh: line connecting GH and the midpoint of the EL and EM, pointing to GH 
xh: line perpendicular to the plane formed by EL, EM, and GH, pointing forward 
zh: common line perpendicular to the yh- and zh-axis, pointing to the right 
 
 
The scapular and humeral local coordinate systems were described with respect to the thorax local 
coordinate system as demonstrated by Figures B and C in Table 15. Scapulothoracic and 
humerothoracic joint descriptions were based on the Euler YXZ and YXY’ rotation sequences, 
respectively, as recommended by the International Society of Biomechanics (Wu, et al., 2005) and 
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described in Table 16. Euler decomposition and rotational transformation matrices are depicted in 
Appendix G. 
Table 16 Description of segment rotations using Euler angles according to recommendations by the International 
Society of Biomechanics (Wu, et al., 2005). Scapulothoracic rotations were described using the YXZ Euler sequence, 
and humerothoracic rotations were described using the YXY’ Euler sequence. 
Segment Rotation Sequence 
Motion of the scapula 




e1: axis fixed to the thorax and coincident with the Yt-axis of the thorax 
coordinate system.  
Rotation (γST): retraction (negative) or protraction (positive) 
 
e3: axis fixed to the scapula and coincident with the Zs-axis of the scapular 
coordinate system.  
Rotation (αST): anterior (negative) or posterior (positive) tilt.  
 
e2: common axis perpendicular to e1 and e3.  
Rotation (βST): lateral (negative) or medial (positive) rotation. 
Motion of the humerus 




e1: axis fixed to the thorax and coincident with the Yt-axis of the thorax 
coordinate system.  
Rotation (γH): GH plane of elevation (0
o
 is abduction, 90
o
 is forward flexion) 
 
e3: axial rotation around the Yh-axis.  
Rotation (γH)2: GH-axial rotation, internal (positive) or external (negative) 
rotation 
 
e2: axis fixed to the humerus and coincident with the Xh-axis of the humerus 
coordinate system.  
Rotation (βGH): elevation (negative) 
 
The orientation of the scapula with respect to the thorax was quantified by extracting the Euler 
angles from Equation 11 where xs, ys and zs are the axes of the scapula local coordinate system and xt, 
yt and zt are the axes of the thorax local coordinate system. The transformation matrix was derived 
using the Y-X-Z Euler sequence (described in Table 16 and Appendix G). The scapulothoracic 
rotations for both left and right sides were described as +upward/-downward rotation (β, about the X 
axis), +anterior/-posterior tilt (α, about the Z axis), and +retraction/-protraction (γ, about the Y axis). 
Scapular kinematics were reported as absolute values with respect to the local coordinate systems 
(the neutral “zero” position was defined as the alignment of the local coordinate systems of the 
scapula and the thorax). 
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(cos 𝛼 cos 𝛾 − sin 𝛾 sin 𝛼 sin 𝛽) −cos β sin 𝛼 sin 𝛼 sin β cos γ + cos α sin 𝛾
cos α sinβ sin 𝛾 + sin 𝛼 cos 𝛾 cos β cos α sin 𝛼 sin 𝛾 − cos α sin β cos γ






The orientation of the humerus with respect to the thorax was quantified by extracting the Euler 
angles from Equation 12, where xh, yh and zh are the axes of the humerus local coordinate system and 
xt, yt and zt are the axes of the thorax local coordinate system. The transformation matrix was derived 
using the Y-X-Y’ Euler sequence (described in Table 16 and Appendix G). The humerothoracic 
rotations were described as magnitude of elevation (β, about the X axis), plane of elevation (γ, about 
the Y axis), and humeral rotation (γ2, about the Y axis). For both left and right sides, elevation was 
positive, plane of elevation was described as -90° in forward flexion and 0° in abduction, and 
humeral ER was positive and IR was negative as shown in Figure 18. Humerothoracic kinematics 
were reported as absolute values with respect to the local coordinate systems (the neutral “zero” 
position was defined as the alignment of the local coordinate systems of the humerus and the thorax). 






(cos 𝛾 cos 𝛾2 − sin 𝛾 sin 𝛾2 cos 𝛽) sin 𝛽 sin 𝛾2 cos 𝛾2 sin γ + cos β cos γ sin 𝛾2
sin 𝛽 sin 𝛾 cos 𝛽 − cos 𝛾 sin 𝛽









Figure 18 Humerothoracic plane of elevation (rotation about gamma) for left and right sides. Abduction represents 
a plane of elevation of 0° and forward flexion is -90°. 
 
Section 4.3.3 Statistical testing 
The maximal and minimal angles achieved during each functional task were determined, and 
averaged for each of the 2 sets of repeated tasks.  Range of motion (minimal subtracted from 
maximal angle) was reported, similar to Hall et al. (2011). To investigate differences in range of 
motion of humerothoracic (β, γ, γ2) and scapulothoracic (β, γ, α) angles between affected and 
unaffected sides, repeated measures ANOVA were performed with ROM, maximal and minimal 
humerothoracic and scapulothoracic angle components named the dependent variables, with task 
performance side (affected or unaffected) with subject as a random variable named the independent 
variables, and the within (‘by’) variable was listed as the task group (ROM-Reach, ROM-Rotation, 
ADL and work tasks). 
For all tasks, a repeated measures ANOVA was used to determine the effects of task 
performance side (affected or unaffected side) on TME, within task type (ROM-Reach, ROM-
Rotation, ADL or work task). The average TME was named the dependent variable, and the task 
performance side (affected or unaffected) and subject as a random variable were listed as the 
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independent variables. The within (‘by’) variable was listed as the task type (ROM-Reach, ROM-
Rotation, ADL, work).  
To determine what specific muscles had higher levels of activation during unilateral tasks, 
eight repeated measures ANOVA were performed to determine the effect of task performance side 
on integrated EMG within the task groups. The integrated EMG for the 8 muscles collected were 
named the dependent variables, the task performance side (affected or unaffected) with subject as a 
random variable were named the independent variables, and the within (‘by’) variable was listed as 
the task group (ROM-Reach, ROM-Rotation, ADL, work).  
To identify differences in MVF values between affected and unaffected sides, seven repeated 
measures ANOVA were performed. The dependent variables were listed as the MVF for seven 
muscles (latissimus dorsi, pectoralis major, posterior deltoid, serratus anterior, infraspinatus, 
supraspinatus and upper trapezius) and the independent variables were listed as task performance 
side (affected or unaffected) and subject as a random variable. 
To investigate differences in ratings of perceived discomfort (RPD) between sides, repeated 
measures ANOVA with RPD for each of the seven muscles were listed as the independent variables, 
with side (affected or unaffected) and subject as a random variable listed the dependent variables. 
Total muscle effort per participant was calculated as the summation of affected side TME 
during all tasks. To determine if a quantitative measure of physical function (total muscle effort 
during all tasks) was related to quality of life or disability scores, linear and polynomial correlations 
were explored. Specifically, total muscle effort values were plotted against FACT-B and 
QuickDASH scores. 




Section 4.4 Results 
Section 4.4.1 Kinematic results 
In general, unaffected scapulothoracic ROM was greatest in upward/downward rotation (24.7° 
[SD±19.0°]), followed by retraction/protraction (16.3° [SD±15.3°]) and then anterior/posterior tilt 
(14.3° [SD±15.0°]). In general, affected scapulothoracic ROM was greatest in upward/downward 
rotation (24.4° [SD±18.6°]), followed by retraction/protraction (15.9° [SD±17.8°]) and then 
anterior/posterior tilt (15.2° [SD±16.2°]). Analysis of scapulothoracic kinematics revealed there were 
some statistically significant differences in ROM between unaffected and affected sides within some 
groups of tasks (Figure 19): 
 During ADL and work tasks, the affected side demonstrated more anterior/posterior tilt 
ROM compared to the unaffected side (16.2° vs. 14.4°, p = 0.0428; and 16.6° vs. 14.6°, p = 
0.0307), respectively. 
 
Figure 19 Comparison of scapulothoracic ROM (maximum minus minimum angle) between unaffected and affected 
sides during four types of tasks (ROM-Reach, ROM-Rotate, ADL and work tasks). LSM±SD. Significance (*) 




On average, unaffected humerothoracic ROM was greatest in humeral rotation (42.4° [SD±40.4°]), 
followed by elevation (38.5° [SD±28.7°]) and then plane of elevation (32.5° [SD±27.1°]). On 
average, affected humerothoracic ROM was greatest in humeral rotation (47.1° [SD±45.8°]), 
followed by elevation (40.6° [SD±32.5°]) and then plane of elevation (28.7° [SD±26.5°]). Analysis 
of humerothoracic kinematics revealed there were some statistically significant differences in ROM 
between unaffected and affected sides within some groups of tasks (Figure 20): 
 During ROM-Reach tasks, the affected side demonstrated reduced ROM in the plane of 
elevation (32.3° vs. 39.0°, p = 0.0034) 
 During ROM-Rotate tasks, the affected side demonstrated reduced ROM in elevation angle 
and in the plane of elevation (9.7° vs. 12.0°, p = 0.0121; and 15.3° vs. 18.6°, p = 0.0440); but 
increased ROM in humeral rotation (33.6° vs. 26.5°, p = 0.0036) compared to the unaffected 
side. 
 During work tasks, the affected side demonstrated more ROM in elevation compared to the 




Figure 20 Comparison of humerothoracic ROM (maximum minus minimum angle) between unaffected and affected 
sides during four types of tasks (ROM-Reach, ROM-Rotate, ADL and work tasks). LSM±SD. Significance (*) 
between sides is indicated. 
 
For all tasks, the unaffected scapulothoracic maximal angles demonstrated that on average the 
scapula was upwardly rotated at 18.0° [SD± 22.7°]), anteriorly tilted at 17.5° [SD±20.0°], and 
protracted at -28.6° [SD±20.9°]. For all tasks, the affected scapulothoracic maximal angles 
demonstrated that on average the scapula was upwardly rotated at 19.9° [SD± 22.4°]), anteriorly 
tilted at 16.6° [SD±23.3°], and protracted at -26.1° [SD±26.8°]. Analysis of scapulothoracic 
kinematics revealed there were some statistically significant differences in maximal angles between 
unaffected and affected sides within some groups of tasks (Figure 21): 
 During ROM-Rotate tasks, the affected side demonstrated more upward rotation compared 
to the unaffected side (7.0° vs. 4.2°, p = 0.0050). 
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 During ADL and work tasks, the affected side demonstrated less protraction compared to the 
unaffected side (-28.4° vs. -31.8°, p = 0.0111; and -26.3° vs. -30.2°, p = 0.0136, 
respectively). 
 
Figure 21 Comparison of scapulothoracic maximal angles between unaffected and affected sides during four types of 
tasks (ROM-Reach, ROM-Rotate, ADL and work tasks). Upward rotation, anterior tilt and retraction are shown as 
positive values. Downward rotation, posterior tilt and protraction are shown as negative values. LSM±SD. 
Significance (*) between sides is indicated. 
 
The unaffected humerothoracic maximal angles demonstrated that on average the humerus was 
elevated to 76.8° [SD± 27.5°]), externally rotated to 4.4° [SD±37.6°], and in a plane of elevation of -
9.7° [SD±34.5°] during all tasks. The affected humerothoracic maximal angles demonstrated that on 
average the humerus was elevated to 75.3° [SD± 31.7°]), externally rotated to 0.7° [SD±42.3°], and 
in a plane of elevation of -13.2° [SD±34.8°] during all tasks. Analysis of humerothoracic kinematics 
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revealed there were some statistically significant differences in maximal angles between unaffected 
and affected sides within some groups of tasks (Figure 22): 
 During ROM-Rotate tasks, the affected side demonstrated a reduced angle of elevation 
compared to the unaffected side (48.4° vs. 54.9°, p < 0.0001). The affected side humerus was 
kept in a plane of elevation that was more anterior to abduction, compared to the unaffected 
humerus which was kept closer to the abduction plane (-21.1° vs. -17.2°, p = 0.0449). 
 During work tasks, the affected side demonstrated a more neutral humeral rotation compared 
to the more externally rotated unaffected side (0.4° vs. 9.3°, p = 0.008). 
 
Figure 22 Comparison of humerothoracic maximal angles between unaffected and affected sides during four types 
of tasks (ROM-Reach, ROM-Rotate, ADL and work tasks). Elevation and external rotation are shown as positive 
values. Internal rotation is shown as negative values. Plane of elevation is 0° at abduction and -90° in flexion. 




Average minimum angles during all tasks indicated the unaffected scapula was downwardly rotated 
at -7.1° [SD± 13.0°]), anteriorly tilted at 3.0° [SD±20.1°], and protracted at -45.2° [SD±17.9°]; 
similar to the affected side scapula which was downwardly rotated at -4.5° [SD± 14.7°]), anteriorly 
tilted at 1.4° [SD±24.5°], and protracted at -42.0° [SD±22.2°]. Analysis of scapulothoracic 
kinematics revealed there were some statistically significant differences in minimal angles between 
unaffected and affected sides within some groups of tasks (Figure 23): 
 During ROM-Reach and ROM-Rotate tasks, the affected side scapula demonstrated less 
downward rotation compared to the unaffected side (-6.7° vs. -10.1°, p = 0.0003; and -1.9° 
vs. -5.4°, p < 0.0001, respectively).  
 During ROM-Rotate tasks, the affected side scapula demonstrated less protraction compared 
to the unaffected side (-37.1° vs. -40.7°, p = 0.0066). 
 During ADL tasks, the affected side scapula demonstrated less downward rotation compared 
to the unaffected side (-6.3° vs. -9.2°, p = 0.0010). 
 During Work tasks, the affected side scapula demonstrated less downward rotation, more 
posterior tilting and less protraction compared to the unaffected side (-3.5° vs. -6.7°, p < 




Figure 23 Comparison of scapulothoracic minimum angles between unaffected and affected sides during four types 
of tasks (ROM-Reach, ROM-Rotate, ADL and work tasks). Upward rotation, anterior tilt and retraction are shown 
as positive values. Downward rotation, posterior tilt and protraction are shown as negative values. LSM±SD. 
Significance (*) between sides is indicated. 
 
The average unaffected humerothoracic minimal angles during all tasks demonstrated that the 
humerus was minimally elevated to 37.8° [SD± 14.8°]), internally rotated to -39.1° [SD±39.1°], and 
in a minimal plane of elevation of -42.8° [SD±36.1°]. The affected humerothoracic minimal angles 
demonstrated that on average the humerus was minimally elevated to 34.7° [SD± 16.6°]), internally 
rotated to -47.4° [SD±39.7°], and in a minimal plane of elevation of -42.0° [SD±33.6°] during all 
tasks.  Analysis of humerothoracic kinematics revealed there were some statistically significant 
differences in minimal angles between unaffected and affected sides within some groups of tasks 
(Figure 24): 
 During ROM-Reach and ROM-Rotate tasks, the humerus reached lower angles of elevation 
on the affected side (29.5° vs 35.2°, p = 0.0001; 38.5° vs. 42.7°, p < 0.0001, respectively). 
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 During ROM-Rotate tasks, the humerus was more internally rotated on the affected side (-
26.5° vs. -18.6°, p = 0.0124). 
 During ADL tasks, compared to the unaffected side, the affected side humerus reached a 
lower minimum angle of elevation (35.1° vs. 39.0°, p = 0.0003), and was more internally 
rotated (-69.5° vs. -61.0°, p = 0.0073). 
 During work tasks, the affected side humerus was also more internally rotated compared to 
the unaffected side (-46.7° vs. -33.6°, p < 0.0001). 
 
Figure 24 Comparison of humerothoracic minimum angles between unaffected and affected sides during four types 
of tasks (ROM-Reach, ROM-Rotate, ADL and work tasks). Elevation and external rotation are shown as positive 
values. Internal rotation is shown as negative values. Plane of elevation is 0° at abduction and -90° in flexion. 




Mean scapulothoracic and humerothoracic angles for unaffected and affected sides of all subjects 
during ROM-Reach, ROM-Rotation, ADL and work tasks are shown in Table 17 and Table 18. 
Mean scapulothoracic and humerothoracic angles for all subjects, for each of the 24 tests are outlined 
in Appendix H in Table 41,Table 42, Table 43, Table 44, Table 45 and Table 46. Due to an 
irrecoverable software issue, all kinematic data was lost for 1 subject (both sides); and due to an 
unrelated wrist injury on the unaffected side, kinematics were collected for only the affected side for 
one other subject. Typical time-series profiles of scapulothoracic and humerothoracic kinematics are 




Table 17 Mean scapulothoracic angles during ROM-Reach, ROM-Rotation, ADL and Work Tasks for unaffected 
and affected [shaded cells] sides. Angles shown are ROM angles (maximum minus minimum angles); maximum 
angles (upward rotation, anterior tilt and retraction angles are denoted as positive values); and minimum angles 
achieved (downward rotation, posterior tilt and protraction angles are denoted as negative values). Angles are in 
degrees. 
 Mean SD± Mean SD± Mean SD± 
  
Scapulothoracic 
Beta ROM Angles 
(max-min) 
Scapulothoracic Beta 
Max Angles (Upward 
Rot'n = [+]) 
Scapulothoracic Beta 




45.6 25.7 36.4 29.5 -9.2 13.7 
44.1 24.0 37.3 27.2 -6.8 12.9 
ROM-Rotate 
Tasks 
9.4 7.3 4.4 13.2 -5.0 11.7 
9.0 7.3 7.0 15.9 -2.0 14.3 
ADL Tasks 
21.2 13.0 12.5 19.5 -8.7 13.6 
20.6 13.1 14.4 20.2 -6.3 15.7 
Work Tasks 
30.4 13.0 24.5 18.1 -5.9 12.8 
30.0 12.9 26.4 17.0 -3.6 14.6 
  
Scapulothoracic 
Alpha ROM Angles 
(max-min) 
Scapulothoracic Alpha 
Max Angles (Ant. Tilt = 
[+]) 
Scapulothoracic Alpha 
Min Angles (Posterior 
Tilt = [-]) 
ROM-Reach 
Tasks 
26.0 26.2 22.3 20.9 -3.7 24.5 
23.1 24.3 20.2 27.3 -2.9 27.2 
ROM-Rotate 
Tasks 
6.9 6.3 12.9 19.9 6.0 19.6 
7.4 13.2 12.1 21.6 4.6 22.9 
ADL Tasks 
14.5 9.9 18.8 19.9 4.3 19.5 
16.1 15.1 18.9 23.6 2.8 22.5 
Work Tasks 
14.3 11.4 17.4 18.8 3.1 17.4 






Gamma Max Angles 
(Retraction = [+]) 
Scapulothoracic 
Gamma Min Angles 
(Protraction = [-]) 
ROM-Reach 
Tasks 
24.2 23.4 -19.5 27.0 -43.7 19.3 
20.6 22.6 -19.1 30.3 -39.7 25.5 
ROM-Rotate 
Tasks 
11.2 10.7 -29.3 18.3 -40.5 16.6 
10.4 10.5 -26.8 24.5 -37.1 21.2 
ADL Tasks 
14.5 11.6 -32.0 17.6 -46.4 18.5 
15.8 16.8 -28.7 24.2 -44.5 21.3 
Work Tasks 
18.9 13.9 -29.9 20.6 -48.9 16.7 





Table 18 Mean humerothoracic angles during ROM-Reach, ROM-Rotation, ADL and Work Tasks for unaffected 
and affected [shaded cells] sides. Angles shown are ROM angles (maximum minus minimum angles); maximum 
angles (elevation and external rotation angles are denoted as positive values); and minimum angles achieved 
(internal rotation angles are denoted as negative values). Plane of elevation was 0° at abduction and -90° in forward 
flexion. Angles are in degrees. 
 Mean SD± Mean SD± Mean SD± 
  
Humerothoracic 
Beta ROM Angles 
(max-min) 
Humerothoracic Beta Max Angles 
(Elevation = [+]) 
Humerothoracic Beta Min 
Angles (Elevation = [+]) 
ROM-Reach 
Tasks 
64.9 30.6 100.1 31.3 35.2 15.1 
67.2 32.3 97.0 32.7 29.8 16.3 
ROM-Rotate 
Tasks 
12.2 12.7 54.7 14.4 42.5 12.2 
9.6 9.5 48.7 15.2 39.1 14.2 
ADL Tasks 
34.1 21.8 73.0 21.0 38.9 14.2 
36.1 27.9 71.6 27.1 35.4 16.1 
Work Tasks 
51.9 22.4 86.2 24.2 34.3 16.0 





Humerothoracic Gamma Max 
Angles (Plane of Elevation: -90 = 
flexion, 0 = abduction) 
Humerothoracic Gamma Min 
Angles (Plane of Elevation: -90 = 
flexion, 0 = abduction) 
ROM-Reach 
Tasks 
39.1 26.7 3.9 35.8 -35.2 38.6 
32.2 23.4 2.2 39.0 -30.1 38.1 
ROM-Rotate 
Tasks 
19.0 20.5 -17.0 24.7 -36.0 24.7 
15.3 19.2 -20.9 25.1 -36.2 22.4 
ADL Tasks 
38.8 30.3 0.9 40.6 -38.0 45.3 
34.3 29.0 -4.8 40.4 -39.1 41.3 
Work Tasks 
35.6 24.5 -22.1 27.7 -57.6 27.2 





Humerothoracic Gamma2 Max 
Angles (ER = [+]) 
Humerothoracic Gamma2 Min 
Angles (IR = [-]) 
ROM-Reach 
Tasks 
38.1 31.3 -2.1 38.7 -40.2 29.8 
37.0 33.0 -5.3 42.5 -42.3 29.0 
ROM-Rotate 
Tasks 
26.9 25.8 8.1 30.8 -18.8 34.3 
33.6 31.8 7.0 35.6 -26.6 41.6 
ADL Tasks 
61.4 50.6 0.4 35.7 -61.0 41.8 
68.3 55.3 -1.2 42.1 -69.5 38.0 
Work Tasks 
43.0 37.3 8.8 43.0 -34.2 33.8 





Figure 25 Representative comparison of scapulothoracic angles during flexion between affected and unaffected sides 
of one participant. Upward rotation [A] and anterior tilt [B] angles are denoted as positive values. Protraction 




Figure 26 Representative comparison of humerothoracic angles during flexion between affected and unaffected sides 
of one participant. Elevation [A] and external rotation [C] angles are denoted as positive values. Internal rotation 




Section 4.4.2 Total muscle effort 
The TME of the affected side was greater than the unaffected side during work tasks (p = 0.0258); 
there was no statistically identifiable difference of TME between sides within the ROM-Reach group 
(p = 0.1750), ROM-Rotation group (p = 0.4099) or ADL tasks (p = 0.1368) [Figure 27], though the 
mean values were higher on the affected side for each group. Mean TME for all subjects are shown 
in Appendix F [Table 40]. 
  
Figure 27 Comparison of TME between sides. LSM ±SD. Asterix (*) indicates significant differences between sides. 
 
Section 4.4.3 Integrated EMG 
Analysis of iEMG revealed there were differences between unaffected and affected sides within 
certain muscles and groups of tasks: 
1. For ROM-Reach tasks 
a. iEMG affected > unaffected for posterior deltoid and supraspinatus [p values = 
0.0116 and 0.0161, respectively.] 
b. iEMG unaffected > affected for pectoralis major sternal, infraspinatus [p values = 






































c. No difference in iEMG between sides for pectoralis major clavicular, latissimus 
dorsi, upper trapezius or serratus anterior [p values = 0.1880,0.5361, 0.0586 and 
0.0594, respectively.] 
2. For ROM-Rotation tasks 
a. iEMG affected > unaffected for posterior deltoid [p = 0.0032] 
b. iEMG unaffected > affected for pectoralis major sternal and infraspinatus [p = 
0.0032 and 0.0328, respectively.] 
c. No difference in iEMG between sides for pectoralis major clavicular, latissimus 
dorsi, serratus anterior, upper trapezius and supraspinatus [p = 0.6650, 0.8349, 
0.0714, 0.0955, 0.0520, respectively.] 
3. For ADL tasks 
a. iEMG affected > unaffected for posterior deltoid, upper trapezius, supraspinatus [p 
values = 0.0065, 0.0486 and 0.0380, respectively.] 
b. iEMG unaffected > affected for pectoralis major sternal [p values = 0.0230, 
respectively.] 
c. No difference in iEMG between sides for pectoralis major clavicular, latissimus 
dorsi, serratus anterior, infraspinatus [p values = 0.6972, 0.6833, 0.0533 and 0.4327, 
respectively.] 
4. For work tasks 
a. iEMG affected > unaffected for posterior deltoid, serratus anterior, upper trapezius, 
supraspinatus [p values = <0.0001, 0.0019, 0.0009, and 0.0003, respectively.] 
b. iEMG unaffected > affected for pectoralis major sternal, infraspinatus [p values = 
<0.0001 and 0.0002, respectively.] 
c. No difference in iEMG between sides for pectoralis major clavicular, latissimus 
dorsi [p values = 0.6717 and 0.4330, respectively.] 
These relationships are demonstrated in Figure 28. Mean integrated EMG values for all subjects are 




Figure 28 Least squared mean iEMG during ROM-Reach, ROM-Rotation, ADL and work tasks (LSM±SD and 
Significance* between sides are shown) 
 
Section 4.4.4 Strength 
The strength of the infraspinatus, supraspinatus and upper trapezius were weaker on the affected side 
(p values were 0.0028, 0.0057, and <0.0001, respectively). There was no difference in strength 
(MVF values) between sides for the latissimus dorsi (p = 0.2179), pectoralis major (p = 0.6860), 
posterior deltoid (p = 0.2333) or serratus anterior (p = 0.7036). Least mean squared MVFs and 
significant differences are demonstrated in Figure 29 and average strength values for all participants 





















* * * 
* represents significant difference 
Error bars = ±SD  
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Table 19 Mean strength (MVF values) for all participants during maximal voluntary force exertions. Affected 
[shaded] and unaffected sides are listed. Standard deviation and range (minimum and maximum) values are listed. 
Note: bilateral comparisons were not collected for subscapularis. 
Muscle Median Avg SD Min Max 
R Grip (kg) 22 22 5 11 38 
L Grip (kg) 20 21 5 9 36 
Subscapularis MVF (N) 
85 87 24 35 129 
Infraspinatus MVF (N) 
59 63 19 32 118 
Infraspinatus MVF (N) 
64 67 18 29 292 
Latissimus Dorsi MVF (N) 126 128 48 43 151 
Latissimus Dorsi MVF (N) 123 125 47 43 306 
Pectoralis Major MVF (N) 78 80 29 5 122 
Pectoralis Major MVF (N) 80 81 29 25 161 
Supraspinatus MVF (N) 61 62 22 19 125 
Supraspinatus MVF (N) 66 66 20 16 120 
Posterior Deltoid MVF (N) 78 76 25 21 123 
Posterior Deltoid MVF (N) 78 87 96 32 994 
Upper Trapezius MVF (N) 56 60 25 8 262 
Upper Trapezius MVF (N) 65 67 26 16 145 
Serratus Anterior MVF (N) 112 110 41 36 133 
Serratus Anterior MVF (N) 108 111 45 28 290 
 
Section 4.4.5 Ratings of perceived discomfort, quality of life and disability scores 
In general, the ratings of perceived exertions reported during MVC testing revealed the affected side 
discomfort to be higher than the unaffected side, although significantly so only during infraspinatus 
and posterior deltoid maximal exertions (4% vs. 2% RPD, p = 0.018; 6% vs. 3% RPD, p = 0.0064, 
respectively) (Figure 30).Mean, variability and range of RPD scores for all participants are outlined 




Table 20 Mean ratings of perceived discomfort for all subjects during maximal voluntary contraction testing. 
Minimum, maximum and standard deviations are listed. Affected side [shaded] vs. unaffected sides. Note: bilateral 
comparisons were not collected for subscapularis. 
Muscle Avg SD Min Max 
Subscapularis RPD 6 15 0 85 
Infraspinatus RPD 4 11 0 70 
Infraspinatus RPD 2 8 0 60 
Latissimus Dorsi RPD 5 15 0 70 
Latissimus Dorsi RPD 4 9 0 40 
Pectoralis Major RPD 5 13 0 70 
Pectoralis Major RPD 4 12 0 50 
Supraspinatus RPD 8 15 0 70 
Supraspinatus RPD 5 14 0 75 
Posterior Deltoid RPD 6 14 0 80 
Posterior Deltoid RPD 3 10 0 70 
Upper Trapezius RPD 6 16 0 80 
Upper Trapezius  RPD 5 15 0 75 
Serratus Anterior RPD  3 13 0 70 
Serratus Anterior RPD 2 8 0 40 
 
The average QuickDASH score was 19 (out of a total score of 100, with 0 indicating no disability 
and 100 indicating severe disability). The average FACT-B Trial Outcome Index Score was 70 (out 
of a total score of 92); the average FACT-G total score was 89 (out of a total score of 108) and the 
average FACT-B total score was 114 (out of a total score of 144), with a higher score indicating 
better quality of life. Mean, standard deviations and ranges of disability and QoL scores for all 
participants are outlined in Table 21. The average difference in volume between limbs was 131.40 
mL (SD±252.66 mL; range 0.2 mL-1673.14 mL). Lymphedema was defined as a difference of 200 
mL or more between sides, and 5 participants had lymphedema as per this definition. Additional self-





Figure 30 Comparison of rating of perceived discomfort between sides during MVC tests 
 
Table 21 Summary of mean disability (QuickDASH) and quality of life (FACT-B) scores for all participants. A 
higher QuickDASH score indicates more severe disability. A higher FACT-B scores indicates better quality of life. 
 Score Avg SD Min Max 
QuickDASH 19 18 0 84 
FACT-B score (Trial Outcome 
Index Score: range 0-92) 
70 14 21 89 
FACT-B score (FACT-G Total 
Score: range 0-108) 
89 16 35 105 
FACT-B score (FACT B Total Score: 
range 0-144) 























Error bars = +SD 
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Table 22 Participant self-reported characteristics 
Description N 
Employment Status:   
Unemployed or retired 27 
Full-time 17 
Part-time 6 
Exercise Status:   
Sedentary 6 
Exercise <= 3 d/wk 9 
Exercise  >= 4 d/wk 35 
Subjective Scores:   
reported compromised ADL performance 16 
reported affected chest/shoulder tightness 30 
reported affected ROM was reduced 26 
reported consistent pain on affected side 26 
reported weaker on affected side 24 
reported swelling on affected side 25 
reported cording on affected side 9 
reported numbness on affected side 31 
Routinely wore compression garments 10 
Had Reconstructive Surgery 11 
 
Section 4.4.6 Relationship between total muscle effort and quality of life and disability scores 
Correlation analysis revealed modest linear relationships between disability and QoL scores with 
summation of affected side TME for all exertions [Equation 13, Equation 14]: 
Equation 13 Relationship between muscle effort and disability score 
𝑇𝑀𝐸 = 672,709(𝑄𝑢𝑖𝑐𝑘𝐷𝐴𝑆𝐻) + 5𝐸+07             𝑅2 = 0.1465 
Equation 14 Relationship between muscle effort and quality of life score 
𝑇𝑀𝐸 =  −329,310(𝐹𝐴𝐶𝑇. 𝐵) + 9𝐸+07             𝑅2 = 0.0315 
Non-linear relationships were also investigated, but these relationships greatly complicated 




Figure 31 Relationships between summation of affected side TME during all exertions with disability scores 
(QuickDASH). Linear and polynomial relationships are shown. 
 
 
Figure 32 Relationship between summation of affected side TME during all exertions with quality of life (FACT-B) 
scores. Linear and polynomial relationships are shown. 
 
  
y = 672709x + 5E+07 
R² = 0.1465 
y = -5345.9x2 + 1E+06x + 5E+07 








































y = -329310x + 9E+07 
R² = 0.0315 
y = -12071x2 + 927959x + 6E+07 










































Section 4.5 Discussion 
The purposes of this investigation were to describe upper limb capabilities and dysfunction of breast 
cancer survivors in terms of 3-D upper limb kinematics, muscle activation patterns and strength; and 
to determine the relationships between a physical quantity of function (total muscle effort) with 
subjective functional measures (QoL and disability scores). Accurate documentation of physical 
capability and dysfunction is the first step towards developing targeted treatment and preventative 
strategies for this disabled population. In general, the kinematic findings demonstrated reduced angle 
of elevation and increased internal rotation on the affected side humerus; and reduced protraction, 
less downward rotation, and more posterior tilting on the affected side scapula. These kinematic 
changes coincided with other factors suggestive of dysfunction on the affected side, including: 
weakness (reduction in muscle-specific strength), enhanced muscle effort (increased activity levels 
insinuating increased effort required or increased fatigue due to damage or dysfunction), reduced 
muscle capability (reduced activity levels due to damage or dysfunction) and discomfort (increased 
RPD scores).  
Section 4.5.1 Addressing the hypotheses 
Revisiting Hypothesis 1: It was hypothesized that survivors would demonstrate reduced humeral 
angle of elevation and external rotation range of motion, but increased scapular protraction range of 
motion on their affected side compared to the contralateral limb.  
The humerothoracic kinematic results confirmed the hypotheses and demonstrated that 
survivors averaged 3.9° - 6.5° reductions in humeral elevation and 8.9° less humeral external rotation 
on the affected side. Further, survivors were 7.9° - 13.1° more internally rotated. 
 The scapulothoracic kinematic results partly confirmed the hypotheses and demonstrated 
that although both sides of survivors were always in a state of protraction during all tasks, the 
affected side demonstrated reduced scapular protraction compared to the degree of protraction on the 
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unaffected side during ROM and work tasks. Specifically, 3.4° less of protraction compared to the 
unaffected side during ADL and work (maximal angles), and 3.6° and 4.4° less protraction during 
ROM-Rotate and work tasks (minimal angles). Increased protraction (‘winged scapula’) have been 
documented previously (as determined by visual clinical assessment and classified as either ‘winged’ 
or ‘normal’) in the BCP (Lauridsen, Torsleff, Husted, & Erichsen, 2000). In a previous study of 11 
participants performing scaption, increases of scapular protraction by 3.9° were displayed on the 
affected arm, compared to the unaffected arm post-surgery. 
Revisiting Hypothesis 2: It was hypothesized that survivors would demonstrate reduced strength and 
increased muscle activity on the affected side. 
 Total muscle effort was significantly greater on the affected side during work tasks, 
confirming the hypothesis of increased muscle activity. In partial support of the hypothesis, 
reductions in muscle-specific strength of the affected side of 4 N, 4 N and 7 N were seen in only the 
infraspinatus, supraspinatus and upper trapezius exertions, respectively. 
Revisiting Hypothesis 3: It was hypothesized that as total muscle effort increased, there would be a 
decrease in quality of life (FACT-B scores) and an increase in disability (QuickDASH) scores. 
 This hypothesis was confirmed, and small correlations were found between quantitative and 
subjective measures of function, affirming poorer ratings of quality of life and higher ratings of 
disability with higher levels of total muscle effort. 
Section 4.5.2 Kinematics 
All three angle calculations (maximum and minimum achieved angles and total ROM (the difference 
between maximum and minimum angles)) should be considered when interpreting bilateral changes 
in scapulothoracic and humerothoracic kinematics. A wider task ROM calculation (maximum minus 
minimum angles) could reflect variability of movement strategies used, or relate to available range. 
Maximum and minimum angles must be carefully interpreted based on their polarity in the context of 
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the task being investigated (e.g. a negative humeral rotation angle would be expected during perineal 
care tasks, but not during an external rotation exertion).  
Section 4.5.2.1 Interpretation of ROM calculations 
There was little difference in the overall scapulothoracic and humerothoracic task ROM (the 
difference between maximum and minimum achieved angles) between unaffected and affected sides. 
The affected side demonstrated reduced ROM only in elevation angle during ROM-Rotate tasks (-
2.3°) and in plane of elevation during ROM-Reach (-6.7°) and ROM-Rotate tasks (-3.3°). A reduced 
ROM in plane of elevation could suggest the BCP was less variable in their movement strategies 
between planes, keeping movements in a tighter range of planes. In many instances, the affected side 
demonstrated movement through a greater ROM: 1.8° and 2.0° more ROM in anterior/posterior tilt 
during ADL and work tasks, respectively; 7.1° more humeral rotation ROM during ROM-Rotate 
tasks, and 5.3° more ROM in elevation during work. Past clinical assessments have reported 
reductions in elevation angle ROM on the affected side during abduction (-6.4°, -7.5° and -21°) and 
flexion (-4.3°, -5.7°, -12°), as well as reduced external rotation ROM (-6.2°) (Hack, Cohen, Katz, 
Robson, & Goss, 1999; Kuehn, et al., 2000; Rietman, Dijkstra, Debreczeni, Geertzen, Robinson, & 
De Vries, 2004). However, maximum and minimum absolute angle values must be considered before 
making any conclusions regarding affected side having greater ROM, as enhanced total ROM is 
sometimes explained by a lower minimum starting angle (e.g. the affected side reached lower 
maximum elevation angles, but started at lower humeral elevation angles, resulting in a greater 
overall ROM). It is difficult to compare ROM values between previous studies as it is unknown if the 
starting position was consistent within tasks and studies, and if that starting position was similar to 
the current thesis study. Detail regarding the minimum and maximal angles, as is described in the 
next section, provides further insight into the movement differences between sides. 
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Section 4.5.2.2 Interpretation of the scapulothoracic angles in terms of maximum and 
minimum angles and comparison with previous literature 
Both minimum and maximum angles revealed that the affected side scapula was less protracted, 
more upwardly rotated, less downwardly rotated, and more posteriorly tilted. The significance of 
these relationships was dependent on the group of tasks being performed. The affected scapula 
displayed 3.4° - 3.9° less protraction compared to the unaffected side during ADL and work tasks 
(according to maximum angles), respectively; and 3.6° – 4.4° less protraction during ROM-Rotate 
and work tasks (according to minimum angles). The scapula demonstrated 2.8° more upward rotation 
on the affected side during ROM-Rotate tasks, and non-significant trends indicated increases in 
upward rotation (0.9° – 2.6° more) for all other groups of tasks. Interpretation of the minimum angles 
revealed that the affected scapula displayed 2.9°– 3.5° less downward rotation compared to the 
unaffected side during all four groups of tasks. The affected side scapula demonstrated 4.1° more 
posterior tilt during work tasks. 
These kinematic findings partly contrast with previous reports, although it is difficult to 
make direct comparisons between scapulothoracic changes reported in the BCP due to the limited 
number of studies available and the differing methodologies used (population characteristics, type 
and timing of treatment and measurements, recording methods and exertions examined). A recent 
study investigated scapulothoracic kinematics of the BCP during bilateral flexion, abduction and 
scaption, and reported that women with dominant-side mastectomies exhibited greater upward 
rotation during arm elevation during scaption (5.0° – 9.3° more) and abduction (5.5° – 11.9° more) 
on the affected side compared to a healthy control group (Crosbie, et al., 2010). Shamley et al. 
(2009) compared affected left and right-sided scapulothoracic changes in the BCP post-surgery, and 
found that the both sides displayed increased posterior tilt (~2° and depended on the angle of 
elevation) but left-affected scapulothoracic changes included increased protraction (~10° and 
depended on the angle of elevation) and decreased upward rotation; whereas right-affected 
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dysfunction included increased retraction and increased upward rotation. Later, Shamley et al. (2012) 
compared the scapular kinematics of survivors during scaption to healthy controls, and reported that 
patients demonstrated greater upward rotation on the affected side (p<0.0001, CI 4.82 – 8.51 for left 
affected side; CI 3.91 – 7.71 for right affected side) (associated with a decrease in pectoralis major 
activity and an increase in serratus anterior activity) and a non-significant increase in posterior tilt. 
Borstad and Szucs (2012) investigated scapular kinematics of the BCP 2 months post-surgery while 
performing scaption and reported scapular protraction increased post-surgery by 8.1° and was 
increased on the affected arm by 3.9°. Trends indicated increases of 3.4° in upward rotation and 
increases of 3.5° in anterior tilt on affected arm, but there was no significant change in scapular 
rotation or tilt (Borstad & Szucs, 2012). Despite a lack of data available for comparison (especially 
for the range of tasks investigated in the current study), there was general agreement between the 
current study and previous work that the affected side of the BCP demonstrated more scapular 
posterior tilting (Shamley, Srinaganathan, Oskrochi, Lascurain-Aguirrebena, & Sugden, 2009), 
increased upward rotation (Crosbie, et al., 2010; Shamley, Lascurain-Aguirrebena, Oskrochi, & 
Srinaganathan, 2012). 
Differences in findings within and between past research and the current study may be due to 
methodological differences. Crosbie et al. (2010) and Shamley et al. (2012) reported increased 
upward rotation on the affected side during flexion, abduction and scaption, but in the current study 
upward rotation was significantly greater during only ROM-Rotate tasks, although trends suggested 
increases in all tasks. Crosbie et al. (2010), Shamley et al. (2009; 2012) and Borstad & Szucs (2012) 
used electromagnetic tracking devices to record kinematics, but the acromion tracking technique 
used in the optoelectronic recording method of the current study underestimates upward rotation 
(Karduna, McClure, Michener, & Sennett, 2001). Grewal (2011) further confirmed that the acromial 
tracking technique underestimated upward rotation by about 9° – 11° compared to other methods. 
Conflicting reports of posterior tilt and protraction angles may also be due to differing 
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methodologies. Grewal (2011) recommended the acromial tracking technique to measure scapular 
orientation, but cautioned interpretation of results since the method overestimated posterior tilt at 
overhead elevation angles [recall significant increases in posterior tilt were seen during work tasks of 
elevated reaching in the current study] and underestimated it at low elevation angles; and 
underestimated protraction in the frontal plane at low elevation angles, but overestimated it for all 
other postures, with errors increasing with internal rotation and elevation angle [recall survivors were 
always in a state of protraction in the current study]. Other investigators have similarly reported the 
inaccuracy of scapular protraction measures using the acromial tracking techniques at higher 
elevation angles (Karduna, McClure, Michener, & Sennett, 2001; van Andel, van Hutten, Eversdijk, 
Veeger, & Harlaar, 2009). These methodological differences could partly influence the kinematic 
discrepancies reported between scapulothoracic ranges of motion displayed by Shamley et al. (2009) 
during scaption (~12° ROM in protraction/retraction, ~45° ROM in upward/downward rotation and 
~10° ROM in anterior/posterior tilt) compared to the mean ranges of motion found during the current 
study’s ROM-Reach tasks (20.6° ROM in protraction/retraction, 44.1° ROM in upward/downward 
rotation 23.1° ROM in anterior/posterior tilt). Future study of this population should incorporate 
standardized methods so that kinematics can be accurately compared. 
Adaptive changes may reflect the scapulothoracic kinematic changes seen between sides. It 
has been speculated that the altered motor patterns of the scapula may be evidence of an adaptation 
made due to reduced frequency and amplitude of arm elevation following surgery (Crosbie, et al., 
2010). Following surgery, a drain is often inserted into the chest wall to reduce risk of seroma 
formation and women are recommended to limit arm elevation and guard their limb (disallowing 
even blood pressure measurements on the affected side), in order to reduce incidence of 
lymphedema. Further, patients receiving chemotherapy may have a port catheter surgically inserted 
under the skin of the chest wall (usually on the right side at the location of the internal jugular vein), 
and associated risks and complications may cause some patients to limit mobility and experience 
127 
 
pain even after it has been removed. In the current study the BCP was found to be in a consistent 
state of scapular protraction on both sides. The participants also exhibited more upward rotation and 
less downward rotation on the affected side, which may reflect adaptive changes to motor patterns 
and learned usage as suggested by Crosbie et al. (2010). Increased upward rotation could also reflect 
a compensatory change due to postures of increased scapular protraction. Healthy populations in 
slouched trunk postures were found to have more upward rotation and less posterior tilting of the 
scapula compared to erect posture (Kebaetse, McMclure, & Pratt, 1999).  Increases in posterior tilt 
seen in the current study may reflect a compensatory movement to increase the subacromial space 
(reducing risk of impingement) due to the degree of protraction and reduction in downward rotation. 
Decreased scapular upward rotation and posterior tilting, and increased protraction have all been 
associated with subacromial impingement syndrome (Ludewig & Reynolds, 2009). These adaptative 
kinematic changes seen in the scapula suggest the body may be compensating to guard against 
movements that are difficult, cause pain, or infer risk of subacromial impingement. 
Section 4.5.2.3 Interpretation of humerothoracic angles in terms of maximum and minimum 
angles and comparison with previous literature 
Interpretation of both minimum and maximum angles revealed that the affected side humerus 
reached lower elevation angles, maintained a more anterior plane of elevation and was less externally 
rotated and more internally rotated. The significance of these relationships depended upon the group 
of tasks being performed. Trends indicated the affected humerus reached lower maximal angles of 
elevation for all tasks, although only significantly so during ROM-Rotate tasks. The affected 
humerus reached 6.5° lower maximal angles of elevation and was maintained in a more anterior 
plane of elevation (-21.1° vs -17.2°) during ROM-Rotate tasks compared to the unaffected limb. 
Three-dimensional humerothoracic kinematics of the BCP have not been described previously, but 
clinical assessments have reported similar reductions in elevation angles (-6.4 and -7.5 during 
abduction; -4.3 and -5.7 during flexion) (Hack, Cohen, Katz, Robson, & Goss, 1999; Rietman, 
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Dijkstra, Debreczeni, Geertzen, Robinson, & De Vries, 2004). With the exception of the work task 
group, the affected side humerus reached 3.9° – 5.7° lower minimum angles of elevation during all 
other groups of tasks. During work tasks of the current study the humerus was 8.9° less externally 
rotated, which is similar to past research which reported reductions of external rotation of -6.2° on 
the affected side (Rietman, Dijkstra, Debreczeni, Geertzen, Robinson, & De Vries, 2004). With the 
exception of the ROM-Reach tasks, the affected humerus was 7.9° – 13.1° more internally rotated 
during all other groups of tasks. 
This is the first published study to report 3-D humerothoracic angles of the BCP so direct 
comparisons are challenging, but many studies have described clinical assessments of humeral angles 
from which comparisons can be made. Similar to the findings of the current study, previous clinical 
investigations have determined reductions in elevation angle and external rotation amongst the BCP. 
In the current study survivors maximal end reach height was reduced on the affected side humerus by 
6.5° during ROM-Reach tasks, and survivors started tasks with their arm closer to their side (3.9° - 
5.7° reduced minimal angle) during ROM-Reach, Rom-Rotate and ADL tasks. Clinical assessments 
using goniometry have reported reductions in elevation angles of survivors during flexion and 
abduction with differences in range of motion between sides from 4° to 6° (Hack, Cohen, Katz, 
Robson, & Goss, 1999), 12° and 21°(Kuehn, et al., 2000), and 6° to 8°, respectively (Rietman, 
Dijkstra, Debreczeni, Geertzen, Robinson, & De Vries, 2004). In the current study, the affected 
humerus externally rotated 8.9° less than the unaffected limb during work tasks, and internally 
rotated 7.9°, 8.5° and 13.1° more ROM-Rotate, ADL and work tasks, respectively. Reductions of 6° 
external rotation have been reported previously during clinical examination of survivors (Rietman, 
Dijkstra, Debreczeni, Geertzen, Robinson, & De Vries, 2004). Smaller magnitudes of maximal 
elevation angles reported in the current work from some previous clinical assessments may be due to 
the fact that angles extracted from recorded motion tracking tend to underestimate angles as the arm 
elevates, which has been attributed to trunk tilting during arm elevation (Grewal, 2011). McClure et 
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al. (2001) similarly reported extracted angles underestimating goniometer measurement of humeral 
elevation by about 15°. In the current study, neutral trunk posture was encouraged, but it was not 
constrained and participants were seated on a backless stool. Extracted angles also tend to 
overestimate elevation angles at lower (more neutral) arm postures, due to surrounding soft tissue of 
the arm and thorax which disallows alignment of the two local y-axes (Grewal, 2011). Further, the 
definition of “zero” between clinical assessments with the current work may limit direct comparison 
of data. Often, neutral or zero positions are defined as the anatomical stance in clinical settings, 
whereas zero was defined as the alignment of the humerus and thorax local coordinate systems in the 
current study. 
The maximal angles of elevation were on average lower on the unaffected side compared to 
healthy populations performing similar exertions, suggesting bilateral kinematic changes occur in the 
BCP. Humerothoracic kinematics had been examined for a similar battery of exertions examined in 
this body of work in elderly healthy and impingement populations by Hall et al. (2011). Hall et al. 
(2011) reported the maximal humerothoracic elevation angles during flexion and abduction as: 145° 
[±24°] (healthy, flexion) and 108° [±28°] (impinged, flexion), 140° [±20°] (healthy, abduction) and 
96° [±30°] (impinged, abduction). The BCP of the current study achieved maximal elevation angles 
more similar to the impingement population, with lower angles of elevation on even the unaffected 
side compared to the healthy group: 115.1° [±25.3°] (BCP unaffected side, flexion) and 114.5° 
[±24.7°] (BCP affected side, flexion), 110.5° [±25.5°] (BCP unaffected side, abduction) and 107.0° 
[±24.8°] (BCP affected side, abduction) (as described in Table 44). Bilateral changes have been 
reported by Shamely et al. (2012), who identified scapular kinematic and muscle activation changes 
in both arms of unilateral BCP when compared to healthy participants. Compensatory changes on the 
unaffected arm (due to overuse, radiated pain and overflow effects of radiation or surgery), as well as 
prophylactic bilateral mastectomy (N=16 participants in the current study) may have altered the 
‘unaffected’ side and resulted in bilateral changes. 
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Section 4.5.2.4 Kinematic changes between sides are small but meaningful 
Despite modest magnitudes of kinematic differences (2.8° – 13.1°) found between sides in the 
current study, these differences are believed to be important. These differences are believed to be 
important because they are thought to demonstrate biological and clinical relevance, as well as 
mathematical (statistical) significance. Statistical significance is distinct from biological and clinical 
significance. Statistical significance is determined mathematically and describes the likelihood of a 
chance finding that will not hold up in future replications, but does not provide information regarding 
if that difference was biologically or clinically relevant. Biological significance determines if the 
differences identified have some biological affect. For example, the results indicated the affected 
limb demonstrated a 9° reduction in humeral ER in comparison to the contralateral limb: it is 
necessary to know if this reduction in ER would result in lower muscle activation of the 
infraspinatus. The results did in fact show synchronous reductions in infraspinatus muscle activation 
that coincided with the reductions in ER ROM. However, yet even another level needs to be 
examined as it should be determined if the magnitude of reductions in infraspinatus activity are 
important in clinical terms – such as if this lack of ER ROM, reduced muscle activation and 
subsequent reduction in muscle force disallows an individual from performing a routine functional 
task (eg. dressing, driving a manual shift vehicle). The remainder of this section and the following 
section will describe how the modest differences identified were associated with synchronous 
biological changes (EMG, strength, RDP) which could lead to basic functional impairment, and will 
refer to other literature that has reported similar magnitude changes interpreted as being clinically 
meaningful. 
Some groups have defined impaired shoulder ROM as a loss of 20° compared to the 
unaffected limb (Box, Reul-Hirche, Bullock-Saxton, & Furnnival, 2002; Rietman, Dijkstra, 
Debreczeni, Geertzen, Robinson, & De Vries, 2004), however other groups have shown that much 
smaller changes are clinically meaningful.  Ludewig & Cook (Ludewig & Cook, 2000) demonstrated 
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the clinical importance of modest angular kinematic differences, showing that 4° – 6° difference in 
scapular kinematics distinguished between healthy and impinged populations. Similarly, Ebaugh et 
al. (2005) demonstrated 4° - 5° of scapular kinematic differences were important in assessing the 
effects of muscle activity on kinematics; and Lukasiewicz et al. (1999) reported a 5° difference 
between healthy and impingement groups to be clinically meaningful. Borstad and Szuks (2012) 
reported a clinically meaningful increase of 11.5° protraction of breast cancer survivors post-surgery. 
The considerable variability seen in the current work is not surprising due to the wide variety of tasks 
performed and differing participant factors (e.g. cancer severities, treatments, timing). Shamley et al. 
(2012) indicated that larger movement deviations (and greater pain) were seen in scapulothoracic 
kinematics of survivors that had mastectomies compared to those with local wide excision. Shoulder 
kinematics are highly variable across even healthy individuals, and it has been demonstrated that 
several measures of variability as indicated by the standard deviations exceed 100% of the recorded 
ROM (Picco B. , 2012). Hall et al. (2011) reported considerable variability in range of humeral 
elevation and rotational angles during ADL tasks of elderly healthy adults (±30° variation in 
elevation angle and ±36° variation in humeral rotation angle), which was almost average to the 
variability observed of the BCP in the current study during similar tasks (elevation: ±21.8° 
(unaffected) and ±27.9° (affected); rotation: ±50.6° (unaffected) and ±55.3° (affected)). Significant 
differences in kinematics were found despite considerable variability, emphasizing their importance. 
Small magnitude differences found between sides of the BCP emphasize the need for quantification 
of 3-D scapulothoracic and humerothoracic kinematics, as these changes may be difficult to evaluate 
using clinical assessment tools. 
Section 4.5.3 Interpretations of kinematic changes are enhanced when RPD scores, strength 
and EMG results are considered 
The kinematic data corresponds synchronously to the RPD scores, strength and EMG results, aiding 
in the explanation of the dysfunctions identified. Total muscle effort was significantly greater on the 
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affected side during work tasks, and reductions in muscle-specific strength during tasks thought to 
functionally isolate muscles were seen on the affected infraspinatus, supraspinatus and upper 
trapezius. Weakness in the affected side infraspinatus (a primary ER) and supraspinatus (involved in 
abduction and ER) could result in reductions in humeral elevation angles, as well as reduced external 
rotation. Weakness or dysfunction of the affected side infraspinatus was reflected subjectively by a 
higher RPD score. Higher RPD scores during the posterior deltoid MVC testing position may also 
reflect weakness of the supraspinatus, infraspinatus and upper trapezius weakness as each of these 
muscles would also be recruited in the testing position of resisted humeral abduction and extension 
during external rotation. Total muscle effort was greatest during ROM-Reach tasks (when moment 
arms would be extended to allow for maximal reach), followed by work tasks, suggesting more effort 
was required of these muscles; or increased amplitudes were indicative of fatigue of damaged or 
deconditioned muscles. Since the work tasks involved greater moment arms during extended 
reaching and in some cases lifting external loads, these tasks were assumed to be more muscularly 
demanding compared to ADL and ROM-Rotate tasks. The iEMG was greater on the affected side 
posterior deltoid, upper trapezius and supraspinatus during all tasks – again suggesting that these 
muscles may have had some level of dysfunction (requiring them to activate to higher levels and 
produce more effort to result in the same movement as the unaffected side) or the response was 
indicative of compensatory changes (muscle was working at a greater extent because it was able to, 
and needed to compensate for other muscles that were less functional). Previous works have 
indicated that survivors experience decreased functional capacity, meaning they exert more effort 
relative to their maximal ability to perform usual activities, therefore leading to higher levels of 
fatigue (Mock, et al., 2005). Recently, the activation of the upper trapezius in breast cancer survivors 
during a functional writing task was found to be greater on the affected side, and greater in both sides 
compared to a control group (Galiano-Castillo, Fernandez-Lao, Cantarero-Villanueva, Fernandez-de-
las-Penas, Menjon-Beltran, & Arroyo-Morales, 2011). Survivors with greater shoulder pain scores 
exhibited greater EMG amplitude within the affected upper trapezius, suggesting that increases in 
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EMG may be due to pain (resulting in muscle tension) or the fear of pain  (Galiano-Castillo, 
Fernandez-Lao, Cantarero-Villanueva, Fernandez-de-las-Penas, Menjon-Beltran, & Arroyo-Morales, 
2011). Patients with chronic neck pain exhibit increased upper trapezius and sternocleidomastoid 
muscle activation (Falla, Bilenkij, & Jull, 2004). 
The serratus anterior was suspected to have some level of dysfunction due to the persistent 
presence of scapular protraction evident in both sides of the BCP, and the reduction of protraction 
demonstrated on the affected side.  The serratus anterior is primarily responsible for scapular 
protraction and is active during anterior reaching (Moore, Dalley II, & Agur, 2014). Greater muscle 
activation levels (iEMG) of the serratus anterior were only evident during work tasks, which did 
involve some anterior reach tasks with and without external loads. Increased activity in the serratus 
anterior has been seen previously in affected shoulders of breast cancer survivors during scaption, 
compared to a healthy population (Shamley, Lascurain-Aguirrebena, Oskrochi, & Srinaganathan, 
2012). Ebaugh et al. (2005) demonstrated the important role serratus and upper trapezius have in 
producing upward rotation of the scapula, especially during mid-range of arm elevation. In a healthy 
population, an increase in muscle activity resulted in more scapular retraction and more upward 
rotation when the arm was elevated (Ebaugh, McClure, & Karduna, 2005). These findings are 
consistent with the current study’s results. The serratus was relied upon heavily during work groups 
tasks as these tasks involved several outstretched arm reaches with some external loads, whereas the 
serratus would be recruited less during ADL tasks when the hand was often kept close to the body. 
Although ROM-Reach tasks involved several outstretched arm reaches, no external loads were 
applied and it is assumed that the serratus was not relied upon to the same extent it was during work 
tasks. Scapular kinematics demonstrated that on average the survivor population was always in a 
state of scapular protraction (even on the unaffected side). The survivors may have exhibited some 
thoracic flexion (kyphosis or slouching) while seated: they were seated on a backless stool and often 
had their hands placed in front of them on a table. Thoracic kyphosis increases in healthy women 
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over the age of 40 years, and raises from 43° between 55 to 60 years of age to 52° in women 76 to 80 
years old (Ensrud, Black, Harris, Ettinger, & Cummings, 1997). The current study’s environmental 
seating factors, increased participant age, and also anteriorly directed task demands would encourage 
a tendency of thoracic slouching and a posture of scapular protraction – especially if the participant 
became weary during the duration of the study. Habitual scapular protraction even during standing 
can be resultant of every day anteriorly directed tasks (eg. sitting, driving, computer work). A portion 
of this population may also exhibit scapular protraction as a self-conscious response in attempt to 
hide the sometimes rather obvious results of mastectomy. Prosthetic breasts are available, but are 
expensive, cumbersome and uncomfortable. The affected side serratus anterior had to produce more 
effort (higher activation) and demonstrated a reduction in protraction range, which is suggestive of 
some level of serratus anterior dysfunction that could be a result of nerve damage. Forty eight of the 
fifty participants had axillary node dissections. The serratus anterior is supplied by the long thoracic 
nerve, which is susceptible to damage during axillary node dissections (Lauridsen, Torsleff, Husted, 
& Erichsen, 2000), and this potential damage could explain the dysfunction seen. Galiano-Castillo et 
al. (2011) also suggested that chemotherapy and/or neuropathy could induce muscle damage which 
would promote changes in muscle recruitment and result in alterations to exhibited motor strategies. 
Loss of tissue and damage to the pectoralis major sternal muscle may explain reduced 
activation seen during all tasks. Reduction in pectoralis major activity has been seen previously in 
affected shoulders of breast cancer survivors during scaption, compared to a healthy population 
(Shamley, Lascurain-Aguirrebena, Oskrochi, & Srinaganathan, 2012). Dysfunction was expected in 
the pectoralis major sternal portion as it is highly susceptible to surgical and radiation exposure 
(Dalberg, Krawiec, & Sandelin, 2010; Sugden, Rezvani, Harrison, & Hughes, 1998) . Scar tissue and 
adhesions to the anterior chest wall can inhibit smooth muscle and tissue movement (Lauridsen, 
Overgaard, Overgaard, Hessov, & Cristiansen, 2008) and may dampen the electromyographic signal 
from the underlying muscle. Residual effects (surgical scarring, fibrosis) could affect movement 
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mechanics through tethering soft-tissue or inhibiting movement due to pain (Crosbie, et al., 2010). 
The pectoralis major is supplied by the pectoral nerve, which is also susceptible to damage during 
axillary node dissections (Lauridsen, Torsleff, Husted, & Erichsen, 2000), and may be a partial cause 
of the reduction in muscle activation seen in this muscle. The affected side pectoralis major and 
minor muscles were measured with MRI and found to be significantly smaller in size (mean muscle 
area) following various breast cancer treatments (Shamley, et al., 2007). Reduction in length of the 
pectoralis major may affect the patients’ ability to reach up and elevate the arm (Shamley, et al., 
2007). Dysfunction in the pectoralis major sternal muscle may explain reduced humerothoracic 
elevation angles. Further possible implications of the reduced capacity of the pectoralis major muscle 
were investigated in Study 4 of this thesis.  
Section 4.5.4 Secondary changes associated with BCP 
It is apparent that some dysfunction associated with the survivors is not due to direct surgical or 
radiation damage, but may be reflective of compensatory changes due to kinematic differences. 
Despite predominate anteriorly-directed treatments to the chest (ex. lumpectomies, mastectomies, 
anteriorly-directed radiation), posterior chest muscles also demonstrated dysfunction as evidenced 
by:  
- weakness in the supraspinatus, infraspinatus, and upper trapezius;  
- increased muscle effort required by posterior deltoid, upper trapezius and supraspinatus; 
- reduced muscle contribution (decreased activation) demonstrated by the infraspinatus during 
ROM-Reach, ROM-Rotate and work tasks; 
- elevated RPD scores during infraspinatus and posterior deltoid maximal testing. 
Anterior chest wall damage and resultant scar tissue may be the factor that limits range of humeral 
external rotation and elevation angle. The survivors may be demonstrating a compensatory or 
protective posture of increased internal rotation, during which the humerus is forced into internal 
136 
 
rotation due to adhesions, or voluntarily held in that position to reduce external rotation motions that 
result in painful pulling on tender tissues due to surgical or radiation damaging effects. Lower angles 
of elevation and reduction in external rotation motions would mean that the humeral abductors, 
extensors and external rotators are relied upon less frequently, and therefore may become weak due 
to disuse. Further, postures involving more internal rotation and humeral elevation would mean the 
external rotator muscles are fully lengthened and at a non-optimal length (minimizing the overlap 
between actin and myosin filaments), disallowing maximal tension. This scenario could explain the 
weakness of the infraspinatus and reduced capacity of the infraspinatus (humeral ER), the weakness 
and increased muscle effort required of the supraspinatus (humeral abductor and ER), and the 
discomfort and increased effort required of the posterior deltoid. The upper trapezius acts to draw the 
scapula and clavicle backward, or raise the scapula by rotating the clavicle about the sternoclavicular 
joint (Johnson, Bogduk, Nowitzke, & House, 1994). The affected upper trapezius was weaker 
(produced less force), and demonstrated greater levels of activation during all tasks. Since all 
survivors demonstrated a consistent posture of scapular protraction, the upper trapezius dysfunction 
(weakness, increased effort demands) may also be a result of disuse, as it is recruited less to draw the 
scapula backward, but rather is often in a state of semi-eccentric contraction in a position of scapular 
protraction. Increased upper trapezius activity has been observed previously in the breast cancer 
population (Galiano-Castillo, Fernandez-Lao, Cantarero-Villanueva, Fernandez-de-las-Penas, 
Menjon-Beltran, & Arroyo-Morales, 2011; Shamley, Lascurain-Aguirrebena, Oskrochi, & 
Srinaganathan, 2012), as well as in patients with impingement (Ludewig & Cook, 2000) and 
adhesive capsulitis (Lin, Wu, Wang, & Chen, 2005). Shamley et al. (2007) reported ‘primary’ 
expected changes in the pectoralis muscle and serratus anterior due to their location in the field of 
surgery and radiation, but also recognized ‘secondary effects’ in muscles outside the line of surgery 
or radiation (reduced upper trapezius and rhomboid activity) that persist for years and are associated 
with an inability to perform pain-free functional tasks. Shamley et al. (2007) recommended that 
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exercise programs should include postural correction and education of potential long-term effects, as 
well as ROM programs. 
Section 4.5.5 Caution with generalization of results and recommendations for future works 
Due to the heterogeneity of the population understudy, caution must be used in interpretation and 
generalization of findings. The survivors in the current study reported similar, but slightly higher 
levels of disability than those recorded previously. Crosbie et al. (2010) studied survivors with 
mastectomies who reported DASH scores of 10.12 (±9.39) – 12.97 (±11.60) compared to a healthy 
control score of 3.29 (± 4.75), whereas the BCP from the current study reported scores of 19 (±18). 
The 50 survivors in the current study reported very similar FACT-B scores (114 (±20)) to the 
baseline FACT-B scores of 377 survivors reported by Vallance (2007) (115.1 – 117.5 (±17.3 – 
19.7)). Increases in total muscle effort were lightly correlated with increased QuickDASH scores 
(higher disability) and lower FACT-B scores (poorer quality of life), demonstrating that these 
subjective measures are not sufficient in identifying physical dysfunction, and confirming the need 
for further quantitative analysis of survivor dysfunction. It is not surprising that a quantitative 
measure of physical function (TME) was not strongly related to a multifaceted measure of disability 
or quality of life which considered many other parameters (e.g. social, emotional, relationship) 
besides physical function.  
Potential treatment effects, including possible bilateral changes, may have complicated results 
and compromised interpretation of findings. Hand dominance was not controlled for, nor was side 
affected by cancer, and it is possible these factors may have had an effect on kinematics and muscle 
activation. Shamley et al. (2014) reported the BCP demonstrated a different movement dysfunction 
depending on whether the left or right shoulder was affected, and concluded left affected wide local 
excision and/or mastectomy patients should be considered high risk for developing shoulder 
complications after treatment. Due to the sample size and wide variation of treatments received it 
was not possible to group our participants into treatment groups (nor was it the proposed purpose of 
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this work). By recruiting a much larger sample size, future works could examine specific treatment 
effects. The results of this study provide a broad sense of capability and dysfunction of survivors in 
general, and are not specific to treatments received. In the current study, the affected side was 
compared to the unaffected ‘healthy’ limb as has been done previously (Hack, Cohen, Katz, Robson, 
& Goss, 1999; Kuehn, et al., 2000; Lauridsen, Torsleff, Husted, & Erichsen, 2000; Rietman, 
Dijkstra, Debreczeni, Geertzen, Robinson, & De Vries, 2004; Shamley, Srinaganathan, Oskrochi, 
Lascurain-Aguirrebena, & Sugden, 2009), and as a result it is possible that some dysfunction could 
go unrecognized. In the current population under study there were 16 survivors that received bilateral 
(prophylactic) mastectomy, and it is plausible that some dysfunction would have occurred on the 
unaffected side of these individuals. Shamley et al. (2012) demonstrated altered muscle activity and 
shoulder kinematics on both sides of unilateral breast cancer survivors compared to healthy 
populations. It is possible that presence of pain may have limited maximal voluntary contractions and 
therefore affected the normalization of EMG data: lower maximums could be associated with higher 
muscle activation levels. The classification of tasks into groups was useful to ease interpretation and 
provide a general overview of survivor capacity, however this division may have diminished findings 
by failing to recognize differences between tasks within a group. The ROM-Reach and ADL task 
classifications were similar to Hall et al. (2011). Some changes suggestive of dysfunction (increased 
TME, iEMG and kinematic differences) were more obvious within the ROM-Reach and work tasks 
groups during which there was assumed to be more muscularly demanding tasks since it involved 
extended moment arms (maximal reaches) and lifting external loads. Further works should continue 
to examine a broader range of functional tasks with varied reach distances and external loads. Future 
works should also expand the survivor sample size, narrow (or match groups based by) disease 
characteristics and treatment variability, and compare results with an age-matched healthy 
population, as well as between sides. Animal studies may be useful in future investigations of 
specific treatment effects and efficacy of proposed rehabilitation (eg. irradiate tissue, record 
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muscular and ROM changes before and after exercise treatments), and would be useful to determine 
if EMG is an accurate reflection of muscle changes. 
Section 4.5.6 Summary of study contributions and recommendations for the treatment 
This investigation has produced the most comprehensive collection of 3D humerothoracic and 
scapulothoracic kinematics and electromyographic recordings for the BCP. Details regarding 
physical function during a wide variety of exertions that have not yet been examined in the literature 
have been provided, and the changes discovered reinforce the need for further laboratory 
examinations as these differences would be difficult to assess in a clinical examination. Prior to this 
study, humerothoracic kinematics in a breast cancer population had not been examined, and 
scapulothoracic kinematics had been examined only during scaption (Borstad & Szucs, 2012; 
Crosbie, et al., 2010; Shamley, Srinaganathan, Oskrochi, Lascurain-Aguirrebena, & Sugden, 2009), 
flexion and abduction (Crosbie, et al., 2010). This study provides details regarding survivor 
capability and dysfunction that have never been examined before, and further research must continue 
to allow for generalizability of results and population-specific recommendations. In general, the 
results demonstrate the need to focus on secondary changes following breast cancer treatment. 
Although muscles within the field of surgery and radiation are affected (pectoralis major and 
serratus), additional long-lasting morbidity continues in muscles outside this field. Despite the need 
for strengthening, stretching and ROM of anterior chest muscles, posterior shoulder muscles should 
not be ignored. In particular, therapies should focus on postural control (scapular retraction), 
strengthening of the posterior rotator cuff and upper trapezius muscles, and encourage movements 
involving external rotation.  
Section 4.5.7 Study contribution to science and health 
This study has contributed to science by furthering the knowledge that is currently understood about 
breast cancer survivor  muscle activation, strength and kinematic patterns during ROM, ADL and 
work tasks and how these relate to QoL and disability. This investigation has contributed to health 
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advancement of the breast cancer population by accurately quantifying and assessing physical 
capability and dysfunction during a wide range of functional tasks – a feat which previous to this 
work had not yet been performed. Accurate documentation of physical capability and dysfunction is 





Chapter 5 Study 2 –Empirical quantification of internal and external 
rotation muscular co-activation in healthy shoulders 
[This study has been published: Brookham, R.L. & Dickerson, C.R. (2014) Med Biol Eng Comput, 
52:257-264] 
Section 5.1 Introduction 
Shoulder pain is common in industrial workers, but using high resolution laboratory techniques to 
measure shoulder loading (to estimate risk of injury) is not always feasible in occupational 
environments. Instead, mathematical biomechanical models are often used to replicate exposures and 
estimate shoulder joint and tissue loads. However, in making these predictions, the models frequently 
indicate that antagonistic muscles are inactive or underestimate their contribution (Collins, 1995; 
Dickerson, 2008; Hughes & Chaffin, 1988; Zajac & Gordon, 1989). Optimization procedures often 
involve simplified assumptions, such that the body activates muscles specifically according to the 
minimum total muscle stress  (Crowninshield & Brand, 1981). Using this assumption, antagonistic 
contraction is mathematically counterproductive (as it generally produces moments that fail to 
contribute to the net joint moment, but increase physiological cost) and is therefore discouraged by 
the optimization algorithms. By mischaracterizing the physiologically known co-activation of 
opposing muscles, these models underestimate individual and corporate muscle activity predictions, 
which cascades into low estimates of joint contact forces. 
 Though previous research into documenting co-activation in human joints exists, few efforts 
have focused on the shoulder. Co-activation has been measured at the ankle (Granata, Wilson, 
Massimini, & Gabriel, 2004), knee (Kellis, Arabatzi, & Papadopoulos, 2003; Kingma, Aalbersherg, 
& van Dieen, 2004), trunk (Lee, Rogers, & Granata, 2006) and elbow (Brookham, Middlebrook, 
Grewal, & Dickerson, 2011; Doheny, Lowery, Fitzpatrick, & O'Malley, 2008; Praagman, Chadwick, 
van der Helm, & Veeger, 2010; Solomonow, Guzzi, Baratta, Shoji, & D'Ambrosia, 1986). Shoulder 
co-activation relationships need to be quantified so that they can be included in biomechanical 
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models to increase physiological realism and promote more accurate model predictions. Further, the 
definition of a data base of normative co-activation behaviours could be used to compare against 
injury population groups. This comparison may enhance current clinical assessments of muscular 
dysfunction and inform more effective therapeutic and preventative strategies. 
Physiological cross-sectional area (PCSA) should arguably be considered in co-activation 
calculations to account for known differences in muscle size. Previous examinations of co-activation 
at the knee and elbow have used linear enveloped electromyography (EMG) to define co-activation 
as a ratio of the contribution of one group of muscles activation to the total of that group of muscles 
activation combined with the activation of a defined group of antagonistic muscles (Brookham, 
Middlebrook, Grewal, & Dickerson, 2011; Kellis, Arabatzi, & Papadopoulos, 2003). In this 
traditional non-weighted approach, muscles are equally weighted with respect to contributions to co-
activation. However, muscles at the shoulder vary greatly in size, and therefore, may vary greatly in 
their contribution to activation. PCSA is a measure of the number of sarcomeres in parallel with the 
angle of pull of the muscles (Winter, 2009). The PCSA of the rotator cuff and shoulder muscles that 
individually contribute to internal and external rotation vary greatly. Previous authors have reported 
through the direct measurements of PCSA of humeral rotator muscles, that these values can range 
from less than 2 cm
2 
(teres minor) to greater than 13 cm
2
 (subscapularis) (Veeger, van der Helm, van 
der woude, Pronk, & Rozendal, 1991). Shoulder co-activation descriptions should consider muscle 
specific PCSAs to prevent contribution biasing of muscles in activation equations, by allowing for 
quantification of scaled muscle contributions. 
The primary purpose of this study was to quantify the co-activation relationships of humeral 
internal and external rotators in young healthy adults during a subset of isometric exertions varying 
in intensity and in posture (humeral abduction and rotation angles). These co-activation relationships 
were defined using traditional and novel definitions. First, co-activation was defined using a non-
weighted co-activation index ratio similar to those methods of Kellis et al. (2003) and Brookham et 
al. (2011). Secondly, co-activation was defined using a novel PCSA-weighted co-activation index 
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ratio. It was hypothesized that the novel PCSA-weighted co-activation prediction models will better 
represent empirically measured co-activation (with predictions yielding higher r
2 
values) compared to 
the traditional non-weighted co-activation prediction models. 
Secondary (unpublished) study purpose: 
[The secondary purpose and results of this study have not yet been published, and is not part of 
the (Brookham & Dickerson, 2014) publication. The results and discussion have been included in 
separate sections.] 
 A secondary purpose of this study was to determine if the co-activation relationships 
defined from a subset of exertions can be extrapolated to other additional postures and intensities. It 
was hypothesized that the co-activation relationship determined for a subset of postures (original data 
set) would be appropriately extrapolated to a unique subset of exertions (extrapolated data set). 
Recent work has demonstrated that extrapolation of the co-activation relationships for elbow flexion 
and extension defined by Brookham et al. (2011) to a subset of novel exertions of increased intensity 
and different postures is appropriate (Middlebrook, Brookham, & Dickerson, 2013). 
Section 5.2 Methods 
Twenty healthy participants performed 82 isometric humeral rotation exertions, half of which were 
internal and half of which were external rotations, at various shoulder postures and work intensities. 
Intramuscular electrodes were inserted into the rotator cuff muscles, and surface electrodes were 
placed over surrounding shoulder musculature. Electromyographic data were used to calculate non-
weighted and PCSA-weighted co-activation index ratios, and the influence of arm posture, load and 
subject anthropometric factors were assessed through multiple regression analyses. 
Section 5.2.1 Participants 
Participants included 20 (10 male, 10 female) healthy, right-handed individuals (mean [range]: age 
(years) 22 [18-32], stature (m) 1.7 [1.6-1.8]; weight (kg) 66.6 [48.5-85.0]) which were recruited from 
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a university population. Participants were excluded from the study if they had any of the following 
known health disorders: blood clotting disorders, HIV, Hepatitis B or C, chronic (lasting more than 6 
months) or acute (within the past 6 months) shoulder, elbow, and/or wrist injury, allergies to 
isopropyl alcohol, latex or nickel. Participants gave informed consent before participation in the 
study. This study received institutional ethics clearance. Participants received $30 CAD 
remuneration for completing this study. 
Section 5.2.2 Surface electromyography 
In preparation for the surface electrodes, the skin overlying the muscle of interest was shaved of hair 
and cleansed with isopropyl alcohol. Disposable bipolar Ag/AgCl surface electrodes (Product #272, 
Noraxon, USA, Inc., Arizona, USA) were placed on the right side over the supraspinatus, 
infraspinatus, pectoralis major (clavicular and sternal insertions), posterior deltoid and latissimus 
dorsi (placements are described in Appendix D). Surface supraspinatus and infraspinatus data were 
only used to replace their respective indwelling signals when these latter signals were compromised 
due to artifact, as is described in Section 5.3.1. A reference electrode was placed over the sternum, 
just inferior to the suprasternal notch. A wireless Noraxon TeleMyo 4200T G2 (Noraxon 2 USA Inc., 
Arizona, USA) sampled EMG channels at 4000 Hz. This system had 16-bit resolution on all analog 
inputs with a band-pass filter from 10-1500 Hz, an input impedance > 100 MΩ, a common mode 
rejection ratio > 100 dB and a base gain of 500. 
Section 5.2.3 Intramuscular electromyography 
In preparation for intramuscular electrode insertion, hair surrounding the area of the muscle of 
interest was shaved off, and the skin was cleansed with isopropyl alcohol. Four intramuscular 
electrodes were inserted into one of each of the rotator cuff muscles on the right side: supraspinatus, 
infraspinatus, teres minor and subscapularis. Sterile single-use hypodermic needles of 33 mm in 
length and 25 gauge (~0.55 mm) (Product # 000-318-30, Motion Lab Systems, Inc., Baton Rouge, 
LA) were inserted into the supraspinatus, teres minor and infraspinatus using published instructions 
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from Geiringer (1999). Sterile single-use hypodermic needles of 50 mm length and 25 gauge 
(Product # 000-318-50, Motion Lab Systems, Inc., Baton Rouge, LA) were inserted into the 
subscapularis using published instructions from Nemeth et al., (1990). Each hypothermic needle 
contained two very thin wires (0.051 x 200 mm) which were insulated and hooked at the ends with 
bare-wire terminations. Inter-electrode distance was approximately 1mm. The supraspinatus and 
infraspinatus indwelling electrodes were inserted between (but not under) the bipolar placements of 
the surface electrodes. The relationship between the surface and indwelling electrode placements is 
demonstrated in Figure 33. The wires remained in the muscle for the duration of the study, and then 
were removed with a quick tug. A wireless Noraxon TeleMyo 4200T G2 (Noraxon 2 USA Inc., 
Arizona, USA) sampled EMG channels at 4000 Hz. Further detail regarding insertion procedures are 
listed in Appendix A. 
 
Figure 33 The indwelling electrodes of supraspinatus and infraspinatus were placed in between (but not under) their 




Section 5.2.4 Pre-experimental protocol 
Prior to testing, anthropometric measurements were recorded and the participants exerted maximal 
voluntary forces (MVF) during isometric humeral internal and external rotation (3 sets each) while 
standing with the arm at the side and the elbow flexed to 90°. MVF were performed against a tri-
axial force transducer which sampled at 1024 Hz with a gain of 1000 (MC3-6-500, Advanced 
Mechanical Technology Inc., Watertown, Massachusetts). If greater than 5% difference was seen 
between the 3 sets of MVFs, the MVFs were repeated. MVFs were 6 s in duration, and 2 min of rest 
was given between MVFs. An average of the three resultant force trials for each exertion direction 
was defined as the final MVF. The final MVFs were used to calculate the specific target force 
intensities each participant exerted in each trial (ranging from 10% - 80% MVF). A custom-made 
program (Labview 8.5, National Instruments Inc., Texas, USA) displayed visual force feedback to 
participants during experimental trials (Figure 34). Participants were given opportunity to practice 
achieving appropriate forces using the visual feedback before experimental trials began. Muscle-
specific maximal voluntary contractions (MVCs) were performed against manual resistance as 
described in Table 23. MVCs were 6s in duration and participants were asked to ramp up to their 
maximal strength and maintain it from seconds 2 – 4, and then relax. MVCs were repeated 3 times 
and the peak from a 500ms moving window average of linear enveloped data was used to normalize 




Figure 34 A participant grasps the handle attached to the tri-axial force cube and exerts a rotational force - meeting 
a target displayed by visual force feedback on the computer monitor 
 
Table 23 Maximal voluntary contraction testing protocol 
Muscle Test Contraction: 
Supraspinatus Subject is standing. Shoulder is abducted to 5° with elbow extended 
(thumb pointing up). Abduction is resisted.  
Infraspinatus & Teres Minor Subject is standing. Arm is at side with elbow bent to 90°. External 
rotation of the arm is resisted.  
Subscapularis Subject is standing. Arm is at side with elbow bent to 90°. Internal 
rotation of the arm is resisted. 
Latissimus Dorsi Subject is sitting with shoulder horizontally abducted and externally 
rotated to 90° and elbow flexed to 90° (fingers point to ceiling). 
Shoulder adduction is resisted.  
Pectoralis Major (sternal insertion) Subject is sitting with shoulder horizontally abducted and externally 
rotated to 90° and elbow flexed to 90° (fingers point to ceiling). 
Shoulder horizontal adduction is resisted.  
Posterior Deltoid Subject is sitting. Resistance provided to shoulder extension when 
shoulder is abducted to 90° and externally rotated, with elbow flexed 
to 90° (fingers point to ceiling). 
Pectoralis Major (clavicular 
insertion) 
Subject is sitting with elbow and shoulder flexed to 90°, and is 
horizontally adducting and flexing their shoulder. Resistance is 
provided (from above) proximal to elbow joint in a downward and 




Section 5.2.5 Experimental protocol 
Each participant performed a total of 82 trials of isometric shoulder internal or external rotation 
exertions at varying intensities (10%-80% MVF), humeral rotation angles (absolute angles relative to 
a vertical plane through the humerus: 0°, -45°, 45°) and humeral abduction angles (elevation angles 
in the frontal plane: 0°, 45°, 90°) with the elbow flexed to 90°, as described in Table 24 and Table 
25. In an attempt to reduce the possibility of contribution from the trunk or other muscles, the 
participants were instructed to stand erect with both feet flat on the floor, not to bend or lean, but 
only perform humeral internal or external rotation. Test trials were of 6 s duration. A goniometer was 
used to verify postures. The wrist was maintained in a neutral posture during all exertions, facilitated 
by a fully moveable handle that was locked into position and attached to a tri-axial force transducer 
(MC3-6-500, Advanced Mechanical Technology Inc., Watertown, Massachusetts). Fifty four trials 
were designated as ‘original’ and served as a basis to create the co-activation multiple regression 
prediction models (primary study purpose) (Table 24). The remaining 28 trials were considered 
‘extrapolated’ postural data, and were used to assess if the co-activation relationship (defined from 
the original data set) could be generalized to the extrapolated data set (secondary study purpose) 
(Table 25). The order of exertions was randomized. Force and EMG were collected simultaneously 
with a trigger during all MVCs and test trials. The entire study protocol lasted approximately 2.5 




Table 24 Description of test exertions of the original data set. Test 1-27 represent external rotation type exertions. 
These 27 postures are repeated and performed during internal rotation exertions for tests 28-54 (not shown). Co-













 (% of MVF) 
1 ER 0 0 20 
2 ER 45 0 20 
3 ER 90 0 20 
4 ER 0 -45IR 20 
5 ER 45 -45IR 20 
6 ER 90 -45IR 20 
7 ER 0 +45ER 20 
8 ER 45 +45ER 20 
9 ER 90 +45ER 20 
10 ER 0 0 40 
11 ER 45 0 40 
12 ER 90 0 40 
13 ER 0 -45IR 40 
14 ER 45 -45IR 40 
15 ER 90 -45IR 40 
16 ER 0 +45ER 40 
17 ER 45 +45ER 40 
18 ER 90 +45ER 40 
19 ER 0 0 60 
20 ER 45 0 60 
21 ER 90 0 60 
22 ER 0 -45IR 60 
23 ER 45 -45IR 60 
24 ER 90 -45IR 60 
25 ER 0 +45ER 60 
26 ER 45 +45ER 60 
27 ER 90 +45ER 60 
Tests 28-54: Repeat above abduction, rotation and intensity combinations for IR type 





Table 25 Description of test exertions from extrapolated data set. The generalizability of the defined co-activation 













 (% of MVF) 
55 ER 0 0 10 
56 ER 0 0 30 
57 ER 0 0 50 
58 IR 0 0 10 
59 IR 0 0 30 
60 IR 0 0 50 
61 ER 45 0 10 
62 ER 45 0 30 
63 ER 45 0 50 
64 IR 45 0 10 
65 IR 45 0 30 
66 IR 45 0 50 
67 ER 90 0 10 
68 ER 90 0 30 
69 ER 90 0 50 
70 IR 90 0 10 
71 IR 90 0 30 
72 IR 90 0 50 
73 IR 0 0 80 
74 ER 0 0 80 
75 IR 135 0 10 
76 IR 135 0 20 
77 IR 135 0 30 
78 IR 135 0 40 
79 ER 135 0 10 
80 ER 135 0 20 
81 ER 135 0 30 





Figure 35 Flow-chart of experimental procedures for Study 2. Participants were prepared for surface and 
intramuscular EMG, and maximal voluntary force exertions (MVFs) and maximal voluntary contractions (MVCs) 
were performed, followed by the 82 test exertions. Co-activation prediction models were created from data obtained 
during the 54 original exertions, and these relationships were tested for generalizability using the 28 extrapolated 
test exertions. 
 
Section 5.3 Analysis 
Co-activation ratios were calculated, EMG was linear enveloped and normalized and force was 
filtered and converted to newtons. All data processing was performed in MATLAB™ R2010a 
(Mathworks, USA). Co-activation ratios were inputted into JMP 11
® 
(SAS Institute Inc., Cary, NC) 
where statistical analyses were performed to build co-activation prediction models. 
Section 5.3.1 Data processing 
Force was filtered with a dual-pass Butterworth low pass filter (LPF) at a cutoff of 3 Hz. Force 
(collected in volts) was converted to Newtons using a shunt calibration. The resultant force was 
calculated using Equation 15. Raw EMG was high pass filtered (Fc 30Hz as recommended by Drake 
& Callaghan (2006)) to remove any heart rate or motion artifact. High pass filtered EMG was linear 
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enveloped with a single-pass Butterworth LPF (Fc 2.5Hz, which was confirmed with residual 
analysis). A 500ms moving window average of linear enveloped MVC trials were calculated and the 
highest moving window average from the three sets (for each specific muscle and individual) was 
defined as maximal percent activation. Linear enveloped channels within test trials were normalized 
to their respective MVC. Integrated and normalized EMG (between 2 - 4 s of each trial) was used in 
the calculation of a non-weighted co-activation index (CInon-wght) and a PCSA-weighted co-activation 
index (CIPCSA) (Equation 16 & Equation 17, respectively). The CIPCSA were calculated for all trials 
and participants in the original data set (n = 1080); and the CInon-wght were calculated for all trials and 
participants in both the original and extrapolation data sets (n = 1640). PCSA data used (Table 26) in 
Equation 17 were reported by Veeger et al. (1991), except for the pectoralis major, which was 
reported by van der Helm et al. (1994). 
Equation 15 Resultant force calculation 
     222ForcettanesulR zyx ForceForceForce   
 
Equation 16 Non-weighted co-activation index calculation. Where E = linear enveloped and normalized EMG; R1-4 = 
Internal rotators: subscapularis, pectoralis major clavicular / sternal heads and latissimus dorsi, respectively; R5-7 = 
External rotators: infraspinatus, posterior deltoid and supraspinatus, respectively. 
 
Equation 17 PCSA-weighted co-activation index calculation. Where E = linear enveloped and normalized EMG; R1-4 
= Internal rotators: subscapularis, pectoralis major clavicular / sternal heads and latissimus dorsi, respectively; R5-7 
= External rotators: infraspinatus, posterior deltoid and supraspinatus, respectively. PCSA is physiological cross-










Pectoralis major (clavicular insertion) 3.55 
Pectoralis major (sternal insertion) 8.68 
Latissimus dorsi 8.64 
Infraspinatus 9.51 
Posterior deltoid 13.51 
Supraspinatus 5.21 
 
The CInon-wght provides a relative measure of internal rotation (IR) contribution to total activation (IR 
and external rotation (ER) activation) about the shoulder. The CIPCSA also provides a relative measure 
of IR activation to total activation about the shoulder, but each muscle’s contribution to co-activation 
is limited to its respective PCSA. A CI (either non-weighted or PCSA-weighted) of 0 indicates no co-
activation (IRs are not activated); a CI of 0.5 indicates full co-activation (both IRs and ERs are 
activated equally relative to maximum) and a CI of 1.0 indicates no co-activation (the ERs are not 
activated). Some trials were excluded from analysis due to EMG artifact or errors in target force 
levels. All EMG trials were visually inspected for motion artifact, which was determined by a large 
spike in EMG amplitude. Channels determined to have artifact were removed from the CI ratios, and 
the denominators of such ratios were scaled accordingly to reflect this removal. Trials with 
supraspinatus or infraspinatus wire artifact were replaced with surrogate surface electrode data. The 
actual force produced by each participant was compared to the target force for each trial. This 
comparison ensured removal of trials containing error >5% MVF or >5 N difference between actual 
and target force. Any trials exceeding this error were removed from further analysis and therefore a 
CI was not calculated for such trials. 
Section 5.3.2 Statistical analysis pertaining to the original data set (primary study purpose) 
Statistical analyses were performed in JMP 11® (SAS Institute Inc., Cary, NC). Potential predictor 
variables (height, weight, upper arm length, lower arm length, age, task intensity (%MVF), humeral 
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abduction angle, humeral rotation angle, MVF and gender) were analyzed for inter-correlations and 
redundant variables (variables highly correlated (r>0.7)) were removed. Preliminary stepwise 
multiple linear regression analysis determined which predictors variables should be included in each 
of the co-activation prediction models. The stepwise direction was mixed (forward and back) with a 
stopping rule p-value threshold of 0.25 to enter and 0.25 to leave. Prediction models were developed 
for non-weighted and PCSA-weighted CIs, separately for both IR and ER type exertions (CInon-wght, IR, 
CInon-wght, ER, CIPCSA, IR, and CIPCSA, ER) for the original CI data and the extrapolation data sets using a 
repeated measures analysis of variance. In the repeated measures multiple analysis of variance test 
(ANOVA) the CInon-wght and CIPCSA were considered dependent variables, and the independent 
variables included all predictor variables identified as significant during stepwise multiple linear 
regression analysis. Both main and interaction effects were considered. 
Section 5.3.3 Results pertaining to the original data set (primary study purpose): 
The most parsimonious models for non-weighted co-activation (CInon-wght) and PCSA-weighted co-
activation (CIPCSA) during humeral IR exertions were (Equation 18 & Equation 19): 
Equation 18 Non-weighted co-activation index calculation for internal rotation exertions. Where humeral abduction 
angle is in degrees, and intensity is individual %MVF; whole model p value <0.0001; r2 = 0.70; independent variable 
p values = <0.0001, <0.0001, respectively; independent variable F ratios = 757.99, 131.34, respectively. 
𝐶𝐼𝑛𝑜𝑛−𝑤𝑔ℎ𝑡,𝐼𝑅 = 0.70 − [0.0036 ∙ ℎ𝑢𝑚𝑒𝑟𝑎𝑙 𝑎𝑏𝑑𝑢𝑐𝑡𝑖𝑜𝑛] + [0.0034 ∙ 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦] 
 
Equation 19 PSCA-weighted co-activation index calculation for internal rotation exertions. Where humeral 
abduction angle is in degrees, and intensity is individual %MVF; whole model p value <0.0001; r2 = 0.62; 
independent variable p values = <0.0001, <0.0001, respectively; independent variable F ratios = 467.49, 106.11, 
respectively. 






The most parsimonious models for non-weighted co-activation (CInon-wght) and PCSA-weighted co-
activation (CIPCSA) during humeral ER exertions were (Equation 20 & Equation 21): 
Equation 20 Non-weighted co-activation index calculation for external rotation exertions. Where humeral abduction 
angle is in degrees; whole model p value <0.0001; r2 = 0.35; independent variable p value = <0.0001; independent 
variable F ratio = 22.09. 
𝐶𝐼𝑛𝑜𝑛−𝑤𝑔ℎ𝑡,𝐸𝑅 = 0.22 − [0.00047 ∙ ℎ𝑢𝑚𝑒𝑟𝑎𝑙 𝑎𝑏𝑑𝑢𝑐𝑡𝑖𝑜𝑛] 
Equation 21 PCSA-weighted co-activation index calculation for external rotation exertions. Where humeral 
abduction angle is in degrees, and intensity is individual %MVF; whole model p value <0.0001; r2 = 0.42; 
independent variable p values = <0.0001, 0.0205, respectively; independent variable F ratios = 23.61, 5.40, 
respectively. 
𝐶𝐼𝑃𝑆𝐶𝐴,𝐸𝑅 = 0.29 − [0.00060 ∙ ℎ𝑢𝑚𝑒𝑟𝑎𝑙 𝑎𝑏𝑑𝑢𝑐𝑡𝑖𝑜𝑛] − [0.00064 ∙ 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦] 
Analyses of interaction effects were performed, but inclusion of these effects provided no or little 
improvement in explained variance. Specifically, the inclusion of these interactions had the 
following effects when compared to inclusion of only main effects: 
 For CInon-wght during IR exertions: interaction model explained 1% more variance (r
2
 = 0.71). 
 For CIPCSA during IR exertions: no interactions were significant. 
 For CInon-wght during ER exertions: interaction model explained 2% more variance (r
2
 = 0.37). 
 For CIPCSA during ER exertions: interaction models explained 1% less variance (r
2
 = 0.41). 
Hence, the authors chose prediction equations that included only main effects to enhance parsimony 
and to improve the ease of application of these relationships during future modelling employments.  
 Table 27 outlines the channels and muscles that were excluded from analysis due to signal 
artifact. The teres minor EMG was excluded from this study due to the unstable nature of the signal 
obtained (it was not included in any CI calculations). The teres minor signals were often 
compromised by artifact (17% of trials), which may be attributed to wire movement during changes 
of arm postures required during the experimental protocol, as well as difficulty landmarking and 
inserting the electrode into such a thin small muscle moving along the lateral border of the scapula. 
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Since we obtained good signal from the infraspinatus, we felt we had adequate representation of the 
humeral external rotators and felt it most prudent to exclude teres minor from the analysis. 














53 42 179 115 1 
Percentage of 
trials removed 
(Total = 1080) 
5% 4% 17% 11% 0.09% 
A total of 15 trials (1.4% of total trials) were removed due to erroneous force values. 
 
Section 5.3.4 Discussion pertaining to the original data set (primary study purpose) 
Co-activation relationships (using both traditional non-weighted and PCSA-weighted approaches) of 
humeral rotators were defined for a subset of isometric exertions varying in intensity and posture. 
Regression models were able to predict these co-activation relationships well during humeral IR 
exertions, but only moderately well during humeral ER exertions. In partial support of the 
hypothesis, when compared to non-weighted co-activation predictions, PCSA-weighted predictions 
were modestly more representative of empirically measured co-activation only during ER exertions. 
  The intercepts of each regression equation demonstrate the overall behavior of muscle 
activation during IR and ER exertions. The intercepts of both CInon-wght and CIPCSA are larger (0.70 – 
0.72) during IR exertions than those during ER exertions (0.22- 0.29). Recall that balanced co-
activation between the IR and ER muscles occurs at a CI of 0.50. The magnitudes of these intercepts 
are intuitive in that they indicate an increase in activation of the IR musculature during IR exertions, 
and an increase in activation of the ER muscles during ER exertions. It is important to recall that the 
lowest intensity upon which these models were built was 20% MVC, and assuming for simplicity 
that humeral abduction is at 0°, this intensity would reduce the CIPCSA bias to 0.277 during ER 
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exertions. Greater intensities would further reduce this bias, indicating increased activation of the ER 
muscles during ER exertions. The relative magnitude of the intercepts compared to the coefficients is 
large, indicating model stability. Due to small magnitudes of the coefficients on the other modifying 
factors, changes in humeral abduction angle and task intensity have modest effects on CI predictions 
and importantly do not substantially modify the overall behavior of the model.  
The explanations of variance of co-activation relationships during ER exertions were less 
comprehensive than those during IR exertions. This reduction of r
2 
may be indicative of more 
variable muscle activation strategies occurring during ER exertions, as the body attempts to preserve 
glenohumeral joint stability. Glenohumeral dislocations are most commonly anterior, occurring when 
the humerus is abducted and externally rotated. The dynamic stabilizing roles that muscles play 
change as posture is adjusted. McKernan et al (1990) demonstrated that the subscapularis is an 
important anterior shoulder stabilizer when the humerus is abducted and at neutral rotation, but that it 
becomes less important when the humerus externally rotates. Lee et al (2000) found that in the mid-
range of motion (neutral rotation with the humerus positioned at 60° abduction and 45° extension), 
the supraspinatus and subscapularis provided more stability than the other rotator cuff muscles, but at 
end ranges of motion (90° external rotation with the humerus positioned at 60° abduction and 45° 
extension), the subscapularis, infraspinatus and teres minor provided more stability than the 
supraspinatus. Ligaments are tightened at end ranges of motion, which can provide further passive 
stabilization and alter the surrounding muscle activation requirements. During external rotation, the 
inferior ligament is tightened and upward elevation is limited (Itoi, Morrey, & An, 2009). Differing 
from the IR exertions, the ER exertions of this current study would be more representative of end 
range of motion postures, during which passive ligament constraints may attribute to joint stability. 
Marked variability of joint laxity has been noted among subjects with healthy shoulders (Harryman, 
Sidles, Harris, & Matsen, 1992). The addition of passive stability constraints (their contribution 
variable due to inter-subject differences in laxity) to dynamic (muscular) constraints, could affect the 
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both the selection and magnitude of muscle-specific control. Therefore, during ER exertions 
(especially involving levels of humeral abduction when the humerus is more susceptible to 
glenohumeral dislocation), variability of muscle activation strategies may be large causing co-
activation to be less predictable. 
Initially it was hypothesized that PCSA-weighted prediction equations (compared to non-
weighted) would better represent the empirically measured co-activation, however this was only the 
case during ER exertions (7% more explained variance, although the explained variance remained 
moderate). The inclusion of PCSA weightings lowered the explained variance by 8% in IR exertions 
(although the variance was explained well). The PCSA of anterior (subscapularis) and posterior 
(infraspinatus and teres minor) rotator cuff muscles are approximately equal (Basset, Browne, 
Morrey, & An, 1990). Therefore, the inclusion of PCSA weightings used in this current study may 
not be that beneficial since the summation of IR muscle PCSAs and ER muscle PCSA used were 
approximately equal (34.38 cm
2
 vs. 31.15 cm
2
) as well, nearly balancing their effects in the equation. 
The differences in explanation observed between non-weighted and PCSA-weighted (but nearly 
balanced) prediction equations may then be partly contributed to non-generalizability of the PCSA 
values taken from cadaveric data on this sample of young adults.  
Co-activation during humeral rotation is known to be sensitive to changes in humeral 
abduction and task intensity, which both appear in three of the four prediction equations, and solely 
humeral abduction occurring in the fourth. These factors are quite influential (p<0.0001 for all but 
one instance), and according to the F ratios, humeral abduction always had the largest effect size, 
followed by intensity. Therefore, co-activation is foremost affected by humeral abduction posture, 
followed by task intensity. Despite small coefficients, signs indicate the directional effects each 
factor has on co-activation indices. For instance, in Equation 20, at 100° of humeral abduction the 
intercept changes from 0.22 to 0.173, which is not vastly different, but indicates how muscles are 
activated with respect to each other. As humeral abduction angle increased during IR and ER 
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exertions, both CInon-wght and CIPCSA decreased, indicating an increased activation of external rotators 
relative to total muscular activation. Prediction equations also indicated that in general (with the 
exception of CIPCSA for ER exertions), co-activation index ratios increased as task intensity increased, 
representing increases in activation of humeral internal rotators to total rotational activation. The 
negative coefficient associated with intensity in Equation 21 is not as strong as the positive 
coefficients of intensity associated with IR type exertions. Subscapularis (a humeral internal rotator) 
has been reported to be an important anterior stabilizer during humeral abduction with neutral 
rotation (McKernan, et al., 1990). Subscapularis also has the greatest contribution potential to 
internally rotate, as it has the largest PCSA of the 4 internal rotators identified in the CI indices. It is 
suggested that increases in IR activation related to increased task intensity could be identified as a 
protective response of dynamic stabilizers, as the internal rotators (primarily subscapularis, which 
increases anterior joint stability as previously mentioned), attempt to protect against large forces 
which could compromise joint stability, namely anterior dislocations, which are more common 
during forceful exertions at postures of humeral external rotation and abduction. 
The developed predictions equations are germane to the subset of exertions for which they were 
designed. Currently, the feasibility of extrapolating these relationships to other postures and 
intensities is unknown. However, recent work has demonstrated that extrapolation of co-activation 
relationships defined for elbow flexion and extension defined by Brookham et al. (2011) to a subset 
of novel exertions of increased intensity and different postures was associated with high consistency 
(Middlebrook, Brookham, & Dickerson, 2013).  Elbow co-activation was sensitive to changes in 
posture and applied load, and during elbow flexion and extension tasks the explained variance for CI 
models were 46% and 31%, respectively (Brookham, Middlebrook, Grewal, & Dickerson, 2011). 
Comparatively, the non-weighted CI models for the present study were also sensitive to changes in 
posture and load (task intensity), and models provided similar explained variance during ER 
exertions (35%), but substantially more explained variance during IR exertions (70%). Limitations of 
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this study included the small participant sample size from which these equations were built, and the 
minimal data lost due to the occurrence of motion artifact in some of the intramuscular EMG 
channels. It is possible that the inclusion of resting EMG activation levels may have a limited effect 
on the CI calculations. For future studies considering co-activation of similar exertions sets, we 
recommend against consideration of PCSA in analysis, as this inclusion provided little benefit.  
Further efforts should continue to examine the sensitivity of these relationships during additional 
postures and intensities, as well as to examine the influence of multifunctional muscles on the nature 
of the co-activation relationships. It should be determined whether inclusions of co-activation 
relationships improve model predictions on novel exertions. Future works that encompass these 
multiple scenarios should produce a robust co-activation description that is of utility for a wide range 
of exertions that include axial humeral rotation. This is the first known attempt to empirically 
quantify humeral rotational co-activation relationships. Humeral rotational co-activation is strongly 
dependent upon humeral abduction angle, followed by individual task intensity. Evaluation of the use 
of these constraints in biomechanical modelling must be assessed to determine if their inclusion 
improves predictions of muscle forces and joint loads. 
Section 5.3.5 Statistical analysis and results pertaining to the extrapolated data set (secondary 
study purpose) 
The empirical calculation of CInon-wght (as was described in Section 5.3.1 and Equation 16) was 
performed for tests 55-82 (the extrapolated data set). These calculated co-activation values were used 
to create CIextrap, IR and CIextrap, ER prediction equations using repeated measures ANOVA. The CInon-
wght was considered the dependent variable, and the independent variables included all predictor 
variables identified as significant during stepwise multiple linear regression analysis, as was 
described previously in Section 5.3.2. Main and interaction effects were considered. The most 
parsimonious models built from the extrapolation data set for non-weighted co-activation during 
humeral IR and ER exertions (CIextrap, IR [Equation 22] and CIextrap, IR [Equation 23], respectively) were:  
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Equation 22 Extrapolation data set co-activation index prediction equation during IR type exertions. Where 
humeral abduction angle is in degrees, and intensity is individual %MVF; whole model p value is p<0.0001; r2=0.76; 
independent variable p values = p<0.0001, p<0.0001, respectively, and F ratios = 352.80, 87.69, respectively. 
𝐶𝐼𝑒𝑥𝑡𝑟𝑎𝑝,𝐼𝑅 = 0.63 − (0.0029 ∙ ℎ𝑢𝑚𝑒𝑟𝑎𝑙 𝑎𝑏𝑑𝑢𝑐𝑡𝑖𝑜𝑛) + (0.0040 ∙ 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦) 
 
For IR type exertions, a significant interaction was found between humeral abduction and intensity, 
however it complicated the interpretation of the prediction equation and failed to improve the 
explanation of variance (r
2
 remained to be 0.76). Therefore, only the main effects were considered. 
Equation 23 Extrapolation data set co-activation index prediction equation during ER type exertions. Where whole 
model p < 0.0001; r2=0.40. 
𝐶𝐼𝑒𝑥𝑡𝑟𝑎𝑝,𝐸𝑅 = 0.21 
 
The actual humeral abduction angles and intensity data for the extrapolated data set (Tests 
55-82) were inserted into the extrapolated co-activation index prediction equation for internal 
rotation exertions (Equation 22). All ER type exertions were designated at 0.21, as per Equation 23. 
These calculated co-activation indices were denoted as “CIextrap_calc”. These CI calculated values were 
the same for all 20 participants, since each participant performed the same task set. 
 Using the non-weighted prediction equations developed from the original data set, as 
described in Equation 18 and Equation 20, humeral abduction angles and intensity values for the 
extrapolated data (Tests 55-82) were inserted into their respective IR or ER type exertion equations. 
These calculated co-activation indices were termed “CIoriginal_calc”. These co-activation calculations 





The empirical calculation of co-activation indices using the EMG from the original data set, 
(which was used to create the original prediction equations (CIoriginal,IR [Equation 18] and CIoriginal,ER 
[Equation 20]) were termed CIEMG_calc.  




 To determine if the co-activation relationship determined in the primary purpose of this study could 
be extrapolated to a novel task set, a repeated measures ANOVA was run with the co-activation 
index calculations as the dependent variable, the type of CI calculation method (Type 1, 2, or 3) as 
the independent variables with subject as a random variable, by exertion type (humeral internal and 
external rotation). Both main and interaction effects were considered. 
Post hoc analysis (Student’s T test) revealed that for IR type exertions; there was no 
difference between CIEMG_calc, CIorig_calc or CIextrap_calc. No significant difference was found between the 
values of CI magnitude for these 3 calculation methods to extrapolative tests of IR exertions [p 
values: CIorig_calc vs. CIextrap_calc p=0.8550; CIorig_calc vs. CIEMG_calc p=0.8593; CIEMG_calc vs. CIextrap_calc p 
= 0.9963], as demonstrated in Figure 36. 
 
Figure 36 Least square means plot of co-activation ratios during IR exertions for three calculation methods: EMG 




During ER type exertions, post hoc analysis (Student’s T test) revealed the following 
significant differences: CIEMG_calc and CIextrap_calc significantly overestimated (p<0.0001, p<0.0001) 
the CIs for exertions  in the extrapolative tests of ER exertions as compared to CIorig_calc calculation 
method, as demonstrated in Figure 37. 
 
Figure 37 Least square means plot of co-activation ratios during ER exertions for three calculation methods: EMG 
(1), Original (2) and Extrapolation (3). 
 
A 500 ms moving window average of linear enveloped test trials were calculated between 2 – 4 
seconds of each test, for all participants as shown in Appendix I Table 47 (means) and Table 48 
(standard deviations). This data will be used for comparison in Study 3 of this thesis.  
Section 5.3.6 Discussion pertaining to the extrapolated data set (secondary study purpose) 
In partial support of the hypothesis, the co-activation relationship defined through the primary 
purpose and results of this study (published by Brookham & Dickerson (2014)) was extrapolated 
successfully to a novel task set of IR exertions. However, this relationship was not extrapolated 
successfully during ER type exertions. 
 The prediction equation developed from the extrapolated data set for IR type exertions 
(Equation 22) was very similar to that predicted from the original data set (Equation 18). The 
intercept was slightly lower (0.63 vs. 0.70) than the original, but was still larger than the ER intercept 
(0.21), and indicated that there was an increase in IR muscle activation during IR type exertions. The 
same predictor variables were present: humeral abduction and intensity, and their magnitudes were 
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similar to those of Equation 18. The magnitude of the coefficient of humeral abduction was slightly 
smaller (0.0029 vs. 0.0036), but the direction (and interpretation) was the same, indicating an 
increase in ER muscle activation to total rotation activation as humeral abduction angle increased. 
The magnitude of the coefficient of intensity was slightly larger (0.0040 vs. 0.0034) than the original, 
but the direction was the same, indicating an increase in IR muscle activation to total rotational 
activation as intensity increased. The relative magnitude of the intercept compared to the coefficients 
was large, indicating that there was only modest effect on CI predictions with changes in humeral 
abduction and intensity. The effect size of the model effects reflected that co-activation was foremost 
affected by posture (humeral abduction) and then by intensity, as was shown in the original 
prediction equations. The explained variance of the prediction model built with extrapolation data 
was greater than that from the original data set (r
2
 =  0.76 vs. r
2 
= 0.70) – indicating that the 
prediction model created using the CI’s calculated from the EMG of Tests 55-82 explained 6% more 
variance than the model created from the EMG data from Tests 1-54. This improvement in 
explanation may be due to the specific exertions classed within the extrapolative set, which had less 
variable changes in posture and intensity (only 14 different postures, of which humeral rotation 
always remained unchanged versus 27 different postures in the original data set). 
Stepwise multiple regression analysis identified shoulder abduction and intensity as potential 
predictor variables during ER type exertions. However, repeated measures ANOVA revealed that 
neither of these main or interaction model effects was significant in the prediction of CI during ER 
type exertions and their inclusion did not improve explained variance. Therefore, we did not have 
any variables that accounted for prediction of CI, and as a result CI was set to 0.21for all ER type 
exertions. As a result, the CI was always predicted to be 0.21 regardless of postural or intensity 
changes. The static nature of this prediction equation may explain why the relationship did not 
extrapolate well; since the extrapolation data set contained some very diverse postures (ex. 135 
degrees humeral abduction versus 0 degrees abduction). The magnitude of the intercept was very 
similar to that of the prediction equation based on the original data set in Equation 20 (0.22), 
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however negated the involvement of the humeral abduction or intensity coefficients. The explained 
variance of the extrapolated prediction model was 40%, which was a 5% improvement from that 
explained in the original prediction model, but still represented only a modest ability to predict co-
activation during ER exertions. As was discussed previously, muscles’ roles change as posture 
changes (Lee, Kim, O`Driscoll, Morrey, & An, 2000; McKernan, et al., 1990) and variable muscle 
strategies may be used during ER exertions (especially involving abduction) in order to preserve 
glenohumeral stability, causing the co-activation relationships to be less predictable. Further, the 
exertions in the extrapolation data set did involve a near-end range of motion posture (135 degrees of 
abduction), which likely resulted in ligament involvement and further change to muscle requirements 
to maintain glenohumeral stability. 
In conclusion, the co-activation relationship defined for IR exertions during the primary 
purpose of this study can be successfully extrapolated to novel IR tasks with confidence. However, 
the co-activation relationship defined for humeral ER type exertions has modest prediction ability 
and cannot be successfully extrapolated to novel ER task sets. Future works should encompass more 
diverse data sets and a larger sample size in attempts to develop more predictable relationships of co-
activation during ER exertions, and determine the ability of this relationship to predict appropriately 
in novel task sets.  
Section 5.3.7 Study contribution to science and health 
The findings of this study contribute to science by furthering the knowledge that is currently 
understood about shoulder muscle co-activation. Previous to this work, shoulder internal/external 
rotation co-activation relationships had not yet been quantified. It was demonstrated that these newly 
defined relationships are successfully extrapolated in humeral internal rotation exertions, but further 
quantification of co-activation is required in humeral external rotation type exertions. Successful 
extrapolation supports use of these relationships in biomechanical muscle force prediction models 
replicating similar task sets. The inclusion of these relationships may further the advancement of 
166 
 
these models by enforcing muscle co-activation - improving physiological realism and possibly 
improving accuracy of predictions. The knowledge gained from this study will also indirectly 
contribute to health advancement of breast cancer survivors, by allowing for comparison of co-
activation relationships between survivor and healthy populations, which will be useful in identifying 
dysfunction (discussed in Study 3). This process may be transferred to other patient populations 





Chapter 6 Study 3 – Comparison of humeral rotation co-activation of 
breast cancer survivors and healthy shoulders  
Section 6.1 Introduction 
Upper limb morbidities are common amongst breast cancer survivors, resulting in disabilities that 
affect independence, work and life. Decreased strength is prevalent in 17% to 33% of survivors 
(Rietman, et al., 2003). Strength reductions in breast cancer survivors may be the result of iatrogenic 
neurological structural damage, muscle dysfunction caused by radiation or muscle atrophy caused by 
disuse. These impairments interfere with survivors’ ability to perform ADL and return to work 
(Markes et al., 2006). However, very little research has been performed to investigate the 
electromyographic activity amongst the breast cancer population.  
It appears only two groups have described shoulder electromyographic activity of the breast 
cancer population. The activity of the pectoralis major, rhomboids, upper trapezius and serratus 
anterior was recorded with surface electrodes as survivors (ranging from 6 months – 6 years post 
cancer surgery) elevated their arms in the scapular plane (Shamley, et al., 2007). No other motions or 
muscles were monitored. EMG was not normalized (MVCs were neglected due to pain) and the 
frequency of raw data points from muscles were compared between affected and unaffected sides 
(Shamley, et al., 2007). The authors reported a generalized loss of activity in these four shoulder 
muscles during elevation on the affected side (Shamley, et al., 2007). However, failing to normalize 
EMG, to even a submaximal voluntary contraction (subMVC), could have compromised 
interpretation of findings. Normalization is vital for temporal EMG (Ball & Scurr, 2010) as past 
literature has demonstrated un-normalized EMG can be misinterpreted (Lehman & McGill, 1999). 
Later, Shamley et al. (2012) re-examined normalized muscle activity of pectoralis major, serratus 
anterior, rhomboids and upper trapezius during scaption of a BCP with mastectomy or wide local 
excision (WLE). With the exception of upper trapezius in the mastectomy group, the authors 
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reported an increase in activity of all muscles on the left affected side compared to the left side of a 
healthy control group (UpTrap p < 0.05, CI 2.38 – 15.01 for WLE; Pec p < 0.001, Rhomb p < 0.001, 
Serr p < 0.001, CI 6.09 – 12.9 for WLE and p < 0.05, CI 1.02 – 9.02 for mastectomy) and reported 
greater activation of the upper trapezius (p < 0.001, CI 9.8 – 21.51), rhomboids (p < 0.001, CI 11.1-
15.71) and serratus (p < 0.001, CI 7.16 – 16.26) on the right affected side of patients with 
mastectomy compared to the right side of a healthy control, suggesting the BCP was working at a 
higher level of percent capability. Shamley et al. (2012) also reported a decrease in pectoralis major 
activity and an increase in serratus anterior activity on the affected side compared to the unaffected 
side. Galiano et al. (2011) recorded surface EMG from the sternocleidomastoid, upper trapezius and 
deltoid during a functional writing task and reported increased activation of the upper trapezius 
bilaterally (up to 20% and 4% increases on affected and unaffected side, respectively) and 
sternocleidomastoid muscles (up to 31% increase on affected side) of survivors compared to a 
healthy control group. Galiano-Castillo et al. (2011) suggested 3 possible reasons for increases in 
EMG: increases may be due to pain or fear of pain; or perhaps cancer treatment or neuropathy 
resulting in muscle damage has caused changes in muscle recruitment; or perhaps participants are 
exhibiting altered motor strategies. Others have suggested that reduced mobility amongst the breast 
cancer population could reflect damage to rotator cuff muscles (Thompson, Air, Jack, Kerr, Rodger, 
& Chetty, 1995). Due to the depth, location and size of the rotator cuff muscles, electromyography is 
best recorded with intramuscular electrodes. Further research is needed to investigate activity of 
shoulder muscles of survivors, specifically those of the rotator cuff, during a variety of postures. 
Humeral internal and external rotator co-activation relationships amongst breast cancer 
survivors are unknown. These relationships need to be quantified and compared with co-activation 
relationships defined in a healthy population. Differences observed between population groups may 
assist in clinical interpretation of dysfunction, which could lead to more evidence-based therapeutic 
and preventative interventions within the breast cancer population. If proven interpretable, this 
process may be transferred to other patient populations (such as different injury groups), assisting in 
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dysfunction identification and promotion of effective treatment protocols. Furthermore, 
quantification of co-activation relationships amongst breasts cancer survivors could be useful to 
include in biomechanical models which predict muscle force and demand. These models often negate 
antagonistic co-activation, and including these relationships would increase physiological realism of 
the models and may promote more accurate model predictions. These models could play an essential 
role in the assessment and integration of breast cancer survivors into safe, effective and sustainable 
return to work. 
The two purposes of this study are to: 
1. Quantify the co-activation relationships of humeral internal and external rotators in 
breast cancer survivors 
2. Compare the survivor co-activation relationship with those of a healthy population (as 
defined in Study 2 of this thesis) 
It is hypothesized that muscle-activation patterns of breast cancer survivors will reveal survivors 
have a reduced internal/external humeral rotation co-activation ratio compared to healthy individuals 
during IR exertions (reflecting a decrease in pectoralis major activation). The co-activation ratio 
provides a relative measure of internal rotation (IR) contribution to total activation (IR and external 
rotation (ER) activation) about the shoulder. Due to the location of the breast cancer treatment 
(surgery and radiation is typically directed to the anterior aspect of the chest), the pectoralis muscles 
are primarily in the field of disturbance. It is hypothesized that these anterior chest muscles (humeral 
internal rotators) will be unable to produce force, causing a reduction in total activation of the 
internal rotator muscles in relation to the posteriorly located humeral external rotators. It was 
hypothesized that this dysfunction would present as a reduction in magnitude of the numerator of the 
co-activation ratio, compared to the ratio of a healthy population. 
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Section 6.2 Methods 
Fifty breast cancer survivors performed 22 isometric humeral internal or external rotation exertions 
at various shoulder postures and intensities. Intramuscular electrodes were inserted into three rotator 
cuff muscles, and surface electrodes were placed over surrounding shoulder musculature. 
Electromyographic data was used to calculate co-activation index ratios, and these relationships were 
further predicted using multiple regression analysis. Finally, co-activation relationships of breast 
cancer survivors were compared to those relationships defined in a healthy population (described in 
Study 2 of this thesis). 
Section 6.2.1 Participants: 
Participants included 50 female breast cancer survivors with a mean age of 59.4 yr [+/- 9.7 yr; range 
31-83 yr], mean height of 1.7 m [+/- 0.1 m; range 1.5-1.8 m], mean weight of 71.7 kg [+/- 11.8 kg, 
range 51.4-97.7 kg]. Twenty seven participants had mastectomies (16 bilateral); 34 had 
lumpectomies and 48 had axial node dissection surgeries. Thirty four participants had received 
hormone replacement therapy, 34 had received chemotherapy and 37 had received radiation 
treatments. Average time since diagnosis was 74.9 months (+/-59.6 months; range 12-228 months]. 
Participants were excluded from the study if they had any of the following health disorders: blood 
clotting disorders, HIV, Hepatitis B or C, allergies to isopropyl alcohol, latex or nickel. Participants 
were recruited from the Kitchener-Waterloo area. Participants provided informed consent before 
participation in the study. This study received ethics clearance through the Office of Research Ethics 
at the University of Waterloo. Participants received a gift basket valued at $30 in appreciation for 
their time and efforts. Sample size justification is given in Study 1 in Section 4.2.1 and Equation 5. 
Data collection for Studies 1 and 3 were collected simultaneously and participants were shared.  
Section 6.2.2 Surface electromyography 
In preparation for the surface electrodes, the skin overlying the muscle of interest was shaved of hair 
and cleansed with isopropyl alcohol. Disposable bipolar Ag/AgCl surface electrodes (Product #272, 
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Noraxon, USA, Inc., Arizona, USA) were placed on the affected side (side affected by breast cancer) 
over the pectoralis major (clavicular and sternal insertions), posterior deltoid, latissimus dorsi, 
supraspinatus and infraspinatus. Surface supraspinatus and infraspinatus data were only used to 
replace their respective intramuscular signals if these latter signals were compromised due to artifact, 
as is described in Section 5.3.1, or when the participants did not provide consent to insertion of 
intramuscular electrodes. A reference electrode was placed over the sternum, just inferior to the 
suprasternal notch. Electrode placements are described in Appendix D. A wireless Noraxon TeleMyo 
4200T G2 (Noraxon 2 USA Inc., Arizona, USA) sampled EMG channels at 3000 Hz. This system 
has 16-bit resolution on all analog inputs with a band-pass filter from 10-1500 Hz, an input 
impedance > 100 MΩ, a common mode rejection ratio > 100 dB and a base gain of 500. EMG was 
recorded on the computer using the Vicon Nexus 1.2 software (Vicon, Oxford, UK). 
Section 6.2.3 Intramuscular electromyography 
In preparation for intramuscular electrode insertion, hair surrounding the area of the muscle of 
interest was shaved off, and the skin was cleansed with isopropyl alcohol. Three intramuscular 
electrodes were inserted into one of each of the following rotator cuff muscles on the affected side: 
supraspinatus, infraspinatus, and subscapularis. Sterile single-use hypodermic needles of 33 mm in 
length and 25 gauge (~0.55 mm) (Product # 000-318-30, Motion Lab Systems, Inc., Baton Rouge, 
LA) were inserted into the supraspinatus and infraspinatus using published instructions from 
Geiringer (1999). Sterile single-use hypodermic needles of 50 mm length and 25 gauge (Product # 
000-318-50, Motion Lab Systems, Inc., Baton Rouge, LA) were inserted into the subscapularis using 
published instructions from Nemeth et al., (1990). Further detail regarding insertion procedures are 
listed in Appendix A. A wireless Noraxon TeleMyo 4200T G2 (Noraxon 2 USA Inc., Arizona, USA) 
sampled EMG channels at 3000 Hz.  
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Section 6.2.4 Pre-experimental protocol 
Prior to testing, anthropometric measurements (stature, body weight, upper and lower arm length) 
were recorded and the participants exerted maximal voluntary forces (MVF) with the affected arm 
during isometric humeral internal and external rotation (2 sets each; standing, humerus at the side 
and the elbow flexed to 90°). MVF were performed against a digital hand-held dynamometer 
(ergoFET300
TM
, Utah, USA). MVFs were 3 s in duration, and at least two minutes of rest were 
given between MVFs. An average of the two trials was defined as the final MVF, which was used to 
calculate the specific target force intensities for each trial (ranging from 10% - 60% MVF). A 
custom-made program (Labview 8.5, National Instruments, Texas, USA) was built to display visual 
force feedback to participants during testing trials. Participants were given an opportunity to practice 
achieving specified forces using the visual feedback before testing trials began. Muscle-specific 
maximal voluntary contractions (MVCs) were performed on the affected side. MVCs were 3 s in 
duration (2 sets) and participants were asked to ramp up to their maximal strength and then relax. 
The peak from a 500 ms moving window average of linear enveloped data was used to normalize 




Table 28 Study 3 Description of maximal voluntary contraction tests 
Muscle Maximal Test Contraction: 
Supraspinatus Subject is seated. Shoulder is abducted to 5° with elbow extended 
(thumb pointing up). Abduction is resisted.  
Infraspinatus Subject is seated. Arm is at side with elbow bent to 90°. External 
rotation of the arm is resisted.  
Subscapularis Subject is standing. Arm is at side with elbow bent to 90°. Internal 
rotation of the arm is resisted. 
Latissimus Dorsi Subject is seated with shoulder horizontally abducted and externally 
rotated to 90° and elbow flexed to 90° (fingers point to ceiling). 
Shoulder adduction is resisted.  
Pectoralis Major (sternal and 
clavicular insertions) 
Subject is seated with shoulder horizontally abducted and externally 
rotated to 90° and elbow flexed to 90° (fingers point to ceiling). 
Shoulder horizontal adduction is resisted.  
Posterior Deltoid Subject is seated. Resistance provided to shoulder extension when 
shoulder is abducted to 90° and externally rotated, with elbow flexed 
to 90° (fingers point to ceiling). 
 
Section 6.2.5 Experimental protocol 
Each participant performed 22 trials of isometric shoulder internal or external rotation exertions at 
varying intensities (10%-60% MVF) and humeral abduction angles (0°, 45°, 90°) as described in 
Table 29. Tests 19 – 22 are primarily used for the purposes of Study 4 of this thesis and will not be 
included in analysis of this current study. Test trials were 6 s in duration. A goniometer was used to 
ensure correct posture. The wrist was maintained in a neutral posture during all exertions, facilitated 
by a fully moveable handle attached to a tri-axial force transducer (MC3-6-500, Advanced 
Mechanical Technology Inc., Watertown, Massachusetts). The order of exertions was randomized. 
Force and EMG were collected simultaneously. A custom-built program in Labview 8.5 (National 
Instruments Inc., Texas, USA) provided participants real-time visual force feedback, allowing them 
to produce the required target intensity for each specific exertion. The entire study protocol was 
approximately 2 hours in duration. Experimental methods are outlined in Figure 38.  
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1 10 0 IR 
2 20 0 IR 
3 30 0 IR 
4 40 0 IR 
5 50 0 IR 
6 60 0 IR 
7 10 0 ER 
8 20 0 ER 
9 30 0 ER 
10 40 0 ER 
11 50 0 ER 
12 60 0 ER 
13 20 45 IR 
14 40 45 IR 
15 20 45 ER 
16 40 45 ER 
17 30 90 IR 
18 30 90 ER 
 19 40 N 0 IR 
20 40 N 0 ER 
21 19.6 N 0 IR 





Figure 38 Flow-chart depicting methodology for Study 3. Solid boxes indicate methodological protocol and dashed 
lines indicate outputs and analysis. 
 
Section 6.3 Analysis 
Data was transferred from the receiver to a personal computer, and analysed using Matlab
TM
 R2010a 
(Mathworks Inc., USA). Co-activation ratios were calculated, EMG was linear enveloped and 
normalized, and force was filtered and converted to Newtons. These co-activation ratios were 
assessed in JMP 11
® 
(SAS Institute Inc., Cary, NC) to build co-activation prediction models. 
Section 6.3.1 Data processing 
Raw force signals were filtered with a dual-pass Butterworth low pass filter (LPF) with a cutoff of 3 
Hz. Force (collected in volts) was converted to Newtons using a shunt calibration. The resultant force 
was calculated using Equation 15 defined in Study 2. Raw EMG was high-pass filtered (Fc 30Hz) 
and linear enveloped with a single-pass Butterworth LPF (Fc = 2.5 Hz, confirmed with residual 
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analysis). EMG was normalized to maximal contractions as was discussion in Section 6.2.4. 
Integrated and normalized EMG (between 2 - 4 s of each trial) magnitudes were used in the 
calculation of a co-activation index (CI) which was separately calculated for all trials and 
participants as shown in Equation 24. The CI provides a relative measure of IR contribution to total 
IR and ER activation about the shoulder. A CI of 0% indicates no co-activation (IRs are not 
activated); a CI of 50% indicates full co-activation (both IRs and ERs are activated in equal 
amounts); and a CI of 100% indicates no co-activation (the ERs are not activated).  
Equation 24 Co-activation index calculation for the BCP. Where E = linear enveloped and normalized EMG; R1-4 = 
Internal rotators: subscapularis, pectoralis major clavicular / sternal heads and latissimus dorsi, respectively; R5-7 = 
























 Some trials were excluded from analysis due to EMG motion artifact or error in target force 
levels. All EMG trials were visually inspected for motion artifact, which was identified by a large 
spike in amplitude. Channels determined to have artifact were removed from the CI ratios. The actual 
force produced by each participant was compared to the target force for each trial. Any force trials 
containing error >5% MVF or >5 N difference between actual and target force were removed from 
further analysis. 
Section 6.3.2 Statistical analysis 
Statistical analyses were performed in JMP 11® (SAS Institute Inc., Cary, NC). Potential predictor 
variables (height, weight, upper arm length, lower arm length, age, task intensity (%MVF), humeral 
abduction angle, and MVF) were analyzed for inter-correlations and redundant variables (variables 
highly correlated (r>0.7)) were removed. Preliminary stepwise multiple linear regression analysis 
determined which predictor variables should be included in each of the co-activation prediction 
models. The stepwise direction was mixed (forward and back) with a stopping rule p-value threshold 
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of 0.25 to enter and 0.25 to leave. Prediction models were developed separately for both IR and ER 
type exertions (CIcancer,IR, CIcancer,ER) from Tests 1-18, using a repeated measures ANOVA. The 
CIcancer,IR and CIcancer,ER values were considered dependent variables, and the independent variables 
included all predictor variables identified as significant during stepwise multiple linear regression 
analysis. Both main and interaction effects were considered. 
 To assess differences in muscle strategy used between healthy and breast cancer populations, 
muscle activation levels (normalized, mean moving average activation between 2 – 4 s of each 6 
second duration test) were compared for Tests 1 – 18. Tests 1 – 18 were identical between 
populations, defined by the same intensity, posture and exertion type combinations. Nine repeated 
measures ANOVAs were performed with muscle activation level (for each of the nine muscles) as 
the dependent variables, by exertion type (IR or ER), with population group (healthy or cancer 
survivor) and subject as a random variable termed the independent variables. Post hoc Student’s T 
tests were performed to identify significant difference between population groups for each muscle 
and exertion type. 
Section 6.4 Results 
Co-activation relationships were determined using multiple regression analysis for humeral IR and 
ER exertions for the breast cancer and healthy populations (Study 2). 
Section 6.4.1 Co-activation relationships during internal rotation exertions 
The most parsimonious model for co-activation during humeral IR exertions for the breast cancer 
population was [Equation 25]: 
Equation 25 Co-activation prediction equation for a breast cancer population during IR exertions. Where humeral 
abduction angle is in degrees, and intensity is individual %MVF; whole model p value is p<0.0001; r2=0.77; 
independent variable p values = p<0.0001, p<0.0001, respectively and independent F ratios = 553.67, 41.78, 
respectively. 
𝐶𝐼𝑐𝑎𝑛𝑐𝑒𝑟,𝐼𝑅 = 0.71 − (0.0033 ∙ ℎ𝑢𝑚𝑒𝑟𝑎𝑙 𝑎𝑏𝑑𝑢𝑐𝑡𝑖𝑜𝑛) + (0.0018 ∙ 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦) 
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As determined in Study 2, the most parsimonious models for co-activation of a healthy population 
during humeral IR exertions (CIhealthy, IR) was [Equation 26]: 
Equation 26 Co-activation prediction equation for a healthy population during internal rotation exertions. Where 
humeral abduction angle is in degrees, and intensity is individual %MVF; whole model p value <0.0001; r2 = 0.70; 
independent variable p values = <0.0001, <0.0001, respectively and independent variable F ratios = 757.99, 131.34, 
respectively. 
𝐶𝐼ℎ𝑒𝑎𝑙𝑡ℎ𝑦,𝐼𝑅 = 0.70 − [0.0036 ∙ ℎ𝑢𝑚𝑒𝑟𝑎𝑙 𝑎𝑏𝑑𝑢𝑐𝑡𝑖𝑜𝑛] + [0.0034 ∙ 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦]  
Section 6.4.2 Co-activation relationships during external rotation exertions 
The most parsimonious model for co-activation during humeral ER exertions for the breast cancer 
population was [Equation 27]: 
Equation 27 Co-activation prediction equation for a breast cancer population during ER exertions. Where humeral 
abduction angle is in degrees, and intensity is individual %MVF; whole model p value is p<0.0001, r2 = 0.77; 
independent p values = <0.0001, <0.0001, 0.0047 respectively and independent F ratios = 85.36, 111.52, 8.77 
respectively. 
𝐶𝐼𝑐𝑎𝑛𝑐𝑒𝑟,𝐸𝑅 = 0.18 − (0.00099 ∙ ℎ𝑢𝑚𝑒𝑟𝑎𝑙 𝑎𝑏𝑑𝑢𝑐𝑡𝑖𝑜𝑛) − (0.0023 ∙ 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦) + (0.0038 ∙ 𝑏𝑜𝑑𝑦 𝑚𝑎𝑠𝑠) 
 
The most parsimonious models for co-activation of a healthy population during humeral ER 
exertions (CIhealthy, ER) was [Equation 28]: 
Equation 28 Co-activation prediction equation for a healthy population during external rotation exertions. Where 
humeral abduction angle is in degrees; whole model p value <0.0001; r
2
 = 0.35; independent variable p 
value = <0.0001; independent variable F ratio = 22.09 
𝐶𝐼ℎ𝑒𝑎𝑙𝑡ℎ𝑦,𝐸𝑅 = 0.22 − [0.00047 ∙ ℎ𝑢𝑚𝑒𝑟𝑎𝑙 𝑎𝑏𝑑𝑢𝑐𝑡𝑖𝑜𝑛]  
 
Analysis of interaction effects were performed, but these effects were not significant for either 
exertion type so therefore only the main effects were considered. Twenty four participants agreed to 
have intramuscular electrodes inserted into the rotator cuff muscles, and the remaining 26 
participants declined the needles and opted to have only surface electrodes record EMG. A total of 
22 tests were removed due to erroneous force values, and 50 channels of subscapularis intramuscular 
EMG were removed due to artifact, as outlined in Table 30. When EMG artifact was present, or 
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when subscapularis wire data was not available (participants that declined needles) CI calculations 
were adjusted to reflect the exclusion of subscapularis from the equation (the IR denominator was 
reduced from four to three). 
 To investigate the effects of resting EMG levels on CI calculations, the resting EMG was 
subtracted from raw signals, before linear enveloping and normalizing the EMG. This was done for 
25 participants. The CIs were calculated using both processing methods (Method 1 = no removal of 
resting EMG; Method 2 = subtraction of resting EMG) and compared using a T test. The CI was the 
dependent variable and the independent variables included the method of processing (1 or 2) with 
subjects as a random variable. Results indicated that there was no significant difference between the 
CIs calculated between processing methods (p = 0.7135). The least square means of the CI for 
Method 1 was 0.5313, compared to 0.5267 for Method 2. Since it was demonstrated that subtraction 
of resting EMG had no significant effect on the CI calculations, the EMG processing methods were 
kept the same as the Brookham & Dickerson (2014) publication, and all CIs were calculated for all 
participants using Method 1 (no removal of resting EMG). 
Table 30 Tests affected by force error and EMG artifact 
 Tests removed due to 
erroneous force 
Subscapularis channels 
removed due to artifact 
Number of tests/channels 
affected 
n = 22/1100  n = 50/528  
[24 participants had intramuscular EMG] 
Percentage of tests 
affected 
2.0% 9.5% 
Number of participants 
affected 
N = 10 N = 3 
 
Mean EMG (calculated by taking a 500 ms moving window average of linear enveloped data 
calculated between 2 – 4 seconds of each test) of all participants are shown in Appendix J, Table 49. 
Comparisons of least square mean activation levels between healthy (from Study 2) and breast 
cancer populations for IR and ER type exertions are shown in Table 31. 
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Table 31 Comparison of EMG activation levels (mean and SD) between healthy and cancer populations. 
Significance (p<0.05) are denoted with an asterix (*). 










  mean SD mean SD   
Pectoralis Major 
Clavicular 3.1 3.4 7.4 5.9 p < 0.01* 
Pectoralis Major Sternal 3.1 1.8 11.9 10.0 p < 0.01* 
Posterior Deltoid 10.8 9.6 18.2 15.4 p < 0.01* 
Latissimus Dorsi 7.4 8.3 23.7 19.6 p < 0.01* 
Supraspinatus (surface) 27.4 16.0 28.6 19.7 p = 0.68 
Infraspinatus (surface) 28.1 24.9 29.3 18.8 p = 0.72 
Supraspinatus (wire) 24.6 18.2 40.7 23.4 p < 0.01* 
Infraspinatus (wire) 31.4 24.9 29.2 20.5 p = 0.64 
Subscapularis (wire) 10.4 12.6 24.5 30.1 p = 0.03* 
            








  mean SD mean SD   
Pectoralis Major 
Clavicular 16.7 15.6 24.8 23.8 p = 0.03* 
Pectoralis Major Sternal 23.2 20.9 32.0 28.2 p = 0.03* 
Posterior Deltoid 2.7 2.5 7.2 6.2 p < 0.01* 
Latissimus Dorsi 9.6 12.3 26.5 23.8 p < 0.01* 
Supraspinatus (surface) 1.6 6.8 10.5 11.4 p = 0.11 
Infraspinatus (surface) 6.8 6.1 10.6 10.9 p = 0.05* 
Supraspinatus (wire) 7.8 8.1 16.7 14.4 p < 0.01* 
Infraspinatus (wire) 3.3 4.1 4.3 6.3 p = 0.39 





Section 6.5 Discussion 
Co-activation relationships of humeral rotators were defined in a breast cancer survivor population 
for a subset of isometric exertions varying in intensity and posture. Regression models were able to 
predict co-activation well during both IR and ER type exertions (77% explained variance). There was 
improvement in explained variance of co-activation for the survivor population compared to the 
healthy population, especially during ER type exertions. Co-activation of the breast cancer 
population was defined very similarly to that of the healthy population, reflecting similar joint level 
strategies for maintenance of GH stability, which was supported by various changes in survivor 
muscle. Contrary to the hypothesis, muscle-activation patterns of breast cancer survivors did not 
demonstrate a reduced internal/external humeral rotation co-activation ratio compared to healthy 
individuals during IR exertions (reflecting a decrease in pectoralis major activation). In contrast, 
compared to a healthy population, the survivors demonstrated significant increases in activation of 
the pectoralis major. 
 The CI prediction equations of the breast cancer survivor population were similar to those 
predictions of a healthy population as described in Study 2 and outlined in Equation 18 and Equation 
20. The intercept magnitudes were very similar between the population groups; the survivor intercept 
was slightly higher during IR exertions (0.71 vs. 0.70) and slightly lower during ER type exertions 
(0.18 vs. 0.22). The intercepts of each regression equation demonstrated the overall behavior of 
muscle activation during IR and ER exertions. The larger intercept during IR exertions (0.71) and 
smaller intercept during ER exertions (0.18) demonstrated an increase in activation of the IR 
musculature during IR exertions, and an increase in activation of the ER muscles during ER type 
exertions. The subtle magnitude differences of intercepts between populations indicate that the 
survivors had slightly higher activation of IR musculature during IR exertions, and slightly higher 
activation of ER musculature during ER exertions. In summary, compared to a healthy population, 
the survivor population group had higher levels of rotator muscle activation in their respective 
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rotation-type exertions. Higher levels of activation in the BCP is suggestive of increased effort 
required and increases in amplitude may also be indicative of fatigue. Survivors are known to 
experience decreased functional capacity, meaning they exert more effort relative to their maximal 
ability to perform usual activities, therefore leading to higher levels of fatigue (Mock, et al., 2005). 
Previous researchers have identified increased levels of activation of shoulder muscles in the BCP 
compared to healthy controls during scaption (Shamley, Lascurain-Aguirrebena, Oskrochi, & 
Srinaganathan, 2012) and functional writing tasks (Galiano-Castillo, Fernandez-Lao, Cantarero-
Villanueva, Fernandez-de-las-Penas, Menjon-Beltran, & Arroyo-Morales, 2011). Findings from 
Study 1 of this thesis similarly found that total muscle effort (summation of integrated EMG of 8 
shoulder muscles) was greater on the affected side compared to the unaffected side during reaching 
and lifting tasks. Results from Study 1 also indicated increases in activation of the external rotators 
(supraspinatus and posterior deltoid) during all tasks. Identifying the changes in muscle activation is 
useful to identify muscle strategies used by the BCP in order to preserve glenohumeral joint stability, 
as evidenced by the similar CI relationships. These strategies are further discussed below. 
Humeral abduction followed by intensity were significant factors in the prediction of CI in 
the survivor population, which mirrored the healthy CI results. During IR exertions, the coefficient 
magnitudes were slightly lower for the survivor population (BCP: -0.0033 vs. H: -0.0036 for humeral 
abduction; BCP: 0.0018 vs. H: 0.0034 for intensity), indicating that changes in posture and intensity 
had slightly less effect on CI for the survivor groups. This was also reflected by the smaller effect 
size of these coefficients in the survivor group compared to the healthy population (F ratios = 553.67 
vs. 757.99 for humeral abduction; 41.78 vs. 131.34 for intensity). During ER exertions, the 
coefficient of humeral abduction was greater in the survivor CI prediction (-0.00099 vs. -0.00047), 
albeit still small. Humeral abduction angle (or angle of elevation) was demonstrated to affect muscle 
activation of the BCP during Study 1 of this thesis: total muscle effort (summation of iEMG of 8 
shoulder muscles) was greatest during ROM-Reach tasks in which the participant was maximally 
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elevating the humerus in several difference planes, compared to other tasks with reduced reach 
heights. Shamley et al. (2007) reported loss of muscle activity (in terms of frequency of data points) 
of the pectoralis major, minor, rhomboid and serratus in the BCP to be greatest (most reduction) 
during highest angles of elevation during scaption. The survivor CI prediction for ER exertions also 
contained two additional predictors (intensity and body mass) compared to the healthy group 
prediction. In general, the relative magnitude of the intercepts compared to the coefficients was large, 
indicating model insensitivity to other factors. The small magnitudes of the coefficients suggest that 
changes in humeral abduction angle, intensity or body mass have only modest effects on CI 
predictions and do not substantially modify the overall behavior of the model. For example, during 
internal rotation exertions, if humeral abduction changes by 45°, the CI is reduced by only 0.1. The 
inclusion of a new predictor variable, body mass, in the prediction of CI during ER for the survivor 
population may be due to the difference and variance in demographics compared to the healthy 
population. The healthy population consisted of a tighter demographic consisting of young males and 
females (gender did not affect CI) with a mean body mass of 66.6 kg [range 48.5-85.0, SD 10.9] and 
mean BMI of 23.0. The survivor group consisted of a wider range demographic of older, heavier 
females (71.7 kg [range 51.4-97.7, SD 11.8]), with a mean BMI 26.3. Intensity may play a more 
important role during ER of the breast cancer population due to dysfunctional changes that limit 
humeral ER ROM and increase humeral IR ROM as demonstrated by the kinematic findings of 
Study 1. Study 1 demonstrated weakness and increased effort required in posterior rotator cuff and 
shoulder muscles (which may be the cause or effect of reduced ER movements), and these changes 
were more evident during work tasks, which involved external loads and were higher intensity tasks 
compared to the other ADL tasks performed in Study 1. In the current study, it was evident that 




There was a 42% improvement in explained variance of the CI prediction of the survivor 
group compared to that of the healthy population for ER exertions, suggesting that survivor CI was 
more predictable. This improved explanation of variance for ER exertions is likely due in part to the 
increased sample size (50 survivors vs. 20 healthy) and reduced task set (9 ER tests vs. 27 ER tests) 
upon which the regression equation was built. Also, there may be less variability in the muscle 
strategies that are used or available for use in the survivor population, causing survivor CI to have 
greater explanation of variance. It is known that muscle strategies change with postural changes in a 
healthy population (Lee, Kim, O`Driscoll, Morrey, & An, 2000; McKernan, et al., 1990), but the 
roles of shoulder muscles in co-activation of a breast cancer population have not yet been 
investigated. Future discrimination between levels of disability may allow further improvements in 
explained variance when defining co-activation within this population.  
Differing muscle strategies used by the survivor population may help explain how 
glenohumeral stability is maintained, as was represented by the CI predictions presenting so similar 
to that of the healthy population. In general, results indicated that survivor activation levels are 
higher than those of a healthy population. Specifically, during both IR and ER type exertions, the 
survivors had significantly higher activation in the following four muscles: pectoralis major 
clavicular, pectoralis major sternal, latissimus dorsi, posterior deltoid and supraspinatus (wire). These 
muscle activation patterns agree partially with previous works. In Study 1 of this thesis; during 
which the muscle activation of the unaffected limb was considered the ‘healthy control’ that was 
compared to the affected limb, there was increased Total Muscle Effort (summation of integrated 
EMG) during work tasks on the affected side. Similarly, Study 1 also demonstrated significant 
increases in activation of posterior deltoid and supraspinatus on the affected side during ROM-
Reach, ROM-Rotate (excluding supraspinatus, p=0.0520), ADL and work tasks. However, in 
contrast to the current study findings, Study 1 results demonstrated a reduction in pectoralis major 
sternal activation on the affected side during ROM, ADL and work tasks. This discrepancy could be 
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due to methodological differences or population baseline comparison differences. Firstly, the muscle 
activation may be different due to the vastly different exertions being considered. Reduced pectoralis 
major sternal activation was seen in Study 1 during highly dynamic, functional tasks, which involved 
significant reach distance, extending the moment arm of pectoralis major. Increased pectoralis major 
(sternal and clavicular portions) activation was seen during static postures of IR and ER, during 
which the majority (67%) of exertions were performed with the arm at the side (for only 2% and 1% 
of tests was the humerus elevated to 45° and 90°, respectively). It may be that the pectoralis major is 
more capable of producing activation at lower elevation angles, but that muscle dysfunction is more 
evident in more extreme postures. Scar tissue formation and anterior chest wall tightness is evident in 
this population (Lauridsen, Cristiansen, & Hessove, 2005), and Study 1 kinematics have 
demonstrated the survivors tend to keep the affected arm closer to the side and more internally 
rotated. This may reflect an adaptive change due to a dysfunction in the pectoralis major which is 
more evident at extreme ranges. Increased activation found in these extreme ranges may reflect 
increased levels of pain due to stretching or tearing of tight or damaged tissues. Galiano-Castillo et 
al. (2011) suggested increases in survivor EMG may be due to pain or fear of pain and Shamley et al. 
(2012) demonstrated that pain was associated with higher levels of muscle activation in survivors. 
Secondly, the discrepancy of pectoralis major activity may be due to the fact that the current study 
was comparing activation levels of survivor and healthy populations; whereas activation levels 
between unaffected and affected limbs of survivors were compared in Study 1. Shamley et al. (2012) 
compared muscle activity and scapulothoracic kinematics of both shoulders of survivors and also 
compared to healthy women, and reported bilateral changes of shoulder morbidity. Shamley et al. 
(2012) found that survivors that had mastectomies demonstrated higher pectoralis major activity on 
the affected side compared to a healthy control, but in contrast, survivors that had wide local excision 
demonstrated decreased pectoralis major activity on the affected side compared to a healthy control. 
The discrepancies found in pectoralis major muscle activation may reflect different muscle strategy 
adaptations occurring due to type of movement performed and type of surgery received, and 
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consideration should be taken when comparing within or between populations. In addition, the 
activation of the subscapularis of the survivor group was higher during ER exertions. This is of 
particular interest as it may suggest survivors increased reliance on subscapularis as a primary 
internal rotator to help stabilize the glenohumeral joint during ER exertions (and maintain the CI 
ratio), due to reduced function of the pectoralis major assumed to be adversely affected by adjuvant 
treatments. 
Interpretation of some results is compromised due to conflicting findings between respective 
surface and intramuscular EMG activation levels. Specifically, there is difficulty in interpretation of 
the strategies used by survivors in activation of the supraspinatus during ER exertions, and activation 
of the supraspinatus and infraspinatus during IR type exertions. During ER exertions, the survivors 
had higher levels of supraspinatus activation recorded intramuscularly, but there was no significant 
difference between surface recordings. During IR exertions, the survivors had higher levels of 
infraspinatus (surface) and supraspinatus (wire) signals, but there was no significant difference in 
activation levels between their respective wire and surface recordings. Intramuscular electrodes are 
recommended for recording EMG from the rotator cuff (Waite, Brookham, & Dickerson, 2010), but 
it is not always feasible to use them. Almost half (24) of the participants agreed to insertion of 
intramuscular electrodes, but the remaining individuals declined due to fear of complications or risk 
of lymphedema, so surface electrodes were used to record rotator cuff activity of these participants. 
Surface electrodes have been shown to reasonably reflect activation patterns of their respective 
intramuscular recordings in both maximal (Waite, Brookham, & Dickerson, 2010) and submaximal 
(Allen, Brookham, Cudlip, & Dickerson, 2013) exertions of healthy participants. Surface electrodes 
better represent their intramuscular counterparts during submaximal exertions, compared to maximal 
exertions (Allen, Brookham, Cudlip, & Dickerson, 2013). The exertions of the current study were 
submaximal, and it was assumed that the surface electrode would reasonably reflect the activation 
recorded by the intramuscular (gold standard) electrode. Surface recordings generally overestimate 
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intramuscular recordings, likely in part due to cross-talk contamination of overlying muscles. Waite 
et al. (2010) reported 4 – 11% cross-talk between infraspinatus and upper and middle trapezius, 
posterior deltoid and infraspinatus; and reported 9 - 17% cross-talk between supraspinatus and 
posterior deltoid and upper trapezius during maximal exertions. Other differences between surface 
and intramuscular recordings have been attributed to muscle size and location (which can affect the 
reliable placement of electrodes (Waite, Brookham, & Dickerson, 2010)); posture, intensity and 
whether the muscle was a primary mover (Allen, Brookham, Cudlip, & Dickerson, 2013). The 
statistical differences found between activation levels of surface and intramuscular recordings of 
supraspinatus and infraspinatus may be a result of these above mentioned factors, or could be a 
reflection of the variance seen in the signals (Table 31).  Further, the relationships between these 
electrode types has not been examined in a survivor population, and changes in muscle 
characteristics due to surgery and adjuvant treatments could impact these relationships. Although the 
statistical significance of the differences was not consistent, the general findings agreed that 
activation levels of supraspinatus and infraspinatus for both surface and wire recordings were higher 
in the survivor population compared to the healthy. 
This is the first study to define co-activation patterns of breast cancer survivors. Regression 
models were able to predict survivor CI well during static IR and ER exertions, demonstrating 
greater explanation of variance compared to CI regression models of a healthy population (defined in 
Study 2 of this thesis). There was good agreement between healthy and survivor CI, indicating 
similar joint level strategies for maintenance of GH stability, which was supported by various 
changes in survivor muscle strategies. In general, the survivors demonstrated greater activation in the 
pectoralis major, posterior deltoid, latissimus dorsi and supraspinatus, compared to the healthy 
group. Muscle activation strategies deployed by the survivors were generally coincident with EMG 
and kinematic findings from Study 1 and that of previous work. Differences in study methodologies 
including; exertions examined (type, intensity), population comparisons made (contralateral limb vs. 
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healthy control) and electrode types used (surface vs. intramuscular) made some comparisons 
difficult, and may have confounded some findings. The results of this study are not generalizable to 
other exertions. Due to the nature and location of surgery and radiation, the IRs located on the 
anterior chest wall (pectoralis major clavicular and sternal insertions) are commonly affected 
(Dalberg, Krawiec, & Sandelin, 2010; Sugden, Rezvani, Harrison, & Hughes, 1998), causing 
pectoralis major capability and humeral internal-external rotation exertions to be of most interest 
within this population. Future works should continue to examine breast cancer co-activation by 
attempting to extrapolate this relationship to a wider range of tasks and intensities. 
Section 6.6 Study contribution to science and health 
This study contributes to both science and health by furthering knowledge about shoulder muscle 
activation and coordination in a breast cancer survivor population. This first attempt at quantification 
of these co-activation relationships has provided insight into how survivor muscles compensate 
during dysfunction. Continued advancement of this knowledge could allow knowledge translation to 
clinicians to improve diagnostic capabilities, providing a more thorough understanding of what 
dysfunction is occurring and which muscles are affected, and may promote the generation of 
evidence-based therapeutic preventative and treatment interventions to treat these identified 
dysfunctions. These defined relationships will be used in Study 4 of this thesis in a computational 
shoulder model, to investigate changes to muscle strategy with inclusion of co-activation constraints, 





Chapter 7 Study 4 – Modelling changes in humeral internal and external 
rotation strength of breast cancer survivors to investigated employed 
muscle strategies 
Section 7.1 Introduction 
Biomechanical models are useful for predicting biophysical magnitudes such as moments, joint and 
muscle forces that are difficult, infeasible, or unethical to measure empirically. Biomechanical 
analyses of the upper limb are at a relatively early stage compared to gait and low back biomechanics 
(Dickerson, 2008b). A summary of ten shoulder biomechanical models is provided by Dickerson 
(2008b). Specifically, the Shoulder Loading Analysis Modules (SLAM) is a 3-D, inverse dynamic 
link-segment model of the right upper limb (38 muscle segments) which is not dependent on 
experimental data, includes dynamics and is population scalable (Dickerson, 2005; Dickerson, 
Chaffin, & Hughes, 2007). Mathematical biomechanical models frequently negate co-activation of 
antagonistic muscles (Collins, 1995; Dickerson, Hughes, & Chaffin, 2008; Hughes & Chaffin, 1988; 
Zajac & Gordon, 1989), often because optimization procedures employed assume the body 
activations muscles according to the minimal total muscle stress (Crowninshield & Brand, 1981). In 
these instances, antagonistic contraction would be considered mathematically counterproductive. By 
mischaracterizing the co-activation characteristics of muscles, the models underestimate muscle 
activity predictions, which results in low estimates of joint contact forces. Inclusion of co-activation 
predictions will increase physiological realism of models, and should enhance accuracy of model 
predictions. Humeral IR and ER co-activation has been defined at the shoulder in a healthy 
population (Brookham & Dickerson, 2014), and was defined in a breast cancer population in Study 3 
of this thesis. 
There is a need for models that provide insight into the mechanisms of specific muscle 
disability, such as those experienced within a breast cancer population. It is important to have models 
that can predict strength and link it back to specific tissue injuries. Models which can successfully 
achieve this goal could be useful in the return to work of injured populations (not just exclusively 
190 
 
breast cancer survivors) by evaluating the capacity of workers and assessing this capacity in the 
context of workplace task demands. By modifying inputs to an existing advanced upper limb 
biomechanical model to reflect specific muscle deficits, strength and anthropometrics of a survivor 
population, predictions of muscle strategy and function could be useful in providing insight into 
mechanisms of specific muscle disability. Understanding the mechanisms of disability is an essential 
first step to treating and preventing the disability. 
Capability of the pectoralis major has been shown to be consistently compromised in a breast 
cancer survivor population (Dalberg, Krawiec, & Sandelin, 2010; Rietman, et al., 2003; Sugden, 
Rezvani, Harrison, & Hughes, 1998). Previous investigations have demonstrated that the pectoralis 
major demonstrates changes and dysfunction on the affected side of survivors, thought to be due to 
surgery or cancer treatments. Shamley et al. (2007) used MRI to measure the size of the unaffected 
and affected side pectoralis major and minor, rhomboids and serratus anterior muscles of 57 female 
breast cancer survivors ranging from 6 months to 6 years post-surgery. Pectoralis major and minor 
demonstrated a significant decrease in size on the affected side, which authors reported was not 
surprising due to its location in the field of surgery and radiation (Shamley, et al., 2007). Shamley et 
al. (2007) surmised that reduction in size of the pectoralis major may affect the survivor’s ability to 
reach up, since extensibility of the muscle is required to allow for full humeral elevation. Reductions 
in elevation angle have been reported in previous works (Hack, Cohen, Katz, Robson, & Goss, 1999; 
Kuehn, et al., 2000; Rietman, Dijkstra, Debreczeni, Geertzen, Robinson, & De Vries, 2004), 
including the results of Study 1 of this thesis. Reduction in pectoralis major activity has been seen 
previously in the affected shoulder of survivors during scaption, compared to a healthy population 
(Shamley, Lascurain-Aguirrebena, Oskrochi, & Srinaganathan, 2012). Similarly, results from Study 
1 of this thesis reported reductions in survivor pectoralis major sternal activation during ROM, ADL 
and work tasks. Activation of the pectoralis major can further be compromised by damage to the 
supplying pectoral nerve, which is susceptible to harm during axillary node dissections (Lauridsen, 
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Torsleff, Husted, & Erichsen, 2000). Due to the nature and location of surgery and radiation 
treatment of breast cancer, the internal rotators located on the anterior chest wall (pectoralis major 
clavicular and sternal insertions) are commonly affected, causing pectoralis major capability and 
humeral internal-external rotation exertions to be of most interest within this population. Modeling 
internal and external rotation strength of breast cancer survivors provides a conceptual understanding 
of what type and amount of muscle force decrements most affect functional outcomes. As the 
pectoralis major (sternal and clavicular) muscle force capabilities were reduced and disabled, the 
effect of these simulated changes in muscle strategy were evaluated. The predicted outcomes 
generated an understanding of what functional changes in muscle strategy occur when certain 
pectoralis portions are decremented or disabled. 
The purposes of this study were to modify an existing 3-D, inverse dynamic link-segment 
model of the right upper limb (specifically, the Shoulder Loading Analysis Modules (SLAM) 
(Dickerson, 2005; Dickerson, Chaffin, & Hughes, 2007)) in terms of survivor pectoralis major 
capability, co-activation (defined from Study 3 of this thesis) and population anthropometrics to 
determine the following: 
1) Determine how muscle strategy is affected by specific muscle dysfunction (using an 
inverse-type simulation). Specifically, compare how closely SLAM muscle force predictions 
represent empirically measured survivor EMG during IR and ER exertions. 
2) Determine if inclusion of survivor IR and ER exertion type co-activation constraints 
improve the physiological realism of the muscle force predictions (more closely represent the 
empirically recorded EMG). 
 
It was hypothesized that: 
1. SLAM muscle force predictions will be more closely associated with empirically 
measured EMG activation levels during states of reduced pectoralis major capability. Specifically, 
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correlations between EMG and muscle force predictions will be highest when the pectoralis major 
capability is set to 0.25, 0.50 and 0.75; and correlations will be lowest when capability is set to 0.0 or 
1.0. Similarly, it is assumed that differences between predicted and actual values of activation will be 
smallest when the pectoralis major capability is set to 0.25, 0.50 and 0.75; and differences will be 
greatest when capability is set to 0.0 or 1.0. 
Due to the nature of surgeries and adjuvant treatments received in the population under 
study, and the resultant evidence of dysfunctional changes prevalent in this population (as 
demonstrated by muscle activation and kinematic changes in Study 1 of this thesis), it is assumed 
that survivors will neither have total disability (pectoralis major capability of 0) nor total capability 
(100% capable of producing maximal force) of the pectoralis major muscles. It is hypothesized that 
survivors maintain 0.25-0.75 ability of the pectoralis major capability, which will be reflected by 
higher correlations between EMG and model predictions and lower activation differences during 
these conditions. 
2. Inclusion of the co-activation constraint would result in the muscle force predictions more 
closely representing the empirically recorded muscle activation. Specifically, correlations will be 
greater and activation differences will be smaller when co-activation is enforced. 
Previously, elbow flexor and extensor co-activation constraints were included in an 
optimization muscle force prediction model of the elbow, and results demonstrated that inclusion of 
these constraints improved the model predictions, bringing them closer to the empirically measured 
activation levels (Brookham, Middlebrook, Grewal, & Dickerson, 2011). 
Section 7.2 Methods 
Survivor anthropometrics, posture and hand forces were inputted into the SLAM model. Capability 
of pectoralis major sternal and clavicular portions was adjusted, and survivor IR and ER co-
activation ratios were added as constraints to the inverse-type simulation. Predictions of muscle 
strategy were compared with experimentally collected EMG. 
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Section 7.2.1 Background of the SLAM model 
Before details can be provided regarding modifications made to the SLAM model, the reader must be 
provided a basic overview of what the SLAM model entails. SLAM is a 3-D inverse dynamic link-
segment model of the right upper limb developed by Dickerson (2005) and further detailed by 
Dickerson et al. (2007; 2008). The SLAM model is comprised of 3 major components: 1) a 
geometric model representing shoulder muscles and bones; 2) an external dynamic shoulder torque 
model; and 3) an internal muscle force prediction model. For the purpose of this thesis, only aspects 
of the geometric model and the muscle force prediction model applicable to this thesis’ study will be 
discussed.  
The SLAM geometric model accepts motion files as input. The static posture of interest of 
the current study was with the arm at the side (0° humeral elevation) and the elbow bent to 90°. This 
posture was initially created in the University of Michigan’s 3-D Static Strength Prediction Program 
(3DSSPP) software (described in by Chaffin, Andersson & Martin (1999)), and the orientation and 
relative position of each shoulder bone was transferred to the SLAM model. The SLAM geometric 
model then defined bone parameters (scapula, clavicle, humerus and torso), muscle lines-of-action 
and moment arms for 38 muscle elements represented in the model. (A total of 23 shoulder muscles 
are represented in the model, but some muscles have multiple contributors and are modeled as 
having more than one line of action.) Muscle attachment sites and muscle lines of action were 
numerically determined in the SLAM geometric model. Segment lengths for each bone were 
calculated based on torso length with published proportions (Makhsous, 1999). Muscle attachment 
sites were based on a cadaver study (Hogfors, Sigholm, & Herberts, 1987), and were represented on 
each bone mathematically as a fractional distance along each axis, relative to segment length. Muscle 
line-of-actions were wrapped using variations of spherical and cylindrical geometric wrapping 
techniques as is further detailed in Dickerson (2007). 
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The SLAM muscle force prediction model implements optimization procedures to solve the 
load distribution problem among the muscles that are required to resist external forces, while 
maintaining shoulder stability. Dickerson (2005) described five key elements used to determine one 
unique solution to the load-sharing problem, as described briefly here: 
1. Mechanical equilibrium constraints: sum of forces and moments equal zero  
2. Force bounds for individual muscles: muscles cannot transmit force in tension; upper and lower 
bound for muscle tension are defined 
3. A glenohumeral contact, non-dislocation constraint: stability ratios (directional shear to 
compressive force) of joint dislocation tolerances are used 
4. An objective function to minimize the sum of the cubed muscle stresses 
5. A solution methodology: to minimize the objective function using linear equality constraints 
The outputs of the muscle force prediction model include the prediction of individual muscle forces 
at distinct time points throughout a dynamic exertion (or one static posture as was the case of this 
thesis’ study). These predictions were provided as normalized muscle forces (percentages of 
maximum prediction muscle force). For the purposes of this thesis’ study, only 11 of the 38 muscle 
components force predictions were of interest (to allow for comparison of those 7 muscles EMG was 





Table 32 List of muscle portions modeled that were compared with experimental results from Study 3 
Number Muscle Modeled (Muscle Portion) 
1 Latissimus Dorsi I (Upper) 
2 Latissimus Dorsi II (Lower) 
3 Pectoralis Major I (Sternal Insertion) 
4 Pectoralis Major II (Clavicular Insertion) 
5 Posterior Deltoid 
6 Infraspinatus I (Upper) 
7 Infraspinatus II (Lower) 
8 Subscapularis I (Upper) 
9 Subscapularis II (Middle) 
10 Subscapularis III (Lower) 
11 Supraspinatus 
 
Section 7.2.2 Modifications made to the SLAM model 
Specific inputs and adjustments were necessary to customize the SLAM model to allow survivor net 
glenohumeral internal/external moment to be transformed to specific muscle forces using 
optimization procedures in the posture of interest. Inputs included: 
1. The posture: arm at side at 0° elevation, elbow flexed to 90° 
2. Breast cancer survivor anthropometrics: stature and body mass for 50 survivors (measured 
during Study 3). These parameters were used to generate population-specific bone length 
parameters which were used during link-segment inverse calculations to transform hand 
force to net glenohumeral internal/external moment. 
3. Hand forces: 19.6 N IR, 19.6 N ER, 40 N IR and 40 N ER. These exertions were performed 
by survivors in Study 3 of this thesis: the force produced at the hand was measured with a 
tri-axial force transducer (MC3-6-500, Advanced Mechanical Technology Inc., Watertown, 
Massachusetts) and confirmed with visual force feed-back of breast cancer survivors, as 
detailed in Study 3. It should be noted that the affected (cancer) side was on the right for 23 
participants; and the affected side was on the left for 27 participants. For the left-affected 
participants, forces were mirrored to represent forces acting on the right side so they could 
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be inputted into the right-handed SLAM model. It was assumed that muscle behavior would 
be consistent on either side. 
4. Survivor humeral rotator co-activation constraints: These relationships were defined during 
IR and ER type exertions in Study 3 (Equation 25 and Equation 27). The model was run 
when no co-activation was enforced, and when co-activation was enforced. 
5. Pectoralis major force capability: The force capability of the pectoralis major sternal and 
clavicular muscle portions was adjusted to reflect total disablement, fractions of capability, 
and total capability, as described in Equation 29. This modification simulated reduced 
pectoralis major contribution due to muscle damage resulting from cancer treatments. 
Equation 29 Muscle force capability. Where PCSA is physiological cross-sectional area; ST is specific muscle tension 
for muscle, i; and M is a multiplier that was set at 0 (muscle is disabled), 0.25, 0.50, 0.75 and 1.0 (maximal force 
capability of muscle, i). 
𝐹𝑖 = 𝑃𝐶𝑆𝐴𝑖 ∙ 𝑆𝑇𝑖 ∙ 𝑀 
As mentioned above, optimization was used to solve for specific muscle forces. The objective 
function which was implemented was the sum of the cubed muscle stresses (Equation 30), which has 
been used in several models (Crowninshield & Brand, 1981; Brookham, Middlebrook, Grewal, & 
Dickerson, 2011; Dickerson, 2005; Dickerson, Chaffin, & Hughes, 2007).  
Equation 30 Objective function: Sum of the cubed muscle stresses. Where Θ is the objective function, fi is the force 
prediction in an individual muscle i, and PCSAi is the physiological cross-sectional area of the same muscle i. 







The format of constraints (Equation 31) and set of constraints associated with minimization of the 
objective function within the SLAM model were as follows and were similar to Dul et al., (1984) 




Equation 31 Minimization of the objective function (Θ) using linear equality constraints 
𝐌𝐢𝐧𝐢𝐦𝐢𝐳𝐞 𝚯, such that 𝐀𝐱 = 𝐁 
Equation 32 Constraint 1: Muscle (i) can only develop tensile force (F) 
𝐌𝐢𝐧𝐢𝐦𝐢𝐳𝐞 𝚯, such that 𝐅𝒊 ≥ 𝟎 
 
Equation 33 Constraint 2: Force (F) equilibrium must be maintained. Where F are the forces; m is the mass of 
segment and a is the acceleration of segment COM. External forces are the hand forces and weights of the segments. 
Solving the resulting equation achieves the external joint load at each proximal joint segment. 
𝐌𝐢𝐧𝐢𝐦𝐢𝐳𝐞 𝚯, such that ∑ 𝐅 = 𝒎𝒔𝒆𝒈𝒎𝒆𝒏𝒕 × 𝒂𝑪𝑶𝑴,𝒔𝒆𝒈𝒎𝒆𝒏𝒕 = 𝟎 
Equation 34 Constraint 3: Moment (M) equilibrium must be maintained. Where M is external moment and Ḣ is the 
rate of change of segmental angular momentum. Ḣ is calculated based on segmental moments of inertia and the 
segmental velocities and accelerations. External moments are calculated based on the cross products of the produced 
forces and their moment arms. Moments are calculated at the proximal ends of each segment. 
𝐌𝐢𝐧𝐢𝐦𝐢𝐳𝐞 𝚯, such that ∑ 𝐌 = ?̇? = 𝟎 
Equation 35 Constraint 4: Specific muscle (i) force (F) is limited by maximal (max) muscle force capacity 
𝐌𝐢𝐧𝐢𝐦𝐢𝐳𝐞 𝚯, such that 𝐅𝒊 < 𝐅𝒊𝒎𝒂𝒙 
Equation 36 Constraint 5: Co-activation constraint (k) between IR muscle (IR) and ER muscle (ER) forces (F) 
𝐌𝐢𝐧𝐢𝐦𝐢𝐳𝐞 𝚯, such that ∑ 𝑭𝑰𝑹 = 𝐤 ∙ ∑ 𝑭𝑬𝑹 
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Optimization procedures resulted in predictions of specific muscle forces which were then 
compared directly with experimentally measured EMG of survivors (which was recorded during 
Study 3). The model was run for 2000 iterations, accommodating for 50 survivors, 2 co-activation 
constraints (none or included); 5 force capability constraints for two pectoralis major muscles; during 
4 hand forces (19.6 N and 40 N of IR and ER) as is depicted in Figure 39.  The study methods and 
general model inputs and outputs are depicted in Figure 40. 
 
Figure 39 Break-down of model iterations: model was run for 2 co-activation constraints, 5 force capability 




Figure 40 Study 4 Methods and general inputs and outputs: Posture was recreated in 3DSSP and bone positions 
were implemented into SLAM. Hand force, force capability and co-activation conditions were modified and muscle 
force predictions were solved using optimization procedures. Muscle force predictions were compared with 
experimentally recorded muscle activation. 
 
Section 7.2.3 Predicted muscle force assessment 
Correlation coefficients were calculated to compare model and experimental values, and describe the 
degree (strength and direction) of linear association present. Specifically, 1000 correlations were 
calculated between the model muscle force predictions (% MVF) and experimental EMG (%MVC) 
of internal and external rotator type muscles, grouped by pectoralis major capability (0, 0.25, 0.50, 
0.75, 1.0) and co-activation status (enforced or no co-activation). Similar to Study 2 and 3 of this 
thesis, the internal rotators were defined as the subscapularis, pectoralis major clavicular / sternal 
heads and latissimus dorsi; and the external rotators were considered the infraspinatus, posterior 
deltoid and supraspinatus muscles.  
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To investigate closeness of magnitudes of muscle force predictions with EMG, average 
normalized muscle force predictions (model output) were compared with average empirical measures 
of normalized muscle activation using a simple difference calculation (Equation 37). 
Equation 37 Activation difference calculation. Where MFP = model muscle force prediction (normalized to percent 
maximal force) and EMG = measured muscle activation (normalized to percent maximal exertion). 
𝐷𝑖𝑓𝑓𝑎𝑐𝑡𝑖𝑣𝑎𝑡𝑖𝑜𝑛 = 𝑀𝐹𝑃 − 𝐸𝑀𝐺 
Section 7.3 Analysis 
Model muscle force predictions were compared with experimental electromyographic data in JMP 
11
® 
(SAS Institute Inc., Cary, NC) for 2 muscle types (IR/ER), 2 co-activation constraint conditions, 
4 hand force conditions and 5 pectoralis major capability constraints.  
Section 7.3.1 Statistical analysis 
To determine any differences in correlation coefficients between groups, an ANOVA was run with 
the correlation coefficients as the dependent variable, and the independent variables included subject 
as a random variable, muscle type (IR/ER), CI constraint (on/off) and pectoralis major capability (5 
conditions). Main and interaction effects were analyzed.  
 To determine any differences in magnitudes of predictions and EMG between groups, an 
ANOVA was run with the activation difference (Equation 37) listed as the dependent variable, and 
the independent variables included subject as a random variable, muscle type (IR/ER), CI constraint 
(on/off), hand force (19.6 N IR/ER, 40 N IR/ER) and pectoralis major capability (5 conditions). Main 
and interaction effects were analyzed. 
Post hoc analyses were performed using Student’s t-tests (for differences in correlation 
coefficients between two-level conditions) and Tukey’s Honestly Significant Differences tests (for 
differences in correlation coefficients and activation differences between groups with more than 2 
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levels). Mean and standard deviations of correlation coefficients for all subjects were calculated for 
muscle types between groups (CI constraint and pectoralis major capability). 
Section 7.4 Results 
The ability of the model to predict muscle activation was influenced by muscle type, the CI 
constraint condition, hand force and pectoralis major capability; as well as some interactions of these 
factors. 
Section 7.4.1 Main effect results for correlation coefficients 
The correlations between model predictions and empirically measured muscle activation were 
significantly higher for external rotator muscles compared to internal rotators (r = 0.567 [±0.264] vs. 
0.347 [±0.254], respectively; p < 0.0001; F ratio 272.42. Whole model p< 0.0001.), as depicted in 
Figure 41. 
 


































The correlations between model predictions and empirically measured muscle activation were 
significantly higher when the CI constraint was not enforced (r = 0.580 [±0.286] vs. 0.333 [±0.214], 
respectively; p < 0.0001; F ratio 342.35. Whole model p< 0.0001.), as depicted in Figure 42. 
 
Figure 42 Prediction Ability between co-activation constraints. LSM±SD are shown. Levels not connected by same 
letter are significantly different. 
 
The correlations between model predictions and empirically measured muscle activation were 
significantly higher during pectoralis major capability intermediate levels compared to correlations 
during total disability or total capability (p = 0.0015, F ratio 4.41): 
 r during 0.25, 0.5, 0.75 (r = 0.46 – 0.48) > r during 0 pectoralis capability (r = 0.40) 


































Figure 43 Prediction ability between pectoralis major capability constraints. LSM±SD are shown. Levels not 
connected by same letter are significantly different. 
 
The effect size of main effects variables was in the following descending order: 
CI constraint > Muscle Type > Pectoralis Major Capability  
 
The ANOVA assumptions were not violated as the independence of variables were ensured through 
random sampling, and normality and equal variance was confirmed (mean 0.04, SD = 0.002). 
 
Section 7.4.2 Main effect results for activation differences 
The activation differences between model predictions and empirically measured muscle activation 
were significantly less for external rotator muscles compared to internal rotators (LSM = -20.3% 
[±23.4] vs. -21.7% [±34.0], respectively; p=0.0010; F ratio 10.9. Whole model p< 0.0001.), as 
depicted in Figure 44. Negative values indicate the model predictions were lower (underestimated) 



























Pectoralis Major Capability 




Figure 44 Difference between predicted and actual muscle activation: between muscle types. LSM±SD are shown. 
Levels not connected by same letter are significantly different. 
 
The activation differences between model predictions and empirically measured muscle activation 
were significantly less when the co-activation constraint was enforced compared to predictions 
without co-activation (LSM = -18.4% [±31.9] vs. -23.5% [±27.6], respectively; p< 0.0001; F ratio 










































Figure 45 Difference between predicted and actual muscle activation: between co-activation constraints. LSM±SD 
are shown. Levels not connected by same letter are significantly different. 
 
The activation differences between model predictions and empirically measured muscle activation 
were significantly less when the pectoralis major capability constraint was set to 0.25 compared to 
other capability levels  (LSM = -19.0% [±31.2] vs. -20.9 - -21.89% [±29.5-29.9], respectively; p< 









































Figure 46 Difference between predicted and actual muscle activation during various pectoralis major capability 
constraints (0 (disabled) – 1.0 (fully capable) pectoralis major contributions). Mean differences in activation and 
standard deviations are shown. Levels not connected by same letter are significantly different. 
 
The activation differences between model predictions and empirically measured muscle activation 
were significantly less for lower hand forces (19.6 N) and internal rotation exertions, compared to 
higher hand forces (40 N) and external rotation exertions (LSM = -13.5% [±23.0], -15.8% [±25.8] vs. 
-24.17% [±31.9], -30.41% [±36.4] respectively; p< 0.0001; F ratio 358.4. Whole model p< 0.0001.), 




































Pectoralis Major Capability 




Figure 47 Difference between predicted and actual muscle activation: between hand force conditions. LSM±SD are 
shown. Levels not connected by same letter are significantly different. 
 
The effect size of main effects variables was in the following descending order: 
Hand force > co-activation constraint > muscle type > pectoralis major capability 
 
Section 7.4.3 Interaction effect results for correlation coefficients 
There were significant interaction effects between muscle type and pectoralis major capability 
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Figure 48 Prediction ability by muscle type interacted with pectoralis major capability. LSM±SD are shown. Levels 
not connected by same letter are significantly different. 
 
There were significant interaction effects between co-activation constraint and pectoralis major 
capability correlations (p=0.0021; F ratio = 4.24. Whole model p<0.0001) as depicted in Figure 49. 
The effect size of interaction effects variables was in the following descending order: 






























































Muscle Type (ER/IR) X Pectoralis Major Capability (Disabled 
(0)-Full Capability (1)) 
A A A A A 





Figure 49 Prediction ability by CI constraint interacted with pectoralis major capability. LSM±SD are shown. 
Levels not connected by same letter are significantly different. 
 
Section 7.4.4 Interaction effect results for activation differences 
There were significant interaction effects between activation differences of muscle type and 
pectoralis major capability constraints (p=0.0001; F ratio = 5.7. Whole model p<0.0001) as detailed 
in Table 33. 
Table 33 Interaction effects between activation differences (MFP-EMG) of muscle type X pectoralis major 
capability constraints. Muscle type included internal rotator muscles (IR) and external rotator muscles (ER). 
Pectoralis major capability constraints included 0 (disabled) – 1.0 (fully capable) conditions. 
Level       MFP-EMG SD 
0.25,IR A     -18.2 35.9 
0.75,ER A B   -20.4 23.5 
0.5,ER A B   -20.4 23.5 
1,ER A B   -20.5 23.5 
0.25,ER A B   -20.5 23.5 
0,ER   B C -21.0 23.2 
0.5,IR   B C -21.5 33.3 
0,IR   B C -22.2 34.1 
0.75,IR   B C -22.6 33.2 


























































CI constraint (off=0/on=1) X Pectoralis Major Capability 
(Disabled (0) - Full Capability (1)) 
A A A A B 
C C C C C 
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There were significant interaction effects between activation differences of hand force and co-
activation constraints (p<0.0001; F ratio = 20.6. Whole model p<0.0001) as detailed in Table 34. 
Table 34 Interaction effects between activation differences (MFP-EMG) of hand force X co-activation constraints. 
Hand forces include 19.6 N and 40 N internal (negative values) and external (positive values) rotation exertions. Co-
activation was enforced (1) or not enforced (0). 
Level           MFP-EMG SD 
 -19.6,1 A         -12.0 23.4 
 -19.6,0 A         -13.4 22.6 
19.6,1 A         -13.7 28.1 
19.6,0   B       -19.7 22.8 
 -40,1   B C     -21.4 32.6 
 -40,0     C     -23.6 31.1 
40,1       D   -27.9 41.0 
40,0         E -36.6 30.1 
 
There were significant interaction effects between activation differences of hand force and pectoralis 





Table 35 Interaction effects between activation differences (MFP-EMG) of hand force X pectoralis major capability 
constraints. Hand forces include 19.6 N and 40 N internal (negative values) and external (positive values) rotation 
exertions. Pectoralis major capability constraints included 0 (disabled) – 1.0 (fully capable) conditions. 
Level           MFP-EMG SD 
 -19.6,0.25 A         -10.4 24.0 
 -19.6,0.5 A         -12.5 22.5 
 -19.6,0.75 A B       -13.3 22.5 
 -19.6,0 A B       -13.6 23.1 
 -19.6,1 A B       -13.6 22.6 
19.6,1   B C     -16.7 25.8 
19.6,0.25   B C     -16.7 25.9 
19.6,0.75   B C     -16.7 25.8 
19.6,0.5   B C     -16.7 25.8 
19.6,0   B C     -16.8 25.8 
 -40,0.25     C     -18.0 35.4 
 -40,0.5       D   -22.4 30.6 
 -40,0       D   -23.8 31.8 
 -40,0.75       D   -23.9 30.3 
 -40,1       D   -24.6 30.5 
40,0.5         E -32.0 36.4 
40,0.75         E -32.2 36.4 
40,0.25         E -32.3 36.4 
40,1         E -32.4 36.4 
40,0         E -32.4 36.3 
 
There were significant interaction effects between activation differences of hand force and muscle 
type (p=0.0071; F ratio = 798.4. Whole model p<0.0001) as detailed in Table 36. 
Table 36 Interaction effects between activation levels (MFP-EMG) of hand force X muscle type. Hand forces include 
19.6 N and 40 N internal (negative values) and external (positive values) rotation exertions. Muscle type included 
internal rotator muscles (IR) and external rotator muscles (ER). 
Level             MFP-EMG SD 
 -19.6,ER A           -5.7 7.8 
19.6,IR   B         -10.7 25.4 
 -40,ER   B         -10.7 9.7 
 -19.6,IR     C       -19.6 28.5 
40,IR     C D     -21.5 39.3 
19.6,ER       D     -22.8 24.5 
 -40,IR         E   -34.3 38.2 
40,ER           F -43.1 27.5 
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There were significant interaction effects between activation differences of co-activation constraints 
and muscle type (p<0.0001; F ratio = 126.3. Whole model p<0.0001) as detailed in Table 37. 
Table 37 Interaction effects between activation differences (MFP-EMG) of co-activation constraints X muscle type. 
Muscle type included internal rotator muscles (IR) and external rotator muscles (ER). Co-activation was enforced 
(1) or not enforced (0). 
Level       MFP-EMG SD 
1,IR A     -17.1 36.3 
1,ER   B   -20.4 24.7 
0,ER   B   -20.8 22.1 
0,IR     C -25.9 30.9 
 
There were significant interaction effects between activation differences of hand force and co-
activation constraints and muscle type (p<0.0001; F ratio = 85.7. Whole model p<0.0001) as detailed 




Table 38 Interaction effects between activation differences (MFP-EMG) of hand force X co-activation constraints X 
muscle type. Muscle type included internal rotator muscles (IR) and external rotator muscles (ER). Co-activation 
was enforced (1) or not enforced (0). Hand forces include 19.6 N and 40 N internal (negative values) and external 
(positive values) rotation exertions. 
Level                   MFP-EMG SD 
19.6,1,IR A                 -3.8 27.0 
 -19.6,1,ER A                 -4.4 7.9 
 -19.6,0,ER A B               -7.0 7.4 
 -40,1,ER   B C             -8.6 10.7 
40,1,IR     C D           -11.0 43.1 
 -40,0,ER       D           -12.9 8.0 
19.6,0,IR         E         -17.6 21.5 
 -19.6,1,IR         E F       -19.6 28.7 
 -19.6,0,IR         E F       -19.7 28.3 
19.6,0,ER           F G     -21.9 24.1 
19.6,1,ER             G     -23.7 25.0 
40,0,IR               H   -32.0 31.7 
 -40,1,IR               H   -34.3 38.4 
 -40,0,IR               H   -34.4 38.0 
40,0,ER                 I -41.3 26.7 
40,1,ER                 I -44.8 28.1 
 
There were significant interaction effects between activation differences of hand force and muscle 
type and pectoralis capability constraints (p=0.0189; F ratio = 2.0. Whole model p<0.0001) as 




Table 39 Interaction effects between activation differences (MFP-EMG) of hand force X muscle type X pectoralis 
major capability constraints. Muscle type: internal (IR) and external rotators (ER). Hand forces: 19.6 N and 40 N 
IR [-] and ER [+] exertions. Pectoralis major capability constraints: 0 (disabled) – 1.0 (fully capable) condition. 
Level               MFP-EMG SD 
 -19.6,0.5,ER A             -5.5 7.8 
 -19.6,1,ER A             -5.5 7.8 
 -19.6,0.75,ER A             -5.5 7.8 
 -19.6,0.25,ER A             -5.6 7.8 
 -19.6,0,ER A             -6.3 7.9 
 -40,1,ER A B           -10.4 9.9 
 -40,0.75,ER A B           -10.4 9.9 
 -40,0.5,ER A B           -10.4 9.8 
 -40,0.25,ER A B           -10.4 9.8 
19.6,0.25,IR A B           -10.5 25.4 
19.6,0.5,IR A B           -10.6 25.3 
19.6,1,IR A B           -10.7 25.4 
19.6,0.75,IR A B           -10.7 25.4 
19.6,0,IR A B           -10.8 25.4 
 -40,0,ER A B           -11.8 8.9 
 -19.6,0.25,IR   B C         -15.2 30.6 
 -19.6,0.5,IR     C D       -19.5 27.9 
 -19.6,0,IR     C D E     -20.8 28.6 
 -19.6,0.75,IR       D E     -21.0 27.5 
40,0.5,IR       D E     -21.2 39.2 
40,0.25,IR       D E     -21.4 39.3 
40,0.75,IR       D E     -21.5 39.4 
40,1,IR       D E     -21.6 39.3 
40,0,IR       D E     -21.6 39.2 
 -19.6,1,IR       D E     -21.7 27.5 
19.6,1,ER       D E     -22.7 7.8 
19.6,0.75,ER       D E     -22.7 24.6 
19.6,0,ER       D E     -22.8 24.5 
19.6,0.5,ER       D E     -22.8 24.6 
19.6,0.25,ER       D E     -22.9 24.6 
 -40,0.25,IR         E     -25.6 44.8 
 -40,0.5,IR           F   -34.4 36.2 
 -40,0,IR           F   -35.8 38.2 
 -40,0.75,IR           F G -37.3 34.9 
 -40,1,IR           F G -38.7 34.7 
40,0.5,ER             G -42.8 27.6 
40,0.75,ER             G -42.8 27.6 
40,0.25,ER             G -43.2 27.4 
40,0,ER             G -43.2 27.5 






The effect size of interaction effects variables was in the following descending order: 
Hand force X muscle type > CI X muscle type > hand force X CI X muscle type > hand force X CI > 
pectoralis capability X muscle type > hand force X pectoralis capability > hand force X pectoralis 
capability X muscle type. 
Section 7.4.5 General descriptive findings 
Mean correlation coefficients and associated standard deviations for ER and IR type muscles, by co-
activation constraints and pectoralis major capability constraints are depicted in Figure 50. A typical 
scatterplot matrix of EMG and muscle force predictions for external and internal rotators by co-
activation constraints and pectoralis major capabilities is shown for one subject in Figure 51. 
 
Figure 50 Mean (SD) Correlation Coefficients for all Subjects by muscle type (ERs = A, B; IRs = C, D), CI 





Figure 51 Typical scatterplot matrix of EMG (%MVC) [Y axis] and muscle force prediction (% maximal force) [X 
axis] of internal and external rotator muscles, by co-activation constraint and pectoralis major capability is shown 
for one subject. 
 
Section 7.5 Discussion 
The purposes of this study were to modify an optimization-based muscle force prediction model in 
terms of survivor pectoralis major capability, co-activation and population anthropometrics to 
determine how muscle strategy was affected by specific muscle dysfunction (how closely model 
muscle force predictions were associated to empirically measured survivor EMG); and to determine 
if inclusion of survivor IR and ER exertion type co-activation constraints improved the physiological 
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realism of the muscle force predictions (are model predictions more closely associated with EMG 
when co-activation constraints were enforced). In general, the model underestimated actual muscle 
activity but was able to predict external rotator muscle activity more closely than for internal 
rotators. Predictions were influenced by muscle type, co-activation constraints, hand force and 
pectoralis major capability. The model predictions were closer to empirical measures of muscle 
activation when the co-activation constraint was enforced. 
Section 7.5.1 Addressing the hypotheses 
Revisiting Hypothesis 1: It was hypothesized that model predictions would be more closely 
associated (higher correlation and lower activation difference) with EMG during states of reduced 
pectoralis major capability, and lowest (lower correlation and greater activation difference) during 
total disability or total capability constraints. This hypothesis was partly confirmed. Confirming the 
hypothesis, correlation coefficients were higher during 0.25, 0.50 and 0.75 pectoralis major 
capability constraints, compared to totally disabled or totally capable conditions. Partly confirming 
the hypothesis, activation differences (MFP – EMG) were significantly smaller only during 0.25 
pectoralis major capability constraints, compared to all other conditions; and activation differences 
were greatest during fully disabled and fully capable conditions, however there was no significant 
difference between 0, 0.5, 0.75 or 1.0 pectoralis capability conditions. 
Revisiting Hypothesis 2: It was hypothesized that the inclusion of the co-activation constraint would 
improve the association between model predictions and EMG. This hypothesis was partly 
confirmed. The differences in activation between predicted muscle force and measured muscle 
activation were significantly smaller (indicating closer predictions) when co-activation was enforced. 
However, in terms of correlation coefficients, the linear association between EMG and muscle force 
predictions worsened when co-activation was enforced. 
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Section 7.5.2 Comparison of model predictions with empirical measures 
The modeled muscle force predictions were more closely linearly associated to empirically recorded 
muscle activation levels for external rotator muscles, compared to internal rotators (r = 0.567 
[±0.264] vs. 0.347 [±0.254], respectively; p < 0.0001).  Similarly, despite small magnitude of 
differences, the activation differences were significantly less for external rotator muscles compared 
to internal rotators (LSM differences = -20.3% [±23.4] vs. -21.7% [±34.0], respectively). The results 
of the current study suggest that the ER muscle strategies used by survivors are more predictable 
(more consistent), compared to the strategies employed by IR muscles. Contrarily, in a healthy 
population ER muscle strategies were found to be more variable compared to IR muscles (Brookham 
& Dickerson, 2014). It was demonstrated in Studies 2 and 3 of this thesis that compared to a healthy 
population, co-activation relationships of survivors during external rotation exertions are 42% more 
predictable (r
2 
= 0.77). The healthy population was thought to exhibit more variable activation 
strategies during ER exertions in attempt to preserve glenohumeral stability. The glenohumeral joint 
is more susceptible to dislocation during humeral elevation and ER. Muscle stabilization roles 
change with posture (Lee, Kim, O`Driscoll, Morrey, & An, 2000; McKernan, et al., 1990), and 
external rotation exertions often involve extreme or end ranges of motion, during which passive 
ligaments contribute to stability, affecting the selection and magnitude of required muscle control. It 
appears there is a reduction in external rotator muscle strategies used (or available for use) in the 
survivor population, which could be explained by dysfunctional changes and limits to these muscles. 
Study 1 of this thesis demonstrated that survivors exhibit dysfunctional changes (including weakness, 
increased required muscle effort and increased ratings of discomfort) in posterior chest muscles, 
including the posterior rotator cuff (external rotators), posterior deltoid and upper trapezius during 
dynamic, functional tasks. These changes may limit the number of strategies available to ERs for the 
purposes of maintaining joint stability. Consistent ER muscle strategy between survivors would 
allow the model to reflect EMG more closely. Reduced prediction accuracy of IR muscles may be 
due to variability in survivor IR muscle health and may also reflect the exertion and posture under 
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investigation. Heterogeneity of survivors (as described in Studies 1 and 3 of this thesis) was 
evidenced by various type and timing of treatment and interventions. Past works have demonstrated 
pain and movement deviations are greater in survivors who had undergone mastectomy surgeries, 
compared to those who had received wide local excision (Shamley, Lascurain-Aguirrebena, 
Oskrochi, & Srinaganathan, 2012). Variability of IR muscle strategy was demonstrated in Studies 1 
and 3 of this thesis during which survivors demonstrated reduced activation of the pectoralis major 
sternal muscle during dynamic ROM, ADL and work tasks; but increased activity of the clavicular 
and sternal portions during static IR and ER exertions (the majority of static exertions performed 
with the arm at the side – similar to the modeled exertion posture of the current study). Dysfunction 
of the pectoralis major muscles may be more evident during postures which require larger moment 
arms. Therefore, in the modeled posture, dysfunction may be less obvious and survivors may have 
more strategies available for use causing an increase in variability of activation and a reduction in 
prediction accuracy. Palmerud et al. (1995) demonstrated that in a healthy population, different 
subjects may use different muscle strategies, and could voluntarily redistribute muscle activity at the 
shoulder. Posture, task type and inconsistent IR muscle health could cause increased variability in IR 
muscle strategies used and available for use by survivors, and would explain reduced prediction 
accuracy and increased activation differences between modeled muscle forces and EMG. 
 The model predictions were most closely associated with EMG during reduced (but not 
disabled) pectoralis major capability. Activation differences also confirmed that modeled predictions 
were closest to EMG measurements during a state of reduced pectoralis major capability (25% 
capability). This confirms the hypothesis, and suggests survivors did have some degree of pectoralis 
major dysfunction, but were not totally disabled. It is not surprising that predictions would be worse 
at fully disabled and fully capable conditions, due to the subject pool and displayed abilities. Every 
subject had some type of intervention or treatment that was likely to compromise pectoralis major 
function to some degree, but each participant demonstrated some ability in terms of strength, muscle 
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activation and kinematics to negate suggestions of total disability. Radiation is thought to cause 
vascular changes that result in muscle ischemia (Soulen, Romero, Chuba, Evelhouch, Simpson, & 
Forman, 1997; Wedgewood & Benson, 1992), which when accompanied with connective tissue 
constraints may affect the efficacy of muscle contraction (Blomlie, Rofstad, Tvera, & Lien, 1996; 
Gutman, Kersz, Barzilai, Haddad, & Reiss, 1990). MRI scans have shown pectoralis major and 
minor to be smaller on the affected side, suggesting induced muscle morbidity (Shamley, et al., 
2007). There was no difference between correlation coefficients within 25-75% pectoralis major 
capability conditions, and no difference in activation between modeled and predicted values within 
0% and 50% - 100% pectoralis major capability conditions (despite fully disabled and fully capable 
conditions demonstrating the greatest non-significant differences). These results suggest that in 
general the survivors under study best reflected a population with only 25% pectoralis capability; and 
that the muscle strategies used by survivors with dysfunction did not differ between most reduced 
capability levels. The prediction ability of the model during pectoralis major capability constraints is 
encouraging, as it demonstrates that specific muscle dysfunction can be modeled and that predictions 
sufficiently (r = 0.465 – 0.483; underestimated actual values by 19.0% - 21.9%) represent 
empirically measured activation levels. This shows promise for continued investigations, which 
should incorporate a larger sample size and data set, that would allow for individual muscle (rather 
than grouped) comparisons between tasks types. This method could also be expanded to investigate 
other disabilities or injuries: MRI studies have demonstrated muscle morbidity in cervical cancer 
(Blomlie, Rofstad, Tvera, & Lien, 1996) and prostate cancer (Soulen, Romero, Chuba, Evelhouch, 
Simpson, & Forman, 1997). 
 In support of the hypothesis, predictions were closer to actual values when co-activation 
constraints were enforced. The model predictions underestimated actual values by 18.4% [±31.9] 
when co-activation was enforced, but this difference was significantly greater when co-activation 
was not enforced (-23.5% [±27.6]). It was hypothesized that the inclusion of a survivor co-activation 
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constraint would improve the physiological realism of the model, and resultantly improve model 
predictions. A previous study demonstrated inclusion of elbow flexion/extension co-activation 
constraints into an optimization-based muscle force prediction model of the elbow improved model 
predictions of a healthy population, bringing them closer to empirically measured activation levels 
(Brookham, Middlebrook, Grewal, & Dickerson, 2011). Enforcing co-activation enhanced the 
physiological realism of the model (Study 3 demonstrated that this co-activation does exist), and the 
smaller magnitude of activation differences demonstrated that inclusion of this information does 
improve model predictions, bringing them closer to actual values. Contrary to hypothesis, linear 
association between predicted and actual values was weaker when co-activation was enforced (0.333 
[±0.214] vs. r = 0.580 [±0.286], respectively; p < 0.0001). The decrease in correlation when co-
activation was enforced emphasizes the nonlinearity of muscle demand. The relationship between the 
myoelectric signal and force is not a truly linear relationship, as has been shown by Lawrence & De 
Luca (1983). The predictions could perhaps be further improved (in terms of further reducing 
prediction underestimations, and strengthening correlations between actual and predicted values) by 
refining the co-activation constraint. The misestimated predictions during enforcement of the 
constraint may be explained by a limit in the generalizability of the defined co-activation. The 
survivor co-activation defined in Study 3 was built off of 18 static exertions of IR or ER at various 
intensity levels ranging from 10 – 60% individual MVF, during which the majority (67%) of 
exertions were performed with the arm at the side (for only 2% and 1% of tests was the humerus 
elevated to 45° and 90°, respectively). Despite good explained variance within the tasks upon which 
it was built, this co-activation constraint was then applied to this model and its use was generalized 
to absolute values of intensity (19.6 and 40 N of IR and ER), upon which its extrapolative ability was 
untested. It’s obvious that the co-activation constraints did extrapolate reasonably well (as evident by 
the reduction in activation differences) to these new intensities (which would have varied drastically 
between survivors, depending on individual strength), but it’s possible that further refinement of the 
co-activation constraint could have been useful in allowing it to more adequately represent survivor 
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co-activation for the exertions being modeled. Future works should continue refining definitions of 
survivor co-activation by expanding sample size, postures and intensities, and assessing ability of the 
defined relationships to extrapolate to novel tasks sets (as was similarly performed in a healthy 
population described in Study 2 of this thesis). 
 In terms of correlation coefficients, prediction ability was most strongly influenced by the 
main effects of co-activation (F = 342.4) and muscle type (F = 272.4), but it was also influenced by 
interaction effects between muscle type and pectoralis major capability (p<0.0001; F ratio = 12.93); 
and between co-activation and pectoralis major capability constraints (p<0.0021; F ratio = 4.24). The 
interaction effects outlined a similar message as the main effects: correlation coefficients were 
greater for ER muscles during all capability levels, compared to IR muscles during all capability 
levels. The lowest correlation occurred for internal rotator muscles defined to be totally disabled. 
Morbidity of the pectoralis major can be caused by radiation or nerve damage. Complete severance 
of the pectoral nerve is possible during surgery, but the introduction of sentinel node biopsies has 
reduced the morbidity rates associated with dissection (Lauridsen, Overgaard, Overgaard, Hessov, & 
Cristiansen, 2008; Rietman, et al., 2003). Total disablement of the pectoralis major was unlikely, and 
lower associations were likely to occur when the pectoralis major was considered totally disabled as 
all subjects demonstrated some muscle activity in the pectoralis major during all conditions. Further, 
as discussed previously, pectoralis major dysfunction may be less evident in a posture lacking an 
extended moment arm, and as a result the survivors may have had more muscle strategies available 
to them. Increased variability of muscle strategies used between survivors would result in lower 
correlations with model predictions. The interaction between co-activation and pectoralis major 
capability constraints demonstrated lower correlation coefficients when co-activation was enforced 
(no difference between capability levels) compared to when there was no co-activation. Compared to 
other capability levels with no co-activation, there were significantly lower correlations when there 
was no co-activation and the pectoralis was disabled. This again demonstrated how the total 
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disability constraint influenced the magnitude of the correlation coefficients, as no participant ever 
exhibited 0% MVF of pectoralis major activity (as was displayed in Figure 51). 
 In terms of activation differences, prediction ability was influenced by several main and  
interaction effects, the strongest including hand force X muscle type (F = 798.4), hand force (F = 
358.4), co-activation (F = 164.1), co-activation X muscle type (F = 126.3) and hand force X co-
activation X muscle type (F = 85.7). Main effect results demonstrated how predicted values were 
closest to actual values during lower intensity exertions and during IR exertions. Despite predictions 
being closest for ER type muscles, it was interesting to note that predictions were closest during IR 
exertions, when ER muscles would not be primary movers. This antagonistic activation would 
largely be negated in models that did not include co-activation (Collins, 1995; Dickerson, Hughes, & 
Chaffin, 2008; Hughes & Chaffin, 1988; Zajac & Gordon, 1989). Interaction effects demonstrated 
that as predictions were closest in ER type muscles during low intensity IR exertions (underestimated 
actual values by only 5.7%); and worst at high intensity exertions (underestimated actual values by 
34.3% and 43.1% for IR and ER type muscles, respectively). These results suggest that dysfunction 
was more evident as muscle demand increased (as mentioned previously with regards to lengthened 
moment arm). The interaction between muscle type, hand force and co-activation again reiterated the 
improvement of predictions with the enforcement of co-activation (predictions underestimated actual 
values by only 3.8% - 4.4%. during low intensity exertions of IR and ER type muscles, respectively). 
 The misestimate of muscle forces is likely attributed to model assumptions, population and 
experimental factors. The SLAM models’ prediction ability was evaluated previously during static 
hold and dynamic reach tasks in a healthy population, and predictions correlated positively with 
EMG and demonstrated good correlations for prime movers (r = 0.53 - 0.63) (Dickerson, Hughes, & 
Chaffin, 2008). In the current study, all predictions correlated positively over all subjects with EMG, 
and the predicted force of the external rotator muscles was similarly sufficient (r = 0.567), although 
internal rotators had lower correlation coefficients (r = 0.347), and variations existed across co-
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activation and pectoralis major capability constraints. Although variations existed across main and 
interaction conditions, at best the model predictions underestimated actual values by only 3.8% - 
4.4% (when co-activation was enforced during low intensity exertions of IR and ER type muscles, 
respectively). The model assumes consistent subject characteristics including segment scaling and 
muscle attachment sites (based on bone length). Ignoring intersegment length variations and changes 
to muscle moment arms could magnify muscle force prediction accuracies. The upper force bounds 
limiting a muscle are based on PCSA values taken from a cadaveric data set (Hogfors, Sigholm, & 
Herberts, 1987) and since the morphological characteristics have been reported to change due to 
factors such as shrinkage (Friedrich & Brand, 1990), they may not be representative of the survivor 
population. Shamley et al. (2007) performed paired t-tests for total mean muscle area (cm
3
) 
determined from the MRI of 57 breast cancer patients and reported a significant decrease in size of 
the pectoralis major on the affected side (t = 2.177, p = 0.034). With future acquisition of accurate 
PCSA data for the BCP, the co-activation ratios should be weighted accordingly. Misestimates of 
true capabilities would impact the model predictions. Pain could inhibit force production in reality, 
but the objective function used in optimization procedures (minimized cubed muscle stresses) is not 
sensitive to that inhibition, and as a result, may provide higher estimates of force capabilities than 
were physiologically likely. Controlling for pain mathematically would be an extremely speculative 
process. Related to that, experimental and population factors can affect prediction accuracy. In 
particular, muscle force predictions and EMG comparisons rely on consistent normalization 
techniques. Although standardized testing protocols were used (and similar to those tested in a 
healthy population), true maximal exertions may not have been achieved. Survivors may have been 
involuntarily limited from, or may have voluntarily refrained from true maximal exertions due to 
pain, fear of pain or mechanical constraints (scar tissue formation limiting ROM, muscle dysfunction 
as evidenced in Studies 1 and 3). Improper normalization would have affected the correlation 
between recorded percent muscle activation and percent muscle force predictions. Further, there is 
limited confidence that the same proportion of maximum muscle activity results in identical muscle 
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forces for different individuals (Cram & Kasman, 1998). As discussed previously, the possible lack 
of generalizability of the co-activation constraint to the exertion modeled may have also contributed 
to misestimates. 
 This is the first known attempt to model potential specific muscle dysfunction of a breast 
cancer survivor population. EMG data was used to assess muscle force predictions generated by a 
mathematical model. Overall the model effectively estimated muscle activity in the ERs, and 
provided some insight into how IR and ER muscle strategy was affected by specific muscle 
dysfunction. The model’s ability to approximate EMG was greatest for the ER muscle group, and 
demonstrated some difficulty predicting muscle force for the IR muscle group. The model 
predictions were more closely associated with EMG during reduced (but not dysfunctional) 
pectoralis major capability conditions. Inclusion of survivor co-activation constraints improved 
predictions, emphasizing the importance of including co-activation in biomechanical muscle force 
prediction models. Future works should incorporate a larger, more homogenous sample upon which 
the co-activation relationship was built, and should incorporate more postures and intensities from 
which EMG can be compared from. Further refinement and testing of the generalizability of 
population specific definitions of co-activation is advised. Future works should continue 
investigating modelled dysfunction in this and other patient populations, as predicted outcomes will 
generate an understanding of muscle strategies used during disability, which can be useful in the 
development of treatment plans. 
Section 7.5.3 Study contributions to science and health 
This study has contributed to science by expanding the current biomechanical modeling procedures 
to a breast cancer survivor population, modelling predicted muscle strength during specific muscle 
dysfunction. Advancements of this work could include other patient populations, which could be 
useful in the return to work of injured populations by evaluating the capacity of workers and 
assessing this capacity in the context of workplace task demands. Additional study with the survivor 
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population will specifically contribute to the advancement of health of breast cancer survivors, by 
providing a conceptual understanding of what type and amount of muscle force decrements most 
affect functional outcomes. Definition of the problem is the first step towards designing effective and 




Chapter 8 Summary 
This chapter will address the global thesis objectives and revisit the associated hypotheses. Novel 
contributions of this work and their significance to science and health will be reviewed and future 
research directions will be suggested. 
Section 8.1 Addressing the global thesis objectives and hypotheses  
Study 1 Objectives: 
1. Describe the upper limb capabilities and dysfunction of breast cancer survivors in terms of  
3-D scapulothoracic and humerothoracic kinematics, muscle activation patterns, and muscle-
specific strength. 
2. Determine relationships between total muscle effort (a physical muscle activation quantity of 
(dys)function) with subjective measures of function (QoL and disability scores) during 
ROM, ADL and work task performance. 
Study 1 Hypotheses: 
1. Three-dimensional kinematics will reveal survivors have reduced humeral elevation angles 
and external rotation range of motion, but increased scapular protraction range of motion on 
their affected side compared to the contralateral limb. 
2. Breast cancer survivors will demonstrate reduced strength and increased muscle activity on 
the affected side when performing muscle-specific strength tests, ROM, ADL and work tasks 
compared to their unaffected side.  
3. As physical data indicates increased dysfunction (increased total muscle effort), there will be 
decreased QoL scores (FACT-B) and increased disability scores (QuickDASH). 
Study 1 Main Findings: 
 In general, survivors demonstrated kinematic and muscle activation changes on the affected 
side including:  
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 reduced humeral elevation angle: trends indicated reduced maximal elevation angle on the 
affected side during all tasks, although only significant less (-6.5°) during ROM-Rotate 
tasks. 
 reduced humeral external rotation: 8.9° less externally rotated during work tasks 
 increased humeral internal rotation: 7.9° – 13.1° more internally rotated during ROM-
Rotation, ADL and work tasks 
 reduced scapular protraction (although both sides were protracted): 3.4° - 3.9° less 
protraction during ADL and work tasks (according to maximum angles), respectively; and 
3.6° – 4.4° less protraction during ROM-Rotate and work tasks (according to minimum 
angles). 
 increased scapular posterior tilting: 4.1° more during work tasks 
 increased scapular upward rotation: trends indicated increased upward rotation during all 
tasks, although only significantly more (+2.8°) during ROM-Rotate tasks. 
 less downward rotation: 2.9°– 3.5° less during all tasks 
Some muscles on the affected side exhibited changes suggestive of dysfunction as evidenced by: 
 increased total muscle effort (summation of integrated EMG): affected side TME was 
significantly greater during work tasks 
 increased effort/activation levels: posterior deltoid was increased during all tasks, as was 
supraspinatus with the except of ROM-Rotate tasks (p = 0.052). Upper trapezius and serratus 
anterior also showed increases in activation that were depended upon task performance. 
 reduced activation: Pectoralis major sternal muscle was significantly reduced during all 
tasks; infraspinatus was reduced in all tasks excepting ADL tasks 
 weakness: infraspinatus, supraspinatus and upper trapezius demonstrated reduced force 
during functional testing 
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 increased discomfort scores: RPD scores were greater during infraspinatus and posterior 
deltoid maximal functional exertions on the affected side. 
Both primary and secondary muscles (outside of the field of surgery and radiation) were affected. 
Total muscle effort was only modestly related to disability and QoL scores. 
 
Study 2 Objectives: 
1. Quantify co-activation relationships of humeral internal and external rotators in young 
healthy adults using non-weighted and PCSA-weighted co-activation index ratios. 
2. Determine if the co-activation relationships defined from a subset of exertions can be 
extrapolated to other additional postures and intensities.  
Study 2 Hypotheses: 
1. It was hypothesized that the PCSA-weighted co-activation prediction models would better 
represent empirically measured co-activation compared to non-weighted co-activation 
prediction models. 
2. It was hypothesized that the co-activation relationship determined for a subset of postures 
would be appropriately extrapolated to a unique subset of exertions. 
Study 2 Main Findings: 
Co-activation was defined for a healthy population during a subset of static IR and ER 
exertions: 
 co-activation relationships were successfully defined for IR exertions (r2 = 0.70) 
 there was considerable unexplained variance in the co-activation relationships during ER 
exertions (r
2
 = 0.35) 
 humeral abduction and intensity were important factors in the prediction of co-activation 
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 there was no or minimal improvement in r2 using PCSA-weighted co-activation ratios (r2 = 
0.62 and 0.42 for IR and ER exertions, respectively) suggesting low utility  
 non-weighted co-activation relationship was successfully extrapolated to a novel set of IR 
exertions (r
2
 = 0.76 and 0.40 for IR and ER exertions, respectively). 
 
Study 3 Objectives: 
1. Quantify the co-activation relationships of humeral internal and external rotators in breast 
cancer survivors 
2. Compare survivor co-activation relationships with those of a healthy population  
Study 3 Hypothesis:  
It was hypothesized: 
 muscle-activation patterns of the BCP will reveal survivors have a reduced internal/external 
humeral rotation co-activation ratio compared to healthy individuals during IR exertions 
(reflecting a decrease in pectoralis major activation). 
Study 3 Main Findings:  
Co-activation was defined for the BCP during a subset of static IR and ER exertions: 
 co-activation relationships were successfully defined for IR exertions (r2 = 0.77) 
 co-activation relationships were successfully defined for ER exertions (r2 = 0.77) 
 Survivor co-activation relationships were very similar to healthy co-activation relationships, 
suggesting different muscle strategies were being employed to maintain glenohumeral 
stability.  
o humeral abduction and intensity continued to play important roles in co-activation 
o body mass affected the prediction of co-activation during ER exertions of the BCP 
 co-activation ratios demonstrated the BCP had higher levels of rotator muscle activation 
during their respective rotation-type exertion 
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 Survivors demonstrated significant increases in activation of the pectoralis major muscles 
(up to +8.7%), compared to the healthy population, suggesting dysfunction may be more 
evident in more extreme ranges of motion when the moment arm is lengthened. 
 
Study 4 Objectives: 
1. Determine how muscle strategy is affected by specific muscle dysfunction (using an inverse-
type simulation). Specifically, compare how closely SLAM muscle force predictions 
represent empirically measured survivor EMG during IR and ER exertions. 
2. Determine if inclusion of survivor IR and ER exertion type co-activation constraints improve 
the physiological realism of the muscle force predictions (more closely represent the 
empirically recorded EMG). 
Study 4 Hypotheses: 
1. SLAM muscle force predictions will be more closely associated with empirically measured 
EMG activation levels during states of reduced pectoralis major capability. Specifically, 
correlations between EMG and muscle force predictions will be highest when the pectoralis 
major capability is set to 0.25, 0.50 and 0.75; and correlations will be lowest when capability 
is set to 0.0 or 1.0.  
2.  Inclusion of the co-activation constraint would result in the muscle force predictions more 
closely representing the empirically recorded muscle activation.  
Study 4 Main Findings: 
 Specific muscle dysfunction of a breast cancer population was modeling using an 
optimization based muscle force prediction model, and predicted muscle forces were compared to 
experimentally measured muscle activation levels: 
 the model consistently underestimated actual muscle force 
 model predictions were influenced by muscle type, co-activation constraints, hand force and 
pectoralis major capability 
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 correlation analysis revealed the model was able to predict ER muscle group activity 
sufficiently (r = 0.567), while displaying lower prediction accuracy for IRs (r = 0.347) 
 the model predicted EMG better during reduced (but not disabled) pectoralis major 
capability conditions, demonstrating the BCP did have some level of pectoralis major 
dysfunction 
 model predictions more closely represented empirically measured EMG when BCP co-
activation was included as a model constraint (p<0.0001), reinforcing the importance of 
inclusion of co-activation in biomechanical models 
 model predictions were closer to actual measures during low intensity exertions (p<0.0001) 
 
Section 8.2 Research contributions and significance 
Previous to this body of work the physical capabilities and dysfunction of breast cancer survivors had 
not been rigorously documented, particularly for the upper extremity. This limits the effectiveness of 
treatments and strategies to improve BCP function and ability to return to work. The studies within 
this thesis provide further information about the capability and dysfunction of breast cancer 
survivors, which can be used to further the research, treatment and preventative strategies 
surrounding this population. 
Study 1 Contributions and significance: 
This investigation has produced the most comprehensive collection of 3D humerothoracic 
and scapulothoracic kinematics and electromyographic recordings for the BCP. Further, although 
strength and measures of quality of life and disability have been established before in this population, 
they have never been associated with the physical quantities (kinematics and EMG) as described in 
this current work. The results from this work have furthered the knowledge that is currently 
understood about survivor muscle activation, strength and kinematic patterns during a wide range of 
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tasks. Accurate documentation of physical capability and dysfunction is the first step towards 
developing targeted treatment and preventative strategies for this disabled population. 
Study 2 Contributions and significance: 
 This is the first known attempt to quantify healthy co-activation at the shoulder. Co-
activation was defined with confidence during internal rotation exertions, and was shown to 
extrapolate successfully to novel tasks. Accurate quantification of co-activation would be useful to 
researchers, aiding in the understanding of muscle functional changes with posture to meet stability 
demands, and would be useful to compare to patient populations in hopes of identifying dysfunction. 
Inclusion of co-activation into biomechanical models as constraints would improve physiological 
realism and may improve accuracy of muscle force predictions. 
Study 3 Contributions and significance: 
This is the first known attempt to quantify breast cancer survivor co-activation at the 
shoulder. Survivor co-activation was defined for both internal rotation and external rotation 
exertions, displaying high levels of explained variance, during a modest group of static tasks. The 
survivor co-activation relationships defined were incorporated into an optimization-based muscle 
force prediction model (Study 4). Further, these co-activation levels were compared with healthy co-
activation relationships to provide insight into specific muscle strategies employed by the patient 
population. This study demonstrated that pectoral major activation was higher than that of a healthy 
population in postures mostly involving modest pectoralis major moment arms. This was an 
important finding as pectoralis major sternal activation was found to be reduced in survivors 
performing ROM, ADL and work tasks (from Study 1), suggesting that pectoralis major dysfunction 
is more evident as its moment arm is extended. Continued advancement of this knowledge could 
allow knowledge translation to clinicians to improve diagnostic capabilities, providing a more 
thorough understanding of what dysfunction is occurring and which muscles are affected, and may 
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promote the generation of evidence-based therapeutic preventative and treatment interventions to 
treat these identified dysfunctions. 
Study 4 Contributions and significance: 
This is the first known attempt to model specific muscle dysfunction of a breast cancer 
survivor population. Overall the model effectively estimated muscle activity in the ERs, and 
provided some insight into how IR and ER muscle strategy was affected by specific muscle 
dysfunction. The model predictions were more closely associated with EMG during reduced (but not 
dysfunctional) pectoralis major capability conditions, suggesting the survivors did have some level of 
pectoralis major dysfunction. Model predictions were more close to measured activation levels when 
survivor co-activation constraints were enforced. Advancements of this work will specifically 
contribute to the health of breast cancer survivors, by providing a conceptual understanding of what 
type and amount of muscle force decrements most affect functional outcomes. Additional works 
could include other patient populations, which could be useful in the return to work of injured 
populations by evaluating the capacity of workers and assessing this capacity in the context of 





Overall Thesis Contributions: 
 This thesis accomplished three major goals: Study 1 defined capacity of the BCP, Studies 2 
and 3 compared capacity of the BCP with that of a healthy population, and Study 4 predicted 
capacity of the BCP. The main findings demonstrated that differences in ROM (altered kinematics), 
muscle activation (altered muscle strategies), and strength (reductions in force) were quantifiable on 
the affected cancer side in comparison with the contralateral limb. Despite modest absolute changes, 
the values were both statistically significant and clinically meaningful. Changes in kinematics 
aligned with synchronous changes in muscle activation, strength and ratings of perceived discomfort. 
Similar magnitudes of change have been reported in other injury populations, and have been linked 
to important biological alterations (Borstad & Szucs, 2012; Ebaugh, McClure, & Karduna, 2005; 
Ludewig & Cook, 2000; Lukasiewics, McClure, Michener, Pratt, & Sennett, 1999). Secondary 
changes were evident, showing that posterior shoulder muscles outside the primary field of surgery 
and radiation were affected, stressing the importance of their focus in rehabilitation in addition to 
that of the anterior chest wall muscles, and recommending consideration of the entire shoulder 
mechanism in treatment approaches. Co-activation of the BCP was very similar to that of the healthy 
population at the joint level, demonstrating the maintenance of joint stability, which was maintained 
through the adoption of alternative muscle strategies. Despite caution with generalization of the 
results, the BCP is encouraged to strengthen and enhance ROM for the posterior chest wall muscles, 
in addition to the regularly administered stretching, ROM and strengthening of muscles within the 
primary field of treatment and disturbance. This research has provided a breadth and depth of novel 
contributions to the field with respect to biomechanical quantification of capacity and disability of 
the BCP, and provides an important foundational base for many future biomechanical studies, which 
are essential to the development of effective preventative and treatment regimes. Improving the 
physical function of the BCP will have a positive impact on their level of independence, ability to 
work and support themselves, fulfill their required family responsibilities and in general improve 
their quality of life. This improvement will result in less reliance upon health and social assistance 
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programs, which will undoubtedly have profound economic and societal benefits in the nation and 
world-wide. 
 
Section 8.3 Future directions 
This study assessed BCP kinematics and muscle activity to an unprecedented extent during a wide 
variety of tasks, which made little data available for comparison. Some findings displayed 
considerable variability which was not surprising due to the variety of tasks performed and the 
diversity of the population under study. Future works should involve larger sample sizes which could 
allow for grouping of participants into treatment types. Future studies should also involve pre and 
post-surgical assessments to allow for baseline comparisons. Comparisons between healthy control 
groups, as well as within patients (unaffected vs. affected side comparisons) should continue as 
kinematic and muscle activation changes have been reported bilaterally in survivors. Exertions 
involving greater reach distances and lifting external loads should be of particular interest, as muscle 
dysfunction may be more evident in more muscularly demanding conditions. 
 Co-activation relationships in both healthy and survivor populations should continue to be 
examined in a wider range of tasks, intensities and demographic. The ability of these relationships to 
be extrapolated to novel tasks must be evaluated, as its successful integration into biomechanical 
modeling is dependent upon it. Future modeling attempts should investigate appropriate PCSA 
values for survivor populations, and should continue to enforce further-refined survivor co-activation 
constraints. 
 Furthering these research directions will undoubtedly enhance the knowledge and 
understanding of breast cancer capability and dysfunction, and will promote more targeted and 
effective treatment and preventative techniques that will enhance the ability, function and quality of 
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Appendix A: Standard operating procedures: intramuscular electromyography insertion into 
the rotator cuff muscles 
Participant Preparation for Intramuscular Electrodes: 
1.1   Prior to coming to the lab, each potential participant is asked at the time they volunteer if s/he 
has an allergy to latex or isopropyl alcohol. If s/he is allergic s/he is informed that s/he cannot 
participate in the study. 
1.2   Prior to coming into the lab, each potential participant will be asked to fill out a self-report 
health screening checklist to assess past health problems as well as present health problems. 
Participants who report blood clotting disorders, HIV, Hepatitis B or C will not be able to participate 
in the study. 
1.3   Participants are reminded to ask any questions whether they relate to the science or the 
procedure. 
1.4    Prior to coming to the lab, participants will be advised that they will be asked to wear a 
sleeveless shirt during experimental set-up and testing. Male subjects may choose to go shirtless if 
that is their preference. The participant will lay prone on a clinical bench and the skin area over the 
muscle will be thoroughly cleaned with isopropyl alcohol. 
1.5   Sterile single-use hypodermic needles of 3.5 inches or less and 27 gauge or smaller will be 
inserted through the skin into four muscles of the shoulder. This will feel similar to the prick of a 
needle that would be received at the doctor’s office. The needle contains two very thin wires (44 
gauge) of similar size to a strand of hair. The wires are bent at the end, so that once the needle is 
removed from the skin, the thin wires will remain in the muscle during testing. The wires extend by 
approximately 7 cm beyond the surface of the skin. It is unlikely that the participant will feel the 
presence of these wires within their muscle. After testing, these wires will be removed easily with a 
gentle tug. This removal will be painless because each wire is so pliable that the barb straightens out 
on traction and offers little, if any, palpable resistance (Basmajian, 1985). This wire will record the 
electrical activity of the muscle as the participant performs various movements. Four needles are 
inserted (one into each of four muscles), each needle containing two wires, so a total of eight fine 
wires will remain in the muscle during the testing (approximately 2 hours). Once the desired muscle 
contractions are completed, the fine wire will be removed from the muscle by pulling on the end of 
the wire that is lying outside the skin, the area will be cleaned with isopropyl alcohol, and a bandage 
will be placed over the area if required due to bleeding. The hypodermic needles will not be reused. 
After removal, hypodermic needles will be disposed of into a sharps container labelled biohazard 
waste. 
1.6   The total depth into tissue will vary from participant to participant depending on the amount of 
subcutaneous fat present overlying the muscle. It is expected that the needles will be inserted 
approximately 1 cm into the supraspinatus, infraspinatus and teres minor. The needle for the 
subscapularis will be inserted approximately 3 cm deep. 
1.7   The intramuscular electrode insertions will be carried out by Mrs. Rebecca Brookham, MSc, 
PhD Candidate. Mrs. Brookham is very familiar with the shoulder anatomy: she has 2 years of work 
experience working as a student Kinesiologist treating shoulder injuries and disorders, and has 
completed 4 years of academic research in shoulder biomechanics. Prior to intramuscular electrode 
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training on live participants, Mrs. Brookham observed Dr. Linda McLean from Queen’s University 
insert approximately 50 intramuscular electrodes into the rotator cuff muscles during Mrs. 
Brookham’s MSc thesis data collection (ORE 14008), and as well, Mrs. Brookham practiced 
inserting intramuscular electrodes into cadavers in the University of Waterloo anatomy lab. Mrs. 
Brookham then received training to insert intramuscular electrodes into the rotator cuff muscles on 
live male and female participants from Dr. McLean at Queen’s University. Dr. McLean is an 
Associate Professor at Queen’s University in the department of Rehabilitation Therapy and is an 
expert at inserting intramuscular electrodes. Dr. McLean has over eight years of experience and has 
performed numerous intramuscular insertions into the rotator cuff muscles, as well as into many 
other muscles. Dr. McLean has not once experienced any form of complication during or as a result 
of her needle insertions. Mrs. Brookham has inserted approximately 30 intramuscular insertions and 
is proficient at this skill. 
1.8 Researcher Preparation   The researcher will wear latex gloves at all times during insertion 
procedures. Used gloves will be discarded in the garbage and new latex gloves will be used for each 
participant. 
1.9 Skin Preparation   All skin in the area surrounding the insertion sites will be cleansed with 
isopropyl alcohol. Sufficient time (approximately 30 s to 2 min depending on room temperature, 
humidity and participant skin temperature) will be given for the isopropyl alcohol to dry (confirmed 
visually) before needles are inserted. Allowing the isopropyl alcohol to dry will allow for 
sterilization to occur and will prevent isopropyl alcohol to be leaked into the insertion site which 
could cause potential tissue irritation. 
1.10 Biohazard Material Disposal   Once the needles are removed from the skin, they will not be 
recapped. Used needles will be put directly into a biohazard material sharps container. 
1.11 Fine Wire Removal   Fine wires will be removed with a quick tug out of the skin in the 
direction opposite to that in which the needle was inserted. These wires will be thrown in the garbage 
since any small amounts of blood that may be present on these wires will dry quickly and since the 
wires are flexible and not sharp, there is no risk of anyone being punctured by them. Disposal of 
these wires in the garbage would be similar to throwing out a bloodied adhesive bandage. 
1.12 General Insertion Techniques   The participant should relax the muscle of interest (muscle in 
which the needle will be inserted), as flexing the muscle could result in potential discomfort during 
insertion. The skin in the area over the insertion site will be pulled taut so that the needle can easily 
and quickly puncture the skin. Once the needle has punctured the skin, the needle should progress 
slowly to the final destination within the muscle. Several pauses can be taken at increments of a few 
millimetres at a time before the needle is progressed further. Slow and paused insertion procedures 
will decrease discomfort to the participant (Daube & Rubin, 2009). 
The needle should avoid contact with bone (scapula). If the wire were to hit the bone, this could 
cause discomfort to the participant (periosteum pain) and the wires could become lodged in the bone 
and would not record any signal from the muscle of interest. If the needle were to contact to the 
bone, the needle and wires will be removed, and a new needle will be inserted.  Visual and auditory 
electromyography cues will guide insertions. 
If participant experiences any burning, tingling or pain (indicating the needle has hit a nerve) the 
needle will be immediately removed, and can be re-inserted into a slightly different area. 
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1.13 Auditory and Visual Guidance during Insertions   During needle insertion, the researcher 
will feel different levels of resistance as the needle passes through the skin, subcutaneous fat, fascia 
connective tissues and muscle. Before insertion, the electromyographic recordings will appear and 
sound very noisy (large random spikes and sound like static).  If equipment permits auditory 
recording, insertional activity will be heard (“swish”) and seen as a burst of activation as the needle 
is first inserted into the muscle: this activity is the electrical response of the muscle to the mechanical 
damage produced by the movement of the needle (Daube & Rubin, 2009). After the needle has first 
punctured the muscle and is progressing into it, a contraction of that muscle will result in contraction 
activity that will be heard (“swish”) and seen (distinct motor units which appear as large obvious 
spikes, as seen in Figure 1 and 2). Using the visual-auditory electromyographic guidance during 
insertion, the depth and location of the needle can be adjusted to proper positioning, and reduce the 
likelihood of improper placements, and re-insertions. Proper insertion can then be further verified by: 
i) Contraction of the muscle of interest: Expect large amplitude of electromyographic 
activity. 
ii) Contraction of surrounding nearby muscle (where the needle could mistakenly be 
inserted): expect very limited activation. 
 





Figure 2: Visual Guidance during Intramuscular Insertion: The appearance of motor units 
1.14 Specific Insertion Placements   The insertion placement procedures for supraspinatus, 
infraspinatus and teres minor are taken from guidelines outlined in Anatomic localization for needle 
electromyography, 2
nd
 Ed., Steve R Geiringer (1999). The insertion placement procedures for 





 (similar to Geiringer, 1999)
 
Participant Position: Prone with arm relaxed at side. 
Localization: Landmark spine of scapulae, and lay finger along spine. Insert needle 2 fingerbreadths 
superior to spine, at medial one-third of scapular spine (approximately 2 cm from edge of medial 
border). Insert needle parallel to skin in direction towards the finger which overlays the spine. Direct 
needle towards suprascapular fossa to ensure bone is beneath insertion (this will avoid risk of 
pneumothorax). Needle will pass through middle trapezius before inserting in supraspinatus. 
Test: Have participant abduct against resistance with arm at side. Expect audio-visual EMG 
confirmation.  
Figures 3 and 4 demonstrate landmarking techniques for supraspinatus intramuscular electrode 
insertion. 
 









 (similar to Geiringer, 1999)
 
Participant Position: Prone with arm relaxed at side. 
Localization: Landmark scapular spine, medial and lateral borders and find centre of infraspinatus 
fossa (halfway between scapular spine and inferior angle, midway between lateral and medial 
borders). Insert needle into centre of infraspinatus fossa. Needle will pass through middle trapezius 
before reaching infraspinatus. 
Test: Confirm with scapular retraction the needle is not in middle trapezius (expect little EMG 
activation). Confirm with external rotation (while arm is at side), that needle is in infraspinatus 
(expect large EMG activation).  









Figure 6 Landmarking technique for infraspinatus insertion 
 
 






 (similar to Geiringer, 1999)
 
Participant Position: Prone with arm relaxed at side. 
Localization: Landmark midpoint between acromion and inferior angle on lateral border of 
scapulae. Trace ribcage and ensure that at this midpoint, the ribcage is not underneath the scapulae – 
this will ensure the needle is not inserted through the ribcage. Palpate the lateral border and insert the 
needle immediately lateral to the border at this midpoint (should be at similar height on the scapulae 
as the infraspinatus insertion). 
Test: Expect large EMG activation when participant externally rotates arm at side. 
Figure 8 – 10 demonstrate landmarking techniques and insertion for teres minor intramuscular 
electrode insertion. 
 
Figure 8 Landmarking the midpoint between the inferior angle and acromion for the teres 





Figure 9 Direction of needle for teres minor insertion 
 
 






Subscapularis Axilla Insertion – preferred technique 
(similar to Nemeth et al., 1990)
: 
Patient Position: Sitting, with arm abducted 90°, elbow flexed 90° and humerus internally rotated. 
Have an assistant hold the participants’ arm and protract the scapula. 
Localization: Palpate the inferior angle and lateral border of scapulae. Find midpoint between 
acromion and inferior angle of scapulae. Researcher will support the scapulae with the palm of their 
hand, and will indent the skin anterior to scapulae (grabbing the lateral border) at this midpoint. 
Insert the needle posteriorly into the direction of the subscapular fossa. Since this insertion site is 
slightly below the axilla, there is minimal risk of complications including pneumothorax, brachial 
plexus or arterial injury (Nemeth et al., 1990). Ensuring the needle is pointing posteriorly and 
directed towards the subscapular fossa and in a direction away from the rib cage will ensure there is 
no risk of pneumothorax. 
Test: Expect large EMG activation in internal rotation. 
Figures 11 and 12 demonstrate landmarking techniques used for insertion of the subscapularis 
intramuscular electrode through the axilla. 
 
Figure 11 Landmarking techniques of the subscapularis intramuscular electrode through the 





Figure 12 Landmarking techniques of the subscapularis intramuscular electrode through the 
axilla 
 
Subscapularis Medial Border Insertion – used if participant has limited range of scapular 
protraction 
(similar to Kadaba et al., 1992)
 
Participant Position: Sitting, with the hand behind the back (approximately level of L5), causing 
the scapula to wing.  
Localization: Landmark inferior angle and move superiorly up the medial border approximately 3 
finger breadths. Insert the needle horizontally in the direction towards the anterior portion of the 
scapula (subscapular fossa). The needle will pass through the middle trapezius, rhomboids and 
possibly the serratus anterior (Decker 2003) before entering the subscapularis. Steer the needle in a 
direction opposite to (away from) the ribcage. If the needle is not pointing enough towards the 
subscapular fossa, the needle will continue laterally in the scapular retractors, and not enter the 
subscapularis. 
Test: Expect large EMG activation with internal rotation. Should see very limited activation during 
scapular retraction.  
Figures 13 and 14 demonstrate landmarking techniques used for insertion of the subscapularis 





Figure 13 Landmarking techniques of the subscapularis intramuscular electrode through the 
medial border of the scapula on a skeletal model 
  
Figure 14 Landmarking techniques of the subscapularis intramuscular electrode through the 
medial border of the scapula 
-------------------------------------------------------------------------------------------------------------------------- 
1.15 Protocol Immediately following insertions   Firm pressure will be applied to reduce any risk 
of bleeding and/or bruising. The ends of the fine wires will be looped and taped down to the skin 
before the participant moves from insertion positioning. 
References: 
Daube, J.R. & Rubin, D.I. (2009). Needle Electromyography. Muscle and Nerve, 39, 244-270. 
Geiringer, S.R. (1999). Anatomic Localization for Needle Electromyography. 2nd Ed. Philadelphia, Hanley & Belfus, Inc. 
Kadaba, M.P., Cole, A., Wootten, M.E., McCann, P., Reid, M., Mulford, G., April, E. & Bigliani, L. (1992). Intramuscular wire 
electromyography of the subscapularis. Journal of Orthopaedic Research, 10, 394-397. 
Nemeth, G., Krongberg, M. & Brostrom, L. (1990). Electromyogram (EMG) Recordings from the Subscapularis Muscle: Description of a 
Technique. Journal of Orthopaedic Research, 8, 151-153. 
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Upper Arm Length:________  
Lower Arm Length:________ 
Affected (cancer) side (right or left): _______ 
Dominant Hand (right or left): _______ 
Grip strength (right hand): _______ 
Grip strength (left hand): _______ 
 
Treatment Information: 
1) Approximate date of breast cancer diagnosis: 
________________________________________  
 
2) Did you have surgery?                                                                                                               
YES  /  NO 
 
a. If yes, what type of surgery? Check all that apply: 
i. Radical Mastectomy________ 
ii. Lumpectomy________ 
iii. Axial Node Dissection 
1. Sentinel Node Dissection________ 
2. Full Node Dissection________ 
3. Number of nodes removed________ 
 
b. Approximate date of most recent surgery: 
____________________________________ 
 
3) What type of adjuvant therapy did you receive? Please check all that apply: 
a. Hormone Replacement Therapy________ 
i. Ongoing?        YES  /  NO 
ii. Date completed:________ 
b. Chemotherapy________ 
c. Radiation Treatment________ 
d. Other (please 
specify):____________________________________________________ 
Daily Living Information 
1) Are you currently working?                                                                                                           
YES  /  NO 
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a. Full- time of Part- 
time?__________________________________________________ 
 
2) Do you exercise regularly?    YES  /  NO 
a. How many days per 
week?________________________________________________ 
 
3) Do you have any difficulty in completing daily tasks?                                                               
YES  /  NO 




4) Do you often feel tightness in the chest or shoulder of your affected arm?                        
YES  /  NO 
a. If yes: 
i. Does this occur at a certain time of day or after a certain activity (i.e., 
morning, night, after exercise)? 
_____________________________________________________________
__ 




iii. Do you experience the following in the chest/shoulder/arm of affected side? 
1. Pain________ 
2. Swelling________ 




7. Other? Please describe. 
5) Have you had any shoulder or arm injuries un-related to your cancer treatments? (example: 























Electrode Placement: Between sternoclavicular joint and the caracoidus process, 2 cm 
below the clavicle (on an angle down and laterally). 
Test Contraction: While sitting, flex elbow and shoulder to 90º, horizontally adduct & 
flex shoulder. Resist (from above) proximal to elbow joint in a downward and outward 
direction. 
 Pectoralis Major 
(sternal) 
Electrode Placement: 6 cm above the nipple. 
Test Contraction: Subject lies supine. Shoulder is horizontally abducted to 30º with 
elbow flexed to 90º. Resist horizontal adduction of shoulder. 
Latissimus Dorsi Electrode Placement: 6 cm below the inferior angle of the scapula. 
Test Contraction: Sit with shoulder abducted to 90º and elbow flexed to 90º. Adduct 
shoulder against resistance. 
Posterior Deltoid Electrode Placement: 2 cm below lateral border of scapular spine, oblique angle 
toward arm (parallel to muscle fibers). 
Test Contraction: Subject is prone with head turned to right side. Resist shoulder 
extension when shoulder is abducted to 90º, elbow flexed to 90º and thumb points up 
to ceiling. 
Upper Trapezius Electrode Placement: 2/3 on the line between the trigonum spinae and the 8
th
 thoracic 
vertebrae, 4 cm from muscle edge, at approximately a 55° oblique angle. 
Test Contraction: Subject is prone with head turned to right side. Resist shoulder 
abduction at 90º with elbow extended, thumb down to floor. 




 rib, anterior to 
latissimus dorsi and placed vertically.* 
Test Contraction: Forward punch (resisted) at 90° shoulder abduction and 105° 
horizontal abduction.* 
Infraspinatus Electrode Placement: Parallel to spine of scapulae, approximately 4 cm below, over 
the infrascapular fossa. 
Test Contraction: Subject is lying on left side. Arm is at side with elbow bent to 90°. 
External rotation of the arm is resisted. 
Supraspinatus Electrode Placement: Midpoint and 2 finger-breadths superior to scapular spine* 
Test Contraction: Subject is lying of left side. Shoulder is abducted to 5° with elbow 
extended (thumb forward). Abduction is resisted. 
Similar to Daniels & Worthingham (1986); Cram & Kasman (1998) 
 *similar to Hintermeister et al. (1998) 





Appendix F: Mean total muscle effort and integrated EMG for BCP in Study 1  





mean SD mean SD mean SD mean SD mean SD mean SD mean SD mean SD mean SD
1 3.2E+06 2.E+06 2.3E+05 2.E+05 2.7E+05 2.E+05 2.3E+05 1.E+05 4.2E+05 3.E+05 6.4E+05 3.E+05 4.4E+05 3.E+05 5.3E+05 4.E+05 4.5E+05 7.E+05
1 3.2E+06 2.E+06 2.1E+05 1.E+05 2.3E+05 2.E+05 2.7E+05 2.E+05 4.1E+05 4.E+05 6.8E+05 5.E+05 4.4E+05 2.E+05 5.4E+05 3.E+05 3.4E+05 3.E+05
2 3.0E+06 2.E+06 1.8E+05 1.E+05 2.8E+05 2.E+05 5.1E+05 2.E+05 7.5E+05 1.E+06 3.4E+05 3.E+05 2.4E+05 2.E+05 4.3E+05 3.E+05 3.6E+05 4.E+05
2 3.0E+06 2.E+06 1.6E+05 1.E+05 2.4E+05 2.E+05 6.2E+05 5.E+05 6.3E+05 6.E+05 3.6E+05 4.E+05 2.7E+05 2.E+05 5.5E+05 3.E+05 3.3E+05 3.E+05
3 3.1E+06 2.E+06 1.9E+05 1.E+05 2.6E+05 2.E+05 2.7E+05 2.E+05 3.9E+05 3.E+05 5.4E+05 3.E+05 4.5E+05 2.E+05 5.8E+05 5.E+05 4.7E+05 7.E+05
3 3.4E+06 2.E+06 1.9E+05 1.E+05 2.3E+05 2.E+05 3.4E+05 2.E+05 4.1E+05 4.E+05 6.5E+05 6.E+05 5.3E+05 3.E+05 6.7E+05 4.E+05 3.9E+05 3.E+05
4 2.2E+06 1.E+06 1.1E+05 7.E+04 2.2E+05 2.E+05 1.5E+05 8.E+04 3.3E+05 3.E+05 3.0E+05 2.E+05 2.1E+05 2.E+05 4.1E+05 4.E+05 4.8E+05 3.E+05
4 2.4E+06 1.E+06 1.1E+05 9.E+04 1.9E+05 2.E+05 1.8E+05 1.E+05 3.4E+05 3.E+05 3.5E+05 3.E+05 2.7E+05 2.E+05 4.5E+05 3.E+05 4.6E+05 3.E+05
5 2.1E+06 1.E+06 1.3E+05 8.E+04 2.4E+05 2.E+05 2.5E+05 1.E+05 2.7E+05 2.E+05 2.7E+05 2.E+05 2.4E+05 2.E+05 4.1E+05 3.E+05 2.8E+05 3.E+05
5 2.2E+06 1.E+06 1.3E+05 9.E+04 2.1E+05 2.E+05 3.1E+05 3.E+05 2.6E+05 2.E+05 3.1E+05 3.E+05 2.8E+05 2.E+05 4.8E+05 3.E+05 2.7E+05 3.E+05
6 3.2E+06 1.E+06 2.3E+05 2.E+05 2.8E+05 2.E+05 2.4E+05 1.E+05 4.0E+05 3.E+05 6.2E+05 3.E+05 4.8E+05 2.E+05 5.8E+05 4.E+05 4.8E+05 7.E+05
6 3.3E+06 1.E+06 2.2E+05 1.E+05 2.4E+05 2.E+05 3.0E+05 2.E+05 4.1E+05 3.E+05 7.0E+05 6.E+05 5.3E+05 3.E+05 6.4E+05 4.E+05 3.9E+05 3.E+05
7 9.3E+05 7.E+05 5.9E+04 5.E+04 2.0E+05 2.E+05 4.1E+04 4.E+04 2.5E+05 2.E+05 1.6E+05 1.E+05 6.1E+04 7.E+04 7.3E+04 8.E+04 1.1E+05 2.E+05
7 9.7E+05 8.E+05 7.6E+04 1.E+05 1.7E+05 2.E+05 5.0E+04 6.E+04 2.5E+05 2.E+05 1.7E+05 2.E+05 7.8E+04 1.E+05 9.7E+04 1.E+05 8.5E+04 9.E+04
8 2.0E+06 1.E+06 2.2E+05 2.E+05 3.1E+05 2.E+05 7.5E+04 6.E+04 3.7E+05 3.E+05 4.6E+05 3.E+05 1.8E+05 2.E+05 1.9E+05 2.E+05 2.1E+05 2.E+05
8 2.1E+06 1.E+06 2.3E+05 2.E+05 2.7E+05 2.E+05 1.0E+05 1.E+05 3.6E+05 3.E+05 4.9E+05 4.E+05 1.9E+05 1.E+05 2.1E+05 2.E+05 2.0E+05 1.E+05
9 2.6E+06 2.E+06 1.4E+05 9.E+04 2.4E+05 2.E+05 1.3E+05 1.E+05 7.2E+05 7.E+05 2.9E+05 2.E+05 4.1E+05 3.E+05 4.4E+05 2.E+05 3.0E+05 4.E+05
9 2.8E+06 2.E+06 1.5E+05 1.E+05 2.1E+05 2.E+05 1.7E+05 2.E+05 6.9E+05 6.E+05 3.1E+05 2.E+05 5.0E+05 5.E+05 5.4E+05 4.E+05 2.6E+05 3.E+05
10 4.1E+06 1.E+06 5.3E+05 3.E+05 3.8E+05 2.E+05 2.3E+05 1.E+05 4.1E+05 3.E+05 6.3E+05 3.E+05 5.4E+05 3.E+05 6.4E+05 4.E+05 7.2E+05 8.E+05
10 4.1E+06 1.E+06 5.3E+05 3.E+05 3.4E+05 2.E+05 2.8E+05 1.E+05 4.5E+05 4.E+05 7.2E+05 4.E+05 5.6E+05 2.E+05 6.9E+05 3.E+05 5.3E+05 3.E+05
11 3.2E+06 1.E+06 3.3E+05 2.E+05 3.1E+05 2.E+05 1.3E+05 9.E+04 4.2E+05 3.E+05 5.3E+05 3.E+05 4.5E+05 3.E+05 5.0E+05 5.E+05 5.5E+05 5.E+05
11 3.2E+06 2.E+06 3.3E+05 2.E+05 2.7E+05 2.E+05 1.7E+05 1.E+05 4.2E+05 3.E+05 5.9E+05 4.E+05 4.7E+05 3.E+05 5.0E+05 4.E+05 4.6E+05 3.E+05
12 3.2E+06 1.E+06 6.2E+05 3.E+05 6.2E+05 4.E+05 9.3E+04 7.E+04 3.8E+05 3.E+05 5.7E+05 3.E+05 4.3E+05 3.E+05 3.2E+05 3.E+05 2.6E+05 3.E+05
12 3.4E+06 2.E+06 6.5E+05 3.E+05 5.6E+05 4.E+05 1.1E+05 8.E+04 3.8E+05 3.E+05 6.3E+05 5.E+05 4.5E+05 3.E+05 3.7E+05 3.E+05 2.5E+05 2.E+05
13 2.9E+06 2.E+06 2.6E+05 2.E+05 3.6E+05 3.E+05 3.6E+05 2.E+05 7.5E+05 8.E+05 3.6E+05 3.E+05 2.1E+05 2.E+05 3.3E+05 3.E+05 3.8E+05 3.E+05
13 3.2E+06 2.E+06 2.4E+05 1.E+05 3.3E+05 3.E+05 4.1E+05 3.E+05 8.0E+05 8.E+05 3.7E+05 3.E+05 2.5E+05 2.E+05 3.8E+05 2.E+05 4.2E+05 3.E+05
14 2.1E+06 1.E+06 3.6E+05 2.E+05 3.6E+05 2.E+05 6.7E+04 5.E+04 3.1E+05 3.E+05 3.4E+05 2.E+05 2.5E+05 2.E+05 2.3E+05 2.E+05 1.8E+05 2.E+05
14 2.1E+06 1.E+06 3.8E+05 2.E+05 3.1E+05 2.E+05 9.0E+04 9.E+04 3.0E+05 2.E+05 3.8E+05 3.E+05 2.6E+05 2.E+05 2.3E+05 2.E+05 1.9E+05 1.E+05
15 1.8E+06 1.E+06 1.9E+05 1.E+05 2.2E+05 2.E+05 6.4E+04 4.E+04 2.8E+05 2.E+05 2.6E+05 2.E+05 2.5E+05 2.E+05 2.7E+05 2.E+05 2.4E+05 2.E+05
15 1.9E+06 1.E+06 2.1E+05 1.E+05 1.8E+05 1.E+05 8.8E+04 9.E+04 2.8E+05 2.E+05 3.2E+05 3.E+05 2.8E+05 2.E+05 3.1E+05 3.E+05 2.1E+05 2.E+05
16 2.1E+06 1.E+06 1.6E+05 1.E+05 2.7E+05 2.E+05 2.6E+05 1.E+05 4.8E+05 5.E+05 2.5E+05 2.E+05 1.9E+05 1.E+05 2.9E+05 2.E+05 2.7E+05 2.E+05
16 2.3E+06 1.E+06 1.6E+05 9.E+04 2.4E+05 2.E+05 3.4E+05 3.E+05 4.6E+05 4.E+05 2.7E+05 2.E+05 2.2E+05 2.E+05 3.5E+05 2.E+05 2.9E+05 3.E+05
17 2.5E+06 2.E+06 2.1E+05 1.E+05 3.2E+05 3.E+05 3.3E+05 2.E+05 5.4E+05 6.E+05 2.9E+05 2.E+05 2.2E+05 2.E+05 3.2E+05 3.E+05 3.1E+05 3.E+05
17 2.7E+06 2.E+06 1.9E+05 1.E+05 2.9E+05 2.E+05 4.0E+05 4.E+05 5.1E+05 5.E+05 3.0E+05 2.E+05 2.6E+05 2.E+05 3.8E+05 3.E+05 3.4E+05 3.E+05
18 2.7E+06 1.E+06 2.3E+05 2.E+05 2.5E+05 2.E+05 1.8E+05 2.E+05 3.3E+05 3.E+05 5.5E+05 4.E+05 4.0E+05 2.E+05 4.4E+05 3.E+05 3.8E+05 5.E+05
18 2.9E+06 2.E+06 2.4E+05 2.E+05 2.2E+05 2.E+05 2.0E+05 1.E+05 3.7E+05 3.E+05 6.1E+05 6.E+05 4.4E+05 3.E+05 5.5E+05 4.E+05 3.0E+05 2.E+05
19 3.5E+06 2.E+06 3.9E+05 3.E+05 3.1E+05 2.E+05 1.9E+05 1.E+05 3.9E+05 3.E+05 6.6E+05 4.E+05 4.9E+05 3.E+05 5.7E+05 4.E+05 5.7E+05 7.E+05
19 3.8E+06 2.E+06 3.8E+05 2.E+05 2.6E+05 2.E+05 2.4E+05 2.E+05 4.2E+05 3.E+05 8.0E+05 8.E+05 5.7E+05 3.E+05 6.7E+05 4.E+05 4.9E+05 3.E+05
20 2.4E+06 1.E+06 2.2E+05 2.E+05 2.5E+05 2.E+05 1.3E+05 9.E+04 3.0E+05 3.E+05 4.5E+05 3.E+05 3.3E+05 2.E+05 3.9E+05 3.E+05 3.4E+05 5.E+05
20 2.5E+06 1.E+06 2.4E+05 2.E+05 2.2E+05 2.E+05 1.6E+05 1.E+05 3.4E+05 2.E+05 5.3E+05 6.E+05 3.6E+05 2.E+05 4.3E+05 3.E+05 2.7E+05 2.E+05
21 3.3E+06 2.E+06 4.0E+05 3.E+05 3.0E+05 2.E+05 1.6E+05 1.E+05 3.6E+05 3.E+05 6.1E+05 4.E+05 4.4E+05 2.E+05 5.1E+05 3.E+05 5.3E+05 7.E+05
21 3.3E+06 2.E+06 3.9E+05 2.E+05 2.5E+05 2.E+05 2.0E+05 2.E+05 4.0E+05 3.E+05 7.3E+05 9.E+05 4.9E+05 3.E+05 5.6E+05 4.E+05 4.4E+05 3.E+05
22 2.3E+06 1.E+06 1.2E+05 8.E+04 2.3E+05 2.E+05 2.3E+05 1.E+05 3.0E+05 3.E+05 2.8E+05 2.E+05 3.7E+05 2.E+05 4.9E+05 4.E+05 3.6E+05 6.E+05
22 2.6E+06 1.E+06 1.5E+05 1.E+05 1.9E+05 2.E+05 2.9E+05 2.E+05 3.0E+05 2.E+05 3.5E+05 4.E+05 4.2E+05 2.E+05 5.7E+05 3.E+05 2.8E+05 3.E+05
23 3.3E+06 2.E+06 2.9E+05 2.E+05 2.7E+05 2.E+05 2.8E+05 1.E+05 3.6E+05 3.E+05 4.2E+05 3.E+05 5.3E+05 3.E+05 6.5E+05 5.E+05 5.7E+05 7.E+05
23 3.5E+06 2.E+06 3.0E+05 2.E+05 2.4E+05 2.E+05 3.2E+05 2.E+05 3.8E+05 3.E+05 5.1E+05 4.E+05 5.7E+05 3.E+05 7.5E+05 4.E+05 4.5E+05 3.E+05
24 2.3E+06 1.E+06 3.1E+05 2.E+05 2.9E+05 2.E+05 9.9E+04 5.E+04 4.7E+05 4.E+05 3.6E+05 2.E+05 2.3E+05 2.E+05 2.7E+05 2.E+05 3.1E+05 3.E+05
24 2.4E+06 1.E+06 3.0E+05 2.E+05 2.4E+05 2.E+05 1.3E+05 1.E+05 4.6E+05 4.E+05 4.0E+05 3.E+05 2.7E+05 2.E+05 3.2E+05 2.E+05 3.2E+05 2.E+05
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Appendix H: Scapulothoracic and humerothoracic angles for all tests in Study 1 
Table 41 Mean scapulothoracic (ST) beta angles for all subjects for each test. Angles (°) shown include ROM angles 
(max – min), maximum and minimum achieved angles. Upward rotation is described as a positive value, and 
downward rotation is denoted as a negative value. Unaffected and affected [shaded cells] sides are shown. 
 
ST Beta ROM 
Angle (max-
min) 



















Test Mean SD± Mean SD± Mean SD± Mean SD± Mean SD± Mean SD± 
1 58.0 16.5 48.6 22.3 -9.4 15.0 55.8 14.7 48.2 18.7 -7.6 10.9 
2 10.3 5.8 -1.3 12.2 -11.6 11.4 9.4 4.7 1.9 16.7 -7.5 16.2 
3 57.0 19.0 48.9 22.6 -8.1 13.9 56.3 15.2 50.4 17.9 -6.0 11.9 
4 12.1 6.8 8.9 12.5 -3.2 11.7 11.4 5.8 10.9 14.9 -0.5 14.0 
5 6.1 3.5 1.4 12.6 -4.8 12.1 6.1 3.4 3.5 17.2 -2.6 16.6 
6 56.6 18.4 48.7 21.6 -7.9 14.3 54.8 15.3 48.8 18.9 -6.0 12.5 
7 1.6 2.6 -4.1 11.0 -5.6 11.2 1.5 2.9 -0.9 13.6 -2.4 13.8 
8 17.2 7.3 11.2 13.8 -6.0 12.6 16.8 6.8 15.2 14.5 -1.5 13.4 
9 13.7 5.2 8.1 11.8 -5.6 12.2 13.1 7.2 10.3 16.0 -2.8 14.6 
10 5.7 2.8 0.7 10.9 -5.0 10.8 5.3 2.4 3.2 13.8 -2.1 14.0 
11 41.1 14.7 36.9 18.1 -4.1 13.7 39.3 13.2 36.3 17.6 -3.1 13.2 
12 31.2 9.8 26.2 15.9 -4.9 13.3 31.3 14.0 29.1 13.6 -2.3 15.0 
13 15.9 6.8 -0.5 13.9 -16.4 13.8 15.4 4.9 2.9 16.2 -12.5 15.8 
14 17.7 6.6 14.4 13.9 -3.2 11.7 17.7 7.6 16.2 13.6 -1.5 14.4 
15 15.8 8.7 10.8 14.8 -5.0 13.4 14.6 8.6 11.5 16.4 -3.2 15.3 
16 12.0 4.6 -0.3 10.1 -12.4 10.5 12.1 3.6 2.1 15.9 -10.1 15.6 
17 15.3 6.3 0.6 11.7 -14.7 11.9 14.0 4.6 2.6 17.4 -11.4 16.9 
18 38.8 11.3 33.5 18.4 -5.3 14.5 39.4 12.1 35.7 14.7 -3.8 14.8 
19 36.7 12.9 31.3 18.1 -5.4 13.8 37.4 13.0 33.9 14.7 -3.5 14.7 
20 33.8 10.2 29.2 14.2 -4.6 10.0 33.4 9.7 30.2 14.9 -3.2 13.3 
21 33.1 12.7 28.0 14.1 -5.1 10.8 31.5 10.5 28.2 16.1 -3.3 14.7 
22 30.9 10.7 24.7 16.8 -6.1 13.4 27.6 7.7 24.9 15.6 -2.8 15.1 
23 24.5 10.0 19.9 15.8 -4.6 13.5 23.2 8.1 21.5 14.4 -1.7 14.1 





Table 42 Mean scapulothoracic (ST) alpha angles for all subjects during each test. Angles (°) shown include ROM 
angles (max – min), maximum and minimum achieved angles. Anterior tilt is described as a positive value, and 
posterior tilt is denoted as a negative value. Unaffected and affected [shaded cells] sides are shown. 
 ST Alpha ROM 
Angle (max - 
min) 








ST Alpha ROM 
Angle (max - 
min) 








Test Mean SD± Mean SD± Mean SD± Mean SD± Mean SD± Mean SD± 
1 30.8 27.1 22.0 20.3 -8.8 23.1 27.6 26.5 19.7 28.1 -7.9 27.3 
2 15.8 11.0 22.9 22.2 7.2 21.3 17.4 19.0 23.3 24.3 5.9 22.8 
3 28.9 31.8 22.6 21.2 -6.3 25.7 23.9 25.7 19.5 27.8 -4.4 28.8 
4 5.4 2.9 11.8 19.8 6.3 19.7 6.1 5.8 10.5 21.2 4.4 22.9 
5 6.3 4.7 13.6 21.2 7.3 20.5 7.5 8.7 13.4 20.6 5.9 22.0 
6 28.4 27.8 21.9 20.4 -6.5 24.9 23.6 25.1 18.4 29.2 -5.3 28.1 
7 1.4 3.0 9.1 19.7 7.7 19.5 1.2 2.1 8.3 20.9 7.1 21.5 
8 11.3 8.0 15.4 21.4 4.1 20.6 9.2 5.8 13.3 21.6 4.1 21.4 
9 12.8 5.5 18.7 19.0 5.9 20.5 17.1 27.5 18.9 23.2 1.8 28.2 
10 3.7 1.5 8.6 17.5 4.9 17.4 3.6 2.8 8.1 21.0 4.6 21.2 
11 17.6 13.7 17.4 16.4 -0.2 17.0 19.0 17.7 16.8 22.3 -2.2 24.9 
12 18.4 11.0 22.3 19.5 3.9 18.9 20.8 18.2 20.3 23.5 -0.5 24.9 
13 16.1 8.7 21.7 22.0 5.6 22.2 17.3 12.7 22.7 24.6 5.3 21.1 
14 10.4 6.3 15.2 19.5 4.8 17.2 11.2 7.3 13.1 20.5 1.9 21.3 
15 7.7 7.7 12.2 17.9 4.5 19.6 8.4 11.3 11.4 20.6 3.1 23.0 
16 16.1 10.0 21.2 20.0 5.1 21.2 16.9 12.1 23.0 24.2 6.1 20.6 
17 15.3 5.6 21.3 22.1 6.0 20.6 18.8 18.9 24.8 26.6 6.0 21.2 
18 14.6 11.4 17.2 17.6 2.6 16.8 19.5 22.3 16.5 21.9 -2.9 29.5 
19 14.0 12.2 16.4 17.8 2.4 16.6 18.7 22.2 15.3 21.1 -3.4 28.3 
20 13.5 10.4 16.4 17.8 2.8 16.3 14.9 15.0 13.7 21.0 -1.2 25.8 
21 15.5 13.8 17.6 18.3 2.1 15.1 16.1 15.0 14.7 21.0 -1.5 24.2 
22 14.2 14.8 18.3 18.8 4.1 17.3 14.3 14.8 15.9 20.8 1.6 25.7 
23 11.0 7.4 14.5 17.2 3.6 16.8 12.6 12.4 13.1 21.3 0.5 24.3 






Table 43 Mean scapulothoracic (ST) gamma angles for all subjects during each test. Angles (°) shown include ROM 
angles (max – min), maximum and minimum achieved angles. Retraction is described as a positive value, and 
























Test Mean SD± Mean SD± Mean SD± Mean SD± Mean SD± Mean SD± 
1 31.4 30.7 -16.9 33.1 -48.4 19.8 23.1 22.1 -19.3 33.0 -42.4 26.2 
2 14.4 6.6 -22.7 13.8 -37.1 14.0 17.3 28.8 -19.3 26.0 -36.6 20.9 
3 26.2 25.5 -17.5 29.3 -43.8 21.2 21.0 19.4 -17.7 31.4 -38.8 27.0 
4 9.2 4.7 -26.6 16.9 -35.8 16.0 8.9 6.4 -22.5 27.1 -31.4 22.9 
5 6.1 6.2 -31.1 15.6 -37.2 13.9 6.0 8.3 -27.0 24.6 -33.0 19.3 
6 24.8 20.9 -20.7 28.0 -45.5 20.3 20.9 19.0 -20.0 31.1 -40.9 27.9 
7 1.8 3.3 -35.2 15.9 -37.0 15.9 1.4 2.4 -33.7 19.2 -35.1 19.2 
8 19.2 6.9 -32.7 20.1 -51.9 19.8 17.1 7.0 -32.7 22.9 -49.9 21.5 
9 26.4 9.7 -12.8 16.1 -39.2 14.7 25.0 9.6 -9.9 23.1 -34.9 19.8 
10 3.9 2.2 -37.8 13.9 -41.7 13.7 3.9 3.0 -34.7 20.9 -38.6 19.8 
11 19.9 12.1 -27.7 22.0 -47.6 16.7 20.7 14.9 -24.3 29.6 -45.0 22.5 
12 27.4 10.7 -33.0 20.8 -60.4 23.2 29.6 24.6 -30.3 29.6 -60.0 25.0 
13 12.1 16.4 -28.8 16.7 -40.9 17.3 11.7 12.7 -28.1 19.4 -39.8 15.6 
14 15.5 5.5 -36.9 16.6 -52.4 17.7 16.2 7.3 -33.3 21.1 -49.4 21.7 
15 6.2 5.5 -35.2 16.3 -41.4 17.2 7.4 10.0 -29.9 25.3 -37.3 20.8 
16 11.0 7.0 -30.9 13.1 -41.9 12.2 12.2 12.1 -27.6 20.2 -39.8 16.7 
17 9.6 4.3 -31.3 15.6 -40.8 15.1 12.8 19.5 -27.1 22.3 -39.9 17.4 
18 16.9 8.5 -33.5 19.8 -50.4 18.2 17.6 13.1 -27.5 31.7 -45.1 23.2 
19 16.2 11.1 -34.4 20.9 -50.6 17.6 15.1 13.1 -30.8 28.7 -45.9 21.4 
20 16.8 7.6 -33.9 17.4 -50.7 16.7 15.1 10.0 -31.7 26.1 -46.8 21.2 
21 21.1 27.2 -32.3 24.3 -53.4 17.1 16.2 17.3 -30.0 28.1 -46.1 21.6 
22 19.2 13.2 -21.3 20.6 -40.5 12.9 19.0 16.6 -18.2 32.4 -37.2 20.7 
23 20.0 10.6 -22.2 17.6 -42.2 13.5 19.4 12.6 -19.9 28.5 -39.3 19.4 




Table 44 Mean humerothoracic (HT) beta angles for all subjects during each test. Angles (°) shown include ROM 
angles (max – min), maximum and minimum achieved angles. Elevation is described as a positive value. Unaffected 
and affected [shaded cells] sides are shown. 
 
HT Beta ROM 
Angle (max - 
min) 
HT Beta Max 
Angle 
(Elevation [+]) 
HT Beta Min 
(Elevation [+]) 
HT Beta ROM 
Angle (max - 
min) 
HT Beta Max 
Angle 
(Elevation [+]) 
HT Beta Min 
(Elevation [+]) 
Test Mean SD± Mean SD± Mean SD± Mean SD± Mean SD± Mean SD± 
1 79.7 23.2 115.1 25.3 35.4 14.3 83.9 28.2 114.5 24.7 30.6 15.5 
2 27.0 15.1 62.5 13.3 35.5 13.8 28.9 17.1 59.1 17.3 30.2 14.7 
3 76.0 23.1 110.5 25.5 34.4 17.1 78.5 24.5 107.0 24.8 28.5 17.0 
4 11.3 11.5 55.7 10.7 44.4 11.9 6.9 5.0 48.0 14.0 41.1 14.1 
5 13.6 10.8 62.0 11.6 48.4 11.4 10.5 7.1 53.1 14.4 42.7 13.1 
6 76.4 23.5 111.8 24.4 35.4 15.3 77.2 23.4 107.1 28.7 29.9 18.2 
7 1.7 4.0 43.8 13.2 42.2 12.2 1.1 2.1 39.1 13.4 38.0 13.5 
8 24.3 18.6 63.6 17.4 39.4 13.0 19.6 13.9 57.1 15.9 37.5 13.2 
9 11.6 7.2 50.6 11.8 39.0 11.8 9.6 7.1 43.9 11.5 34.3 14.2 
10 10.8 7.9 52.4 11.2 41.6 11.0 9.7 6.7 50.9 15.4 41.2 15.7 
11 55.9 18.9 92.7 18.8 36.8 16.8 60.3 22.5 95.8 24.6 35.5 17.9 
12 56.8 25.0 93.4 19.4 36.6 17.2 62.8 31.3 95.4 28.5 32.6 16.3 
13 22.0 11.4 63.0 11.9 41.0 10.7 18.9 10.8 57.1 11.7 38.2 14.1 
14 34.5 18.4 73.0 22.7 38.4 15.6 45.6 31.1 77.4 29.6 31.7 17.1 
15 24.7 14.2 62.0 14.8 37.2 16.6 28.0 18.6 62.7 23.2 34.6 17.2 
16 21.6 12.3 62.5 12.9 40.9 10.3 18.7 10.4 56.1 11.6 37.4 14.2 
17 23.8 13.6 65.3 13.1 41.5 9.7 18.5 11.2 56.5 12.1 38.0 15.0 
18 66.2 16.9 100.2 19.0 34.0 16.2 74.5 25.2 108.0 24.6 33.4 20.8 
19 62.0 19.3 96.5 18.7 34.4 18.8 65.9 24.8 101.0 27.6 35.2 19.1 
20 65.5 18.4 99.7 19.0 34.2 16.2 73.4 21.6 104.5 24.7 31.1 18.6 
21 60.4 19.3 96.2 22.4 35.8 19.5 61.2 23.4 95.8 26.3 34.6 21.3 
22 35.6 15.0 70.7 20.5 35.1 13.4 36.9 18.7 69.8 23.2 32.9 18.7 
23 31.4 16.3 66.1 18.0 34.8 13.7 36.5 16.3 68.9 20.8 32.5 16.1 




Table 45 Mean humerothoracic (HT) gamma angles for all subjects during each test. Angles (°) shown include ROM 
angles (max – min), maximum and minimum achieved angles. Plane of elevation is described as 0° at abduction and 
























Test Mean SD± Mean SD± Mean SD± Mean SD± Mean SD± Mean SD± 
1 46.4 32.0 -13.7 32.3 -60.1 25.9 35.0 22.2 -19.1 31.4 -54.1 23.6 
2 35.2 21.8 50.2 22.5 15.0 34.3 36.1 27.8 52.9 26.3 16.8 38.2 
3 37.2 27.6 -8.2 18.8 -45.3 19.3 30.3 23.0 -8.2 23.7 -38.5 21.1 
4 15.5 13.2 -9.4 20.1 -24.9 20.2 11.8 10.6 -13.3 20.0 -25.1 20.5 
5 17.8 17.5 -7.6 27.2 -25.4 23.7 14.1 11.9 -8.4 20.7 -22.5 20.7 
6 37.4 23.7 -12.1 20.3 -49.4 18.8 27.5 19.3 -16.9 18.8 -44.4 18.2 
7 2.6 3.8 -28.9 18.2 -31.5 18.6 2.7 6.4 -33.1 20.8 -35.8 22.1 
8 31.1 25.1 -25.3 19.0 -56.4 31.0 20.9 17.4 -30.1 19.8 -51.0 19.1 
9 35.7 25.1 -2.1 29.8 -37.8 19.6 33.7 33.1 -5.8 32.1 -39.5 20.2 
10 11.6 9.4 -28.1 17.1 -39.6 18.4 9.4 6.2 -34.0 18.6 -43.4 18.3 
11 36.0 29.1 -24.1 19.7 -60.0 30.3 29.4 22.8 -29.4 20.9 -58.8 25.4 
12 52.9 37.6 -32.0 32.9 -84.9 33.8 39.3 30.0 -39.6 30.1 -78.9 30.0 
13 41.1 29.1 41.2 23.1 0.1 32.0 43.0 37.6 35.7 22.6 -7.3 35.3 
14 43.0 31.3 -27.6 20.2 -70.6 30.6 34.0 28.0 -32.6 23.2 -66.6 23.7 
15 16.8 12.0 -28.2 17.1 -45.0 19.4 14.6 10.7 -31.9 21.9 -46.5 22.3 
16 41.9 28.1 38.9 24.4 -3.0 34.8 40.9 28.3 32.9 20.9 -8.0 34.6 
17 40.7 28.7 37.0 22.9 -3.7 35.5 38.9 29.7 31.5 20.8 -7.3 35.1 
18 31.7 20.7 -29.3 31.8 -61.0 27.0 31.2 26.9 -30.4 26.5 -61.6 23.6 
19 32.7 23.7 -30.4 28.4 -63.1 26.4 28.7 27.5 -32.4 29.2 -61.1 24.4 
20 35.0 20.9 -29.8 27.2 -64.8 25.8 29.9 24.4 -30.6 28.2 -60.5 21.6 
21 33.0 20.9 -30.8 29.0 -63.8 26.6 26.2 18.7 -34.9 25.6 -61.1 22.4 
22 28.6 19.5 -9.2 18.5 -37.8 20.4 30.6 24.8 -10.2 21.1 -40.9 23.6 
23 32.5 19.5 -10.0 19.0 -42.4 20.7 33.0 24.7 -11.8 20.9 -44.8 22.6 




Table 46 Mean humerothoracic (HT) gamma2 angles for all subjects during each test. Angles (°) shown include 
ROM angles (max – min), maximum and minimum achieved angles. External rotation is described as positive values 




















Test Mean SD± Mean SD± Mean SD± Mean SD± Mean SD± Mean SD± 
1 40.2 31.3 -2.6 35.5 -42.8 25.5 35.8 30.9 -7.7 39.8 -43.5 24.7 
2 34.4 28.7 -13.3 36.5 -47.7 36.3 37.7 26.8 -5.2 42.8 -42.9 39.4 
3 38.0 31.5 3.9 42.3 -34.1 29.3 37.6 36.2 -5.1 44.3 -42.7 24.5 
4 22.1 16.7 24.9 28.2 2.8 26.5 26.0 22.1 24.7 30.1 -1.3 33.6 
5 38.6 28.5 -1.9 25.3 -40.5 29.4 42.2 29.2 -6.7 30.2 -48.9 33.0 
6 39.9 34.2 3.5 38.6 -36.4 25.9 37.0 37.7 -3.2 44.0 -40.2 25.5 
7 3.8 7.1 1.8 30.2 -2.0 30.4 6.6 15.0 -5.7 35.1 -12.4 37.0 
8 41.1 26.7 3.8 32.0 -37.3 35.6 57.8 38.3 4.7 35.6 -53.1 49.4 
9 38.3 30.3 17.3 30.4 -21.0 29.3 52.4 29.5 24.5 34.6 -27.9 37.3 
10 17.0 12.4 2.5 30.8 -14.6 30.7 16.7 12.6 0.7 34.4 -16.0 30.7 
11 47.1 44.4 -3.2 40.0 -50.2 35.4 46.0 45.7 -3.2 45.7 -49.2 25.2 
12 68.0 52.7 -5.0 40.6 -73.0 39.3 62.3 48.2 -4.7 43.9 -67.0 25.2 
13 80.2 58.5 9.0 31.7 -71.2 46.3 96.0 56.8 4.8 39.3 -91.2 40.9 
14 55.8 36.3 -14.6 30.5 -70.3 34.3 52.2 44.2 -16.6 38.3 -68.8 36.8 
15 25.6 21.4 2.0 36.8 -23.6 26.9 29.1 28.2 -10.0 40.7 -39.1 28.8 
16 74.7 53.5 6.1 33.0 -68.6 41.8 91.7 56.5 9.3 42.7 -82.4 36.3 
17 77.8 54.1 6.0 32.5 -71.8 41.3 95.9 55.3 7.7 39.4 -88.3 37.9 
18 37.2 31.0 0.7 40.7 -36.5 31.1 43.4 40.6 -4.5 46.8 -47.8 24.3 
19 40.8 32.3 3.5 40.9 -37.4 26.6 41.2 36.3 -4.8 46.1 -46.0 22.6 
20 40.4 33.5 3.2 41.7 -37.3 28.9 42.2 36.8 -4.5 46.6 -46.7 22.4 
21 37.3 32.7 0.4 39.9 -36.9 27.2 37.3 36.6 -11.5 44.4 -48.8 22.2 
22 26.3 22.7 3.3 38.8 -23.0 31.6 28.9 29.2 -1.8 38.8 -30.7 27.2 
23 26.9 25.2 6.7 41.6 -20.2 31.0 32.9 33.3 1.3 43.3 -31.6 29.9 
24 93.0 41.3 44.0 42.5 -49.0 48.4 108.4 61.8 29.2 54.9 -79.2 52.9 
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Appendix I: Mean activation and standard deviation of healthy participants in Study 2 
Table 47 Mean activation (%MVC) of healthy participants during Study 2 exertions, including wire and surface supraspinatus 




Table 48 Standard Deviation of Mean EMG of Healthy Participants during Study 2 Exertions, including wire and 
surface supraspinatus (SupraW/S) and infraspinatus (infraW/S), surface pectoralis major sternal/clavicular, 




Appendix J: Mean muscle activation of BCP during Study 3  
Table 49 Mean muscle activation and standard deviation of breast cancer population during Study 3 exertions. 
Test 
Pec Maj Clav Pec Maj Stern Post Delt Lat Dorsi Supra Surface Infra Surface Supra Wire Infra Wire Subscap Wire 
  
mean SD mean SD mean SD mean SD mean SD mean SD mean SD mean SD mean SD 
1 
13.4 11.6 15.5 12.3 2.6 2.1 14.8 13.6 7.2 6.6 4.6 3.4 13.4 7.3 15.5 2.6 2.6 23.9 
2 
18.5 11.9 23.0 13.0 3.3 2.3 19.0 14.8 6.5 6.7 6.4 4.2 18.5 7.4 23.0 2.8 3.3 19.7 
3 
25.2 16.5 32.0 18.9 4.1 3.0 24.6 18.8 6.7 7.3 8.8 6.7 25.2 8.0 32.0 3.1 4.1 27.8 
4 
32.8 23.8 40.5 24.3 4.9 3.0 30.3 21.2 7.3 7.7 11.6 11.4 32.8 9.1 40.5 3.8 4.9 32.8 
5 
41.7 27.3 55.0 33.7 6.8 4.4 38.0 27.0 8.8 10.2 14.7 15.3 41.7 15.3 55.0 6.0 6.8 32.2 
6 
52.3 34.2 66.9 38.6 9.1 5.6 49.3 39.0 10.8 16.8 18.6 16.0 52.3 15.2 66.9 5.7 9.1 50.4 
7 
5.3 4.3 10.2 8.7 6.4 6.1 15.9 12.8 12.4 7.5 11.6 6.1 5.3 8.6 10.2 6.6 6.4 19.2 
8 
5.6 4.7 10.4 8.9 8.6 5.4 17.9 14.1 15.3 8.9 17.0 7.8 5.6 10.5 10.4 10.3 8.6 20.2 
9 
6.4 4.9 11.0 9.3 13.6 11.6 21.7 22.4 18.7 9.9 24.4 10.6 6.4 12.8 11.0 14.3 13.6 21.3 
10 
7.4 5.3 11.6 9.2 19.0 14.6 26.3 23.2 25.1 16.2 30.7 13.9 7.4 17.5 11.6 17.3 19.0 23.3 
11 
8.3 6.1 13.0 10.0 25.0 19.4 27.7 20.7 31.0 17.5 40.4 18.4 8.3 22.7 13.0 19.6 25.0 35.9 
12 
9.7 6.5 13.4 9.6 33.8 20.4 36.1 20.4 41.3 19.7 51.5 22.8 9.7 23.4 13.4 25.1 33.8 42.2 
13 
9.7 7.0 14.4 10.7 6.6 3.7 14.1 10.8 13.1 9.4 6.7 5.2 9.7 8.0 14.4 2.5 6.6 12.3 
14 
17.5 11.8 22.8 14.6 10.3 4.5 27.3 18.6 11.8 9.1 11.1 9.2 17.5 7.5 22.8 3.3 10.3 38.4 
15 
5.6 4.6 10.9 9.4 13.1 9.2 17.2 14.0 28.6 14.6 20.8 10.0 5.6 14.8 10.9 13.2 13.1 13.5 
16 
7.9 6.4 12.7 12.0 22.9 11.8 24.3 21.6 40.1 17.9 34.5 14.6 7.9 23.3 12.7 26.0 22.9 44.4 
17 
8.4 7.1 14.4 11.6 16.9 9.1 20.1 12.1 22.3 14.7 12.2 10.9 8.4 27.6 14.4 15.1 16.9 27.1 
18 
9.9 7.9 13.7 12.7 21.4 11.3 23.6 16.9 45.8 25.8 32.1 20.7 9.9 32.7 13.7 17.4 21.4 26.6 
19 
42.1 27.0 56.2 35.6 6.8 4.1 37.3 31.3 8.5 7.2 17.5 21.5 42.1 10.0 56.2 4.7 6.8 40.3 
20 
11.3 7.1 14.7 10.6 35.4 17.6 37.5 30.6 43.7 22.5 55.6 25.3 11.3 39.2 14.7 24.8 35.4 41.4 
21 
21.5 16.8 32.6 31.0 3.9 3.6 25.4 29.2 7.3 8.1 8.3 7.9 21.5 9.1 32.6 2.5 3.9 29.1 
22 
6.4 6.2 11.6 11.2 17.1 15.5 25.0 29.0 26.7 28.7 29.8 25.0 6.4 19.5 11.6 9.7 17.1 25.3 
 
